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Table 1.0: Compounds isolated from Croton gratissimus Burch, Croton sylvaticus Hoescht 
and Croton pseudopulchellus Pax and some derivatives
Code Structure Status of 
isolation
Yield Page of 
discussion
Appendix Bioactivity test
Compounds isolated from Croton gratissimus Burch
CG.l
H
^CG.l
Novel 30.0 mg 6 1 -6 7 ^ - l - ^ - l O
CG.2 18
7  13 1 4 /  1 5 \\ 17
H
0  CGj
Novel 19.0 mg 6 8 -7 0 v l - l l - y l - 2 0
CG.3 .18
H..\
, K
o1
Novel 6 . 1  mg 7 1 -7 6 v4-21 - ^ -3 0 1) Anti-plasmodial 
activity against P. 
falciparum (CQS) DIO  
strain
2) Cytotoxicity tests on 
tumour liver cells 
(HUH7 strain), ovarian 
cancer cells (PEOl and 
PEOlTaxR)
CG.4
6
\7
H
°CG.4
Novel 1 2 . 0  mg 7 7 -8 2 v4-31-y4-48 1) Anti-plasmodial 
activity against P. 
falciparum (CQS) DIO  
strain
2) Cytotoxicity tests on 
tumour liver cells 
(HUH7 strain), ovarian 
cancer cells (PEOl and 
PEOlTaxR)
CG.5
\7
H
0 CG.5
Novel 6 . 8  mg 8 3 -8 5 A -4 9 -A -5 8
CG.6
\  CG.6
Novel 23.0 mg 8 6 -8 9 A -5 9 -A -6 8
XXVlll
CG.7
H 0-3
CHjOCO'
Âcetylated CG.7
Novel
Novel
(Derivative)
9.7 mg
4.5 mg
9 0 -9 6 A -69—A-86 1) Anti-plasmodial 
activity against P. 
falciparum (CQS) DIO 
strain
2) Cytotoxicity tests on 
ovarian cancer cells 
(PEOl and PEOlTaxR)
1) Anti-plasmodial 
activity against P. 
falciparum (CQS) DIO 
strain
2) Cytotoxicity tests on 
tumour liver cells 
(HUH7 strain)
CG.8 Novel
H b - 3
6.5 mg 97 - 100 A -8 1 -A -9 6 1) Cytotoxicity tests on 
tumour liver cells 
(HUH7 strain)
O CG.8
CG.9 Novel 40.0 mg 101 - 103 A -91-A -106 1) Anti-plasmodial 
activity against P. 
falciparum (CQS) DIO 
strain
2) Cytotoxicity tests on 
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General Abstract
Plants have been used as medicinal agents for over a thousand years and have proved to be an 
important source of many clinical drugs. Several species belonging to the Croton genus 
(Euphorbiaceace) are employed as traditional medicinal agents in Africa, Asia and South 
America. The Croton species are popularly used to treat cancer, hypertension, inflammation, 
rheumatism, bleeding gums, malaria, asthma, syphilitic ulcers, diabetes, pain and ulcers. The 
Croton genus is rich in alkaloids, flavonoids, triterpenoids, diterpenoids and sesquiterpenoids. 
Some of the substances that have been isolated from the Croton genus have been evaluated for 
their biological activities including anti-cancer, anti-hypertensive, anti-inflammatory, anti- 
malarial, anti-ulcer, anti-viral and anti-microbial effects.
The study involved a phytochemical and pharmacological analysis of three Southern African 
Croton species, C. gratissimus Burchell, C. sylvaticus Hoechst and C. pseudopulchellus Pax 
which are traditionally used for the treatment of various ailments. Twenty-five diterpenoids, 
four sesquiterpenoids, six triterpenoids, three phytosterols and two lignan derivatives were 
isolated from the three plants. The structures of these compounds were determined using FTIR, 
MS, ID and 2D NMR studies. Thirteen diterpenoids are reported for the first time, including 
one cembranoid diterpenoid that possess a new rearranged skeleton. Several of the isolated 
compounds were screened for cytotoxicity effects against PEOl and PEOlTaxR (paclitaxel 
resistant) ovarian cancer cell lines, liver tumour (HUH7 strain) cell line and anti-plasmodial 
activities against the Plasmodium falciparum (CQS) DIO strain. Compounds CG.3, CG.4, CG.7 
and CG.9 displayed moderate cytotoxic effects against the PEOl and PEOlTaxR cell lines.
The phytochemical analysis of the three Croton species was also undertaken in order to ascertain 
the presence of limonoids in the Euphorbiaceae family. This is because limonoids which were 
thought to be restricted to the Meliaceae, Simaroubaceae and Rutaceae families were reported 
from the African Croton jatrophoides (Euphorbiaceae). Therefore, the absence of limonoids 
from the three Croton plants evaluated in this study further raises doubts about the occurrence of 
limonoids from the Euphorbiaceae family, and about the certainty of identification of the C. 
jatrophoides Pax that was reported to yield limonoids.
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CHAPTER ONE: MEDICINAL PLANTS AS A SOURCE OF DRUGS
1.1 Medicinal plants and representative compounds
The use of plants as medicinal agents dates back thousands of years. Medicinal plants continue 
to provide new and important leads to clinical drugs against various diseases including malaria 
and cancer.^ Early chemical analysis of plants used medicinally led to the landmark discoveries 
of morphine [1.1] from the Opium poppy in 1806 by Friedrich Sertuner^ and quinine [1.2] from 
the bark of Cinchona in 1817 by the French scientists Caventou and Pelletier.^
HO.
HO,N— OH
OH
HO'
1.3: Salicylic acid1.1: Morphine 1.2: Quinine
Figure 1.1: Active principles isolated from medicinal plants
Natural products have also been employed as precursors for clinical drugs. An example of a 
drug made from a natural product is aspirin, synthesized in 1897 by Arthur Eichengrun and Felix 
Hoffman from salicylic acid [1.3],  ^ isolated from the bark of the Willow tree, Salix.^ Towards 
the end of the 20* century, the role of natural products declined due to the advances in synthetic 
analogues, combinatorial chemistry and molecular modelling^ adopted by pharmaceutical 
companies and other funding organizations. However, natural products, particularly from 
medicinal plants, remain important sources of new drugs or new drug leads. ^  Schmidt et al? 
point out that after a comprehensive study of the 847 clinical drugs introduced from 1981 to date, 
natural products continue to make a dramatic impact in drug discovery^’  ^ [Table 1.1], 63% of 
the 847 drugs were either natural products or inspired by natural products [Figure 1.2].
Drug discovery from medicinal plants is often a long, complex and a multifaceted process that 
encompasses numerous disciplines and methodologies.^ Primarily, it begins with a botanist who 
identifies and collects plants of interest. The collection may involve ethnomedicinally used
plants or random selection for screening. Plant extracts are then prepared, biologically screened 
and active compounds isolated and characterized.^
Table 1.1: Sources of clinical drugs introduced since 1971^
No. Source of drug Number Percent
A Unchanged natural products 43 5
B Those derived from natural products 232 27
C Synthetic molecules with a natural product inspired pharmacophore 262 31
D Synthetic molecules from structure-activity guided synthesis, 
combinatorial chemistry and computational (in silico) drug design 310 37
Total 847 100
□  A  
m B
□  C
□  D
Figure 1.2: A pie chart showing the percentages of the sources of clinical drugs introduced
since 1981^
Examples of plant-derived drugs and/or drug leads introduced to the market recently include 
taxol [1.4], the anti-cancer agent isolated from the Pacific Yew in 1971,^’  ^ plaunotol [1.5], the 
anti-mucosal agent isolated from Croton suhlyratus Kurz,^ and forskolin [1.6], a vasodilator 
isolated from Coleus forskohlii in 1977  ^ [Figure 1.3]. Other compounds include artemisinin 
[1.7], an anti-malarial isolated from the Chinese Artemisia annual galanthamine [1.8], isolated 
from Galanthus woronowii Losinsk used for the treatment of Alzheimer’s disease^ and nitisinone
compound [1.9], which is based on the structure of leptospermone [1.10] isolated from 
Callistemon citrinus Stapf. [Figure 1.3], is used to treat tyrosinaemia.^
AcO OHOH
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1.5: Plaunotol 1.6: Forskolin
1.4: Taxol
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1.7: Artemisinin 1.8: Galanthamine 1.10: Leptospermone1.9: Nitisinone
Figure 1.3: Examples of new medicinal plant drugs^’ ^
1.2 Medicinal plants and medicine
Anti-malarial and anti-cancer agents arising from natural products will be discussed in depth as 
compounds isolated in this work have been screened against these conditions.
1.2.1 Plant derived natural products as anti-malarial agents
Plant derived natural products have made an impact in the area of anti-malarial drugs. The first 
effective anti-malarial drug was quinine [1.2], extracted from the bark of the Cinchona tree, that 
was used by the Indians of Peru as an anti-pyretic.^^ Quinine led to the development of many 
other effective anti-malarial drugs such as chloroquine [1.11].^  ^ Presently, a sesquiterpenoid 
possessing a peroxy-bridge, artemisinin [1.7], is employed in combined therapy in the fight 
against malaria. Artemisinin is isolated from the sweet wormwood, Artemisia annua, which has 
been used for over 2000 years by the Chinese to treat malaria.^
1.2.2 Plant derived natural products as anti-cancer agents
Some of the most effective cancer treatments to date are natural products or compounds derived 
from natural products.Podophyllotoxin [1.12], a compound isolated from Podophyllum
peltaturrf in 1947, is an effective anti-mitotic agent. However, podophyllotoxin was found to be 
unsuitable for clinical use due to its toxic side effects. Two synthetic derivatives of 4’ -  
demethylepipodophyllotoxin [1.13], also isolated from Podophyllum peltatum^ etoposide [1.14] 
and teniposide [1.15], are very effective anti-cancer agents used for the treatment of small cell 
lung cancer, testicular cancer and lymphomas, and are usually used in combination therapy with 
other anti-cancer drugs with minimum side effects.^
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Figure 1.4: Anti-malarial and anti-cancer agents8,12
The ‘vinca alkaloids’, vinblastine [1.16] and vincristine [1.17], isolated from the Madagascan 
periwinkle, Catharanthus roseus, are also used in cancer chemotherapy.^ Vinblastine is used 
mainly in the treatment of Hodgkin’s disease, a cancer affecting the lymph glands, spleen and 
liver. Vincristine is used in the treatment of childhood leukaemia, with a high rate of remission. 
Vinblastine, due to its lower toxicity, is clinically more important than vincristine that has more 
neurotoxic effects.^ Other synthetic derivatives based on vinblastine, such as vindesin [1.18] and 
vinorelbine [1.19], are used for the treatment of acute lymphoid leukaemia in children and for its 
broader anti-cancer activity, respectively.
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Figure 1.5: Anti-cancer agents derived from vinblastine and taxol^
Taxol [1.4], extracted from the bark of the Pacific Yew, Taxus brevifolia,^ is used clinically in 
the treatment of ovarian and breast cancers, non -  small -  cell lung cancer, small -  cell lung 
cancer and cancers of the head and neck. Docetaxel [1.20], a side chain analogue of taxol, is also 
being used clinically against ovarian and cancers.^
1.2.3 Biodiversity Hot Spots: Southern Africa
The above examples of anti-malarial and anti-cancer agents from natural sources clearly 
demonstrate the potential of natural products to provide medicinal agents that cannot be obtained 
from other sources such as structure guided synthesis, combinatorial chemistry and 
computational drug design. The challenge therefore is to continue the search for new drugs from 
previously unexplored natural sources with the hope of finding new commercially viable lead 
drugs. The way forward is to find strategies that will expand the range of natural products 
available for drug screening such as untapped geographical sources of plant based diversity. 
Developing countries, which still rely on traditional medicine practioners and local medicinal 
plants for primary healthcare, are a major source of plant material.
The use of traditional medicines and medicinal plants as alternative medicine in the Southern 
Africa region is widespread.*^ Mulholland and Drewes (2004)*  ^ reported the importance of 
ethnomedicinal plants in this region of the world where many indigenous people earn their 
income from trading indigenous plants [Picture 1.1]. This is because of the local traditions, 
beliefs and indigenous knowledge about the medicinal plants.*^ The Southern African flora is 
rich and diverse and the area is categorized as a biodiversity hot spot. Southern Africa occupies
only 2% of the world’s surface area, yet it is the home to nearly 10% of the world’s plant 
species.*  ^ Southern Africa is home to over 24 000 plant species, with over half being endemic.'*^
Picture 1.1: A photograph showing indigenous South African people selling 
ethnomedicinally used plant parts [Photograph by Prof. Neil Crouch]
Despite the fact that there are several active research groups in Southern Africa working in the 
natural products chemistry area, few of the more than 4000 taxa employed as traditional 
medicine have been phytochemically studied.*^ Therefore, there is need to look deeper into the 
Southern African ethnomedicinally used plants for potential drugs.
1.3 Objectives of the present study
The study involved a phytochemical and pharmacological analysis of three Southern African 
Croton species: C. gratissimus Burchell, C. sylvaticus Hoechst and C. pseudopulchellus Pax 
which are used for the treatment of various ailments.*^’ Some of the resulting chemical 
constituents were screened against PEOl and PEOlTaxR (paclitaxel resistant) ovarian cancer 
cell lines, liver tumour (HUH7 strain) cell line and against the P. falciparum (CQS) DIO strain.
The phytochemical analysis of the three Croton species was also undertaken to ascertain the 
presence of limonoids in the Euphorbiaceae. Limonoids were originally thought to be restricted 
to the Meliaceae, Simaroubaceae and Rutaceae families.^^ They have also been reported from
Cneoraceae^^ and Flacourtiaceae^"  ^ families. The first report of limonoids from the24
Euphorbiaceae family was by Kubo and his co - workers from the East African plant that they 
identified as Croton jatrophoides Pax^ .^ A plant specimen of the plant they examined was not 
immediately deposited in any herbarium?^ However, in subsequent papers published by Kubo 
and CO workers^^’ it is reported that the plant specimen (AC 76 - 134) was deposited in the 
Department of Botany Herbarium at the University of Nairobi.
Doubts of the occurrence of C. jatrophoides Pax in Kenya have been recently raised in a recent 
meeting between Prof. N. Crouch of the South African National Biodiversity Institute with Dr.
H. Beentje, the author of “ Kenya Trees, Shrubs and Lianas” . D r .  Beentje is unaware of the 
occurrence of C. jatrophoides Pax in Kenya. A look at the Kew botanical holdings by Prof. N. 
Crouch and Dr. H. Beentje, only showed material from northern Tanzania. Furthermore, Prof. J.
O. Kokwaro in his book, “ Medicinal Plants of East Afi'ica” does not show that the plant occurs 
in Kenya.^^ Interestingly, the Swahili name ‘msinduzi’ of C. jatrophoides Pax^  ^ is also used by 
Prof. Kokwaro for C. sylvaticus Hoechst and used by Dr. Beentje for C. talaeporos that grow in 
the general vicinity of Mombasa.
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1.21: Dumsin
Figure 1.6: Structure of a limonoid reported from C. jatrophoides Pax (Euphorbiaceae)25
Therefore, until other members of the Croton are shown to yield limonoids, the correct 
identification of the C. jatrophoides Pax, worked on by Kubo et ah remains questionable.^^
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CHAPTER TWO: THE CROTON GENVS: BOTANICAL ASPECTS AND ITS
CHEMICAL CONSTITUENTS
2.1 The Euphorbiaceae family and the genus Croton
2.1.1 The Euphorbiaceae family
The Euphorbiaceae family is a large and diverse family which comprises 340 genera and 
between 8, 000 -  9, 000 species/'^ Species of the Euphorbiaceae family occur as herbs, shrubs 
or trees?
2.1.2 The genus Croton
Croton is a large genus of the family Euphorbiaceae sensu stricto established by Carolus 
Linneaus? The Croton genus consists of approximately 1223 shrubs, trees and herbs distributed 
worldwide in the tropics and subtropics? Southern Africa is home to eleven species of the large 
Croton genus and all the eleven species are used ethnomedicinally to treat various ailments? 
However, the eleven Croton species that occur in Southern Africa have not been evaluated for 
their chemical constituents? The Croton genus is famous for the dragon’s blood (Sangre de 
Drago), a deep red resin that oozes out from the trunk of some Croton trees when they are cut or 
wounded. Croton lechleri Mull Arg. and other Croton plants that grow in Peru and other Latin 
American countries are the major sources of the dragon’s blood, renowned for diverse medical 
applications including the treatment of cancer and rheumatism.^’
The Croton species that occur in South Africa include C. gratissimus Burch, C. pseudopulchellus 
Pax, C  sylvaticus Hoechst, C. steevenkampianus, C. megalohotrys, C. menyhartii, C. scheffleri 
and C. leuconeurus. C. gratissimus Burch has been divided into two varieties, namely C. 
gratissimus var. gratissimus and C. gratissimus var. suhgratissimus. The difference between the 
two varieties is that the gratissimus variety has no hairs on the upper surface, whereas the variety 
suhgratissimus has stellate hairs on the upper surface and is distributed mainly in Zimbabwe, 
Botswana and the far northern areas of South Africa.^ Three Croton plants, namely, C. 
gratissimus Burch var. gratissimus, C. pseudopulchellus Pax and C. sylvaticus Hoechst have 
been chosen for this study (Table 1).
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Table 2.1: Ethnobotanical activity review of the Croton species under study
Species Uses Part of plant Extract/Mode
C. gratissimus Burch Treatment o f dropsy^ Bark Hot water/oral
Treatment of rheumatism^ Leaf Hot water/oral
C. pseudopulchellus Pax Treatment o f tuberculosis^ Dried aerial parts Not stated
For asthma relief^ Entire plant Hot water/oral
Treatment o f colds & chests’ Leaves Not stated
Treatment o f gonorrhea’ Leaf + twigs Decoction/oral
Anti-mycobacteriaf Aerial parts Aceton/agar pla
C. sylvaticus Hoechst Treatment o f abdominal disorders^ Bark Infusion/oral
Mitogenic’° Stem bark Saline/mouse spleen
Treatment of tuberclosis** Root bark Decoction/oral
Purgative" Root bark Decoction/oral
Treatment of kwashiorkor" Leaves Decoction/washing
2.2 Phytochemistry of the genus Croton
Approximately 700 out of the over 1223 species of the Croton genus have been phytochemically 
evaluated and have yielded mainly alkaloids (species occurring in America), flavonoids, 
triterpenoids (and their derivatives such as limonoids), diterpenoids (species occurring in Africa) 
and sesquiterpenoids?’ Compounds produced by the Croton genus are described below
according to their classes. Sources of the compounds are also described.
2.2.1 Alkaloids
Alkaloids that can be classified as aporphine [Table 2.2], proaporphine [Table 2.6] or morphinan 
[Table 2.10] or their reduced forms have been isolated from many members of the Croton genus. 
The Croton genus also produces bis -  morphinanedienone [Figure 2.1], tetrahydroprotoberberine 
[Table 2.12], benzylisoquinoline [Table 2.14], glutarimide [Table 2.15], guaiane-type 
sesquiterpene [Table 2.16], barman type [Table 2.17], tyramine type [Table 2.18] and peptide 
derived [Figure 2.2] alkaloids. Descriptions of the structures and the plant sources of the 
alkaloids are shown below.
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2.2.1.1 Aporphine, proaporphine and morphinan alkaloids from the Croton genus
The Croton genus produces a wide range of benzylisoquinoline-derived alkaloids possessing
aporphine [Table 2.2], proaporphine [Table 2.6] and morphinan [Table 2.11] skeletons. 
Aporphine, abnormal aporphine, proaporphine and dihydro derivatives of proaporphine 
constitute the major classes of alkaloids isolated from the members of the Croton genus.
Table 2.2: Structures of aporphine alkaloids from the Croton genus
Code Name Structure Source
R Ri R2 Rs R4 Rs
A.1 Glaucine^^”^^ MeO MeO H MeO MeO Me C. lechleri
A.2 Thaliporphine*^ MeO OH H MeO OMe Me C. lechleri
A.3 Norisoboldine^ MeO OH H MeO OH H C. lechleri
A.4 Isoboldine^^ MeO OH H MeO OH Me C. celtidifolius
A.5 Magnoflorine^^ MeO OH OH MeO H (Me) 2+ C. lechleri
A. 6 Sparsiflorine*^ Meo OH H OH H H C. sparsiflorus
A.7 N-methyl-sparsiflorine^^ MeO OH H OH H Me C. sparsiflorus
A.8 Wilsonirine*^’'*^ OH OH H MeO MeO H C. wilsonii
A.9 Hemovine^^’'*^ MeO MeO MeO OH H H C. wilsonii
A.10 A-methylhemovine^^’ OH MeO MeO OH H Me C. wilsonii
A l l 10-O-Methylhemovine*^’ MeO MeO MeO MeO H H C. wilsonii
A. 12 A  O-Dimethylhemovine^^ MeO MeO MeO MeO H Me C. wilsonii
A.12 0 ,0 -  Dimethylhemovine^^ MeO H Me H H Me C. hemiargyeus
A.13 Isocorydine^^ MeO Me H H H Me C. hemiargyeus
A.14 S (+) -Magnoflorine bromide MeO OH OH MeO H Br C. turumiquire- 
nsis^^
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MeO
Table 2.3: Structures of abnormal aporphine alkaloids from the Croton genus
Code Name Structure Source
Ri Rz
A.15 Hemiargine Me H C. hemiargyeus
A.16 Norcorydine^^ H Me C. hemiargyeus
A.17 0 , 0 -  Dimethylhemovine^^ Me Me C. hemiargyeus
MeO-
RO Me
Table 2.4: Structures of abnormal aporphine alkaloids of the Croton genus
Code Name Structure Source
R
A.18 Nomuciferine^^ H C  sparsiflorus
A.19 Nuciferine^^ Me C. sparsiflorus
Table 2.5: Structures of proaporphine alkaloids from the Croton genus
Code Name Structure Source
R Ri Rz
A.20 Linearisine^’ OH MeO Me C. linearis
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A.21 Homolinearisine^^’ OH MeO Me C  linearis
A.22 Pronuciferine^^ MeO MeO Me C. linearis
/L23 Base MeO HO Me C. linearis
A.24 Jacularine^’'^ ’^'^ ^ MeO HO H C. linearis
A.25 Crotsparine/crotoflorine^ MeO HO H C. sparsiflorus
/L26 A-Methy Icrotsparine ^ ^ MeO H Me C. sparsiflorus
A.27 A, O-Dimethylcrotsparine^^ MeO Me Me C. sparsiflorus
Table 2.6: Structures of proaporphine alkaloids
Code Name Structure Source
R Ri Rz
A.28 Amuronine^^ MeO MeO Me C. flavens
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Table 2.7: Structures of proaporphine alkaloids from the Croton genus
Code Name Structure Source
R Ri Rz
A.29 Crotonosine^’ OH MeO H C. linearis
A.30 A, O-Dimethylcrotonosine^^ MeO MeO Me C. plumieri
A.31 Methylcrotonosine^^ OH MeO Me C. discolor
15
HO.
RO Me
HO
Table 2.8: Structures of proaporphine alkaloids from the Croton genus
Code Name Structure Source
R
A.32 Discolorine^^ H C. discolor
A.33 Jaculadine^^ Me C. discolor
12, M. .V__!
I  >\io /
< >
1/ ^o
Table 2.9: Structures of 8, 9 - dihydroproaporphine alkaloids from the Croton genus
Code Name Structure Source
R Ri R2
A.34 Crotsparinine^^’ MeO HO H C. sparsiflorus
A.35 N, O-Methylcrotsparinine^^ MeO MeO Me C. sparsiflorus
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Table 2.10: Structures of morphinandienone alkaloids from the Croton genus
Code Name Structure Source
R Ri R2 Rs R4
A.36 Salutaridine^"^’ H MeO HO MeO Me C. jlavens
A.37 Norsalutaridine^'^’ H MeO HO MeO H C. salutaris
A.38 8, 14-Dihydrosalutaridine^’'^ ’^'^ ^ H MeO HO MeO Me C. linearis
A.39 8, 14-Dihydronorsalutaridine^’^ ^ H MeO HO MeO H C. linearis
A.40 Flavinine^^’'^ ’^'^ ^ MeO HO H H H C. flavens
A.41 Flavinantine^^’ 22,37,38, 43,46 MeO HO H MeO Me C. chilensis
A.42 0-Methylflavinantine^^’ MeO MeO H MeO Me C. ruizianus
A.43 Salutarine^^ H MeO OH MeO Me C. flavens
A.44 Isosalutaridine^^ OH MeO H MeO Me C. chilensis
Table 2.11: Structures of morphinandienone alkaloids from the Croton genus
Code Name Structure Source
R Ri Rz Rs
A.45 Norsinoacutine'^’ MeO HO MeO H C. lechleri
A.46 Sinoacutine^^’^^ ’'^ ^ MeO HO MeO Me C. lechleri
A.47 4,5-dihydroxymorphinandien-7-one^ MeO HO H H C. bonplandianum
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A.49A.48
Figure 2.1: Biarylic bis-morphinanedienone alkaloids from the Croton genus32
Biarylic bis-morphinanedienone alkaloids saludimerine A [A.48] and saludimerine B [A.49] 
have been isolated from C.flavens^^ [Figure 2.1].
2.2.1.2 Tetrahydroprotoberberine alkaloids from the Croton genus
Tetrahydroprotoberberine alkaloids have been reported from three Croton plants. The plants are 
C. hemiargyresus^^’^^ , C. tonkinensis^^ and C.flavens^^ [Table 2.12].
MeO-
Me
RO
OMe
Table 2.12: Tetrahydroprotoberberine alkaloids from the Croton genus
Code Name Structure Source
R Ri Rz
A.50 Hemiargyrine*^ H OH H C. hemiargyeus
A.51 T etrahydropalmatrubine^^ Me H OH C. hemiargyeus
A.52 Xylopinine^^ Me Me H C. hemiargyeus
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Table 2.13: Tetrahydroprotoberberine alkaloids from the Croton genus
Code Name Structure Source
Ri R2 R3 R4
A.53 Corytenchine^^ H MeO OH H C. tonkinensis
A.54 Corytenchirine^^ Me MeO OH H C. tonkinensis
A.55 Coreximine^^ H OH OH H C. flavens
A.56 Scoulerine^^ H H H OH C. flavens
2.2.1.3 Benzylisoquinoline alkaloids from the Croton genus
Laudanidine, reticuline and norlaudanosine [Table 2.14] belonging to the benzylisoquinoline 
class of alkaloids have been isolated from three Croton species [Table 2.14].
NR.
RiO
ORz
Table 2.14: Benzylisoquinoline alkaloids from the Croton genus
Code Name Structure Source
Ri Rz Rs
A.57 Laudanidine^^ Me H Me C. celtidifolius
A.58 Reticuline^ ^ H H Me C. lechleri
A.59 Norlaudanosine^^ Me Me H C. hemiar^eus
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2.2.1.4 Glutarimide alkaloids from the Croton genus
0
f  V
0 H
Table 2.15: Glutarimide alkaloids from the Croton genus
Code Name Structure Source
R
A.60 Julocrotine^"^ H C. membranaceus
A.61 Julocrotone^^ = o C. cuneatus
A.62 Isojulocrotol^^ (3-OH C. cuneatus
A.63 Julocrotol^^ a - OH C. cuneatus
2.2.1.5 Guaiane-type sesquiterpenoid alkaloids from the Croton genus
Three guaiane-type alkaloids [Table 2.16] have been isolated from C. muscicapa. Alkaloids 
derived from diterpenes and steroids are widespread in plants.^^ However, guaiane-type 
sesquiterpene alkaloids were isolated for the first time from the genus Croton?^
Table 2.16: Structures of guaiane-type sesquiterpene alkaloids from the Croton genus
Code Name Structure Source
Ri R2
A.64 Muscicapine A °^ H Me C. muscicapa
A.65 Muscicapine (Me)2CHCH2 H C. muscicapa
A.66 Muscicapine C °^ Et(Me)CHCH2 Me C. muscicapa
2 0
2.2.1.6 Harman type alkaloids from the Croton genus
NH
Me
Table 2.17: Structures of barman type alkaloids from the Croton genus
Code Name Structure Source
Ri R2
A.67 2-Ethoxycarbonyltetrahydroharman^^ H C02Et C. moritibensis
A.68 6-Hydroxy-2-methyltetrahydroharman^'^ OH Me C. moritibensis
2.2.1.7 Tyramine alkaloids from the Croton genus
^ ^ .(C H 2 )n N H M e
jT J
Table 2.18: Structures of tyramine alkaloids from the Croton genus
Code Name Structure Source
A.69 A-Methyltyramine^^ n = 2 C  humilis
A.70 A-Methylhomotyramine^^ n = 3 C. humilis
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2.2.1.8 Peptide derivative alkaloids from the Croton genus
A.71
NH
NH
NH NH
A.72
A.73
Figure 2.2: Structures from peptide derivative alkaloids from the Croton genus 
Table 2.19: Structures from peptide derivative alkaloids from the Croton genus
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Code Name Source
A.71 N -  Benzoylphenylalaninof^ C. hieronymi
A.72 Aurentiamide acetate^^ C. hieronymi
A.73 N -  Benzoylphenylalaninyl- N  -benzoylphenylalaninate C. hieronymi
2.2.1.9 Other types of alkaloids of the Croton genus
Other alkaloids isolated from the Croton genus include the known nicotine derivative anabasine 
[A.79]^" [Table 2.20].
OMeMe MeMeO. HO.Me
NH;
Me
A.76 MeO
A.77OMe
A.75
HO.
.NO
HO
A.79HO' A.78
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Table 2.20: Other alkaloids from the Croton genus
Code Name Source
A.75 C. lechleri, C. draco, C. campestris
A.76 Hemiargine C. hemiargyeus
A.77 Hemiargine C. hemiargyeus
A.78 1,2,10-Trihydroxycrotosinoline-N-oxide'^® C. campestris
A.79 Anabasine^^ C. muscicapa
2.2.2 Flavonoids: Their structures and sources
Common flavonoids including ayanin [F.l], vitexin [F.3], tiliroside [F.5], rutin [F.IO] and 
quercetrin [F .ll] have been isolated from Croton species [Figure 2.3].
OH
OHMeO,
HO
OH
OH OH ^O HOH
F.l: Ri = OMe R% = OH R3  = OMe R4  = H 
F.2: Rj = OMe R% = OH R3  = OH R4  = H 
F.6 : Ri = H R2  = H R3  = H R4  = OMe 
F.7: Ri = OMe R2  = H R3  = H R4  = OMe 
F.8 : Rj = OMe R2 = H R3  = H R4  = OH
^  ^O H
F.5
OHHO
HO HO
OH
HO
OH OH
OH
F.4
F.3
OH
OH
OHHO
HO
CH-
OHOH
OHHO
HO OH
OH
OH F .llOH
Figure 2.3: Structures of flavonoids from the Croton genus50-57
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Table 2.21: Flavonoids isolated from the Croton genus
Code Name Source
F.l Ayanin^^’^^ C. schiedeanus
F.2 Quercetin-3, 7-dimethyl ether^ ® C. schiedeanus
F.3 Vitexin^ C. tonkinensis
F.4 Isovitexin^^’ C. tonkinensis
F.5 Tiliroside^^’^^ C. tonkinensis
F.6 5 -Hydroxy-7, 4'-dimethoxyflavone^'‘ C. betulaster
F.7 Kaempferol-3-O-rutinoside^'^’ C. menthodorus
F.8 Kaempferol-3,4  ’ ,7 -trimethylether^^ C. cajucara
F.9 Kaempferol-3, 7-dimethylether^^ C. cajucara
F.IO Rutin^^ C. menthodorus
F.ll Quercitrin^^ C. glabellus
2.2.3 Triterpenes of the Croton genus: Their classes, structures and sources
By 1969, fifty-six species belonging to the Croton genus^ had been phytochemically examined 
and by then, not a single triterpene had been isolated or reported.^ However, a substantial 
number of triterpenoids belonging to different classes of triterpenoids have since been reported 
[Figure 2.4 -  Figure 2.10].
2.2.3.1 Taraxeraue type
COOH
T.l
Figure 2.4: Taraxeraue type triterpeuoids from the Croton geuus^ ’^ 
Table 2.22: Taraxeraue type triterpeuoids from the Croton genus
Code Name Source
T.l Acetyl aleuritolic a c i d C. cajucara, C. tonkinensis, C. megalocarpus,
C. hovarium, C. ururucana
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2.2.3.1 Lupane type
HO'
T.3 T.4
T.5HO
■CH2OH
HO'
T.6
T.7
,53, 60, 64Figure 2.5: Lupane type triterpeuoids from the Croton genus
Table 2.23: Lupane type triterpeuoids from the Croton genus
Code Name Source
T.3 Lupeol^^ C. megalocarpus
T.4 Lupenone^^ C. betulaster
T.5 3p -  0  -  Acetoacetyl lupeol^^ C. megalocarpus
T.6 Betulin^ C. megalocarpus
T.7 20 -  Hydroxylupan~3-one^'^ C. betulaster
2.2.3.3 Friedelane type
T.8
Figure 2.6: Friedelane type triterpeuoids from the Croton genus63
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Table 2.24: Friedelane type triterpenoids from the Croton genus
Code Name Source
T.8 Friedelin^^ C. hovarum
2.2.3.4 Oleanane type
'COOH
'COOH
HO
T.IOT.9
T .l l
Figure 2.7: Oleanane type triterpeuoids from the Croton genus^^’ 
Table 2.25: Oleanane type triterpeuoids from the Croton genus
Code Name Source
T.9 p - Amyrin^^ C. hovarum
T.IO 3 — Oxo — clean — 12 — en — 28 — oie aeid C. betulaster
T .ll 3 -  Oxo -  olean -  18- e n - 2 8 -o ie  acid^^ C. betulaster
2.2.3.S Ursane type
RO'
T.12: R = H 
T.13: R = Ac
Figure 2.8: Ursane type triterpeuoids from the Croton genus^®’ 
Table 2.26: Ursane type triterpeuoids from the Croton genus
Code Name Source
T.12 a  - Amyrin "^^ C, hieronymi
T.13 a  - Amyrin aeetate^®’^^ C. hieronymi, C. tonkinensis
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2.2.3.6 Taraxastane type
HO,
T.14
Figure 2.9: Taraxastane type triterpenoids from the Croton genus^^ 
Table 2.27: Taraxastane type triterpenoids from the Croton genus
Code Name Source
T.14 3 -  Oxo -  20p - hydroxytaraxastane53 C. betulaster
2.2.3.1 Hopane type
OH
HO
T.15 T.16
Figure 2.10: Hopane type triterpenoids from the Croton genus^^’^^  
Table 2.28: Hopane type triterpenoids from the Croton genus
Code Name Source
T.15 3 -  Oxo -  22 -  hydroxyhopane^^ C  betulaster
T.16 Hop -  22 (29) -  en - 3P - oP* C. hieronymi
2.2.4 Phytosterols from the Croton genus
Several known plant steroids have been isolated from the Croton genus. They include 
sitosterol,^® stigmasterol,^^ campesterol,®  ^ 3 -  oxocycloart -  2AE -  en -  26 -  oie acid,^  ^ 22 -  
dihydrobrassicasterol,^^ cholesterol,^^ ergosta -  4, 22 -  dien -  3 -  one,^  ^cholest -  8(14) -  en - 3p 
- ol,^  ^gramisterol,^^ lophenol,^^ isofucosterol,^^ cholest -  4-en -  3 -  one^^and p-sitostenone.^^’^^
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2.2.5 Limonoids from the Croton genus
The isolation of dumsin [LM.1], zumsin [LM.2], dumnin [LM.3], dumsenin [LM.4], zumketol 
[LM.5], zumsenin [LM.6] and zumsenol [LM.7] has been reported from C jatrophoides Pax.^^’ 
69, 70,71 [LM.3], dumsenin [LM.4], musidunin [LM.8] and musiduol^^ [LM.9] [Figure
2 .11] showed potent anti-feedant activity (PC50 < 2.0 pg/ml) against the larvae of the pink 
bollworm, Pectinophora gossypiela, and/or fall armyworm Spodoptera frugiperda?^ The 
isolation of these limonoids by Kubo and his co workers from a plant of the Croton genus has 
raised much interest and scepticism.^^’
OAc OAcOAc AcO9  AcOAcO.
HO'
LM.2
LM.1 LM-3
OAc
AcO OAc
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LM.5 LM.6
OAc OAc
AcQ,
AcO.
"OAc
OH
LM.7 LM.8
LM.9
.68,69,70, 71Figure 2.11: Limonoids from the Croton genus
2.2.6 Diterpenoids from the Croton genus
The Croton genus yields diterpenoids of varied skeletons. These include acyclic [D.l], bicyclic 
(e.g. labdanes [D.2] and clerodanes [D.3]), tricyclic (e.g. pimaranes [D.4] and abietanes [D.5]),
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tetracyclic (e.g. kauranes [D.6], phorbol diterpenoids [D.7]), pentacyclic (e.g trachylobanes 
[D.8]), macrocyclic diterpenoids (e.g cembranes [D.9]) and their derivatives.^^’ Since most of 
the compounds isolated from the three plants investigated in this work are diterpenoids, a review 
of biologically active diterpenoids isolated previously from the Croton genus follows.
D.l: acyclic
D.2: labdane D.3: clerodane
D.6 : kauraneD.4: pimarane D.5: abietane
D.8 : trachylobane
D.7: phorbol D.9: cembrane
Figure 2.12: Skeletons of various diterpenoids reported from the Croton genus 
(stereochemistries not specified)
2.2.6.1 Acyclic diterpenoids from the Croton genus
Plaunotol [A.l], the active ingredient of a commercial drug named Kelnac™, is a mucosal 
protective factor-enhancing anti-ulcer agent, originally found in the leaves of C. sublyratus Kurz. 
(subsequently renamed as C. stellapilosus^^)?^ Various geranyllinalool derivatives, for example 
3, 12-dihydroxy-1, 10, 14-phytatriene-5, 13-dione [A.2] from C. salutaris, have been reported. 
rrfl«5-phytol [A.3] has been isolated from C. zambesicus Muell. Arg.^^’^^
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OH OH
OH
OH
A.1 A.3A.2
Figure 2.13: Acyclic diterpenoids from the Croton genus (Stereochemistry for A.2 is not
given)
2.2.6.2 Labdane diterpenoids from the Croton genus
2a,3a-Dihydroxylabda-8(17),12,14-triene [L.l] and 2a-acetoxy-3a-dihydroxylabda- 
8(17),12,14-triene [L.2] were isolated from C. ciliatoglanduliferus and were found to inhibit 
photophosphorylation, electron transport (basal, phosphorylating and uncoupled) and the partial 
reactions of both photosystems in spinach thylakoids.^^
RO, RO Y h> oh r— t v - - -
A f l
L.5:R = H ;R i = H L.7: R = OH; L.8 : R = H
L.6 : R = Ac; Ri = Ac 
OH
OH
HO
L.l: R = H; L.2 R = Ac L.3: R = H; L.4: R = Ac
OR
OH
HO
L.9: R = OH; L.IO: R = Ac
L.14L.13L.11: R = H R i = H 
L.12:R = H R i = OH
OH HO;
OH
L.15
L.16
Figure 2.14: Labdane and e/zt-Iabdane diterpenoids from the Croton
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Labdane-8a, 15-diol [L.3] and 15-acetoxylabdan-8a-ol [L.4] were isolated from C. eluteria 
which is a small tree indigenous to the Bahamas and has been used to treat fever.^^ A bioassay 
guided fractionation of the moderately cytotoxic extract from C  glabellus yielded austroinulin 
[L.5] and 6-0-acetylaustroinulin [L.6] Several labdane derivatives were isolated from C. 
ohlongifolius which were shown to possess non-specific and moderate cytotoxicity against five 
human tumour cell lines.^  ^ The compounds isolated from C  ohlongifolius were labda- 
7,12 (^ , 14-trien-17-oic acid [L.7], labda-7,12,14-trien-17-al [L.8], 17-hydroxylabda-7,12,14- 
triene [L.9], 17-acetoxylabda-7,12,14-triene [L.IO], labda-7,13-dien-17,12-olide [L.ll], 15- 
hydroxyl abda-7,13-diene-17,12-olide [L.12] and 12,17-dihydroxylabda-7,13-diene [L.13]. Ent- 
3a-hydroxymanoyl oxide [L.14] was also isolated from C. ohlongifolius^^ Crotonadiol [L.15] 
was isolated from the leaves of C. zambesicus}^ The secolabdane, maruvic acid [L.16] has been 
obtained from C. matourensis^^ [Figure 2.14].
Cembranoid diterpenes have been isolated from two Croton species. Neocrotocembranal [C.l],^"^
2.2.6.3 Cembrane diterpenoids from the Croton genus
crotocembranoic acid [C.3] and neocrotocembranoic acid [C.4]^  ^ have been isolated from the 
stem bark of C  ohlongifolius, and poilaneic acid [C.2] was isolated from C. poilanei}^ 
Neocrotocembranal has been found to inhibit platelet aggregration induced by thrombin, with an 
IC50 value of 47.21 pg/ml, and also exhibited cytotoxicity against P-388 cells in vitro, with an 
IC50 value of 6.48 pg/ml. Neocrotocembranal [C.l], poilaneic acid [C.2], crotocembranoic acid 
[C.3] and neocorotocembranoic acid [C.4] have been studied for their inhibitory activity on 
cAMP phosphodiesterase^^ and it was found that the cembranoids with the carboxylic acid 
functional groups showed higher inhibitory activities. Three fiirano-cembranoids [C.5], [C.6], 
[C.7] and a lactonized cembranoid [C.8]^  ^ have been isolated from C. ohlongifolius and have 
been found to show broad cytotoxic activities against five cell lines-BT474, CHAGO, Hep-G2, 
KATO-3, and SW-620 by the MTT [3-(4,5-dimethylthiazol-2-yl-2,5-diphenyltetrazolium 
bromide] colourimetric method.^^
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c.l c.3
OH OH OHOH
HO.HO.
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C.8
.84,85,86,87,88Figure 2.15: Cembrane diterpenoids from the Croton genus
2.2.6.4 ^'«/-pimarane, isopimarane and ent -isopimarane diterpenoids from the Croton 
genus
Diterpenoids belonging to the isopimarane and ew^isopimarane groups have also been isolated 
from species of Croton occurring in Africa, South America and Asia. An e«/-isopimarane, 
yucalexin P-4^^’ ^  [F.l], has been isolated from the Argentinian Croton sarcopetalus Muell. The 
Thai Croton joufra Roxb., which is used as an anthelmintic, peptic promoter and for the 
treatment of dysentery,^^ yielded 3(3-hydroxy-19-acetoxy-gM^-isopimara-8, 15-dien-7-one [P.2],^  ^
whereas the ent-pmm2i-l, 15 -  dien -  19 -  oic acid [F.3] was isolated from the Asian Croton 
ohlongifolius?^ The African endemic Croton zambesicus Muell. Arg., whose leaf decoction is 
used in Benin as an anti-hypertensive, an anti-microbial and to treat fever associated with 
malaria, yielded isopimara-7, 15-dien-3p-ol [F.4].^ "^
OCOCH319 18
Figure 2.16: jF/i/-isopimarane [F.l and F.2], e«/-pimarane [F.3] and isopimarane [F.4] 
diterpenoids from the Croton genns '^*’*^ ’ ®^’ *^
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2.2.6.S Trachylobane diterpenoids from the Croton genus
The trachylobane diterpenoids are rare in Nature. Compounds T.l, T.2, T.3, T.4, T.5 and T.6, 
have been reported from one of the Croton species, Croton zambesicus, which is native to 
Benin. "^^ ’ ^  Trachylobanes, [T.l, T.2, T.5 and T.6] have been evaluated for their
vasorelaxant acticities on Wistar rat aorta and were found to demonstrate vasorelaxant properties 
at low concentrations (IC50 < 1 0  The East African C. macrostachys gave 3p,19 -
dihydroxytrachylobane [T.7] and 3p,18,19-trihydroxytrachylobane [T.8].^^
T .l: R  = CH2 OH T.3: Rj = COjH R  ^= Ac 
T .2:R  = CH3
2 0
T.4:R = CH3R2 = H
OR2
HO' HO'
T .7:R  = CH3Ri = CH20H 
T.8: R, Ri = CH2 OH
Figure 2.17: Trachylobane diterpenoids from the Croton genus '^*’
2.2.6.6 Kaurane diterpenoids from the Croton genus
The tropical shrub Croton tonkinensis, which is native to Northern Vietnam and which is used to 
treat stomach ache, abscesses, impetigo, gastric and duodenal ulcers, malaria, urticaria, leprosy, 
psoriasis, and genital organ prolapse, has yielded twelve kauranes and ent-kauranes (K.1 -  
K.12). A crude extract of C. tonkinensis has been found to show significant cytotoxicity against 
MCF-7, NCI-h460, and SF-268 tumour cell lin e s .G ia n g  et al., isolated fourteen ew^-kauranes 
[K.14 -  K.27] from the leaves of C. tonkinensis Gagnep. collected in the suburbs of Hanoi, 
Vietnam^^’ whereas Minh et al?^ isolated 1 a-acetoxy-7 p, 14a-dihydroxykaur-16-en-15 -one
[K.28].^^ Argyrophilic acid [K.29], a stereoisomer of cunabic acid, has been isolated from the 
Brazilian plant C. argyrophylloides and was found to have bactericidal activity against gram 
positive bacteria in v i t r o . Separately, C. argyrophylloides also yielded e n t- \5  -oxokaur -  16 
-  en -  18 -  oic acid [K. 31].^ ®^  The Japanese plant, C. sublyratus yielded ent-\6f>, 17- 
dihydroxykaurane [K.30].^^  ^ The Asian Croton kongensis has yielded two ewf-kauranes 
including [K.32]^^  ^ whereas C. hutchinsonianus gave e«^-kauran-16p, 17-diol and ent-kmvm-
16p, 17, 19-triol^ '^^  and C. lacciferus yielded three e«/-kauranoids [K.33 -  K.35] 105
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Figure 2.18: Kaurane diterpenoids from the Croton genus 96-105
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2.2.6.T Ent - clerodane diterpenoids from the Croton genus
OH
1=0
OH
COiMe COzMe
CL.5
CL.9
COiMe
CL.13
H \  .^vC02Me 
 ■"
CO2MG C02Me CO2M6 C02Me
H \ ....L
C02Me
CL.12CL.11CL.10
g  ^  ,.CH20H ^  ^  ,CH20Ac C^02Me
CL.14 CL.15 CL.16
Figure 2.19: Ent - clerodane diterpenoids from the Croton genus^^’
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Ent - clerodane diterpenoids are the most common class of compounds from the Croton genus. 
Slightly over one hundred clerodane compounds have been isolated from this genus. A few 
examples of the ent - clerodane diterpenoids are showed in Figure 2.19 above. Specifically, 
three Croton species, C. schieddeanus Schlecht, C. sonderianus and C. cajucara Benth have 
been found to be rich sources of clerodanes.O ther Croton plants that produce ent - clerodane 
diterpenoids include C. caudatus Geisel,^^  ^ C. niveus}^^ C. diasii}^^ C. lucidus}^^ C. 
ciliatoglanduliferus}^^ C. glabellus^^md C. argyratus}^^
The /ra«5-dehydrocrotonin [CL.l], a nov-ent - clerodane diterpenoid isolated from C. cajucara, a 
plant native to the Amazon, shows a wide range of biological a c t i v i t i e s . H 4 , 115 Derivatives 
of /ra«5'-dehydrocrotonin have been isolated fi“om a number of Croton plants such as CL.2 
isolated from C. sondcrianus^^^ and CL.3 and CL.4 isolated fi*om C. schieddeanus Schlecht.^ 
Other ent - clerodane diterpenoids isolated from Croton species include cw^clerodane 
diterpenoids CL.5, CL.6 and CL.7 isolated from C. zambesicus} Vigor et alJ^ report the 
isolation of three furano - ent - clerodanes, CL.8, CL.9 and CL.IO from C. eluteria Bennett 
whereas Peres et al}^^ report three other furano - ent - clerodanes, C L .ll, CL.12 and CL.13 
from C. ururucana. The Brazilian C. campestris yielded two ^«/-clerodanes CL.14 and 
CL.15^^^ and C. cajucara has yielded the clerodane diterpenoid CL.16.^^
Tra«.y-dehydrocrotonin [CL.l] has been found to possess insect growth-inhibiting, anti­
inflammatory and anti-nociceptive (stops pain) activities.^Rodriguez et al.^^  ^assessed the anti- 
ulcerogenic (stops ulceration) properties of /rara-dehydrocrotonin [CL.l] and found out that this 
compound displayed significant protection properties against ulcers. The anti-tumour activity of 
the /mw-dehydrocrotonin [CL.l] against sarcoma 180 and Ehrlich carcinoma ascetic tumours in 
rats has been reported.^^® It was found that 80 and 120 mg/kg of /ra«^-dehydrocrotonin [CL.l] in 
rats showed significant anti-tumour activity.
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2.3 The chemataxonomy of the Croton genus
The chemical distribution patterns amongst the Croton members have been observed.^’ The 
members of the Croton genus that are native to America have been seen to predominantly yield 
the taspine and/or benzylisoquinoline-like alkaloids,^’ the Croton plants that grow in Asia and 
Africa predominantly yield diterpenoids. Salatino et al}^^ reported that only a single Croton 
plant (C. draco) that was endemic to America yielded diterpenoids. However, the literature 
review presented above [Section 2.2, Pages 28-36], showed that several Croton plants native to 
America such as C. schiedenus}^^ C. cajucara}^^ C. lechleri, C. stipuliformis}^^ C.
campestris, also yield diterpenoids.
2.4 Biosynthesis of diterpenoids
Diterpenes are a group of structurally diverse C20 terpenoid compounds, consisting of four 
isoprene units, and are all derived from 2E, 6E, \0E -  geranylgeranyl pyrophosphate (GGPP) 
[BD.l] by a series of biotransformations.[Scheme 2.1] 2E, 6E, lOE -  Geranylgeranyl
pyrophosphate (GGPP), the basic biosynthetic precursor of all diterpenoids, is formed firstly by 
dimethylallyl diphosphate (DMAPP) combining with isopentenyl diphosphate (IPP) via the 
enzyme prenyl transferase (one of the few enzymes that has been showed to proceed via a SnI 
reaction) to produce geranyl diphosphate (GPP) [Scheme 2.1].^^  ^ Secondly, the addition of a C5 
unit to GPP yields famesyl diphosphate (FPP), after which, an extra IPP molecule is added to 
produce geranylgeranyl diphosphate (GGPP) [Scheme 2.1].^^^
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OPP
Dimethyl ally! diphosphate 
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OPP
Allylic cation Isopentenyl diphosphate 
(IPP) Geranyl diphosphate (GPP)
OPP
OPP
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(IPP)
OPP
OPP
Isopentenyl diphosphate 
(IPP)Famesyl dÿhosphate (FPP)
OPP
OPP
Geranylgeranyl pyrophosphate (GGPP) 
BD.l
Scheme 2.1: Formation of geranylgeranyl diphosphate (GGPP)
The structures of diterpenes are variable and they are classified into two basic groups, acyclic 
and cyclic.^  ^ Acyclic diterpenoids are linear molecules which may have cyclic or lactone groups 
incorporated. Cyclic diterpenoids are classified according to the number of rings (bi-, tri- and
tetracyclic) they possess.^^ The cyclic diterpenoids are further classified into two distinct 
enantiomeric groups referred to as the normal and the ent -  series, with opposite configurations 
at C-5, C-9 and C-10 of the geranylgeranyl skeleton.^^’
Acyclic diterpenoids, such as phytol [BD.2] and plaunotol [BD.3] are simple linear diterpenoids 
formed by the reduction of geranylgeraniol [Scheme 2.2].^^’ The cyclizations reactions of 
the GGPP are mediated by carbocation formation and Wagner-Meerwein rearrangements which 
determine a variety of cyclic diterpenoid s k e l e t o n s . T h e r e  are two different modes of 
carbocation formation that lead to the formation of different diterpenoids.
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Scheme 2.2: Formation of acyclic and macrocyclic diterpenes
The loss of diphosphate generates a geranylgeranyl carbocation which leads to cyclization to 
form a 14-membered polyunsaturated macrocyclic cation [Scheme 2.2] leading to cembranes 
such as P-nephthenol [BD.4]^ ^® and taxadiene [BD.4], which are formed through an electrophilic 
addition to the alkene to result in cyclization and the formation of a tertiary verticillyl cation, 
followed by the loss of a proton to generate verticillene [BD.6]. Protonation of the alkene results 
in the formation of a carbocation and further electrophilic addition leads to further cyclization 
and the formation of taxadiene, a precursor to taxol [BD.7],^^  ^ an important anti-cancer agent 
with a broad range of activities.^ The second mode of cyclization, facilitated by the loss of the
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diphosphate involves the protonation of the alkene at the head of the chain and results in a series
of concerted cyclizations to form hi-, tri- and tetracyclic diterpenes/^^ (+) -  Copalyl PP, (-) -  
copalyl PP, pimaradiene, abietadiene and ent -  kaurane [Scheme 2.3, scheme 2.4 and scheme 
2.5] are the major intermediates that form different cyclic diterpenes.^^^
OPP
geranylgeranyl PP
geranylgeranyl PP
copalyl PP synthase e«/-copalyl PP synthase
OPP
tram decalin tram decalin
OPPOPP
(+) copalyl diphosphate(-) copalyl diphosphate
labdane
Scheme 2.3: Formation of labdane and g/iMabdane diterpenes from (+) - copalyl and (-) -
copalyl diphosphate^^^
Bicyclic diterpenes can belong to the labdane or clerodane classes. Bicyclic diterpenes are 
formed from GGPP via protonation of the C-14 double bond followed by the ««//-parallel 
additions of the C-10 and C-6 double bonds to form the /r«w-decalin intermediate. A loss of a 
proton from the methyl group resulting in double bond formation usually terminates cyclizations.
4 0
Two bicyclic enantiomers, (+) -  copalyl PP (labdadienyl PP) and (-) -  copalyl PP {ent -  copalyl 
PP) are formed via enzymatic regulation of the folding of geranylgeranyl diphosphate on the 
surface of the two enzymes, copalyl and ent -  copalyl diphosphate synthase. Reduction and 
further modifications of copalyl and ent -  copalyl diphosphate synthase yield the labdane and 
e«/-labdane series of diterpenoids respectively [Scheme 2.3]. The two enantiomers differ in the 
configuration at the C-5, C-9 and C-10 chiral centers forming the ent -  and normal series of 
labdane diterpenes respectively.^^’ The termination of cyclization is usually accomplished by 
hydration of the cation or by another appropriate rearrangement [Scheme 2.4]. Clerodane
diterpenoids arise from labdanes by two methyl migrations [Scheme 2.4]. ’73,132
OPP OPP
OPP
#  Folding mediated
I .by copalyl t Folding mediated  ^by ent copalyl 
diphosphate synthase;
Geranylgeranyl pyrophosphate (GGPP) 
BD.l
diphosphate
synthase
(+) - copalyl PP
(-) - copalyl PP
OPP
OPP
OPP
OPP OPPOPP
Cis - clerodaneTrans - clerodaneTrans -ent - clerodane Cis -ent - clerodane
Scheme 2.4: Formation of clerodane and e«/-clerodane diterpenes from (+) - copalyl and (-)
- copalyl diphosphate133
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Tricyclic and tetracyclic diterpenes arise by further cyclization of (+) -  copalyl PP and (-) -  
copalyl PP {ent -  copalyl PP). A loss of pyrophosphate enables a carbocation mediated formation 
of the third and fourth ring systems accompanied by Wagner -  Meerwein shifts. Isopimaranes 
arise through the cyclization of (+) -  copalyl PP, catalyzed by abietadiene synthase, and can 
occur by attack on C-13 by the exocyclic double bond or by the migration of the C-13 double 
bond and stabilization of the cation by elimination of a proton from C-7 or C-14 [Scheme 2.5]. 
Protonation of the exocyclic alkene, allows for methyl migration (1,2 shift) and modification of 
the side chain. An abietenyl carbocation is formed as an intermediate and loss of a proton (H - 8)
generates the abietadiene [Scheme 2.5]. 129
OPP
Abietediene
Synthase
(-) - PimaradieneCopalyl PP Pimarenyl eation 
(an isopimarane)
Abietenyl cation(-) - Abietadiene
129Scheme 2.5: Formation of (-) abietadiene from copalyl diphosphate
Further cyclization of ent -  copalyl PP, catalyzed by ew^-kaurene synthase, results in the 
formation of ent -  kaurane through the loss of diphosphate with generation of an ent -  pimarenyl 
carbocation. In this case, cyclization of the alkene onto the cation produces a five-membered ring 
with a secondary carbocation. This is then followed by a Wagner -  Meerwein shift of the methyl 
group to form a tertiary carbocation. The loss of the methyl proton (C-17) generates the double 
bond of the ent -  kaurene [Scheme 2.6].^^^
4 2
^  cyclization o f  
15 alkene onto
OPP 
5^ -^ ent -kaurene
Synthase
cation produces 
secondary catioi
ent - copalyl PP secondary cationent - pimarenyl cation
W - M 1, 2 alkyl shift
/  sequential oxidation 
{ 5  o f  methyl to f
  I.
carboxylic aeid loss o f  proton 
generates an alkene ^ CO2H
ent - kaurenoic acid ent - kaurene tertiaiy cation
Scheme 2.6: Formation of ent - kaurene from ent - copalyl diphosphate 129
The diterpenoids are further modified by oxidations which may result in the formation of 
lactones for the bicyclic systems and the corresponding acids for the tri -  and tetracyclic systems. 
Glycosylation of these substrates is also possible leading to further structural differentiation and 
diversification and hydration of any of the carbocation intermediates also leads to other
structures.129
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CHAPTER THREE: THE PHYTOCHEMISTRY OE CROTON GRATISSIMUS
BURCHELL (EUPHORBIACEAE)
3.1 Introduction
Croton gratissimus is a member of the Croton genus, the largest genus of flowering plants, with 
between 1200 -  1300 species of herbs, shrubs and trees J C. gratissimus grows mainly as a shrub 
or a small tree that reaches different heights depending on where it grows. In South Africa it 
may grow to 10 m tall whereas in North Africa it grows to 20 m tall.^ The leaves [Picture 3.1] of 
C. gratissimus are simple and alternate with an under -  surface that is covered by dense scales of 
a silvery colour whereas the upper surface is usually dark green and shiny without hairs.^’^
Picture 3.1: Leaves of Croton gratissimus^
C. gratissimus bears golden yellow flowers [Picture 3.2] in spikes of about 10 cm long. The 
fruit, which is a three lobed capsule, are usually formed between September and November, first 
appearing as green, then as they mature they turn yellow in late autumn, then the capsule dries 
out and explodes flinging the seed some distance from the mother plant.^’ ^
Picture 3.2: Golden yellow flowers of Croton gratissimus
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c. gratissimus as a tree grows over a wide range of altitudes, in a variety of woodland vegetation 
types that are mainly associated with stony soils and rocky outcrops. It occurs mainly in 
Botswana, Malawi, Mozambique, Zambia, Zimbabwe and the northern parts of South Africa."  ^
C. gratissimus has been divided into two varieties, C. gratissimus var. gratissimus and C 
gratissimus var. subgratissimus. The difference is that variety gratissimus has no hairs on the 
upper surface, whereas the variety subgratissimus has stellate hairs on the upper surface and is 
distributed mainly in Zimbabwe, Bostwana and the far northern areas of South Africa.^
The Croton genus was established by Linnaeus in 1737 and its common name is rushfoil or 
Croton. The name of the genus comes from the Greek word kroton meaning ticks because of the 
resemblance of its seeds to ticks. The species name gratissimus is a Latin word which means 
most pleasing. Locally C. gratissimus is called “ mologa” by Setstwana people and 
“ umhuluga” by the Zulu people of South Africa. C. gratissimus has wide traditional uses and it 
is documented that the Bushman girls dry the young branches and powder them to make perfume 
due to their pleasantly aromatic nature.^ It is also reported to be used in the treatment of dropsy, 
rheumatism^ and bleeding gums.^ In Namibia it is also used as an important stock fbod.^
Phytochemical analysis of C. gratissimus has not been reported before. Some researchers^ have 
claimed that C. gratissimus is synonymous to Croton zambesicus Muell. Arg. (Syn. C. amabilis 
Muell. Arg.). C. zambesicus Muell. Arg., is documented to be widespread in tropical Africa^ and 
has been extensively studied phytochemically yielding a wide range of compounds including, 
labdane^, clerodane,^ and trachylobane^ diterpenoids and flavone-C-glycosides.^^ Therefore, one 
of the aims of this investigation was to see whether C. zambesicus Muell. Arg. and C. 
gratissimus yielded the same compounds.
Steenkamp and co workers^ ^  demonstrated that methanol and water extracts of C. gratissimus 
showed scavenging ability of hydroxyl radicals whereas Frum and Viljoen (2005) demonstrated 
the 5-lipoxygenase inhibitory activity of the water and methanol extracts of C. gratissimusP
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3.2 Structural elucidation of compounds isolated from Croton gratissimus
The phytochemical analysis of the leaves and the stem bark of Croton gratissimus Burch, var. 
gratissimus yielded ten new cembranoids, one known sesquiterpenoid, two known triterpenoids 
and one known phytosterol. (+) -  [lOi?] -  cembra-lZ, 3Z, IE, IIZ, 15-pentaen-20, 10-olide, 
CG.2 and (+) -  [16", 47?, 86", 107?] - 1, 4, 8 - trihydroxycembra-2E, 6E, 1 lZ-trien-20, 10-olide, 
CG.IO were isolated from the leaves of C. gratissimus [Figure 3.1]. (+) -  [17?, 2<S, IS, SS, 127?] -  
7, 8 - epoxy- 2, 12 - cyclocembra-3E, lOZ-dien-20, 10-olide, CG.3 and (-) -  [15*, 4S, IS, 107?] - 
1, 4, 7 - trihydroxycembra-2E, 8(19), IIZ- trien-20, 10-olide, CG.8 were isolated from the stem 
bark of C. gratissimus [Figure 3.2]. (+) -  [107?] - cembra-lÆ ,^ 3E, IE, IIZ, 15-pentaen-20, 10- 
olide, CG.l, (+) -  [17?, 4S, 107?] - 4 - hydroxycembra-2Z, IE, 1 lZ-trien-20, 10-olide, CG.4, (-) -  
[17?, 47?, 107?] - 4 - hydroxycembra-2E, IE, IIZ- trien-20, 10-olide, CG.5, (+) -  [17?, 107?] - 
cembra-2E, 4E, IE, 1 lZ-tetraen-20, 10-olide, CG.6, (+) -  [15", 45", 77?, 107?] - 1, 4, 7 - 
trihydroxycembra-2E, 8(19), IIZ- trien-20, 10-olide, CG.7 and (-) -  [IS, 4S 107?] - 1, 4 - 
dihydroxycembra-2E, 6E, HZ- trien-20, 10-olide, CG.9 were isolated from both the leaves and 
stem bark of C. gratissimus [Figure 3.3]. Eudesm-4(15)-ene-ip, 6a -diol, CG.ll, 3a - hydroxy- 
D: B-friedoolean-5-ene, CG.12, 3p - hydroxylup-20(29)-ene, CG.13 and 24-ethylcholesta-4, 22- 
dien-3-one, CG.14 were also isolated from the leaves and stem bark of C. gratissimus [Figure
3.4].
;H0
19 =
HO
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Figure 3.1: Cembranoids isolated from the leaves of Croton gratissimus
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Figure 3.2: Cembranoids isolated from the stem bark of Croton gratissimus
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Figure 3.3: Cembranoids isolated from both the leaves and the stem bark of Croton
gratissimus
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Figure 3.4: Other compounds isolated from the leaves and stem bark of Croton gratissimus
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3.2.1 Structural elucidation of compound CG.l: (+) - [lOR] - Cembra-IE, 3E, IE, IIZ, 15- 
pentaen-20,10-olide
Compound CG.l was isolated as a colourless oil from the combined hexane and methylene 
chloride extracts of the leaves of Croton gratissimus and also from the hexane extract of the stem 
bark of the C. gratissimus. Compound CG.l was identified as (+) -  [lOR] - cembra-lE, 3E, IE, 
IIZ, 15-pentaen-20, 10-olide.
CG.l
Figure 3.5: Structure for compound CG.l: (+) -  [101?] - Cembra-IE, 3E, IE, IIZ, 15-
pentaen-20,10-olide
The HRMS spectrum [Spectrum 3.1.1] for compound CG.l gave a [M + Na]^ ion at m/z 
321.1825 which indicated a molecular formula of C20H26O2. A double bond equivalence of eight 
was calculated. The FTIR spectrum [Spectrum 3.1.2] for compound CG.l showed absorption 
bands at 2924 and 2863 cm‘^  attributable to CH stretchesand a diagnostic ester absorption band 
at 1753 cm'  ^that was ascribed to a carbonyl group stretch of an a, p-unsaturated y-lactone ring.^  ^
The ^^ C NMR [Spectrum 3.1.4], DEPT [Spectrum 3.1.5] and HSQCDEPT [Spectrum 3.1.6] 
spectra displayed twenty carbon resonances for compound CG.l, which included a carbonyl 
carbon resonance at 5 174.5 and ten double bond carbon resonances. Compound CG.l was 
therefore found to be a bicyclic diterpenoid.
The presence of exo - methylene group proton resonances at 8 5.02 (s) and 5.08 (s), which 
showed a correlation in the HMBC spectrum [Spectrum 3.1.7] with a methyl group carbon 
resonance at 8 21.7, and also long range coupling in the COSY spectrum [Spectrum 3.1.8] 
between the methyl group proton resonance (8 1.96, s) and one of the exo -  methylene group 
proton resonances (8 5.02, s) indicated that compound CG.l possessed an isopropenyl group. 
From the various classes of diterpenoids reported earlier from the Croton genus, two classes.
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namely the abietanoid, which is usually tetracyclic and cembranoid which is usually monocyclic, 
often possess the isopropyl g r o u p . C o m p o u n d  CG.l which was determined to be bicyclic 
was therefore tentatively assumed to be a lactonized cembranoid diterpenoid.
The exo - methylene group proton resonances at 5 5.02 (m) and 5.08 (s) [Spectrum 3.1.3] were 
assigned as H-16A and H-16B of a cembranoid diterpenoid. The methyl group carbon resonance 
at 5 21.7 that showed correlations in the HMBC spectrum with H-16A and H-16B was assigned 
as the C-17 carbon. Further correlation in the HMBC spectrum between the H-16A, and H-16B 
proton resonances and a methine carbon resonance at 5 142.9 led to the assignment of C-1.^^
The C-1 carbon resonance, in turn, showed correlation in the HMBC spectrum with an alkene 
proton resonance at 6 6.43 (d, J  = 11.50 Hz) that was assigned as H-2. The corresponding C-2 
carbon resonance was seen at 5 124.3 in the HSQCDEPT spectrum. Correlations were also seen 
in the HMBC spectrum between the H-2 proton resonance and carbon resonances at 6 123.6, 
139.9, 24.7 and 137.9 that were assigned as C-3, C-4, C-14 and C-15 respectively. The H-3 
methine proton resonance at 8 6.06 (d, J=  11.50 Hz) was seen to be coupled to the H-2 proton 
resonance in the COSY spectrum [Spectrum 3.1.8]. The C-1/C-2 double bond was assigned the 
E configuration (the isopropenyl group was on the same side as H-2), because of correlations 
seen in the NOES Y spectrum [Spectrum 3.1.9] between the H-2 and 3H-17 (5 1.96 s) and H- 
16A proton resonances.
The H-3 methine proton resonance exhibited correlations in the HMBC spectrum with a methyl 
group carbon resonance at ô 16.5 that was assigned to C-18. The corresponding 3H-18 proton 
resonance at 5 1.79 (s) showed correlations in the HMBC spectrum with a fully substituted 
carbon resonance at 6 139.9 and a methylene group carbon resonance at 6 40.3 that were 
assigned as C-4 and C-5 respectively.
The C-5 carbon resonance at 5 40.3 was seen to correspond in the HSQCDEPT spectrum to two 
proton resonances at 5 2.26 and 2.17 (2H-5). The two H-5 proton resonances were seen to be 
coupled in the COSY spectrum to two methylene group proton resonances at 5 2.31 (m) and 2.18 
that were assigned as the two H-6 methylene group proton resonances. The two H-6 proton
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resonances, in turn, showed coupling in the COSY spectrum with an alkene proton resonance at 
5 5.08 (hr s) that was assigned as H-7. The H-7 proton resonance exhibited correlations in the 
HMBC spectrum with carbon resonances at 8 25.8, 44.5 and 16.8 that were assignable to C-6, C- 
9 and C-19 respectively. The corresponding 3H-19 (8 1.58, s) proton resonance, in turn, 
exhibited a correlation in HMBC spectrum with the C-7 (8 130.0) and C-9 (8 44.5) carbon 
resonances and a carbon resonance at 8 129.9 that was assigned to the C-8 carbon.
The proton resonances corresponding to the C-9 carbon were observed at 8 2.68 and 2.17 in the 
HSQCDEPT spectrum. The two H-9 proton resonances displayed correlations in the the HMBC 
spectrum with the C-7 (8 130.0), C-8 (8 129.9) and C-19 (8 16.8) carbon resonances and the 
carbon resonances at 8 79.8 and 149.3 which were assigned as C-10 and C-11 respectively. The 
COSY spectrum showed a correlation between the two H-9 proton resonance and a downfield 
proton resonance at 8 5.08 (hr s 4.95 hr s fVi/2 = 18.80 Hz) which could be assigned as H-10.
The H-10 proton resonance was seen to be correlated with the C-8 (8 129.9), C-9 (8 44.5) and C- 
11 (8 149.3) carbon resonances and a quaternary carbon resonance at 8 133.9 which was 
assigned as C-12. Furthermore, the corresponding H-11 (8 7.27, s) proton resonance was seen to 
correlate with the C-10 (8 79.8), C-12 (8 133.9), C-13 (8 23.7) and C-20 (8 174.5) carbon 
resonances in the HMBC spectrum. The corresponding two H-13 proton resonances were seen 
at 8 2.55 (m) and 2.45 (m) in the HSQCDEPT spectrum. The two H-13 (8 2.55, m and 2.45, m) 
and two proton resonances at 8 2.86 (m) and 2.67, that were assigned as the two H-14 proton 
resonances, were seen to be coupled in the COSY spectrum. A further correlation was seen in 
the HMBC spectrum between the two H-14 proton resonances and the C-15 (8 137.9) carbon 
resonance. Thus all twenty carbon resonances of compound CG.l could be assigned.
The magnitude of the ^^ C NMR chemical shift of a vinylic methyl carbon resonance has been 
used by Crombie et al}'^ and Olsson et al?^ to determine the configuration of a methyl- 
substituted double bond. Lange and Lee (1986) reported that a vinylic methyl group carbon 
resonance value of < 20 ppm is indicative of an E configuration, whereas a carbon resonance 
value of > 20 ppm is indicative of a Z configuration.^^ The single crystal X-ray study of the 
crystalline compound CG.3 [Section 3.2.4, Page 71 - 76] confirmed that the NMR chemical
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shift value of the vinylic methyl group (C-18, 5 15.1) that is lower than 20 ppm was attached to 
an alkene with an E  geometry. Therefore for compound CG.l, the ^^ C NMR chemical shift of 
the C-18 methyl group of 5 16.5 (< 20 ppm) indicated an E geometry of the -  double bond 
and hence the 3H-18 methyl group was trans to the vinylic proton H-3.^  ^ The trans
configuration of the 3H-18 methyl group to the vinylic H-3 proton was further supported by the 
absence of a correlation between the H-3 and 3H-18 proton resonances in the NOES Y spectrum. 
The ^^ C NMR chemical shift of C-19 at ô 16.8 ppm also indicated an E  configuration for the - 
double bond and thus the 3H-19 methyl group was trans to the vinylic H-7 proton resonance.
20, 21, 22 NOES Y spectrum supported the trans relationship between the 3H-19 proton 
resonance and the vinylic H-7 proton, due to an absence of a correlation between the 3H-19 and 
the H-7 proton resonances.^^’
Seven cembranoid diterpenoids have, so far, been isolated from Croton oblongifolius^^’ and 
one cembranoid diterpene isolated from Croton poilanei?^ Three of the cembranoids possess 
carboxylic acids at C-20, one possesses an aldehyde group at C-20, three possess a ftiran ring 
(20, 10-olide) and one possesses a lactone ring (20, 10-olide) [Figure 2.15 described on page 32]. 
The comparison of the ^^ C NMR chemical shifts of crotocembraneic acid [R.1] and 
neocrotocembraneic acid [R.2] with those of compound CG.l showed that besides the absence 
of a double bond in the isopropyl group of the two cembranoids^"  ^which cause a downfield shift 
for C-2 (5 124.3) and C-3 (5 123.6), there was also a remarkable downfield shifting of the carbon 
resonances for C-9 (8 44.5), C-12 (8 133.9), C-13 (8 23.7) and C-14 (8 24.7) [See Table 3.1 for 
comparisons of the ^^ C NMR chemical shifts for compound CG.l and those of R.1 and R.2 
cembranoids] which was attributed to the presence of a lactone group in compound CG.l.
The FTIR Vmax values exhibited by compound R.1 were 3400 -  3000 cm‘  ^ (OH), 1690 cm'  ^
(carbonyl) and 1640 cm"^  (double bond) and those of compound R.2 were 3400 -  3050 cm"^  
(OH), 1684 cm'  ^ (carbonyl) and 1640 cm'  ^ (double bond). The FTIR carbonyl group stretch was 
observed to have shifted to 1753 cm'  ^for compound CG.l, therefore confirming the presence of 
a lactone group.'^
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R.1 R.2
Figure 3.6: Structures for crotocembraneic acid [R.1] and neocrotocembraneic acid [R.2] *^’ 
whose NMR chemical shifts are displayed in Table 3.1
$
Picture 3.3: A top view photograph of a model for compound CG.l: (+) -  [lOJ?] - Cembra-
lE, 3£", IIZ, 15-pentaen-20,10-olide
The '^C NMR chemical shifts for C-18 (ô 16.5) and C-19 (8 16.8) and the NOES Y spectrum 
were used to determine the relative stereochemistry of compound CG.l. It has been reported 
that the configuration of a methyl substituent on a trisubsituted double bond of a macrocyclic 
terpenoid can be deduced from the geometry of the double bond.^^’ *^ If the double bond exhibits
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a trans geometry then the methyl substituent is present on the P -  face of the molecule and vice 
20,21versa.
i
Picture 3.4: A side view photograph of a model for compound CG.l: (+) -  [10/?] - Cembra-
lE, 3E, IIZ, 15-pentaen-20,10-olide
Therefore the 3H-18 and 3H-19 methyl groups of compound CG.l were placed on the p -  face 
of a model of the molecule [Pictures 3.3 and 3.4]. A correlation between the 3H-19 methyl 
group proton resonance and the H-10 oxymethine proton resonance was seen in the NOESY 
spectrum, therefore, the H-10 proton was placed to be on the p -  face of the molecule and the 
chiral centre at C-10, was assigned as R based on the Cahn-Ingold-Prelog sequence.'^’ An 
optical rotation value of + 24.22° for compound CG.l was measured. Compound CG.l was 
therefore deduced to be (+) -  [\0R] - cembra-l-E, 3E, IE, 1IZ, 15-pentaen-20, 10-olide.
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3.2.2 Structural elucidation of compound CG.2: (+) -  [IOjR] - Cembra-lZ, 3Z, IE, IIZ, 15- 
pentaen-20,10-olide
Compound CG.2 was isolated as a colourless oil from the combined hexane and methylene 
chloride extracts of the leaves of Croton gratissimus. Compound CG.2 was found to be an 
isomer of compound CG.l, and was identified as (+) -  [lOR] -  cembra-lZ, 3Z, IE, IIZ, 15- 
pentaen-20, 10-olide.
CG.2
Figure 3.7: Structure for compound CG.2: (+) -  [lOiî] - cembra-lZ, 3Z, IE, IIZ, 15-
pentaen-20,10-olide
The HRMS spectrum [Spectrum 3.2.1] of compound CG.2 gave a [M + Na]^ ion at m/z 
321.1819 which indicated a molecular formula of C20H26O2, the same as for compound CG.l. 
The FTIR spectrum [Spectrum 3.2.2] of compound CG.2 showed an absorption band at 1749 
cm'  ^that was attributed to a carbonyl group stretch of an a, p-unsaturated y-lactone ring.^  ^ The 
^^ C NMR data [Spectrum 3.2.4] displayed twenty carbon resonances, which included ten double 
bond resonances and one carbonyl carbon resonance at 5 174.5. Compound CG.2 was therefore 
determined to be a bicyclic diterpenoid on the basis of the calculated double bond equivalence 
value of eight and the NMR chemical shifts.
A comparison of the ^^ C NMR chemical shifts for compound CG.l with those of compound 
CG.2 indicated that the chemical shifts were the same, except for the C-4, C-5 and C-18 carbon 
resonances, which compound CG.l exhibited 5 139.9, 40.3 and 6 16.5 respectively whereas 
compound CG.2 gave carbon resonances at 5 141.5, 31.4 and 5 24.0. The NMR chemical 
shifts also showed significant differences for the H-3, 2H-5 and 3H-18 resonances where 
compound CG.l exhibited resonances at 8 6.06 (d, J =  11.50 Hz), 2.17 and 2.26 (m) and 1.79 (s) 
whereas, compound CG.2 exhibited resonances at 5 6.29 (d, 11.03 Hz), 2.79 and 2.00 (dt, J=
68
4.00, 3.55 Hz ) and 1.88 (s) respectively. The presence of a correlation in the NOESY spectrum 
[Spectrum 3.2.9] between the H-3 (6 6.29, d, J  = 11.03 Hz) proton resonance and the 3H-18 (8 
1.88, s) proton resonance, and the magnitude of the NMR chemical shift for C-18 of 8 24.0 
(>20 ppm) indicated a Z configured A^ - double bond and the H-3 and the 3H-18 methyl group 
were trans to each other whereas in compound CG.l the A -^ double bond was E configured.^ 
The A^ - double bond was also determined to have the Z configuration due to the absence of a 
correlation between the H-2 (8 6.45, à J  = 11.03 Hz) and H-3 (8 6.29, d J =  11.03 Hz) proton 
resonances in the NOESY spectrum.
As in compound CG.l and based on the NMR chemical shift for C-19 at 8 16.1 the 3H-19 
was placed on the P -  face of the m o l e c u l e . A  correlation in the NOESY spectrum between 
the 3H-19 methyl group proton resonance and the H-10 oxymethine proton resonance allowed 
for the assignment of the H-10 proton to the p -  face of the molecule. The C-10 chiral centre, 
same as compound CG.l, was therefore assigned the R configuration. An optical rotation value 
of + 18.57° was measured for compound CG.2, which was identified as (+) -  [lOR] -  cembra- 
IZ, 3Z, IE, IIZ, 15-pentaen-20,10-olide.
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Table 3.2: Correlation table for compound CG.2: (+) -  [lOJ?] - Cembra-lZ, 3Z, IE, IIZ , 15-
pentaen-20, 10-olide
No. NMR (125 
MHz) CDCI3
NMR (500 MHz) 
CDCI3
HMBC (H-^C) COSY NOESY
1 143.3 C - - - -
2 124.2 CH 6.45 d J =  11.03 Hz 1 ,3 ,4 ,1 4 3 14a, 18
3 123.4 CH 6.29 d J =  11.03 Hz 2 ,5 ,1 8 2 , 18 5a, 11,18
4 141.5 C - - - -
5a 31.4 CHz 2.79* 18 5P, 6 a, 6 P 5P
5P 2.00 dt J =  4.00, 3.55 Hz 5a, 6 a, 6 P 5a, 13a
6 a 26.6 CH2 2.52 m 5a, 5p, 6 p, 7 6 P, 7, 14a, 19
6 p 2.16 d J =  16.71 Hz 5a, 5p, 6 p 6 a, 13p
7 129.6 CH 4.96* 5 ,9 6 a 6 a
8 129.8 C - - - -
9a 46.0 CH2 2.79* 1 0 , 1 1 9P 9P, 13p
9P - 1.69 s 10,11,19 9a, 10 9a
1 0 79.1 CH 4.93* 9a, 9p, 11 19
1 1 150.4 CH 7.23 d J =  1.30 Hz 1 0 , 1 2 , 2 0 10, 13a, 13P 3 , 14a
1 2 131.6 C - - - -
13a 23.7 CH2 2.70 m 15 13P 5p, 3P, 4a
13P 2.34 m 15 13a, 14a, 14p 5P, 6 P, 9a, 13a
14a 23.3 CH2 2.92 td y =  3.75, 9.05 Hz 1 ,2 ,12 ,15 13a, 13P, 14P 3 ,6 a , 11,3a, 14p
14P 2.64 s 12, 15 14a 14a
15 137.3 C - - - -
16A 113.4 CH2 4.96* 15, 17 16B, 17 17
16B - 4.96* 15, 17 16 A, 17 17
17 21.6 CH3 1 . 8 8  s* 1 ,2 ,1 5 ,1 6 16B, 16E 16B, 16A
18 24.0 CH3 1 . 8 8  s* 5 3 2 ,3
19 16.1 CH3 1.67 s 7, 9 ,19 - 6 a, 1 0
2 0 174.6 C - - - -
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the NMR and 5 29.9 in the NMR spectra are for an impurity 
present in the sample.
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3.2.3 Structural elucidation of compound CG.3: (+) -  [IJ?, 2S, 7S, 8 5 ,12R] -  7, 8 - Epoxy- 2, 
12 - cyclocembra-3^, lOZ-dien-20,10-olide
Compound CG.3 was isolated as a white solid from the hexane extract of the stem of Croton 
gratissimus and was identified as (+) -  [li?, 25, 75, 85, \2R \- 7 , 8 -  epoxy- 2, 12-  cyclocembra- 
3E, lOZ-dien-20, 10-olide.
CG.3
Figure 3.8: Structure for compound CG.3: (+) -  [lüf, 25, 75, 85, 12jR] -  7, 8 - Epoxy- 2,12 -
cyclocembra-3E, lOZ-dien-20,10-olide
The HRMS spectrum [Spectrum 3.3.1] gave a [M + Na]^ ion at m/z 339.1921 which indicated a 
molecular formula of C20H28O3. A double bond equivalence of seven was calculated. The FTIR 
spectrum [Spectrum 3.3.2] exhibited an absorption band at 1777 cm'  ^which was attributed to a 
carbonyl group stretch of enol y-lactone ring.^  ^ This absorption band at 1777 cm'  ^ was higher 
than the absorption bands at 1753 cm'  ^ and 1749 cm'  ^ for compounds CG.l and CG.2. 
Therefore, it is possible that there is no conjugation of the carbonyl group for compound CG.3 ^ 
The presence of twenty carbon resonances, which included one carbonyl carbon resonance at 6 
183.6, which had shifted from the 8 174.5 and 174.6 for compounds CG.l and CG.2, and four 
double bond carbon resonances in the NMR spectrum [Spectrum 3.3.4] suggested that 
compound CG.3 was a tetracyclic diterpenoid. Compound CG.3 was seen to possess an 
isopropyl group due to two secondary methyl group proton resonances at 8 0.85 (d, J=  6.60 Hz) 
and 8 0.95 (d, J  = 6.60 Hz) [Spectrum 3.3.3] which were each seen to be coupled to the same 
methine proton resonance at 8 1.68 (m) in the COSY spectrum [Spectrum 3.3.8]. A further 
methyl group (8 1.42, s) attached to a fully substituted carbon atom carrying an oxygen 
[Spectrum 3.3.6], one vinylic methyl group due to a methyl group proton singlet resonance (8
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1.52, s) and a carbon of a y-lactone ring (ô 183.6) indicated that compound CG.3 was a 
lactonized cembranoid diterpenoid possessing two other rings.
The two methyl group doublet proton resonances at 5 0.85 (d, J=  6.60 Hz) and 0.95 (d, J=  6.60 
Hz) were ascribed as 3H-16 and 3H-17, and the methine proton resonance at 5 1.68 (m) was 
assigned as H-15 of the isopropyl group of the cembranoid skeleton. The 3H-16 and 3H-17 
proton resonances showed a correlation in the HMBC spectrum [Spectrum 3.3.7] with a carbon 
resonance at 5 54.0 that was assigned as C-1. The corresponding H-1 proton resonance was 
observed at 5 1.70 (m) in the HSQCDEPT spectrum [Spectrum 3.3.6]. The COSY spectrum 
showed coupling between the H-1 proton resonance and a proton resonance at 5 2.91 (t, J=  9.60 
Hz) ascribed as H-2 which, in turn, was seen to be coupled to a double bond resonance at 5 4.85 
(d, J=  9.60 Hz) that was ascribed as H-3. The corresponding carbon resonances for the H-2 and 
H-3 proton resonances were observed at 5 54.8 and 128.5 in the HSQCDEPT spectrum 
respectively. A correlation was observed in the HMBC spectrum between the H-2 proton 
resonance and the C-15 carbon resonance.
The H-15 proton resonance further showed correlations in the HMBC spectrum with a carbon 
resonance at 6 28.2 which was ascribed as C-14. The corresponding two H-14 proton resonances 
at 5 1.84 and 1.67 were observed in the HSQCDEPT spectrum. One of the H-14 (5 1.84, m) 
proton resonance was seen to be coupled to a proton resonance at ô 2.14 (m) in the COSY 
spectrum that was assigned as one of the H-13 proton resonance. The ô 2.14 (m) proton 
resonance which was, in turn, coupled in the COSY spectrum to a proton resonance at 5 1.78 (m) 
and was ascribed as the other H-13 proton resonance. The two H-13 proton resonances was seen 
to correlate in the HMBC spectrum with the carbonyl carbon resonance at ô 183.6 that was 
ascribed to C-20. The C-20 carbon resonance was further seen to correlate with a proton 
resonance at 5 5.05 (hr s Wm = 2.77 Hz) that was ascribed to H-11. The H-11 proton resonance 
was, in turn, seen to correlate in the HMBC spectrum with a carbon resonance at 5 58.3 ascribed 
as C-12.
The earlier assigned H-3 proton resonance showed correlations in the HMBC spectrum with 
carbon resonances at 5 38.5 and 15.1 that were assigned to C-5 and C-18 respectively. The
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corresponding 2H-5 and 3H-18 proton resonances were seen at 5 2.23 (dd, J=  3.98, 8.80 Hz) and 
1.68 (m) respectively. The H-3 proton resonance showed long range coupling in the COSY 
spectrum with the 3H-18 methyl group proton resonance. The 2H-5 proton resonance were seen 
to be coupled to proton resonances at 5 1.87 and 1.57 (m) that were assigned to two H-6 protons. 
One of the H-6 (5 1.57, m) proton resonances was observed to be coupled to a downfield proton 
resonance at ô 2.64 (d, J  = 9.95 Hz) that was ascribed to the H-7 proton. The corresponding 
carbon resonances were seen to occur at ô 38.5 (C-5), 23.2 (C-6) and 63.0 (C-7) in the 
HSQCDEPT spectrum. The H-7 proton resonance showed correlations in the HMBC spectrum 
with a carbon resonance at 8 61.9 that was assigned as C-8. The C-7 and C-8 carbon resonances 
were deduced to be part of an epoxide ring due to their characteristic ^^ C NMR chemical shifts, 
accounting for the third ring.^^
The C-7 carbon resonance showed correlation in the HMBC spectrum with a proton resonance at 
8 1.98 (d, 13.50 Hz) which, in turn, showed coupling with a proton resonance at 8 2.86 (q,
4.30 Hz) in the COSY spectrum. The two proton resonances at 8 1.98 (d, J=  13.50 Hz) and 2.86 
(q, J=  4.30 Hz) were ascribed to the two H-9 protons. The two H-9 proton resonances showed 
correlations in the HMBC spectrum with carbon resonances at 8 19.2, 151.2 and 110.6 that were 
ascribed to C-19, C-10 and C-11 respectively. The correlations in the HMBC spectrum between 
the H-2 (8 2.91, t, 9.60 Hz) proton resonance and C-11 (8 110.6) and C-20 (8 183.6) carbon 
resonances, followed by another correlation between the H-1 (8 1.70, m) proton resonance and 
the C-12 (8 58.3) carbon resonance HMBC spectrum suggested the presence of a spirocyclic 
centre at C-12 (8 58.3) and, in turn, accounted for the final ring. The structure of compound 
CG.3 was confirmed by the Logic for Structure Determination programme.^^’
The NOESY spectrum of compound CG.3 was used to determine the relative stereochemistries 
of compound CG.3. The 3H-19 (8 1.42, s) proton resonance showed a correlation in the NOESY 
spectrum with the 3H-18 (8 1.52, d, J =  1.15 Hz) resonance which, in turn, showed a correlation 
with the H-2 (8 2.91, t, J =  9.60 Hz) proton resonance. The H-2 (8 2.91, t, J =  9.60 Hz) proton 
resonance further showed correlation with the H-15 (8 1.68, m) and the 3H-16 (8 0.85, d, J  = 
6.60 Hz) resonances of the isopropyl group [Figure 3.9].
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Figure 3.9: Selected COSY (—) and NOESY (<-^ ) correlations for compound CG.3: (+) -  
[1JÎ, 25, 75, 85, \2R \ -  7 ,8  - Epoxy- 2,12 - cyclocembra-3E, lOZ-dien-20,10-olide
On the other side of the molecule the H-7 (ô 2.64, d, J  = 9.95 Hz) proton resonance showed a 
correlation in the NOESY spectrum with the H-11 proton resonance, which, in turn, showed a 
correlation with the H-3 (6 4.85, d, J  = 9.60 Hz) proton resonance, which itself showed 
correlation with the H-1 (8 1.70, m) proton resonance. The absence of a correlation between the 
H-3 (8 4.85, d, J =  9.60 Hz) proton resonance and the 3H-18 (8 1.52, d, J =  1.15 Hz) proton 
resonance suggested that the two groups were trans to each other, therefore the C-3 (8 128.5) and 
C-4 (8 136.0) double bond was determined to be an E configuration.^^’ ^  The optical 
rotation value of + 39.5° was measured for compound CG.3. The structure and the relative 
stereochemistry of compound CG.3 was further confirmed by X-ray studies [Figure 3.10]. 
Compound CG.3 was identified as (+) -  [li?, 25, 75, 85, \2K\ -  7, 8 - epoxy- 2, 12 - 
cyclocembra-3E, lOZ-dien-20, 10-olide.
»C i3)
A n cm*o
Figure 3.10: ORTEP diagram for compound CG.3: (+) -  [IR, 25, 75, 8 5 ,12R] -  7, 8 - 
Epoxy- 2,12 - cyclocembra-3E, lOZ-dien-20,10-olide
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Several rearranged cembrane diterpenes have been r e p o r t e d . T h e s e  include basmane 
diterpenes which are (2, 12: 7, 11) cyclocembranes [RC.l], eunicellane diterpenes which are 5, 
14-cyclocembranes [RC.2], briaranes diterpenes which are 3, 8-cyclocembranes [RC.3] and 
dolabellane diterpenes which are 4, 5-eyclocembranes have been documented.^^ The isolation 
of (+) -  [IR, 2S, 7S, SS, \2R] -  7, 8 - epoxy- 2 , 1 2 -  cyclocembra-3E, lOZ-dien-20, 10-olide, 
CG.3, a 2, 12-cyclocembranoid diterpenoid from C. gratissimus represents a novel skeletal 
structure which is represented as [RC.4].
RC.4RC.3RC.l RC.2
RC.5
Figure 3.11: Skeletons showing rearranged cembrane16
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Table 3.3: Correlation table for compound CG.3: (+) -  [IR, 2S, IS, SS, 12R] -  7, 8 - Epoxy-
2, 12 - cyclocembra-3£', lOZ-dien-20,10-olide
No (125MHz)
CDCb
NMR (500 MHz) 
CDCI3
HMBC (H ^  C) COSY NOESY
1 54.0 CH 1.70 m 2 , 1 2 2 3
2 54.8 CH 2.911 J =  9.60 Hz 1 ,3 ,4 , 11, 15, 20 1,3 6 P, 15,16,18
3 128.5 CH 4.85 d J =  9.60 Hz 2 ,5 ,1 8 2 , 18 1, 5a, 9a, 11
4 136.0 C - - - -
5a 38.5 CHz 2.23 d d J  =3.98, 8.80 Hz 3, 4, 6 , 7,18 6 a, 6 p 3, 6 a, 7 , 14a
5P 2.23 d d J  = 3.98, 8.80 Hz 6P,18
6 a 23.2 CHz 1.87 4, 5 ,7 5 5a, 6 P
6 P 1.57m 5,8 7 2, 5p, 6 a, 7
7 63.0 CH 2.64 d J =  9.95 Hz 5, 6 , 8 6 P 5a, 6 p, 9a, 1 1 ,14a
8 61.9 C - - - -
9a 39.0 CHz 1.98 d / =  13.50 Hz 8 , 10, 11, 19 9P 7a, 9P, 11
9P 2.86 q J =  4.30 Hz 7 ,1 0 ,1 1 ,1 9 9a 3 ,9a , 11,19
1 0 151.2 C - - - -
1 1 110.6 CH 5.05 br s Wi/2= 2.77 Hz 9, 10,12, 20 - 3 ,7 ,9 a ,9 p
1 2 58.3 C - - - -
13a 33.3 CHz 1.78 m 11, 12,14, 20 13p 13P
13P 2.14 m 14, 20 13a, 14a 13a, 14P
14a 28.2 CHz 1.84 1 ,2 ,13 13P 5a, 7, 14P
14P 1.67 2, 13 13a 13p, 14a
15 29.9 CH 1 . 6 8 14, 16 16, 17 16, 17
16 18.8 CHg 0.85 d J =  6.60 Hz 1,15,16 15 2 , 5P, 15, 17
17 2 2 . 0  CH3 0.92 d J  = 6.60 Hz 1,15,17 15 15, 16
18 15.1 CH3 1.52 d J =  1.15 Hz 3 ,4 ,5 3 2, 5P, 19
19 19.2 CH3 1.42s 8 ,9 - 9P,18
2 0 183.6 C - - -
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the NMR and 5 29.9 in the NMR spectra are for an impurity 
present in the sample.
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3.2.4 Structural elucidation of compound CG.4: (+) -  [li?, 4*S', lOR] - 4 - Hydroxycembra- 
2E, 7E, IIZ- trien-20,10-olide
Compound CG.4 was isolated as a yellow oil from the hexane extract of the stem and the 
methylene chloride extract of the leaves of Croton gratissimus. Compound CG.4 was found to 
be a hydroxy derivative of compound CG.l. A comparison of the ^^ C NMR chemical shifts 
(Table 3.1 and Table 3.4) showed that the C-4 (6 72.5) carbon of compound CG.l had been 
hydroxylated. The A \ and A^  ^ double bonds of compound CG.l had been lost and a new 
double bond between C-2 (5 131.4) and C-3 (6 138.0) had been formed for compound CG.4. 
Compound CG.4 was therefore identified as (+) -  [li?, 45', lOi ]^ - 4 - hydroxycembra-2E, IE, 
1 lZ-trien-20, 10-olide.
HQ ,
CG.4
Figure 3.12: Structure for compound CG.4: (+) -  [IR, 45', lOR] - 4 - Hydroxycembra-2£',
7E, llZ-trien-20,10-olide
The HRMS spectrum [Spectrum 3.4.1] of compound CG.4 gave a [M + Na]^ ion at m/z
341.2079 which indicated a molecular formula of C20H30O3. A double bond equivalence of six 
was calculated. The FTIR spectrum [Spectrum 3.4.2] showed a prominent absorption band at 
3411 cm'  ^ that was indicative of a hydroxyl group stretch and another absorption band at 1738 
cm'  ^ that was attributed to a, p -  unsaturated carbonyl group stretch of a y-lactone ring as in 
compounds CG.l and CG.2.*  ^ The NMR spectrum [Spectrum 3.4.3] displayed four methyl 
group proton resonances at 5 0.84 (d, J=  6.53 Hz), 0.89 (d, J=  6.53 Hz), 1.37 (s) and 1.67 (s), 
each integrating to 3H. The corresponding carbon resonances for the four methyl groups were 
observed at 5 19.6, 20.4, 28.2 and 16.5 in the HSQCDEPT spectrum [Spectrum 3.4.6]. Twenty 
carbon resonances which included a carbonyl carbon resonance at ô 174.2 and six double bond 
carbon resonances at 6 131.4, 138.0, 131.1, 129.4, 149.6 and 133.6 were observed for compound 
CG.4. An isopropyl group, indicated by the two methyl group proton doublet resonances at ô 
0.89 (d 6.53 Hz) and 0.82 (d J =  6.53 Hz) which were both seen to be coupled to the same
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methine proton resonance at ô 1.60 (m) in the COSY spectrum, [Spectrum 3.4.8] was present in 
compound CG.4. The HMBC spectrum [Spectrum 3.4.7] showed that the two 3H-16 (5 0.89) 
and 3H-17 (8 0.82) methyl proton resonances were correlated to a carbon resonance at 8 48.4 
which was assigned as C-1.
The "C  NMR chemical shifts for C-5, C-6, C-7, C-8, C-9, C-10, C-11, C-13 and C-19 displayed 
by compound CG.4 were very similar to those exhibited by compound CG.l (Table 3.4 and 
Table 3.1). Moreover, connectivities for H-1 to H-3, H-5 to H-7, H-9 to H-11 and H-13 to H-1 
were seen in the COSY spectrum, that were the same as those observed for compound CG.l 
[Table 3.1]. The H-2 (8 5.41, m) and H-3 (8 5.6, d, J =  15.7 Hz) proton resonances were seen to 
be coupled to each other in the COSY spectrum and gave a coupling constant value of 15.7 Hz 
which was consistent with a trans c o u p l i n g . C o r r e l a t i o n s  in the HMBC spectrum between 
the H-1 (8 1.58, m) proton resonance and C-2 (8 131.4) and C-14 (8 28.1) carbon resonances, H- 
3 (8 5.60, d, J =  15.7) proton resonance and C-1 (8 48.4), C-3 (8 138.0), C-4 (8 72.5) and C-18 
(28.2) carbon resonances, the two H-5 (8 1.92 and 1.51, m) proton resonances and C-3 (8 138.0) 
and C-7 (8 131.1) carbon resonances were observed for compound CG.4.
Further correlations in the HMBC spectrum between the H-7 (8 5.37, t, J =  7.5, 14.9 Hz) proton 
resonance and C-9 (8 44.7), and C-19 (8 16.5) carbon resonances, the two H-9 (8 2.80, dd, J  = 
7.32, 12.75 Hz and 2.07, dd, J  = 2.61, 12.75 Hz) proton resonances and C-7 (8 131.1), C-8 (8
129.4), C-10 (8 80.3), C-11 (8 149.6) and C-19 (8 16.5) carbon resonances, H-10 (8 5.03, br s, 
W\i2 = 19.63 Hz) proton resonance and C-11 (8 149.6) and C-20 (8 174.2) carbon resonances 
were also observed for compound CG.4. The correlations between the H-11 (8 6.98, d, 1.60 
Hz) proton resonance and the C-10 (8 80.3), C-12 (8 133.6) and C-20 (8 174.2) carbon 
resonances, the correlations between the overlapped 2H-13 (8 2.20, m) proton resonances and the 
C-20 (8 174.2) carbon resonance and the correlation between the overlapped 2H-14 (8 1.49, m) 
proton resonances and the C-13 (8 22.7) carbon resonance in the HMBC spectrum seen in 
compound CG.l were also observed for compound CG.4.
Compound CG.4 has three chiral centres at C-1, C-4 and C-10 whose relative configuration were 
assigned using the NOESY experiment [Spectrum 3.4.9], a model [Pictures 3.5 and 3.6] and by
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comparisons with compound CG.3. The stereochemistry of the H-1 (8 1.58, m) proton 
resonance was tentatively assumed to be the same (a) as that exhibited by the H-1 proton 
resonance of compound CG.3 and that of poilaneic acid [R.3], a cembranoid diterpene isolated 
from Croton poilanei [Figure 3.13].^^ The H-1 proton resonance was seen to show a correlation 
in the NOESY spectrum with the hydroxy group proton resonance at 8 4.36 (s) when the 
spectrum was acquired in DMSG[Table 3.4]. The hydroxy group attached to C-4 was therefore 
placed in the a orientation whereas the 3H-18 methyl group proton was assigned to the (3 face.
3—
R.3
Figure 3.13: Structure for R.3: Poilaneic acid, a cembranoid ditcrpcnoid isolated from
Croton poilanef'^
The NOESY spectrum further showed a correlation between the (3 configured 3H-18 (8 1.37, s) 
methyl group and the isopropyl group (H-15 and 3H-17). The H-10 (8 5.03, br t, W1/2 = 19.63 
Hz) oxymethine proton was also determined to be ^  -  configured since it displayed correlations 
in the NOESY spectrum with the H-11 (8 6.98, d, J =  1.60 Hz) proton resonance and the 3H-19 
(8 1.67, s) proton that was determined to be on the p face.^ '^ 20,21,22 pm^hermore, the absence of 
a correlation between the H-7 (8 5.37 t J  = 7.50 Hz) proton resonance and the 3H-19 (8 1.67, s) 
methyl group proton resonance in the NOESY spectrum showed that the H-7 and the 3H-19 
methyl group were on opposite faces to each o t h e r . ^  The C-7 (8 131.1) and C-8 (8
129.4) double bond was determined to be in the E  configuration due the ^^ C NMR chemical shift 
of the C-19 methyl group of 8 16.5 (< 20 ppm).^^’ Compound CG.4 was identified as (+) -  
[H ,^ 4*5, lOR] - 4 - hydroxycembra-2Z, IE, llZ-trien-20, 10-olide.
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The optical rotation value of + 65.0 for compound CG.4 was measured. Compound CG.4 was 
identified as (+) -  [li?, 45", lOi?] - 4 - hydroxycembra-2£, IE, 1 lZ-trien-20, 10-olide.
HO,
CG.4
Figure 3.14: Selected NOESY correlations for compound CG.4: (+) -  [1/?, 4S, 10/2] - 4 - 
Hydroxycembra-2£', IE, llZ-trien-20,10-olide
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Picture 3.5: A top view photograph of a model for compound CG.4: (+) -  [li?, 4A, 10/?] - 4
Hydroxycembra-2£', IE, 1 lZ-trien-20,10-olide
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»Picture 3.6: A side view photograph of a model of compound CG.4: (+) -  [1/?, 4S, 10/?] - 4 -
Hydroxycembra-2E, IE, llZ-trien-20,10-olide 
Table 3.4: Correlation table for compound CG.4: (+) -  [1/?, 4A, 10/?] - 4 - Hydroxycembra- 
2E, IE, llZ-trien-20,10-olide acquired using CDCI3
No ""C NMR (125 MHz) H NMR (500 MHz) HMBC (H -> C) COSY NOESY
1 48.4 CH 1.58* 2, 14 2 16, 17
2 131.4 CH 5.41 m 1,3, 4,14 1,3 3, 17, 18
3 138.0 CH 5.60 d J  = 15.7 Hz 1,2, 4, 18 2 2, 11, 15, 18
4 72.5 C - - - -
5a 43.7 CH2 1.92’ 3 ,7 5P,6 18
5P 1.51 m 5a
6a 25.6 CH2 2.34 m 5,7 5a, 5P, 7 7
6P 1.59* 5 ,7 5a, 5P, 7 7
7 131.1 CH 5.37 t J =  7.50 Hz 9, 19 6 6a, 6P, 9P, 11
8 129.4 C - - - -
9a 44.7 CH2 2.80 d d J =  7.32,12.7 Hz 7, 8, 10, 11, 19 9p, 10 6, 9P, 10, 19
9P 2.07 d d J =  2.61,12.7 Hz 9a, 10 7, 9a
10 80.3 CH 5.03 br s, Wx!2 = 19.63 Hz 11,20 9a, 9P, 11 9a, 11, 19
11 149.6 CH 6.98 d 1.60 Hz 10, 12, 20 10 3, 7, 10, 14P, 19
12 133.6C - - - -
13a 22.7 CHz 2.20 m’ 20 14 13p, 14a,
13p 2.20 m’ 20 14 13a
14a 28.1 CH2 1 .9 4 ’ 13 1,13 14P
14P 1.49 m X 11, 14a
15 33.9 CH 1.60 m 1 16,17 3, 16, 17, 18
16 20.4 CH] 0.89 d J =  6.53 Hz 1, 15, 17 15 I, 15
17 19.6 CH] 0.84 d y  = 6.53 Hz 1, 15, 16 15 1, 15, 18
18 28.2 CH] 1.37 s 3 ,4 ,5 - 2, 3, 15, 17
19 16.5 CH] 1.67 s 7, 8 ,9 - 9a, 10, 11
20 17 4 . 2  c - - - -
Refer to overlapped proton resonances
 ^Resonances at 5 1.24 in the 'H NMR and Ô 29.9 in the '^C NMR spectra are for an impurity 
present in the sample.
able 3.5: Correlation table for compound CG.4: (+) -  [li?, 4»S, lOR] - 4 - Hydroxycembra-2£, IE,
llZ-trien-20,10-olide acquired using DMSO
No "C NMR (125 MHz) *H NMR (500 MHz) HMBC ( H ^ C ) COSY NOESY
1 47.0 CH 1.52 m 2, 14 2,15 OH, 3
2 127.8 CH 5.25 d d J =  8.00, 15.70 Hz 1 ,4 ,5 ,1 8 1,3 1,3 ,11
3 138.7 CH 5.49 d J =  15.70 Hz 1 ,4 ,18 2 OH, 2
4 70.6 C - - - -
5a 43.5 CH] 1.72 m 6 5P 5P
5P 1.38 m 6 5a 5a, 18
6 a 24.9 CH] 2.30 m 7 6P,7 6 p
6 P 2 . 1 0  m 7 6 a, 7 6 a
7 131.7 CH 5.32 t J =  7.60 Hz 9, 19 6 a, 6 p 9P,11
8 128.4 C - - - -
9a 44.1 CH] 2.68 d d J= 5 .2 0 , 12.60 Hz 8 , 10,11,19 9P,10 9p,10
9p 2.02 dd J= 9 .2 0 , 12.60 Hz 8 ,1 0 ,1 1 ,1 9 9a, 10 7, 9a, 10, 19
1 0 79.9 CH 5.18 br s W\i2 = 18.46 Hz - 9a, 9p, 11 9a, 9P, 11
1 1 150.7 CH 7.11 d y =  1.25 Hz 1 0 , 12, 2 0 1 0 2, 7 ,10
1 2 131.7 C - - - -
13a 22.4 CH] 2 . 2 0  m 2 0 13p, 14P 13P
13P 2 . 0 0  m 1 1 13a 13a, 18
14a 27.7 CH] 1.78 m 2 14p 14P
14P 1.38 m 2 13a, 14a 14a
15 33.4 CH 1.52 m 1 1, 16, 17 16,17
16 2 0 . 6  CH] 0.82 d J =  6.45 Hz 1,15,17 15 15
17 19.6 CH] 0.80 d J  = 6.45 Hz 1,15,16 15 15
18 28.9 CH] 1 . 2 0  s 4 ,5 - O H ,5p, 13P
19 16.6 CH] 1.60 s 7, 8 ,9 - 9P
2 0 173.4 C - - - -
OH - 4.36 s 3 ,4 ,5 , 18 - 1 ,3 ,18
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the^H NMR and ô 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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3.2.5 Structural elucidation of compound CG.5: (-) -  [112, 4/2, 10/2] - 4 - Hydroxycembra- 
2E, IE, IIZ- trien-20,10-olide
Compound CG.5 was isolated as a yellow oil from the methylene chloride extract of the stem of 
Croton gratissimus and found to be an isomer of compound CG.4, (+) — [1/2, AS, 10/2] - 4 - 
hydroxycembra-2E, IE, IIZ- trien-20, 10-olide. A comparison of the NMR [Spectrum
3.5.4] and NOESY [Spectrum 3.5.9] spectra of the (-) -  [1/2, 45', 10/2] - 4 - hydroxycembra-2E, 
IE, IIZ- trien-20, 10-olide and those of compound CG.5 allowed for the identification of 
compound CG.5 as (+) -  [1/2, 4/2, 10/2] - 4 -hydroxycembra-2E, IE, 1IZ- trien-20, 10-olide.
HCL
o  CG.5
Figure 3.15: Structure for Compound CG.5: (-) -  [1/2, 4/2,10/2] - 4 - Hydroxy cembra-2iF,
IE, IIZ- trien-20,10-olide
The HRMS spectrum [Spectrum 3.5.1] of compound CG.5 gave a [M - Na]^ ion at m/z
341.2079 which indicated a molecular formula of C20H30O3. A double bond equivalence of six 
was calculated. The FTIR spectrum [Spectrum 3.5.2] gave an absorption band at 3433 cm'  ^that 
was attributed to a hydroxyl group stretch. An absorption band at 1736 cm'  ^that was attributed to 
an a, p -  unsaturated carbonyl group stretch of a y-lactone ring was also seen in the FTIR 
spectrum. The NMR spectrum [Spectrum 3.5.4] displayed twenty carbon resonances 
which included one carbonyl carbon resonance at 5 174.2 and six double bond carbon 
resonances. The NMR spectrum [Spectrum 3.5.3] of compound CG.5 showed four methyl 
group proton resonances at 5 1.30 (s), 1.67 (s), 0.88 (d, J =  6.40 Hz) and 0.82 (d, J=  6.40 Hz). 
The methyl group proton resonances 5 0.88 (d, J=  6.40) and 0.82 (d, J =  6.40) which were both 
coupled to a methine proton resonance at ô 1.58 (m) in the COSY spectrum were consistent to an 
isopropyl group.
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The NMR chemical shifts for compound CG.5 were found to be very similar to those of 
compound CG.4, 4a - hydroxycembra-2Z, IE, 1 IZ- trien-20, 10-olide except for the C-18 carbon 
resonance at ô 30.3 (ô 28.2 for CG.4) and C-4 resonance at ô 73.6 (5 72.6 for CG.4). The *^ C 
NMR chemical shift of C-19 (5 16.5) (< 20 ppm) indicated an E geometry 20,21,22 -
double bond and hence the 3H-19 (6 1.67, s) was trans to the H-7. The 3H-19 methyl group was 
placed on the p -  face of a model of the molecule [Picture 3.7]. The 3H-19 proton was, in turn, 
observed to show a correlation with the H-10 (8 5.03, br s, Wia = 19.91 Hz) proton. The H-10 
proton was also determined to be on the p -  face of the molecule. The H-1 (8 1.58) proton 
resonance was tentatively placed on the a -  face as was seen in compounds CG.3, CG.4 and 
poilaneic acid isolated from Croton poilanei [Figure 3.13].^^
The presence of a correlation between the H-1 proton resonance and the 3H-18 methyl group 
proton resonance in the NOESY spectrum in conjuction with a model [Pictures 3.7 and 3.8] 
allowed for the assignment of the 3H-18 methyl group to the a -  face of the molecule. 
Furthermore, the NOESY spectrum did not reveal a correlation between 3H-18 proton resonance 
with the 3H-19 proton resonance, therefore, suggesting that they are on the opposite faces of the 
molecule. The measured optical rotation for this compound was found to be -82.93°. Compound 
CG.5 was identified as (-) -  [1/2, 45, 10/2] - 4 - hydroxycembra-27^, IE, 1 IZ- trien-20, 10-olide.
Picture 3.7: A top view photograph of a model for compound CG.5: (-) -  |l/2, 4/2,10/2] - 4 
Hydroxy cembra-2E, IE, WZ- trien-20,10-olide
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Picture 3.8: A side view photograph of a model for compound CG.5: (-) -  [1/2, 4/2,10/2] - 4 - 
Hydroxy cembra-2E, IE, HZ- trien-20,10-olide 
Table 3.6: Correlation table for Compound CG.5: (-) -  [1/2, 4/2,10/2] - 4 - Hydroxycembra-
2E, IE, HZ- trien-20,10-olide
0 . NMR (125 
MHz) CDCI3
H NMR (500 MHz) 
CDCI3
HMBC (H C) COSY NOESY
1 48.7 CH 1.58' 2, 3, 14, 16, 17 2 ,3 ,1 5 18
I 130.5 CH 5.35 t J  = 7.30 Hz 1 ,3 ,4 , 14 1, 13a, 13p 3, 5a, 5P, 6 P, 11
5 138.6 CH 5.50 d J =  16.91 Hz 1 ,2 ,4 ,1 8 1 2 , 1 1
t 73.6 C - - - -
a 43.8 CH] 1.85' 3 ,4 ,1 8 5b 2,5P, 18
P 1.58' 3 ,4 ,1 8 5a, 6 a, 6 p 2, 5a
a 25.7 CHz 2.40 m 4, 5,8 5P, 6 P 6 p
P 2.30 m 4 ,5 ,8 5p, 6 a 6 a, 7
7 129.5 CH 5.51 m 8 19 6 p, 9a, 9P, 10
? 129.9 C - - - -
a 44.6 CH] 2.81 dd J= 5 .4 , 12.6 Hz 7, 8 , 10, 11, 19 9P, 10 7, 9P, 10
'P 2.10 d d J =  10.25, 12.6 Hz 7, 8 , 10,19 9a, 10 7, 9a, 10, 19
0 80.3 CH 5.03 b rs Wi!2= 19.91 Hz 1 1 9a, 9P 9a, 9p, 11,19
1 149.5 CH 7.02 d J -  1.70Hz 10, 12, 13,20 13a 2 ,3 , 10,14P, 19
2 133.9 C - - - -
5a 23.4 CH] 2 . 0 0  m 1 1 14p 13p, 18
3P 2.35 m 1 1 , 1 2 , 2 0 ll ,1 4 P 13a
ta 28.7 CH] 1.85' 1 ,2 ,13 14P 13a, 16, 17
tp 1.58' 1 , 2 13a, 13p, 14a 13p, 14a, 11
5 34.0 CH 1.58' 2 ,3 , 13, 16,17 1, 16, 17 1, 16, 17
6 2 0 . 6  CH] 0.88 d J =  6.40Hz 1,15,17 15 1, 14p, 15, 17
7 19.5 CH] 0.82 d J  = 6.40Hz 1,15,16 15 1, 14P, 15, 16
8 30.3 CH] 1.30 s 3 ,4 ,5 - 1, 5a, 13a
9 16.5 CH] 1.67 s 7 ,9 7 2, 9P, 10, 11
:o 174.2 C - - - -
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the'H NMR and 8 29.9 in the *^ C NMR spectra are for an impurity 
present in the sample.
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3.2.6 Structural elucidation of compound CG.6 : (+) -  [liî, lOÆ] - Cembra-2E, 4E, lE  ^ IIZ- 
tetraen-2 0 , 1 0 -olide
Compound CG.6  was isolated as a colourless oil from the hexane extract of the stem and the 
combined hexane and methylene chloride extract of the leaves of Croton gratissimus and 
identified as (+) -  [li?, lOi?] - cembra-2E, 4E, IE, 1 lZ-tetraen-20, 10-olide.
CG.6
Figure 3.16: Structure of compound CG.6 : (+) -  [1IÎ, 101?] - Cembra-2£', 4JE', IE, IIZ-
tetraen-2 0 , 1 0 -olide
The HRMS spectrum [Spectrum 3.6.1] of compound CG.6  gave a [M - Na]*^  ion at m/z
323.1980 which indicated a molecular formula of C20H28O2. A double bond equivalence of seven 
was calculated. The FTIR spectrum [Spectrum 3.6.2] gave an absorption band at 1745 cm'  ^that 
was consistent with an a, p -  unsaturated carbonyl group stretch of a y-lactone ring such as in 
compounds CG.l, CG.2, CG.4 and CG.S/^ The NMR spectrum [Spectrum 3.6.4] 
displayed twenty carbon rseonances, which included a carbon resonance at 6 174.0 as in 
compounds CG.l, CG.2, CG.4 and CG.5 and eight double bond carbon resonances. The 
NMR spectrum [Spectrum 3.6.3] showed the presence of four methyl group proton resonances 
at 5 1.70 (s), 1.78 (s) and 0.89 (d, J=  6.80 Hz) and 0.82 (d, 6.80 Hz). The presence of an
isopropyl group in compound CG.9 was seen due to two doublet methyl group proton 
resonances at 0.89 (d, J  = 6.80 Hz) and 0.82 (d, J  = 6.80 Hz) which were both seen to be 
coupled in the COSY spectrum [Spectrum 3.6.8] to a methine proton resonance at ô 1.55 (m) 
assignable to H-15.
A comparison of the ^H NMR and NMR chemical shifts for compound CG.6  and those of 
compound CG.4 [Table 3.4 and Table 3.7] showed that compound CG.6  was a - double bond
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analogue of compound CG.4, 4a - hydroxycembra-2Z, IE, 1 lZ-trien-20, 10-olide. The earlier 
assigned H-15 proton resonance was seen to couple with a proton resonance at 8 1.72 (m) that 
was assigned as the H-1 proton. The H-1 proton resonance was seen to be coupled in the COSY 
spectrum with a double bond proton resonance at 8 5.26 (dd, 15.4, 10.0 Hz) that was ascribed 
as H-2 and two proton resonances at 8 2.41 (m) and 1.38 (m) that were assigned to the two H-14 
proton resonances. Coupling was also observed in the COSY spectrum between the H-2 
resonance and a double proton resonance at 8 6.00 (d, J  = 15.4 Hz). The C-2 (8 130.2)/C-3 (8 
130.8) double bond was determined to be in an E configuration based on the magnitude of the 
coupling constant J2,3 ^ 15.4 Hz.* ’^ The HMBC spectrum showed correlations between
the H-3 proton resonance and the C-1 (8 50.1) and C-2 (8 130.2) resonances and resonances at 8 
135.3, 8 125.1 and 8 19.1 that were ascribed to C-4, C-5 and C-18 respectively. The '^C NMR 
chemical shift for the C-18 methyl group at 8 19.6 indicated an E geometry for the - double 
bond, therefore the 3H-18 methyl group was trans to the H-5 (8 5.49 t J  = 7.5, 15.0 Hz) vinylic
proton. 19,20, 21,22
%
Picture 3.9: A top view photograph of a model for compound CG.6 : (+) -  \\R, 10/f] - 
Cembra-2E, 4E, IE, 1 lZ-tetraen-20,10-olide
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Picture 3.10: A side view photograph of a model of compound CG.6 : (+) -  [li?, 107Î] - 
Cembra-2E, AE, IE, llZ-tetraen-20,10-olide
The NMR chemical shift for the C-19 methyl group at 5 18.0 indicated an E geometry for the 
- double bond, therefore the 3H-19 methyl group was trans to the H-7 (5 5.10 &J = 9.56 Hz) 
vinylic proton. 9^.20, 21,22 3H-18 and 3H-19 methi groups were placed on the p face of the
molecule [Pictures 3.9 and 3.10]. The NOESY spectrum in conjuction with a model [Pictures
3.9 and 3.10] was used to assign the relative stereochemistries of compound CG.6 Following 
from compound CG.3 where the stereochemistry at C-1 was assigned as 7? by X -  ray studies, 
the isopropyl group was tentatively assigned the p -  orientation whereas the H-1 (8 1.72, m) 
proton was placed as a -  orientation. The H-10 (8 5.04, br s, W\/2 = 8.09 Hz) proton was also 
determined to be in the p configuration due to the observed correlation in the NOESY spectrum 
with the 3H-19 (8 1.70, s) proton resonance. The optical rotation for compound CG.6 was 
measured to be + 23.77°. Compound CG.6 was identified as (+) -  [1/?, \0R] - cembra-2Æ, 4E, 
7& 1 lZ-tetraen-20, 10-olide.
Table 3.7: Correlation table for compound CG.6: (+) -  [IR, 1012] - Cembra-2E, 4E, IE,
llZ-tetraen-20,10-olide
No. "C NMR (125 
MHz) CDCI3
NMR (500 MHz) 
CDCI3
HMBC (H C) COSY NOESY
1 50.1 CH 1.72 m 14, 15 2, 14a, 14p 3, 14a, 16, 17
2 130.2 CH 5.26 d d 7= 15 .4 , 10.0 Hz 1,4, 14 1,3 3 ,17 ,18
3 130.8 CH 6.00 d 7 =  15.4 Hz 1,2, 4, 5,18 2 1,2, 6 p, 19
4 135.3 C - - - -
5 125.1 CH 5.4917  = 7.5,15 Hz 3 ,6 ,1 8 18, 6 a, 6 P 6 a, 18
6 a 26.4 CH2 2.4 r 5 6 a 5,6p
6 P 3.05 m 4, 5, 7, 8 5, 6 P, 7 3 ,6a , 19
7 129.1 CH 5.10 d 7 =  9.56 Hz 6 , 9, 19 6a, 6 p 9P,11
8 128.1 C - - - -
9a 41.9 CH2 2.78 d 7  = 14.55 Hz 8 ,1 0 ,1 1 ,1 9 9P, 1 0 9P,10
9p 2.46 m 8 , 19 9a, 10 7, 9a, 19
1 0 81.8 CH 5.04 br s fFi/2 = 8.09 Hz 9 9a, 9P, 11 9a, 9P, 11, 19
1 1 151.3 CH 6.80 s 10, 12, 13 1 0 7, 10, 13,19
1 2 132.5 C - - - -
13a 25.1 CH2 2.33 m ' 11, 12, 14, 20 14a, 14P 1 1
13P 2.33 m ' 11,12, 14, 20 14a, 14P -
14a 26.5 CH2 2.4 T 1 1 ,1 3 ,14P 1 , 14P
14p 1.38 m 12,13 1 ,1 3 ,14a 14a
15 33.0 CH 1.55 m 1 ,2 ,1 4 ,1 6 , 17 1, 16,17 1,16, 17
16 20.9 CH3 0.89 d 7  = 6.80 Hz 1,15,17 15 1,15 ,17
17 20.0 CH3 0.82 d 7 =  6.80 Hz 1, 15, 16 15 1,2, 15,16
18 19.6 CH3 1.78 s 3 ,4 ,5 5 2 ,5
19 18.0 CH3 1.70 s 8 , 9, 10 - 3,6p, 9P, 10,11
2 0 174.0 C - - -
*Refer to overlapped proton resonances 
^Resonances at ô 1.24 in the^H NMR and 5 29. 
present in the sample.
9 in the NMR spectra are for an impurity
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3.2.7 Structural elucidation of compound CG.7: (+) -  [15, 45, IR, 101?] - 1 , 4 , 7  -
Trihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
Compound CG.7 was isolated as a colourless oil from the methylene chloride extract of the stem 
bark of the Croton gratissimus. Compound CG.7 was identified as (+) -  [15, 45, IR, 101?] -1 ,4 , 
7 - trihydroxycembra-2E, 8(19), 1IZ- trien-20, 10-olide.
HQ,
OH /16
0  CG.7
Figure 3.17: Structure for compound CG.7: (+) -  [15, 45, IR, 101?] - 1, 4, 7 - 
Trihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
The HRMS spectrum [Spectrum 3.7.1] of compound CG.7 gave a [M -  Na]^ ion at m/z 
373.1978 which indicated a molecular formula of C20H30O5. A double bond equivalence of six 
was calculated. The FTIR spectrum [Spectrum 3.7.2] displayed presence of absorption bands at 
3411 and 1733 cm* that were attributed to stretches of a hydroxyl group and a carbonyl group 
stretch of an a, P-unsaturated y-lactone ring respectively.^^ Furthermore, the FTIR spectrum 
displayed more absorption bands at 1645 and 847 cm"^  that were attributed to exocyclic double 
bond group stretches.
The NMR spectrum [Spectrum 3.7.3] of compound CG.7 displayed the presence of three 
methyl group proton resonances, two of which belonged to an isopropyl group at 5 0.84 (d, J  =
6.80 Hz) and 0.90 (d, J  = 6.80 Hz) assigned as 3H-16 and 3H-17 and the other at 6 1.36 (s) 
assigned as 3H-18. Exocyclic double bond proton resonances at Ô 5.29 (s) and 5.20 (s), double 
bond proton resonances at 5 5.83 (d, J =  16.15 Hz), 5.20 (d, J =  16.15 Hz) and 6 6.88 (d, J  = 1.4 
Hz) and two oxymethine group proton resonances at 5 4.16 (t, J =  7.10 Hz) and 5.17 (br s, Wm =
8.0 Hz) were also observed in the ^H NMR spectrum. The NMR, DEPT [Spectrum 3.7.5] 
and HSQCDEPT [Spectrum 3.7.6] spectra showed one carbonyl carbon resonance at ô 174.0 
and six double bond carbon resonances and thirteen sp  ^ hybridized carbon resonances, four of
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which were oxygen bearing at 5 77.0, 72.6, 89.8 and 79.6. Compound CG.7 was found to be a 
trihydroxylated and lactonized cembranoid diterpenoid.
The 3H-16 and 3H-17 proton resonances of the isopropyl group were seen to be coupled in the 
COSY spectrum [Spectrum 3.7.8] with a proton resonance at 6 1.70 that was assigned as the H- 
15 proton resonance. The corresponding carbon resonance for the H-15 proton resonance was 
seen to occur at ô 38.8 in the HSQCDEPT spectrum. The HMBC spectrum showed correlations 
between the two isopropyl methyl group proton resonances and the fully substituted carbon 
resonance at 6 77.0 which was assigned as the C-1 carbon. The C-1 (6 77.0) carbon resonance, 
in turn, showed correlations in the HMBC spectrum with double bond proton resonances at 6 
5.46 (d, J =  16.15 Hz) and Ô 5.83 (d, 16.15 Hz), which were seen to be coupled to each other
in the COSY spectrum. These were ascribed as H-2 and H-3 respectively. The corresponding C- 
2 and C-3 carbon resonances were observed at ô 131.5 and 135.9 respectively, and the double 
bond was assigned a trans geometry based on the J2,3 of 16.15 Hz.^  ^ The C-3 carbon resonance 
showed correlations in the HMBC spectrum with two methylene proton resonances at 5 1.79 (m) 
and 1.35 (m) that were assigned to the two H-5 proton resonances and a methyl proton resonance 
at 5 1.36 (s) that was assigned as 3H-18. A correlation in the HMBC spectrum was seen between 
the 3H-18 proton resonance and a fully substituted oxygen bearing carbon resonance at 5 72.6 
that was assigned as C-4. The COSY spectrum showed coupling between one of H-5 (5 1.79 m) 
proton resonances and a proton resonance at ô 1.36 (m) which, in turn, showed coupling in the 
COSY spectrum with a proton resonance at ô 1.68. The two proton resonances at 8 1.68 and 
1.36 (m) was seen to correspond to the same methylene carbon resonance at 5 25.1 in the 
HSQCDEPT spectrum and were assigned as the 2H-6 protons.
The 2H-6 proton resonances were seen to be coupled to a proton resonance at 5 4.16 (t, 7.10
Hz) in the COSY spectrum and was assigned as H-7 and it, in turn, showed correlations in the 
HMBC spectrum with the C-5 (8 38.6) carbon resonance and an exocyclic methylene carbon 
resonance at 8 118.4 that was assigned as C-19. The corresponding H-19A and H-19B proton 
resonances were observed at 8 5.29 (s) and 5.20 (s) in the HSQCDEPT spectrum. Correlations 
were observed between the H-19A and H-19B proton resonances in the HMBC spectrum and 
carbon resonances at 8 34.6 and 8 79.6 that were assigned as C-9 and C-10 respectively. The
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corresponding two H-9 and the H-10 proton resonances were observed at 5 2.80 (dd, J=  4.70, 
15.15 Hz), and 2.40 and 5.17 (br s). Coupling was seen between the H-10 and a double bond 
proton resonance at ô 6.88 (s) that was ascribed to the H-11 proton. The corresponding C-11 
carbon resonance was seen at 6 146.5 in the HSQCDEPT spectrum.
A correlation in the HMBC spectrum was seen between the H-11 proton resonance and the C-10 
(5 79.6) carbon and a carbonyl carbon resonance at Ô 174.0 that was ascribed to C-20. The C-11 
carbon resonance showed correlations in the HMBC spectrum with two methylene group proton 
resonances at 6 2.42 (m) and 2.40 that were assigned to the two H-13 proton resonances. The 
two H-13 proton resonances were seen to be coupled in the COSY spectrum with two proton 
resonances 5 2.05 (m) and 1.80 (m) that were assigned to the two H-14 protons. A correlation 
was also seen between the two H-13 proton resonances and the C-1 (6 77.0) carbon resonance in 
the HMBC spectrum.
The correlations observed in the NOES Y spectrum, the use of a model [Pictures 3.11 and 3.12] 
and comparisons of the ^^ C NMR chemical shifts for compound CG.7 with those of compounds 
CG.4 and CG.5 allowed for the determination of the relative configurations at C-1, C-4, C-1 and 
C-10 for compound CG.7. As there was no H-1 proton as in compounds CG.3, CG.4 and CG.5 
and this compound was not crystalline so X-ray analysis could not be undertaken, therefore C-4 
was selected as the starting point for determination of its relative stereochemistry. The ^^ C NMR 
chemical shift for the oxygen bearing C-4 for compound CG.7 (8 72.6) was very similar to that 
of compound CG.4 (8 72.5) and significantly different from that of compound CG.5 (8 73.6). 
Therefore, the stereochemistry at C-4 for compounds CG.7 was tentatively assigned the S  (the 
3H-18 methyl group was on the (3 face and the hydroxy group was placed on the a face) 
configuration as in compound CG.4.
9 2
HO...
b  CG.7
Figure 3.18: Selected NOESY correlations for compound CG.7: (+) -  [IS, 4S, IR, lOi?] - 1,
4,1 - Trihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
A correlation between the p configured 3H-18 methyl group proton resonance and the 3H-16 and 
3H-17 proton resonances of the isopropyl group suggested that the 3H-16 and 3H-17 methyl 
groups were on the p face. Correlations were also observed in the NOESY spectrum between the 
3H-18 methyl group proton resonance with the H-7 proton resonance which, in turn, showed 
correlation with the H-11 proton resonance. The H-11 proton resonance showed a correlation 
with the H-10 proton resonance in the NOESY spectrum. These correlations suggested that the 
H-7, H-10 and H-11 protons were on the p face. The hydroxyl groups at C-1, C-4 and C-1 were 
determined to be on the a face of the molecule [Figure 3.17]. The optical rotation for compound 
CG.7 was measured to be + 100° Compound CG.7 was therefore identified as (+) -  [IS, 4S, IR, 
lOi?] - 1, 4, 7 - trihydroxycembra-2E, 8(19), IIZ- trien-20, 10-olide.
HQ„
OH /16T
Acetylated CG.7
Figure 3.19: Structure for compound CG.7: (+) -  [IS, 4S, IR, IOjR] - 7 -Acetoxy - 1, 4 - 
dihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
Attempts to grow crystals for compound CG.7 proved difficult. Compound CG.7 was acetylated 
[Figure 3.19] but it was still difficult to get it to crystallize. ID and 2D NMR spectra of the 
acetylated compound CG.7 were acquired [Table 3.9]. The ^H and ’^ C NMR chemical shifts of
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the acetylated compound CG.7 were comparable to those exhibited by compound CG.7 except 
for C-1 and C-19 that were shifted upfield as a result of the carbonyl group of the acetate group. 
The NOESY spectrum supported all the correlations that were observed in compound CG.7 
[Figure 3.18].
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Picture 3.11: A top view photograph of a model for compound CG.7: (+) -  [IS, 4S, IR, lOiî] 
-1 , 4, 7 - Trihydroxycembra-2E, 8(19), HZ- trien-20,10-olide
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Picture 3.12: A side view photograph of a model for compound CG.7: (+) -  [15, 45, IR, 
10/?] -1 , 4, 7 - Trihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
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Table 3.8: Correlation table for Compound CG.7: (+) -  [15,45, IR, 10/?] -1 , 4 , 7
Trihydroxycembra-2E, 8(19), HZ- trien-20,10-olide
No. NMR (125 
MHz) CDCb
H NMR (500 MHz) 
CDCI3
HMBC (H -^ C ) COSY NOESY
1 77.0 C - - - -
2 131.5 CH 5.46 d / =  16.15 Hz 1,4 3 3, 9 3 , 15, 16, 17, 18
3 135.9 CH 5.83 d J =  16.15 Hz 1 2 2, 16,17, 18
4 72.6 C - - - -
5a 38.6 CH2 1.35 m 3 ,4 5 3 2 ,53
5P 1.79 m 3 ,4 5a, 63 5a, 7
6a 25.1 CH2 1 .6 8 ' 4 63,7 2,3
6p 1.36 m 4 6a, 7 11
7 89.8 CH 4.16 t J =  7.10 Hz 5,19 6a, 6 3 5a, 11,18, 19E
8 142.0 C - - - -
9a 34.6 CH2 2.80 dd J= 4 .7 0 , 15.15 Hz 8, 10 9 3 , 1 0 9 3 , 1 0
9P 2.40' 8, 10,11,19 9a, 10 2, 3, 9a, 10,11
10 79.6 CH 5.17 br s ' - 11 9a, 9 3 , 1 1
11 146.5 CH 6.88 s 10, 20 10 2, 7, 9 3 , 1 0 ,14a, 18
12 135.9 C - - - -
13a 20.7 CH2 2.42 m 1,11 14a, 1 4 3 2, 18
13(3 2.40' 1,11 14a, 1 4 3 2 ,3 ,11
14a 34.6 CH2 1.80 m 3, 13 13a,133,14a 1 4 3 , 15,17
14(3 2.05 m 2, 3,13 13a, 1 3 3 , 1 4 3 11, 14a, 15, 18
15 38.8 CH 1.70' 1 ,16 ,17 16,17 2 ,1 6 ,1 7
16 17.7 CH3 0.84 d J =  6.80 Hz 1,15 ,17 15 2, 3 ,143 ,15
17 16.8 CH3 0.90 d J =  6.80 Hz 1,15,16 15 2, 3 , 1 4 3 , 15
18 29.9 CH3 1.36 s 3 ,4 ,5 - 2, 3, 6 a, 7, 13a, 14a, 11
19E 118.4 CH2 5.29 s 9, 10 - 7, 1 3 3 , 18 19A
19A 5.20 s 9, 10 - 2, 1 3 3 , 19E
20. 174.0 C - - - -
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the^H NMR and ô 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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Table 3.9: Correlation table for acetylated compound CG.7: (+) -  [15', 45, IR, 10/?] -  7 -
Acetoxy - 1, 4 - dihydroxycembra-2£', 8(19), HZ- trien-20,10-olide
No. NMR (125 
MHz) CDCI3
H NMR (500 MHz) 
CDCI3
HMBC
( H ^ C )
COSY NOESY
1 7 7 . 0  c - - - -
2 131.7 CH 5.44 d J =  16.20 Hz 1,4 3 3, 5a, 10,15,16, 1 7 ,1 8 ,19A
3 136.2 CH 5.80 d J =  16.20 Hz 4 2 2 ,63 ,18
4 72.9 C - - - -
5a 38.5 CH2 1.76' 3 5 3 2 ,3 ,1 8
53 1.31 m 18 5a 7 ,1 1 ,1 6 ,1 7
6a 27.4 CH2 1.81 s 4 ,7 7, 63 7
63 1.48 m 18 7, 6a 3 , 7 , 9 3
7 77.9 CH 4.89 m 9,19 6a, 6 3 5 3 , 6a, 63, 9 3 , 1 1
8 141.2 C - - - -
9a 36.3 CH2 2.77 dd J =  4.00,14.62 Hz 8, 10, 19 9 3 , 1 0 9 3 , 10,11
93 2.50 d d J= 7 .8 0 , 14.62 Hz 8 ,1 0 ,1 1 ,1 9 9a, 10 63, 7, 9a, 10
10 79.4 CH 5.10 m’ 8, 19 11 9a, 9 3 , 11
11 145.8 CH 6.93 d J =  1.55 Hz 10,20 10, 13 2, 5 3 , 7 ,10
12 136.3 C - - - -
13 20.4 CH2 2.39 m 20 1 1 ,14a, 1 4 3 11, 14a
14a 34.5 CH2 1.78’ 12,13 13, 1 4 3 11, 13, 1 4 3 , 16, 17, 19A
143 2.05’ 2 ,1 2 ,1 3 ,2 0 13, 14a 14a, 17
15 38.4 CH 1.71 septet J =  6.85 Hz 2, 16, 17 16, 17 2 ,1 6 ,1 7
16 17.8 CH3 0.87 d J =  6.80 Hz 1,15,17 15 2 , 5 3 ,15
17 16.8 CH3 0.92 d 6.80 Hz 1, 15, 16 15 2 , 5 3 , 143, 15
18 30.6 CH3 1.35 s 3 ,4 ,5 - 2 ,3 ,5 a
19A 119.1 CH2 5.28 s 8 , 9 ,10 - 2, 14a, 19B
19B 5.11s 9, 10 - 19E
2 0 . 173.8 C - - - -
Ac 21.4 2.03 s’ 7 - -  '
Ac 171.1 - - - -
Refer to overlapped proton resonances
^Resonances at 5 1.24 in the^H NMR and 6 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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3.2.8 Structural elucidation of compound CG.8: (+) -  [IS, 45, 75, 10/2] - 1, 4, 7 -
Trihydroxycembra-2£', 8(19), IIZ- trien-20,10-olide
Compound CG.8  was isolated as a colourless oil from the methylene chloride extract of the stem 
of Croton gratissimus and found to be an isomer (C-7 epimer) of compound CG.7. Compound 
CG.8  was identified as (+) -  [15, 45, IR, 10/2] - 1, 4, 7 - trihydroxycembra-2E, 8(19), 1IZ- trien- 
20, 10-olide.
HQ,
HO' OH /16
0  CG . 8
Figure 3.20: Structure for compound CG.8 : (+) -  [15,45,75,10/2] - la , 4a, 7p - 
Trihydroxycembra-2E, 8(19), IIZ- trien-20,10-olide
The HRMS spectrum [Spectrum 3.8.1] for compound CG.8  gave a [M -  Na]^ ion at m/z
373.1980 which indicated a molecular formula of C20H30O3. The FTIR spectrum [Spectrum
3.8.2] showed the presence of absorption bands at 3428, 1739 and 867 cm'  ^that were attributed 
to a hydroxyl group, a, P -  unsaturated carbonyl group of a y-lactone ring and exocyclic double 
bond group stretches respectively.^^ On the basis of a double bond equivalence of six that was 
calculated from the molecular formula, the presence of twenty carbon resonances in the 
NMR spectrum [Spectrum 3.8.4], including one carbonyl carbon resonance at ô 174.1 and six 
double bond carbon resonances, indicated that compound CG.8  was a bicyclic diterpenoid.
The NMR spectrum [Spectrum 3.8.3] of compound CG.8  showed the presence of three 
methyl group proton resonances at 5 1.38 (s), 0.90 (d, J =  6.60 Hz) and 0.87 (d, J  = 6.60 Hz). 
Exocyclic double bond proton resonances at 6 5.19 (s) and 5.03 (s), an oxymethine proton 
resonances at 6 3.93 (t, J=  7.15 Hz) and double bond proton resonances at 6 6.90 (s), 5.80 (d, J=  
16.10 Hz) and 5. 47 (d J =  16.10 Hz) were also observed in the ^H NMR spectrum for compound 
CG.8 .
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A comparison of the NMR chemical shifts for compound CG.7 and those of compound 
CG.8 indicated that the chemical shifts were very similar except for C-6, C-7, C-8 and C-19 with 
compound CG.7 exhibiting 5 25.1, 89.8, 142.0 and 118.4 whereas compound CG.8 exhibited 5
29.6, 76.8, 145.3 and 115.7 respectively. Differences were also observed between the NMR 
chemical shifts for the 2H-6 (8 1.70 and 1.50, m), H-7 (5 3.93, t, 7.15 Hz) and 2H-19 (8 5.19, 
s and 5.03, s) resonances for compound CG.8 and the CG.7 resonances at 8 1.68 and 1.36 
resonances for 2H-6, 8 4.16 (t, 7.10 Hz) for H-7 and 8 5.29 (s) and 5.03 (s) for the 2H-19
protons.
The coupling constants, a model [Pictures 3.13 and 3.14] and the NOESY spectrum of 
compound CG.8 allowed for the assignment of the configurations and the relative 
stereochemistries. The ^^ C NMR chemical shifts for the oxygen bearing C-1 (8 77.0) and C-4 (8 
72.6) were the same for compounds CG.7 and CG.8. However, there was a remarkable 
difference in the ^^ C NMR chemical shifts for the oxygen bearing C-7 (8 89.8) for compound 
CG.7 which occurred at 8 76.8 (C-7) for compound CG.8. The hydroxyl groups in C-1 and C-4 
in compound CG.8 were tentatively assigned the same orientations as those of compound CG.7 
whereas the hydroxy group attached to C-7 was placed on the opposite face to that of compound 
CG.8. The C-2 (8 131.3) and C-3 (8 136.0) double bond was determined to have the E  geometry 
due to the J2,3 of 16.10 Hz.^  ^ [Figure 3.20]. The stereochemistry at C-10 was also tentatively 
assigned R as in compound CG.7 due to similar chemical shifts for the C-10 (8 79.6) for 
compound CG.7 and 8 79.8 for compound CG.8. The optical rotation for compound CG.6 was 
measured to be - 24.76° Compound CG.8 was identified as (-) -  [15, 45, 75, 10/2] - 1, 4, 7 - 
trihydroxycembra-2E, 8(19), 1 IZ- trien-20, 10-olide.
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Picture 3.13: A top view photograph of a model for compound CG.8: (-) -  [lA, 45, 7 5 ,10/Î] 
-1 , 4, 7 - Trihydroxycembra-lÆ", 8(19), IIZ- trien-20,10-olide
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Picture 3.14: A side view photograph of a model for compound CG.8: (-) -  [15, 45, 75, 10/?] 
-1 , 4, 7 - Trihydroxycembra-lÆ", 8(19), HZ- trien-20,10-olide
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Table 3.10: Correlation table for Compound CG.8: (-) -  [15, 45, 75,1012] - 1, 4, 7 -
Trihydroxycembra-2£', 8(19), HZ- trien-20,10-olide
No NM R (125 
MHz) CDCI3
H NM R (500 MHz) 
CDCI3
HMBC (H -> C) COSY NOESY
1 7 7 . 0  c - - - -
2 131.3 CH 5.47 d J =  16.10 Hz 1,14 3 3 ,6a , 6p, 11, 16, 17,18
3 136.0 CH 5.80 d / =  16.10 Hz 1, 18 2 2, 6a, 9p, 14p, 16, 17,18
4 72.6 C - - -
5a 38.8 CH2 1.79 m 4, 18 5P, 6a, 6p 5P
5P 1.30 m 4, 18 5a, 6a, 6P 5a, 11
6a 29.6 CH2 1.70* 5 ,8 5a, 5p, 6p, 7 2, 3 ,1 8 ,19E
6P 1.50 m - 5a, 5P, 6p, 7 2
7 76.8 CH 3.93 t J =  7.15 Hz 5 ,6 ,9 6a, 6P 11, 19E
8 145.3 C - - - -
9a 34.0 CH2 2.80 dd y  = 1 5 .1 0 ,4.85 Hz 8,19 9P, 10 9P,11,19B
9P 2.32 m 8, 19 9a, 10 3 ,9 a , 1 1 ,14p, 19B
10 79.8 CH 5.14 br s B^ i/2 = 20.05 Hz - 9a, 9P 9a, 9p, 11
11 147.0 CH 6.90 s 10,12, 13, 20 - 2, 5p, 7, 9a, 9P, 1 0 ,14p, 19B
12 135.3 C - - - -
13 20.8 CH2 2.40 m 12 14a, 14p 14P
14a 34.8 CH2 1.82 m 13 13a, 13p, 14a 3, 9P, 13, 14a,
14P 2 . 0 1  m 13, 15 13a, 13P, 14P 13, 14P, 16,17
15 38.5 CH 1.70* 16, 17 16, 17 16, 17
16 17.7 CH3 0.90 d J =  6.60 Hz 15, 17 15 2 ,3 ,1 5
17 16.8 CH3 0.87 d J =  6.60 Hz 15, 16 15 2, 14P, 15
18 29.7 CH3 1.38 s 3 ,5 - 2 , 14p, 6 a
19A 115.7 CH2 5.19 s 7 ,9 19P 6 a, 7
19B 5.03 s 7 ,9 19a 9a, 9P, 11
2 0 . 174.1 C - - - -
Refer to overlapped proton resonances
^Resonances at 8 1.24 in the^H NMR and 5 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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3.2.9 Structural elucidation of compound CG.9: (-) -  [15, 45, lOR] - 1, 4 - 
Dihydroxycembra-2£, IE, IIZ- trien-20,10-olide
Compound CG.9 was isolated as a yellow oil from the methylene chloride of the stem and the 
combined hexane and methylene chloride extract of the leaves of Croton gratissimus. 
Compound CG.9 was found to be the hydroxy derivative of compound CG.4 and was identified 
as (-) -  [15, 45 107^ ] - 1, 4 - dihydroxycembra-2E, IE, 11Z- trien-20, 10-olide.
HQ,
OH/16
CG.9
Figure 3.21: Structure for Compound CG.9: (-) -  [15 ,45107Î] -1,4 - Dihydroxycembra-2£',
IE, IIZ- trien-20,10-olide
The HRMS spectrum [Spectrum 3.9.1] for compound CG.9 gave a [M - Na]^ ion at m/z 
357.2037 which indicated a molecular of C20H30O4. A double bond equivalence of six was 
calculated. The FTIR spectrum [Spectrum 3.9.2] showed absorption bands at 3429 and 1740 
cm'  ^ that were consistent with hydroxyl group and a, p -  unsaturated carbonyl group of a y- 
lactone ring stretches respectively.*^ The *^ C NMR spectrum [Spectrum 3.9.3] showed the 
presence of twenty carbon resonances for compound CG.9, which included one carbonyl carbon 
resonances and six double bond proton resonances. The *H NMR spectrum [Spectrum 3.9.3] 
showed presence of four methyl group proton resonances at 5 1.31 (s), 1.60 (s), 0.86 (d, J=  6.80 
Hz) and 0.90 (d, J=  6.80 Hz). The two methyl group doublet proton resonances at 0.86 (d, J  =
6.80 Hz) and 0.90 (d, J  = 6.80 Hz) were both seen to be coupled to the same methine proton 
resonance at 6 1.67, sp, J  = 6.80 Hz, assigned as H-15 and were attributed to presence of an 
isopropyl group of a cembranoid diterpenoid. On the basis of the double bond equivalence and 
above spectroscopic data compound CG.9 was found to be a bicyclic cembranoid diterpenoid.
The NMR spectrum showed three oxygen bearing carbon resonances at ô 77.0, 72.9 and
80.6. The NMR chemical shifts of compound CG.9 for the C-1, C-2, C-3, C-4, C-11, C-12,
101
C-13, C-14, CG-16, CG-17 and C-20 [Table 3.8 and Table 3.11] resonances were the same as 
those of compound CG.7 wheareas the NMR chemical shifts of compound CG.9 for C-5, C- 
6, C-7, C-8, C-9, C-10, C-18 and C-19 [Table 3.4 and Table 3.11] were the same as those of 
compound CG.4. The NOESY spectrum [Spectrum 3.9.9] in conjunction with a model 
[Pictures 3.15 and 3.16] for compound CG.9 showed a correlation between the 3H-18 methyl 
group proton resonance and the 3H-16, 3H-17, 3H-19 methyl group proton resonanes and one of 
the H-14 proton resonances. The 3H-19 methyl group proton resonance was, in turn, seen to 
correlate with the H-10 oxymethine proton resonance. The measured optical rotation for 
compound CG.9 was found to be - 41.99 . On the basis of the relative stereochemistry that were 
observed for compound CG.4 and compound CG.7, compound CG.9 was identified as (-) -  [ 1S, 
4S, 107C] - 1 , 4 -  dihydroxycembra-2E, IE, 1 IZ- trien-20, 10-olide.
Picture 3.15: A top view photograph of a model for compound CG.9: (-) -  [IS, 4S, 10/?] - 1, 
4 - Dihydroxycembra-2£', IE, IIZ- trien-20,10-olide
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Picture 3.16: A side view photograph of a model for compound CG.9: (-) -  [IS, 4S, 10/?] -1, 
4 - Dihydroxycembra-2£', IE, IIZ- trien-20,10-olide 
Table 3.11: Correlation table for Compound CG.9: (-) -  [15', 45,10/?] -1 , 4 - 
Dihydroxycembra-2Æ, IE, IIZ- trien-20,10-olide
No "C  NMR (125 
MHz) CDCI3
‘H NMR (500 MHz) 
CDCI3
HMBC (H C) COSY NOESY
1 77.0 C - - - -
2 131.9 CH 5 .5 7 d J =  16.10 Hz 1 ,3 ,4 , 14, 15 3 13P, 14a, 15, 16, 17, 18, 19
3 135.8 CH 5.76 d J =  16.11 Hz 1,2, 4 ,5 , 18 2 6 a, 7, 14p, 15, 16, 17, 18, 19
4 72.9 C - - - -
5a 42.4 CH2 1.58 m 3 ,4 ,7 5a, 6 a, 6 P 5P
5P 1.83 m 3 ,4 ,7 5P, 6 p 5a, 18
6 a 23.2 CH2 2 . 2 1  m 4, 5, 7, 8 5a, 5p, 7 7, 19
6 P 2.09 m 4, 5, 7, 8 5p,7 7, 18, 19
7 131.8 CH 5.22 t J =  6.85 Hz 5,6 , 9 ,19 6 a, 6 p, 19 3 ,6 a ,6 p , 9, 18, 19
8 . 128.1 C - - - -
9a 42.4 CH2 2.51 d J - 5 .2 5  Hz’ 7, 8 , 10, 11, 19 1 0 7, 10, 11, 19
9p 2.51 d 7= 5.25  Hz’ 7, 8 , 10, 11, 19 1 0 7, 10, 11, 19
1 0 80.6 CH 5.10 m 8 ,9 ,1 1 ,1 2 9,11 9, 19
1 1 148.5 CH 6.87 d 7 =  1.50 Hz 10, 12,13 10, 13a 2 ,3 ,7 , 9, 10, 13P, 19
1 2 135.3 C - - - -
13a 21.3 CH2 2.41 m 1, 11, 12, 13,20 ll,13p,14a,14p 13p, 14a
13P 2.36 m 1, 11, 12, 13,20 13a 13a
14a 33.7 CH2 2 . 1 1  m 1 ,2 ,12 ,13 ,15 14a 2 ,3 , 14p
14P 1.79 m 1,2, 12, 13, 15 13a, 14p 7, 11, 14a, 16, 17, 18, 19
15 38.9 CH 1.67 sp. 7 =  6.80 Hz 1,2, 16, 17 16, 17 14a, 16, 17
16 17.1 CH] 0.86 d 7 =  6.80Hz 1, 15, 17 15 2 ,3 , 14a, 14P, 15, 18
17 17.5 CH] 0.90 d 7 =  6.85Hz 1, 15, 16 15 2 ,3 , 14a, 14p, 15, 18
18 28.8 CH] 1.31 s 3 ,4 ,5 - 6 p, 7, 14P, 19, 16, 17
19 17.9 CH] 1.60s 7, 8 ,9 7 6 a, 6 p, 7, 9, 10, 11, 14p, 18
2 0 174.5 C - - - -
* Refer to overlapped proton resonances
103
3.2.10 Structural elucidation of compound CG.IO: (+) -  [IS, 4R, HS 10IÎ] - 1, 4 8 - 
Trihydroxycembra-2E, 6E, IIZ- trien-20,10-olide
Compound CG.IO was isolated as a colourless oil from the methylene chloride extract of stem of 
Croton gratissimus and was identified as(+ )-[lS , 4R, SS, lOi?] - 1, 4, 8 - trihydroxycembra-2^, 
6E, 1 lZ-trien-20, 10-olide.
19 =
HOHO,
CG.IO
Figure 3.22: Structure for compound CG.IO: (+) -  [IS, 4R, 85, lOR] - 1, 4, 8 -  
Trihydroxycembra-2E, 6E, IIZ -trien-20,10-olide
The HRMS spectrum [Spectrum 3.10.1] for compound CG.IO gave a [M - Na]"^  ion at m/z 
373.1964 which indicated a molecular formula of C20H30O5. A double bond equivalence of six 
was calculated. The FTIR spectrum [Spectrum 3.10.2] of compound CG.IO exhibited 
absorption bands at 3376 cm'  ^that was attributed to a hydroxyl group stretch and an asorption 
band at 1732 cm'  ^ that was attributed to an a, p - unsaturated carbonyl group stretch of a y- 
lactone ring.^  ^ The ^^ C NMR spectrum [Spectrum 3.10.4] for compound CG.IO displayed 
twenty carbon resonances, which included six double bond resonances and one carbonyl group 
carbon resonance. Compound CG.IO was determined to be a bicyclic diterpenoid.
The ^^ C NMR spectrum showed the presence of four oxygen bearing carbon resonances at 6 
76.8, 72.4, 79.1 and 83.6. The and NMR chemical shifts for compound CG.IO were the 
same as those of compound CG.9 except for the C-5, C-6, C-7, C-8 and C-19 resonances. A 
new C-6 (5 127.4) and C-7 (5 134.8) double bond was observed due to two double bond proton 
resonances at at 8 5.64 (m) and 5.55 (d, 16.35 Hz) assigned as H-6 and H-7 respectively. A
correlation was seen in the HMBC spectrum [Spectrum 3.10.7] between the H-7 proton 
resonance and an oxygen bearing carbon at 5 83.6 that was assigned as C-8 . The H-7 proton 
resonance was also seen to be correlated with a methyl carbon resonance at 8 25.8 attributable to
1 0 4
C-19. The A - double bond was assigned the E geometry due to the vicinal coupling constant of 
16.35
The relative stereochemistry of compound CG.IO was assigned using the NOESY spectrum, a 
model [Pictures 3.17 and 3.18] and deductions from compound CG.9. The two methyl proton 
resonances of the isopropyl group 3H-16 (5 0.84, d, 6.80 Hz) and 3H-17 (8 0.87, d, 6.80 
Hz) showed correlation with the 3H-18 (8 1.37, s) methyl proton resonance as was seen for 
compounds CG.4, CG.7, CG.8 and CG.9 and were placed on the p - face whereas the H-10 (8 
5.13, m) proton resonance was correlated with H-11 (8 7.16, s) proton resonance. The hydroxyl 
group attached to the C-8 carbon was placed in the p -  face of the molecule due to absence of a 
correlation between the 3H-19 methyl group resonance and the p configured H-10 resonance. 
Compound CG.IO was identified as (+) -  [15, 4R, 85, 107?] - 1, 4, 8 -  trihydroxycembra-2E, 6E, 
1 lZ-trien-20, 10-olide.
$
Picture 3.17: A top view photograph of a model for compound CG.IO: (+) -  [15, 47?, 85 
107?] - 1, 4, 8 -  Trihydroxycembra-2E, 6E, llZ-trien-20,10-olide
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Picture 3.18: A side view photograph of a model for compound CG.IO: (+) -  [15, 4R, 85, 
107?] -1 , 4, 8 -  Trihydroxycembra-2£', 6E, llZ-trien-20,10-olide 
Table 3.12: Correlation table for Compound CG.IO: (+) -  [15, 47?, 85,107?] - 1, 4, 8 -  
Trihydroxycembra-2E, 6E, llZ-trien-20,10-olide
No. NMR (125 
MHz) CDCI3
H NMR (500 MHz) 
CDCI3
HMBC (H ^  C) COSY NOESY
1 76.8 C - - - -
2 131.8 CH 5.45 16.15 Hz 1 ,4 ,14 ,15 3 3, 14, 15, 16, 17, 18
3 135.5 CH 5.71 dJ= 16.15 Hz 1 ,4 ,5 , 18 2 2,15,16,17,18
4 72.4 C - - -
5a 45.2 CH2 2.47 dd J =  14.50,11.1 OHz 3, 4, 5, 6 5P,6 18
5P 2.37 m 5a, 6 18
6 127.4 CH 5.64 m 5,6 5a, 5p, 7 7, 9P, 19
7 134.8 CH 5 .5 5 d J=  16.35 Hz 5, 6 , 8 , 9, 19 6 6 , 9P, 19
8 83.6 C - - - -
9a 41.3 CH2 2.62 dd J -  19.91, 14.20 Hz 7, 8 , 10, 11, 19 9P, 10 9P, 10, 19
9p 1.93 m 9a, 10 6 , 7, 9a, 10
1 0 79.1 CH 5.13 b rs lC,/2 = 17.97 Hz 9, 10 9a, 9P, 11 9a, 9p, 14p
1 1 150.2 CH 7.16 s 10, 12, 13,20 10, 13 7, 10
1 2 133.1 C - - - -
13a 2 0 . 2  CH2 2.30 m* 11, 12, 14, 20 11, 14a, 14p 14a, OH
13P 2.30 m* 11, 12, 14, 20 11, 14a, 14P OH
14a 35.0 CHz 2.05 m 12, 13 13, 14p 13a, 14p
14P 1.78 m - 13, 14a 2, 14a
15 38.9 CH 1.64 sp J= 6.80 Hz 1, 14, 16, 17 16, 17 2
16 I 7 .8 CH3 0.84 d J =  6.80 Hz 1, 15, 17 15 15
17 16.8 CH] 0.87 d J =  6.80 Hz 1, 15, 16 15 15
18 29.5 CH3 1.37 s 3 ,4 ,5 - 2, 3, 5a, 5P
19 25.8 CH2 1.39 s 7, 8 ,9 - 9a
2 0 175.0 C - - - -
-OH 8.60 broad singlet - - 13a, 13P
‘Refer to overlapped proton resonances
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3.2.11 Structural elucidation of compound CG.ll: Eudesm-4(15)-ene-lp, 6a-dioI 
Compound C G .ll was isolated as a colourless oil from the hexane extract of the stem bark of 
Croton gratissimus and identified as the known eudesm-4( 15)-ene-1 (3, 6a-dioL
OH
OH
CG.ll
Figure 3.23: Structure for compound CG.ll: Eudesm-4(15)-ene-lp, 6a-diol
The LREIMS spectrum [Spectrum 3.11.1] for compound CG .ll showed a molecular formula of 
C15H26O2 due to a molecular ion peak at m/z 238. A double bond equivalence of three was 
calculated. The LREIMS spectrum showed fragment ions at m/z 220, [M-18]^ for a loss of a unit 
of H2O, m/z 202, [M-36]^ for losses of two units of H2O and m/z 177, [M-18-43]^ for a further 
loss of an isopropyl group fragment.^^ The FTIR spectrum [Spectrum 3.11.2] gave an 
absorption band at 3428 cm'  ^ that was attributed to a hydroxyl group stretch and absorption 
bands at 1639 cm'  ^and 873 cm'  ^that were attributed to exocyclic double bond s tre tch es .T h e  
NMR [Spectrum 3.11.4], DEPT [Spectrum 3.11.5] and HSQCDEPT [Spectrum 3.11.6] 
spectra showed that compound CG .ll possessed three methyl groups, five methylene groups, 
five methine groups and two fully susbstituted carbon resonances. The NMR spectrum 
[Spectrum 3.11.3] displayed one methyl group singlet proton resonance at ô 0.71 (s), and two 
methyl group doublet proton resonances at 0.87 (d, J=  7.05 Hz) and 0.95 (d, J=  7.05 Hz), that 
were consistent with an isopropyl group. Exocyclic double bond proton resonances at 5 4.75 (s) 
and 5.02 (s), two oxymethine proton resonances at 5 3.42 (dd, J =  11.6, 4.7 Hz) and ô 3.72 (t, J  = 
9.8 Hz) and a methine proton resonance at ô 2.24 (m) were also observed in the ^H NMR 
spectrum of compound CG.ll The above spectral information was consistent with an 
eudesmane sesquiterpenoid.
The two doublet methyl group proton resonances at 5 0.87 (d, J=  7.05 Hz) and 0.95 (d, J =  7.05 
Hz) of an isopropyl group were assigned as 3H-12 and 3H-13 respectively. The 3H-12 and 3H-
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13 proton resonances displayed a correlation in the HMBC spectrum [Spectrum 3.11.7] with 
carbon resonances at 5 49.5 and 26.2 that were attributable to C-7 and C-11 respectively. The 
corresponding H-7 and H-11 proton resonances were seen in the HSQCDEPT spectrum at ô 1.29 
(m) and 6 2.24 (m) respectively. The COSY spectrum showed coupling between the H-7 proton 
resonance and the oxymethine proton resonance at 8 3.72 (t, J  = 9.8 Hz) that was assigned as H- 
6 which, in turn, showed coupling with a methine proton resonance at 8 1.75 (d, J =  9.80 Hz) 
which was assigned as H-5. The corresponding C-6 and C-5 carbon resonances were seen in the 
HSQCDEPT spectrum to occur at 8 67.2 and 8 56.1 respectively. Correlations were seen 
between the H-5 proton resonance and carbon resonances at 8 42.0 and 11.8 in the HMBC 
spectrum that were assignable to C-10 and C-14 respectively. The C-5 (8 56.1) and C-10 (8 
42.0) carbon resonances showed correlations with a proton resonance at 8 1.85 (m) that was 
ascribed to one of the H-2 protons. The COSY spectrum showed coupling between the first H-2 
proton resonance (8 1.85, m) and the other H-2 proton resonance at 8 1.53 (m) and two other 
proton resonances at 8 2.05 (m) and 2.34 (m) that were assigned to two H-3 protons. A 
correlation was also seen in the HMBC spectrum between one of the H-2 proton resonance (8 
1.53, m) and a carbon resonance at 8 79.2 that was ascribed to C-1. The corresponding C-2 and 
C-3 carbon resonances were assigned as 8 32.1 and 35.3 respectively in the HSQCDEPT 
spectrum. Correlations were observed in the HMBC spectrum between the C-3 (8 35.3) and C-5 
(8 56.1) carbon resonances and the exo- methylene proton resonances as 8 4.75 (d, J=  0.90 Hz) 
and 5.02 (d, J=  0.90 Hz) that were assignable to H-15A and H-15B.
The relative configuration of compound C G .ll was assigned using the NOESY experiment. 
The existence of correlations in the NOESY spectrum between the H-1 (8 3.42, dd J =  11.6, 4.7 
Hz), the H-5 (8 1.75, d J  = 9.80 Hz), and the H-7 (8 1.29, m) proton resonances indicated that H- 
1, H-5 and H-7 were on the same face of the molecule. Therefore, the orientations of the 
hydroxyl groups in C-1 and C-6 positions were on the opposite sides of the molecule to each 
other. The measured optical rotation for compound C G .ll was found to be + 44°, whereas the 
reported optical rotation value was + 45°.^  ^ Compound C G .ll was identified to be the known 
eudesmane sesquiterpenoid, eudesm-4(15)-ene-ip, 6a-diol.^^’ A comparison of the ^^ C 
NMR chemical shifts of compound C G .ll with those of the known eudesm-4(15)-ene-lp, 6a- 
diol ftirther confirmed the proposed structure (Table 3.13).^^ Eudesm-4( 15)-ene-1 p, 6a-diol was
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isolated for the first time by Bohlmann and co workers in 1983^  ^ from Senecio species. Eudesm-
4(15)-ene-ip, 6a-diol has also been isolated from Litsea verticillata^^ and Caragana 
intermedia^^. A  fraction that yielded the eudesm-4(15)-ene-lp, 6a-diol from the Litsea 
verticillata was reported to exhibit 39% inhibition of in vitro HIV-1 replication in H0G.R5 cells 
at 10 pg/ml in the complete absence of cytotoxicity.^^
Table 3.13: Correlation table for compound CG.ll: Eudesm-4(15)-ene-ip, 6a-diol
No. "C NMR (125 
MHz) CDClj
"C NMR (100 
MHz) CDCl;"’
‘H NMR (500 MHz) CDCl; 'H  NMR (400 MHz) 
CDCl;”
HMBC
(H->C)
COSY NOESY
I 79.2 CH 79.1 3.42 d d J =  11.6,4.7 Hz 3.42 d d J =  11.7,4.8 Hz X 2a, 2p 2a, 3a, 5 ,7
2a 32.1 CHz 32.0 1.85 m 1.85 m 5 ,10 1,2P, 3a 1,2P
2p 1.53 m 1.53 q d y = 1 1 .7 ,5 .0  Hz 1 l,2 a ,3 p 2a, 13
3a 35.3 GHz 35.2 2.05 m 2.09 m X la , 2a, 3P 1,3P
3p 2.34 m 2.53 m 5 2p ,3a 3a
4 146.5 C 146.3 - - - - -
5 56.1 CH 55.9 1.75 d J =  9.80 Hz 1.75 d J  = 9.8 Hz 6 ,1 0 ,1 4 6 1
6 67.2 CH 67.1 3.72 t J  = 9.8 Hz 3.71 t d J = 9 .8 ,1.7 Hz X 5 ,7 12, 1 4 ,15A
7 49.5 CH 49.4 1.29 m 1.30 m X 6 1
8a 18.4 CHz 18.2 1.25 m 1.25 m X 8P 8P
sp 1.60 m 1.53 m X 8a 8a
9a 36.5 CH2 36.4 1.19m 1.20 m X 9P 9P
9P 1.90 m 1.90 m X 9a 9a
10 42.0 C 41.8 - - - - -
11 26.2 CH 26.1 2.24 m 2.25 se p td J =  7.0,2.4 Hz 13 12,13 12,13
12 16.4 CH; 16.2 0.87 d J =  7.05 Hz 0 .87d J  = 7.0H z 7 ,1 1 ,1 3 11 6,11
13 21.3 CH; 21.2 0.95 d 7 = 7 .0 5  Hz 0.95 d J = 7.0 Hz 7 ,1 1 ,1 2 11 2P,11
14 11.8CH; 11.7 0.71 s 0.70 s 1 ,5 ,9 , 10 - 6
15A 108.0 CHz 107.9 4.75 s 4 .7 4 d J = l . lH z 3 ,5 15E 6 , 15A
15E 5.02 s 5 .0 2 d J = l . lH z 3 ,5 15A 15E
^Resonances at 5 1.24 in the ^H NMR and 5 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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3.2.12 Structural elucidation of compound CG.12: 3a-Hydroxy-D: B-friedoolean-5-ene (3-
^f-glutinol)
Compound CG.12 was isolated as a white solid from the combined hexane and methylene 
chloride extracts of the leaves of Croton gratissimus and was identified as the known 3-epi- 
glutinol.
HO'
CG.12
Figure 3.24: Structure for compound CG.12: 3-l^f-glutinol
The LREIMS spectrum [Spectrum 3.12.1] for compound CG.12 displayed a molecular ion peak 
at m/z 426 which supported a molecular formula of C30H50O. The LREIMS spectrum showed a 
fragment ion at m/z 393, [M-18-15]^ for a loss of a unit of H2O and a further loss of a CH3 
f r a g me n t . A double bond equivalence of six was calculated for compound CG.12. The FTIR 
spectrum [Spectrum 3.12.2] for compound CG.12 showed an absorption band at 3447 cm'^ that 
was attributable to an hydroxyl group stretch and absorption bands at 2929 and 2865 cm'  ^ that
were attributed to CH stretches. 13
The NMR spectrum [Spectrum 3.12.3] indicated the presence of eight methyl group singlet 
proton resonances at 5 1.04 (s), 1.14 (s), 0.85 (s), 1.11 (s), 1.01 (s), 1.16 (s), 0.99 (s) and 0.95 (s), 
one oxymethine proton resonance at 8 3.47 (br s, W1/2 = 6.0 Hz) and a double bond methine 
proton resonance at 5 5.64 (d, J  = 5.6 Hz). The ^^ C NMR [Spectrum 3.12.4] and DEPT 
[Spectrum 3.12.5] spectra showed thirty carbon resonances including one oxymethine carbon 
resonance at 8 76.6 and two double bond carbon resonances at 8 141.8 and 122.3. On the basis 
of the calculated double bond equivalence, compound CG.12 was found to be a pentacyclic 
triterpenoid possessing one double bond.
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The observed correlations in the HMBC spectrum [Spectrum 3.12.7] for two methyl group 
proton resonances at ô 1.04 (s) and 5 1.14 (s) with an oxymethine carbon resonance at 8 76.6 and 
a double bond carbon resonance at 8 141.8, indicated that compound CG.12 was a 3-hydroxy, 
triterpenoid.^^ The optical rotation of compound CG.12 was found to be + 77.81°. A search in 
the literature for the ^^ C NMR chemical shifts (Table 3.14) showed that compound CG.12 was 
the known a-glutinol^^’ previously isolated fi*om Salvia glutinosa, Scoparia dulcis^^ and 
Melicope octandra^^ but reported here for the first time fi*om the Croton genus.
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Table 3.14: Correlation table for compound CG.12: 3a-Hydroxy-D: B-friedoolean-5-ene
(3-e/7i-glutinol)
No. "C NMR (125 MHz) 
CDCI3
"C NMR" (50.3 MHz) 
CDCl)
‘H NMR (500 MHz) 
CDCl)
*H NMR" (90 MHz) 
CDCl)
la 18.5 CH2 18.2 1.55 m
IP 1.47 m
2a 28.1 CH2 27.8 1.85 m
2P 1.69 m
3 76.6 CH 76.3 3.47brs,Wifl = 6.0Hz 3.44 br s, Wi/2 = 6.0 Hz
4 41.1 C 40.8 -
5 141.8 C 141.6 -
6 122.3 CH 122.1 5.64 d, y  =5.6 Hz 5.61 d ,y=5 .9H z
la 23.9 CH2 23.6 1.96 m
7P 1.85 m
8 47.7 CH 47.4 1.52 m
9 35.1 C 34.8 -
10 49.9 CH 49.6 2.02 m
11a 34.8 CH2 34.6 1.55 m
lip 1.40 m
12a 30.6 CH2 30.3 1.34 m*
12P 1.34 m*
13 38.1 C 37.8 -
14 39.5 C 39.3 -
15a 32.3 CH2 32.0 1.46 m
15P 1.30 m
16a 36.3 CH2 36.0 1.53 m
16P 1.38 m
17 30.3 C 30.1 -
18 43.3 CH 43.0 1.58 m
19a 35.3 CH2 35.0 1.40 m*
19p 1.40 m*
20 28.5 C 28.2 -
21a 33.3 CH2 33.1 1.28 m
2ip 1.26 m
22a 39.2 CH2 38.9 1.54 m
22P 0.92 m
23 29.2 CH3 28.9 1.04 s 1.02 s
24 25.7 CH) 25.4 1.14s 1.14s
25 16.5 CH) 16.2 0.85 s 0.82 s
26 19.8 CH) 19.6 1.11 s 1.02 s
27 18.6 CH) 18.4 1.01 s 0.98 s
28 32.3 CH) 32.0 1.16s 1.23 s
29 32.6 CH) 32.4) 0.99 s 0.96 s
30 34.7 CH) 34.5 0.95 s 0.93 s
Refer to overlapped proton resonances
1 1 2
3.2.13 Structural elucidation of compound CG.13: 3p-Hydroxylup - 20(29) - eue (lupeol) 
Compound CG.13 was isolated as a crystalline white solid from the hexane and methylene 
extracts of the stem bark of Croton gratissimus and identified as the known lupeol, which has 
been isolated previously from many sources.
'29
19 21
HO'
24 CG.13
Figure 3.25: Structure of compound CG.13: 3p-Hydroxylup - 20(29) - ene (lupeol)
The LREIMS spectrum [Spectrum 3.13.1] showed a molecular ion peak at m/z 426, which 
corresponded to a molecular formula of C30H50O. A double bond equivalence of six was 
calculated. The FTIR spectrum [Spectrum 3.13.2] showed an absorption band 3437 cm'  ^that
was attributed to a hydroxy group stretch. 13,33,36
The NMR spectrum [Spectrum 3.13.3] of compound CG.13 showed the presence of seven 
methyl group proton resonances at ô 1.69, 0.77, 0.79, 0.83, 0.97, 0.98, 1.02, and 1.69, which 
corresponded to the carbon resonances at 619.5, 18.2, 14.7, 16.2, 16.3, 15.6, and 28.2 in the 
NMR spectrum [Spectrum 3.13.4] and HSQCDEPT spectrum [Spectrum 3.13.6].^  ^ The 
NMR spectrum showed a proton resonance at 5 3.18 (IH, dd, J=  11.35, J=  4.85 Hz) which was 
seen to correspond to a carbon resonance at 6 79.3 in the HSQCDEPT spectrum. This proton 
resonance and the H-5 proton resonance at 6 0.69 were seen to correlate in the HMBC spectrum 
with the 3H-23 and 3H-24 methyl group resonances at 6 0.97 and 0.77. The HMBC spectrum 
showed correlation between the downfield methyl group resonance at 6 1.69 and the two non­
equivalent methylene proton resonances at 6 4.68 and 4.56 which were ascribed to H-29A and H- 
29B. Compound CG.13 was identified as the known 3p-hydroxylup-20(29)-ene, commonly 
known as the lupeol, which has been evaluated for its anti-inflammatory and anti-angiogenic 
activities.^^’ A literature search revealed that the ^^ C NMR chemical shifts similar to those of 
compound CG.13 had reported for lupeol (Table 3.15).^ "^ ’^^
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Table 3.15: Correlation table for compound CG.13: 3p-Hydroxylup - 20(29) - ene (lupeol)
No. " C  NM R (125 MHz) 
(CDCI3 )
NM R (100 MHz) HNM R (500 MHz) 
(CDCI3 )
HM R (400 MHz)
la 38.9 CH2 38.7 1.65 m 0.90 d
IP 0.91 m 1.671
2 a 27.6 CH2 27.4 1.60 m 1.60 d
2 P 1.56 m 1.56 q
3 79.2 CH 79.0 3.18 d d ,J =  11.35, 4.85 Hz 3.19 dd
4 38.9 C 38.8 - -
5 55.5 CH 55.3 0.69 d, J= 9 .2 5 H z 0 . 6 8  d
6 a 18.5 CH2 18.3 1.51 m 1.51 d
6 P 1.39' 1.39 q
7a 34.5 CH2 34.3 1.38' 1.39 m
7p 1.38' 1.39 m
8 40.1 C 40.8 - -
9 50.7 CH 50.4 1.27 m 1.27d
1 0 37.4 C 37.2 - -
1 1 a 2 1 . 2  CH2 20.9 1.41 m 1.41 d
l ip 1 . 2 1  m 1.23 q
1 2 a 25.4 CH2 25.2 1.06 m 1.07 q
12P 1.67' 1.67 d
13 38.3 CH 38.1 1.64' 1 . 6 6 1
14 43.1 C 42.9 -
15a 27.6 CH2 27.5 1 . 0 0  m 1 . 0 0  d
15p 1.67' 1 . 6 8  t
16a 35.8 CH2 35.6 1.38' 1.371
16P 1.47 d 1.47
17 4 3 . 2  c 43.0 - -
18 48.5 CH 48.0 1.35' 1.36 1
19 48.2 CH 47.9 2.38 m 2.39 m
2 0 151.2 C 151.0 - -
2 1 a 29.9 CH2 29.9 1.32' 1.32 m
2 1 p 1.92 m 1.92 m
2 2 a 40.2 CH2 40.0 1.19 m 1.19 m
22P 1.38' 1.38 m
23 28.2 CH3 28.0 0.97 s 0.97 s
24 15.6 CH3 15.4 0.77 s 0.77 s
25 16.3 CH3 16.1 0.83 s 0.83 s
26 16.2 CH3 16.0 1 . 0 2  s 1.03 s
27 14.7 CH3 14.6 0.98 s 0.95 s
28 18.2 CH3 18.0 0.79 s 0.79 s
29A 109.5 CH2 109.3 4.56 br s 4.56 m
29B 4.68 br s 4.69 m
30 19.5 CH3 19.3 1.69 s 1 . 6 8  s
Refer to overlapped proton resonances
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3.2.14 Structural elucidation of compound CG.14: 24-Ethylcholesta-4, 22-dien-3-one 
Compound CG.14 was isolated as a clear crystalline compound from the hexane and methylene 
chloride extracts of the stem bark of Croton gratissimus and identified as 24-ethylcholesta-4, 22- 
dien-3-one, which is widely found in the Plant Kingdom."^ ®’
29
CG.14
Figure 3.26: Structure of compound CG.14: 24-Ethylcholesta-4,22-dien-3-one
The LREIMS spectrum [Spectrum 3.14.1] for compound CG.14 showed a molecular ion peak at 
m/z 410 which indicated a molecular formula of C29H46O. The FTIR spectrum [Spectrum
3.14.2] gave an absorption band at 1699 cm'  ^that was attributed to a carbonyl group s t r e t c h .A  
double bond equivalence of seven was calculated. The ^^ C NMR spectrum [Spectrum 3.14.4] 
showed presence of a ketone carbon resonance at ô 199.9 and four double bond carbon 
resonances at 5 171.9, 138.3, 130.0 and 124.0. Compound CG.14 was determined to be 
tetracyclic.
The NMR spectrum [Spectrum 3.14.3] of compound CG.14 showed six methyl group proton 
resonances, two of which were doublet methyl group proton resonances at ô 0.81 (d, J =  4.5 Hz) 
and 0.88 (d, J  = 4.5 Hz), consistent with an isopropyl group, three double bond methine proton 
resonances at Ô 5.72 (br s), 5.14 (dd, J  = 8.5, 15 Hz) and 5.02 (dd J  = 8.5, 15 Hz) that were 
ascribable to H-4, H-22 and H-23 respectively of 24-ethylcholest-4, 22-dien-3-one. The 
NMR chemical shifts for compound CG.14 and those of the known 24-ethylcholest-4-en-3-one 
[R.3]"^ ° and 24-ethylcholest-4, 22-dien-3-one were found to be the same."*^  Compound CG.14 
was determined to be the widely known 24-ethylcholest-4, 22-dien-3-one.'^®’'^ *
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Table 3.16: Correlation table for compound CG.14: 24-Ethylcholesta-4,22-dien-3-one
No. NM R (125 
MHz) CDCI3
" C  NM R (175 
MHz) CDCI3
" C  NM R (175 
MHz) CDCI3  IR-Sl""
"H NM R (500 MHz) 
CDCI3
H NM R (300 MHz) 
CDCb^^
la 35.9 CH2 36.40 2 . 0 1  m
IP 1.69 m
2a 34.2 CH2 34.71 2.32 m
2 P 2.40 m
3 199.9 C 200.57 -
4 124.0 CH 124.45 5.72 br s 5.72 s
5 171.9 C 172.62 -
6 a 33.1 CH2 33.70 2.25 m
6 P 2.35 m
7a 32.1 CH2 32.77 1.83 m
7P l.OT
8 35.8 CH 36.33 1.52 m
9 54.0 CH 54.53 0.92 m
1 0 39.7 C 39.34 -
1 1 a 2 1 . 2  CH2 21.75 1.42 m
l ip 1.52 m
1 2 a 39.8 CH2 40.34 2.05 m
12P 1.15 m
13 42.6 C 43.11 -
14 56.1 CH 56.59 i . i r
15a 24.4 CH2 24.92 1 . 2 2  m
15P 1.28 m
16a 28.4 CH2 28.94 1 . 1 0 '
16P 1.60 m
17 56.2 CH 56.71 1 .0 2 '
18 1 2 . 2  CH3 12.69 0.75 s
19 18.1 CH3 18.11 0.83 s
2 0 46.1 CH 41.24 2.07 m
2 1 20.0 CH3 2 1 . 8 6 1.04 s
2 2 138.2 CH 138.89 5.14 d d J =  8.5,15 Hz 5.15 dd J =  15.2, 8.4 Hz
23 130.0 CH 130.15 5.02 dd J =  8.5,15 Hz 5.02 dd J =  15.2, 8.4 Hz
24 51.5 CH 51.97 1.52 s
25 32.1 CH 32.61 1.60 s
26 19.2 CH3 19.76 0.81 d J = 4 .5 H z 0.80 d J  = 6.5 Hz
27 21.2 CH3 21.91 0.88 d J =  4.5 Hz 0.85 d J  =6.4  Hz
28a 26.3 CH2 26.16 1 . 2 0  m
28P 1.45 m
29 12.2 CH3 13.01 0.83 ty =  4.5 Hz 0.81 t J =  7.5 Hz
Refer to overlapped proton resonances
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3.3 Conclusion
C. gratissimus yielded ten novel cembranoid diterpenoids (+) -  [lOi?] - cembra-lE, 3E, IE, 1IZ, 
16-pentaen-20, 10-olide, CG.l, (+) -  [lOi?] -  cembra-lZ, 3Z, IE, IIZ, 15-pentaen-20, 10-olide, 
CG.2, (+) -  [li?, 2S, IS, 85', 12i?] -  7, 8 - epoxy- 2, 12 - cyclocembra-SE, lOZ-dien-20, 10-olide, 
CG.3, (+) -  [li?, 4S, 107?] - 4 - hydroxycembra-2Z, IE, 1 lZ-trien-20, 10-olide, CG.4, (-) -  [17?, 
47?, 107?] - 4 - hydroxycembra-2E, IE, IIZ- trien-20, 10-olide, CG.5, (+) -  [17?, 107?] - cembra- 
2E, 4E, IE, 1 lZ-tetraen-20, 10-olide, CG.6 , (+) -  [1*S, 45, 7R, 107?] -1 , 4, 7 - trihydroxycembra- 
2E, 8(19), IIZ- trien-20, 10-olide, CG.7, (-) -  [15, 45, 75, 107?] - 1, 4, 7 - trihydroxycembra-2E, 
8(19), IIZ- trien-20, 10-olide, CG.8 , (-) -  [15, 45 107?] - 1, 4 - dihydroxycembra-2E, IE, IIZ- 
trien-20, 10-olide, CG.9 and (+) -  [15, 47?, 85, 107?] - 1, 4, 8 - trihydroxycembra-2E, 6E, IIZ- 
trien-20, 10-olide, CG.IO. The occurrence of cembranoid diterpenoids from the Croton genus, 
which has over 1223 species^ has been reported from only three Croton species, C. poilanei^^ 
C. robustus^^ and C. oblongifolius^^’ that are native to Asia. Therefore, the isolation of
cembanoid diterpenoids from the African C. gratissimus is the fourth time from Croton genus 
but the first report from any African Croton species.
It was straightforward to assign the and ^^ C NMR chemical shifts of the ten cembranoid 
diterpenoids from ID and 2D NMR spectra, but it was challenging to assign their absolute or 
relative stereochemistries. One cembranoid diterpenoid, (+) -  [17?, 25, 75, 85, 127?] -  7, 8 - 
epoxy- 2, 12 - cyclocembra-3E, lOZ-dien-20, 10-olide, CG.3 was crystalline and a single X-ray 
crystal experiment was performed, therefore permitting the assignment of its relative 
configuration. Compounds CG.4, CG.5 and CG.6 were assigned the 7? configuration at C-1 as 
compound CG.3 and was further confirmed by the configuration of poilaneic acid, isolated from 
C. poilane?^ and C. robustus.^ The use of models, ^^ C NMR shemical shifts of vinylic methyl 
carbon resonance and NOES Y experiment assisted in the assignment of the configuration
at C-10 as 7?. The C-10 configuration was determined to be the same for nine of the cembranoids 
diterpenoids, CG.l, CG.2, CG.4, CG.5, CG.6, CG.7, CG.8, CG.9 and CG.IO.
Cembranoid diterpenoids are reported to be mainly found in marine invertebrates, insects and 
t o b a c c o V a r i o u s  roles of cembranoids isolated from coral colonies have been reported."^ ’^ 
This include being toxic to fish (mosquitofish),'^^ feeding deterrence (local reef fish),"^ ^
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allelopathy (to eliminate the competition)/^ anti-fouling (to limit/select algae)"^  ^ and spawning 
(explosion of egg of polyp)/^ Previous works have demonstrated that some cembranoid 
diterpenoids possesses significant activities including anti-inflammatory, anti-parasitic and more 
frequently cytotoxic properties/^’ The anti-tumour effect of this class of compounds is one of 
the most important activities/^’ One of them, sarcophytol A [R.4], an oxygenated cembranoid 
diterpenoid isolated from the soft coral Sarcophyton glaucum has been shown to inhibit the 
development of large bowel cancer in female rats, as well as to suppress carcinogenesis in liver, 
breast, thymus and skin in mice/^’
PHPH
OH
R.7R.6R.4 R.5
Figure 3.27: Structures of cytotoxic cembranoid diterpenoids^^’
Three furanocembranoids, R.5, R .6 and R.7 that were isolated from Croton oblongifolius Roxb., 
a Thai folk medicinal plant, have been showed to exhibit good cytotoxicity against BT474 
(human breast ductol carcinoma), CHAGO (human undifferentiated lung carcinoma), Hep-G2 
(human liver hepatoblastoma), KATO-3 (human gastric carcinoma) and SW-620 (human colon 
adreno carcinoma) human tumour cell lines [Figure 3.27].^^
Other compounds isolated from C. gratissimus included eudesm-4(15)-ene-lp, 6a-diol, C G .ll, 
3a-hydroxy-D: B-friedoolean-5-ene, CG.12, 3p-hydroxylup-20(29)-ene, CG.13 and 24- 
ethylcholesta-4, 22-dien-3-one, CG.14. One of the aim of this study was to investigate whether 
C. gratissimus that has been reported to be synonymous to C. zambesicus Muell. Arg. yielded the 
same compounds. However, C. gratissimus yielded cembranoids, sesquiterpenoid and 
terpenoids whereas C. zambesicus Muell. Arg. has been reported to yield labdane, clerodane, 
trachylobane diterpenoids and flavone-C-glycosides.^’ Compounds that were isolated from 
C. gratissimus were evaluated for their anti-plasmodial activities against P. falciparum (CQS) 
DIO strain and cytotoxicities on tumour liver cells (HUH7 strain) and ovarian cancer cells (PEOl 
and PEOlTaxR). Their results are presented in section 6.0 below.
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CHAPTER FOUR: THE PHYTOCHEMISTRY OF CROTONSYLVATICVS HOECHST
4.1 Introduction
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4.1.1 C. sylvaticus Hoechst: Botany, uses and chemistry
Croton sylvaticus is a deciduous tree that grows from 3.5 to 30 m tall with a spreading crown.'’ 
The leaves of C. sylvaticus are broad, 6 -  14 by 3 -  11 cm, and are at first densely stellate 
pubescent then later become sparsely pubescent [Picture 4.1].^’"^
Picture 4.1: The leaves of C. sylvaticus
C. sylvaticus bears greenish -  cream flowers between September and January, which are up to 3 
mm long and consist mainly of male flowers with a few female flowers found towards the base.^ 
The fruits [Picture 4.2] occur between December and May and are orange or red in colour. They 
are trilobed and covered with short hairs.^’ ’^^
Picture 4.2: The fruits of C. sylvaticus
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c. sylvaticus grows in forest and evergreen habitats. It is distributed from Ethiopia in the north 
to the Eastern Cajpe in South Africa.^ This tree is also recorded to be found rarely in Guinea to 
South Nigeria and more widely found in Gabon to Angola^ The species name sylvaticus means 
growing in wood and/or growing in the forest, therefore its common names, Woodland Croton or 
Forest Croton.^ The pulverized bark is steeped in milk and used to treat severe abdominal pains. 
The bark powder is also used to treat rheumatism, chest pains, and inflammation by rubbing into 
scarifications. The bark is also used in Gazaland (modem day Zimbabwe and Mozambique) as a 
fish poison.^’  ^ The Swazi people use powdered bark to treat gall-sickness in cattle.^ The root 
is used as a remedy for indigestion and for the treatment of pleurisy. Some parts of the plant are 
also used to treat malaria.^ C. sylvaticus is used in East Africa for firewood, charcoal, timber, 
poles, shade and as an ornamental, and it is used to line avenues.^
The Luganda people of Uganda call C. sylvaticus “ musogasoga” whereas the Luos of Kenya 
call it “ Chetwindo” .^  The Zulus of South Africa call it “ Umzilanyoni” .^  Watt and Breyer- 
Brandwijk (1962)^ in their book “ the Medicinal and Poisonous Plants of Southern and Eastern 
Africa” report that the root of C. sylvaticus contains toxalbumin crotin (G19). Toxalbumin 
crotin (G19) is a glycoprotein molecule that is attached to crotin, a dihydrochalcone [Figure 4.1], 
and glycosylated protein.^ However, a search for the chemical constituents of the C. sylvaticus 
in the three of the main natural product databases, the Dictionary of Natural Products, SciFinder 
and Napralert, did not reveal any reported phytochemical analysis for C. sylvaticus.
OH
HO.
OH
Figure 4.1: Structure of crotin^
Frum and Viljoen (2005)^ reported that both the water and methanol extracts of C. sylvaticus 
exhibited very promising 5-lipoxygenase inhibitory activity.^
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4.1.2 Classification of elerodanes and e«/-clerodanes diterpenoids
The biosynthesis of the clerodane class of diterpenoids as shown in scheme 2.4 [Page 41] may 
produce up to eight possible stereoisomers [Figure 4.2]. Two major subclasses of clerodane 
(normal and ent), each with four stereoisomers are possible. The normal clerodane subclass 
possesses H-10 in the a -  orientation whereas the ew^clerodane subclass has H-10 in the P -  
orientation [Figure 4.2]. The four possible normal clerodane stereoisomers include the trans - 
(5p, SP) -  form, this means that the methyl groups at C-5 and C-8 are p as per the convention 
used in literature [S. 1], cis - (5a, SP) -  form [S. 2], trans - (5p, 8a) -  form [S. 3] and cis - (5a, 
8a) -  form [S. 4] whereas the four possible ^«/-clerodane stereoisomers include trans - (5a, 8a) 
-  form [S. 5], cis - (5P, 8a) -  form [S. 6], trans - (5a, 8P) -  form [S. 7] and cis - (5p, 8p) -  form 
[S. 8] [Figure 4.2].
120
S.4S.3
S.2S.1
S.6S.5 S.7 S.8
Figure 4.2: Possible skeletons for clerodane and e«/-clerodane classes of diterpenoids [See
section 2.4 Page 37]
4.2 Structural elucidation of compounds isolated from C. sylvaticus
The phytochemical analysis of the leaves and the stem bark of C. sylvaticus yielded three known 
trans-ent-cXQïoàmQ diterpenoids, two known trans -  clerodane diterpenoids, one new trans-ent- 
clerodane norditerpenoid, one known acyclic diterpenoid, three known triterpenoids, a famesene
1 2 6
norsesquiterpenoid, one known phytosterol and one ferulate derivative. 7ra«.s-annonene, CS.l, 
15-hydroxy-/ra«5-cleroda-3, 13-dien-15-ol, CS.3, sitosterol, CS.13 and lignoceryl trans -  
ferulate, CS.14 were isolated from both the leaves and the stem bark of C. sylvaticus [Figure
4.3]. 15, 16 -  Dihydroxy-/ra«^-e«^cleroda-3, 14-diene, CS.2, 15-acetoxy-rra«5'-cleroda-3, 13- 
diene, CS.4, 15-acetoxy-2-oxo-/ra«5'-^«f-cleroda-3, 13- diene, CS.5, the new 19-nor-clerodane, 
sylvaticinol, CS.6 and the acyclic diterpenoid, /rara-phytol, CS.7, were isolated from the stem 
bark of C. sylvaticus [Figure 4.4]. The three known triterpenoids, lupenone, CS.IO, 3p- 
acetoxylup-20(29)-ene, C S .ll, p-amyrin, CS.12, the nor-cyclo-famesene sesquiterpenoid, (+) -  
[5R, 6S, 9R] - 4, 5 -  dihydroblumenol A, CS.8 and the lignan, (+) -  syringaresinol, CS.9 were 
also isolated from the stem bark of C. sylvaticus [Figure 4.4].
OH
20
•''17
HO'
CS.13 O
CS.3C S .l
CS.14
Figure 4.3: Compounds isolated from the leaves and the stem bark of C. sylvaticus
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Figure 4.4: Compounds isolated from the stem bark of C. sylvaticus
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4.2.1 Structural elucidation of compound CS.l: Trans-annonene
Compound CS.l was isolated as a yellow oil from the hexane extract of the leaves and the 
hexane extract of the stem bark of C  sylvaticus and was identified as the known trans-ent- 
clerodane diterpenoid, /row '^-annonene.
CS.l
Figure 4.5: Structure for compound CS. 1: Jra/is-annonene
The LREIMS spectrum [Spectrum 4.1.1] for compound CS.l gave a molecular ion peak at m/z 
286 which indicated a molecular formula of C20H30O. The FTIR spectrum [Spectrum 4.1.2] 
displayed absorptions bands at 3019 cm '\ 2926 cm'  ^ and 2853 cm'  ^ that were attributed to CH 
stretches and an absorption band 1655 cm'  ^ that was attributed to a double bond stretch. The 
NMR [Spectrum 4.1.3], ^^ C NMR [Spectrum 4.1.4] HMBC [Spectrum 4.1.7] and COSY 
spectra [Spectrum 4.1.8] showed that a furan ring was present in compound CS.l. Three 
coupled proton resonances at 5 6.27 (s), 5 7.35 (s) and 5 7.21 (s), typical of a p -  substituted 
furan ring, were evident in the COSY spectrum and were assigned as H-14, H-15 and H-16 
respectively.^^’ The corresponding ^^ C NMR carbon resonances were seen at 5 111.3, 142.8 
and 138.6 for C-14, C-15 and C-16 respectively [Spectrum 4.1.6]. The hilly substituted carbon 
resonance at ô 126.1 was assigned as C-13 due to the observed correlations in the HMBC 
spectrum between this resonance and the assigned H-14 (8 6.27, s), H-15 (6 7.35, s) and H-16 (8 
7.21, s) proton resonances. The C-13 (ô 126.1) carbon resonances showed further correlations in 
the HMBC spectrum with the two proton resonances at ô 1.69 and 1.53 that were assigned as two 
H-11 protons. The two H-11 proton resonances showed a correlation in the HMBC spectrum 
with a carbon resonance at 5 38.9, assigned as C-9. The C-14 (5 111.3) and C-16 (6 138.6) 
carbon resonances showed correlations with the two proton resonances at 8 2.32 (td, J=  4.3, 9.9 
Hz) and 2.24 (td, J=  4.3, 12.8 Hz) in the HMBC spectrum that were assignable to the two H-12
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protons. Furthermore, coupling between the two H-11 (3 1.69 and 1.53, m) proton resonances 
and the two H-12 (6 2.32, td, J=  4.3, 9.9 Hz and 2.24, td, J=  4.3, 12.8 Hz) proton resonances 
was observed in the COSY spectrum.
The C-9 (5 38.9) carbon resonance showed correlations in the HMBC spectrum with a proton 
resonance at 6 1.45 that was assigned as H-10, two proton resonances at 5 1.45 and 1.23 that 
were assigned as 2H-7 and a methyl group proton resonance at 3 0.84 (d, J=  6.7 Hz) that was 
assigned to 3H-17. The presence of this methyl doublet proton resonance at ô 0.84 (3H-17) and 
the twenty carbon resonances in the ^^ C NMR spectrum suggested that this compound was a 
fiirano-clerodane diterpenoid. The earlier assigned H-10 proton resonance was seen to be 
coupled in the COSY spectrum with a proton resonance at 5 1.67, assigned as one of the H-1 
proton resonances, which, in turn, was seen to be coupled with the overlapped two H-2 (5 2.06, 
m) proton resonances. Further couplings in the COSY spectrum were observed between the two 
H-2 proton resonance and the H-3 (5 5.21, br s) proton resonance, which was seen to be further 
coupled to the 3H-18 proton resonance (5 1.61, d, J=  1.5 Hz). The two H-6 (5 1.74 (m) and 
1.21) proton resonances were seen to be coupled to each other in the COSY spectrum, and both 
were seen to be coupled to proton resonances at ô 1.45 and 1.23 that were assigned as the two H-
7. The two H-7 proton resonances were both seen to be coupled to a methine proton resonance 
at 5 1.57 that was assigned as H-8. The HMBC spectrum showed correlations between the 3H- 
18 (5 1.61, d, J =  1.5 Hz) proton resonance and the C-3 (5 120.7), C-4 (5 144.7) and C-5 (5 38.4) 
carbon resonances and between the 3H-19 (8 1.03, s) proton resonance and the C-4 (8 144.7), C- 
6 (8 37.1) and C-10 (8 46.7) carbon resonances.
The NOESY spectrum displayed correlations between the 3H-19 (8 1.03, s) proton resonance 
and the 3H-20 (8 0.76, s), one of the H-6 (8 1.74, m) and one of the H-7 (8 1.45) proton 
resonances. The 3H-20 (8 0.76, s) methyl proton resonance hirther showed correlations in the 
NOESY spectrum with the 3H-17 (8 0.84, d , J=  6.7 Hz) proton resonance. This confirmed that 
the 3H-19 (8 1.03, s), 3H-20 (8 0.76, s), 3H-17 (8 0.84, d, J=  6.7 Hz), one of the H-6 (8 1.74, m) 
and one of the H-7 (8 1.45) protons were on the same face of compound CS.l. On the other 
hand, the H-10 (8 1.45) proton resonance showed a correlation with one of the H-12 (8 2.24, td, J
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= 4.3, 12.8 Hz) proton resonances. The H-8 proton resonance (6 1.57) showed a correlation in 
the NOESY spectrum with the other H-6 (ô 1.21) proton resonance.
A search in the literature showed that compound CS.l was trans-armonQnQ which has been 
isolated previously from Croton sonderianus^  ^and from Solidago arguta A\i}^ The ^^ C NMR 
chemical shifts for compound CS.l and those of the known trans -  annonene were found to be 
similar.^  ^ A negative optical rotation of - 32.9° was measured for compound CS.l, which was 
comparable to the literature values of - 34.3°^  ^ and - 35.5°.^^ Therefore, compound CS.l 
belonged to the trans-ent-cXQiodano, series.
Table 4.1: Correlation table for compound CS. 1: Jraws-annonene
0 . "C NMR (125 
MHz) CDCI3
^^ C NMR (15 MHz) 
CDCI3 "
^H NMR (500 MHz) 
CDCI3
HMBC
( H ^ C )
COSY NOESY
a 18.4 CH2 18.2 1.67' 2, 10 Ip, 2 ,10 la , 3
P 1.45' 2, 10 la , 2 IP, 2P,3
la 27.1 CH2 26.7 2.06 m* 1 ,4 ,10 la , i p ,3 3, 18
:P 2.06 m ' 1 ,4 ,10 l a , i p ,3 Ip, 3, 18
3 120.7 CH 120.6 5.21 br s Wi/2= 9.34 Hz 1,2 ,5 2, 18 la . Ip, 2a, 2P, 19
4 144.7 C 143.7 - - - -
5 38.4 C 37.9 - - - -
ia 37.1 CH2 36.6 1.74 m 8, 10 6p, 7a, 7P 6P, 7a, 8, 19
'P I.2 T 4,5 , 7, 19 6a, 7a, 7p 6a, 8
a 27.7 CH2 27.4 1 .4 5 ' 5 ,9 6a, 6P, 7P, 8 6a, 7p, 17,19
P 1.23' 6 ,9 6a, 6p, 7a, 8 7a
8 36.5 CH 36.2 1.57 m 6, 10, 17, 20 17 6P,17
9 38.9 C 38.4 - - - -
0 46.7 CH 46.1 1.45' 2, 4, 9, 19 la 12B
lA 38.8 CH2 38.5 1.69' 9, 10, 13, 20 IIB , 12A, 12B 20
IB 1.53 m 9, 10, 13,20 11 A, 12A, 12B 12A
>A 18.5 CH2 18.2 2.32 td J =  4.3, 9.9 Hz 11, 13, 14, 16 11 A, IIB , 12B 12B
IB 2.24 t d J =  4.3, 12.8 Hz 11, 13, 14, 16 11 A, IIB , 12A 10, IIB , 12A
3 126.1 C 125.2 - - - -
4 111.3 CH 110.7 6.27 s 12, 13, 15, 16 15 IIB , 15
5 142.8 CH 142.3 7.35 s 13,14,16 14, 16 14, 16
6 138.6 CH 138.0 7.21 s 13, 14,15 15 15
7 16.3 CH3 16.1 0.84 d J =  6.7 Hz 7, 8 ,9 8 7a, 8 , 20
8 18.2 CH3 17.9 1.61 d J =  1.5 Hz 3 ,4 ,5 3 2a, 2P, 6 p, 19
9 2 0 . 2  CH3 19.8 1.03 s 4, 6 ,10 - 3 ,7 a , 18, 20
;o 18.4 CH3 18.2 0.76 s 8 , 9 ,10 - 11 A, 17, 19
Refer to superimposed proton resonances
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4.2.2 Structural elucidation of compound CS.2: 15,16 -  Dihydroxy-trfl«5-e«t-cIeroda-3,13Z
-diene
Compound CS.2 was isolated as a yellow oil from the hexane extract of stem bark of C. 
and was identified as 15, 16-dihydroxy-^ra«5'-e«^cleroda-3, 13Z-diene.
OH
OH
CS.2
Figure 4.6: Structure for compound CS. 2: 15,16 -  Dihydroxy-trfl«s-e/it-cIeroda-3,13Z -
diene
The LREIMS spectrum [Spectrum 4.2.1] for compound CS.2 indicated a molecular formula of 
C20H34O2 due to a molecular ion peak at m/z 306. The FTIR spectrum [Spectrum 4.2.2) gave an 
absorption band at 3400 cm'  ^ attributable to a hydroxyl group stretch. The NMR spectrum 
[Spectrum 4.2.3] showed that compound CS.2 possessed four methyl groups due to four proton 
resonances each integrating to 3H at 5 0.70 (s), ô 0.78 (d, J=  6.40 Hz), 5 0.97 (s) and 5 1.56 (d, J  
= 1.25 Hz). Two oxymethylene group proton resonances at 6 4.14 (2H, d , J =  7.00 Hz) and ô 
4.11 (2H, s) and two double bond proton resonances at ô 5.56 (t, J =  7.00 Hz) and 5 5.15 (br s) 
were also observed in the ^H NMR spectrum. The NMR [Spectrum 4.2.4], DEPT 
[Spectrum 4.2.5] and HSQCDEPT [Spectrum 4.2.6] spectra of compound CS.2 indicated 
twenty carbon resonances (four methyl, eight methylenes, four methines and four quaternary 
carbon resonances).
The ^H and NMR spectral data (Table 4.1 and Table 4.2) showed that rings A and B were the 
same as for compound CS.l. However, the two compounds differed in that compound CS.l had 
a furan ring in the side chain but compound CS.2 was hydroxylated at C-15 and C-16. 
Correlations were observed between the H-14 (H, 6 5.16, t, 7.00 Hz) proton resonance and 
the C-12 (Ô 29.2) and C-15 (5 60.9) carbon resonances in the HMBC spectrum for compound
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CS.2 and further correlations were also observed between the corresponding 2H-15 (5 4.14, d, J  
= 7.00 Hz) proton resonance and the C-13 (8 144.8) and C-14 (5 126.1) carbon resonances. 
Similarly, the other oxymethylene proton resonance at 8 4.11 (s), which integrated to 2H protons, 
was seen to be correlated in the HMBC spectrum with C-13 (8 144.8) and C-14 (8 126.1) carbon 
resonances and was assigned to the 2H-16 protons. The two hydroxyl groups were placed at 
position C-15 and C-16. A correlation was observed in the NOESY spectrum [Spectrum 4.2.9] 
between the two H-12 proton resonances and the H-14 proton resonance, therefore the 
double bond was assigned the Z configuration. A search in the literature showed that the ^^ C 
NMR chemical shifts for compound CS.2 and those of the known 15, 16 -  d\hydvoxy-trans-ent- 
cleroda-3, 13Z -diene (Table 4.2) were s imilar .Compound CS.2 was confirmed to be the 
known 15, 16 -  dihydroxy-/ra«5'-e«t-cleroda-3, 13Z -diene which has been isolated previously 
from Cipadesa jruticosaP
It is reported by Rojatkar and Nagasampagi^^ that subjecting this compound to Jones oxidation 
resulted in compound CS.l, /ra«5-annonene.^^ This transformation suggested that compound 
CS.2 could be the biosynthetic precursor of compound CS.l, ^ra«5-annonene in n a t u r e . A  
negative optical rotation value of - 18.9° was measured for compound CS.l. This value was 
comparable to the - 19.82° value reported in the li tera ture.The NOESY spectrum was used to 
confirm the stereochemistry of compound CS.2. Correlations in the NOESY spectrum were 
observed between 3H-17 (8 0.78, d,J=  6.40 Hz) proton resonance and 3H-19 (8 0.97, s) and 3H- 
20 (8 0.70, s) proton resonances and further correlation for H-8 (8 1.47, m) proton resonance 
with H-10 (8 1.34, m) proton resonance in the NOESY spectrum confirmed that compound CS.2 
was 15, 16-dihydroxy-/ra«^-e«/-cleroda-3, 13Z-diene.
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4.2.3 Structural elucidation of compound CS.3: 15 -  Hydroxy -  trfl«s'-cIeroda-3,13£'-diene 
Compound CS.3 was isolated from both the leaves and the stem bark of C. sylvaticus as a 
colourless oil and was identified as 15-hydroxy-^raw5-cleroda-3, \2>E -diene.
OH
CS3
Figure 4.7: Structure for compound CS.3: 15 -  hydroxy-trawx-cleroda-3,13E -diene
The LREIMS spectrum [Spectrum 4.3.1] for compound CS.3 gave a molecular formula of 
C20H34O due to a molecular ion peak at m/z 290. The FTIR spectrum [Spectrum 4.3.2] 
indicated the presence of a hydroxyl group stretch due to an absorption band at 3413 cm'\^^ The 
NMR spectrum [Spectrum 4.3.3] displayed five methyl group proton resonances each 
integrating to 3H at 6 0.72 (s), 6 1.00 (s), 6 1.58 (s), 5 0.80 (d, J=  6.30 Hz) and 5 1.68 (s), an 
oxymethylene group proton resonance at 5 4.14 (2H, d, 6.85 Hz) and two double bond proton 
resonances at 6 5.40 (t, 6.85 Hz) and ô 5.19 (br s). The NMR [Spectrum 4.3.4], DEPT
[Spectrum 4.3.5] and HSQCDEPT [Spectrum 4.3.6] spectra showed the presence of twenty 
carbon resonances (five methyls, seven methylenes, four methines and four quaternary carbon 
resonances) for compound CS.3.
The ^H and ^^ C NMR spectral data for compound CS.3 slightly differed from those of compound 
CS.2 (Table 4.2 and Table 4.3) with compound CS.2 displaying two oxymethylene carbon 
resonances at 5 60.9 and ô 58.5 whereas compound CS.3 showed only one oxymethylene carbon 
resonance at 8 59.7 but an extra methyl group carbon resonance at 5 16.7. The ^H and *^ C NMR 
spectral data for rings A and B were the same for compound CS.2 and compound CS.3.
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Correlations in the HMBC spectrum [Spectrum 4.3.7] between the H-14 (6 5.40, t, J =  6.85 Hz) 
proton resonance and the C-12 (5 33.0) and C-16 (6 16.7) carbon resonances were observed, 
indicating that a methyl group was present at C-16 rather than an oxymethylene group as in 
compound CS.2. A search in the literature showed that compound CS.3 displayed the same ^^ C 
NMR chemical shifts to those of the known 15-hydroxy-/ra«5-e«^-cleroda-3, \3E  -diene (Table
4.3), which has been reported previously from Hardwickia pinnata,^^’ from copaiba oil, 
commercially obtained from the trunk of various species of the genus Copaifera L. 
(Leguminoceae) and many other sources.
A positive optical rotation value of + 39.3° was measured for compound CS.3, however, this 
measured value was opposite to - 45.7° that was reported by Misra et al}^ for 15-hydroxy-rmM.y- 
gM -^cleroda-3, 13E -diene, which they named kolavenol. Misra and his co-workers were the first 
to report the isolation of kolavenol from Hardwickia pinnata in 1964.^ "^  In subsequent years 
many other authors, such as Monti et al. (1999),^^ Nagashima et al. (1995)^^ and Lu et al. 
(1993)^  ^have reported the isolation of kolavenol. Lu et al. (1993)^^ were the first to assign the 
^^ C NMR spectral data for kolavenol using COSY, ^H, DEPT and HMBC spectra. The 
assignment of the relative stereochemistry of kolavenol using the NOESY experiment has not 
been reported previously. The opposite optical rotation obtained for compound CS.3 led to a 
thorough investigation of the stereochemistry of the molecule using the NOESY spectrum 
[Spectrum 4.3.9]. Unfortunately compound CS.3 was not crystalline, therefore, a single crystal 
X-ray study was not done.
Correlations in the NOESY spectrum were observed between the 3H-17 (5 0.80, d, J =  6.30 Hz) 
proton resonance and the 3H-19 (5 1.00, s) and 3H-20 (5 0.72, s) proton resonances and a further 
correlation was observed between the H-8 (5 1.48) proton resonance and the H-10 (5 1.34) 
proton resonance as was seen with compounds CS.l and CS.2 described above. However, the 
measured optical rotation values for compound CS.l and CS.2 were found to display an opposite 
sign (-32.9° and -18.9° respectively) to that of compound CS.3. It was therefore deduced that 
compound CS.3 possessed an opposite stereochemistry to compound CS.l and CS.3 and could 
be the normal form of 15-hydroxy-/ra«5-cleroda-3, \ZE -diene. Bohlman et al. (1978) reported 
the isolation of the normal form of 15-hydroxy-/ra«5-cleroda-3, 13E -diene from Bedfordia
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salicina and they named it isobedfordiaditerpenalcohol.^^ However, Bohlman et al. (1978) did 
not publish the optical rotation value for isobedfordiaditerpenalcohol.*^
Table 4.3: Correlation table for compound CS.3:15-Hydroxy-trfl«x -cleroda-3,15E -diene
No. " C  NMR (125 
MHz) CDCI3
NM R (100 
MHz) CDCls^^
^H NM R (500 MHz) 
CDCI3
HMBC (H -^C) COSY NOESY
la 18.5 CH2 18.37 1.45 m’ 1 0 2 , 1 0 2 0
IP 1.45 m ' 1 0 2 , 1 0 -
2a 27.1 CH2 26.98 2.05 m ' 1 1,3 3
2 p 2.05 m ' 1 1,3 3
3 120.6 CH 120.52 5.19 b rs  1Fi/2=9.31H z 1 2 , 18 2 , 2 0
4 144.8 C 144.60 - - - -
5 38.4 CH 38.28 - - - -
6a 37.1 CH2 36.94 1.50' 9 6 p, 7a, 7p 6 P
6 P 1 . 2 0  m 9 6 a, 7a, 7p 6 a
7a 27.7 CH2 27.61 1.42 m ' 6 , 8 , 1 0 6 a, 6 P, 8 19, 20
7P 1.42 m ' 6 , 8 , 1 0 6 a, 6 p, 8 -
8 36.5 CH 36.36 1.48' 9, 13,14,16 7a, 7p, 17 10, 12A, 12B
9 38.8 C 38.72 - - - -
1 0 46.6 CH 46.53 1.34' 1 ,2 ,5 , 9 la . Ip 12 A, 12B
l lA 37.0 CH2 36.63 1.70 m 6 , 7 ,9 IIB , 12 A, 12B IIB
IIB 1.36' 6 , 7 ,9 11 A, 12 A, 12B 11a, 12B
12A 33.0 CH2 32.95 1.85 m ' 1 0 , 2 0 11 A, IIB 8 ,10 , IIB
12B 1.85 m ' 1 0 , 2 0 11 A, IIB 8 , 10, IIB
13 141.2 C 140.93 - - - -
14 123.0 CH 123.13 5.40 t J =  6.85 Hz 12,16 15, 16 15
15 59.7 CH2 59.51 4.14 d J =  6.85 Hz 13,14 14 14,16
16 16.7 CH3 16.52 1.68 s 12, 13,14 14 15
17 16.2 CH3 16.07 0.80 d J -  6.30 Hz 6 ,7 ,9 8 7, 20
18 18.2 CH3 18.45 1.58 s 3 ,4 ,6 ,7 3 3
19 20.2 CH3 20.03 1.00 s 4, 5,10 - 1,20
20 18.6 CH3 18.07 0.72 s 9, 10,11 - 1, 7 ,17 ,19
Refer to superimposed proton resonances
^Resonances at 5 1.24 in the ^H NMR and ô 29.9 in the NMR spectra are for an impurity 
present in the sample.
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4.2.4 Structural elucidation of compound CS.4: 15-Acetoxy-tra«5- cleroda-3,13E -diene 
Compound CS.4 was isolated as a yellow oil from the stem bark of C. sylvaticus and was found 
to be an acetoxy derivative of compound CS.3 and was identified as 15-acetoxy-/ra«5'-cleroda-3, 
13E -diene.
OCOCH3
CS.4
Figure 4.8: Structure for compound CS.4: 15-acetoxy-/ra«5-cleroda-3,13^ -diene
The LREIMS spectrum [Spectrum 4.4.1] for compound CS.4 displayed a molecular ion peak at 
m/z 332 which was consistent with a molecular formula of C22H36O2. The LREIMS spectrum 
showed a fi-agment ion at m/z 212, [M-60]^ for a loss of a acetic acid, CH3CO2H fi-agment.^® A 
double bond equivalence of five was calculated. The FTIR spectrum [Spectrum 4.4.2] showed 
an absorption band at I74I cm'  ^that was attributed to a carbonyl group s t re tch .T he  ^^ C NMR 
[Spectrum 4.4.4], spectrum showed twenty-two carbon resonances, which included a carbonyl 
carbon resonance at 8 170.9 and four double bond carbon resonances at 8 120.5, 144.5, 118.0 and 
143.6.
The NMR spectrum [Spectrum 4.4.3] of compound CS.4 displayed six methyl group proton 
resonances each integrating to 3H at 8 0.72 (s), 1.00 (s), 1.59 (s), 0.80 (d, J=  6.20 Hz), 1.70 (d, J  
= 1.1 Hz) and 2.05 (s), an oxymethylene group proton resonance at 8 4.57 (2H, d, J =  7.13 Hz) 
and two double bond proton resonances at 8 5.32 (dt, J =  1.1, 7.13 Hz) and 5.18 (br s). The 
NMR and DEPT spectra showed twenty-two carbon resonances. The methyl doublet proton 
resonance assigned as 3H-17 (8 0.80, d, J =  6.20 Hz) and the acetate singlet proton resonance at 
8 2.05 (s) suggested that compound CS.4 possessed a clerodane acetylated diterpenoid skeleton.
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The and NMR spectral data (Table 4.3 and Table 4.4) showed that rings A and B were the 
same for compound CS.3 and CS.4. However, the two compounds differed in that compound 
CS.4 was the acetylated form of compound CS.3. The HMBC spectrum [Spectrum 4.4.7] 
showed correlations for the 2H-15 oxymethylene proton resonance at 5 4.57 (d, J =  7.13 Hz) 
with carbon resonances at 5 143.6, ô 118.0 attributed to C-13 and C-14, and the carbonyl carbon 
resonance of the acetate group at 6 171.4. The COSY spectrum [Spectrum 4.4.8] showed 
coupling between the 2H-15 proton resonance and a proton resonance at 5 1.70 (d, J =  1.1 Hz) 
that was assigned as 3H-16. The 3H-16 proton resonance showed correlations in the HMBC 
spectrum with carbon resonances at 5 33.1, 143.6 and 118.0 that were assignable to C-12, C-13 
and C-14 respectively.
A search in the literature showed that ^^ C NMR chemical shifts that were the same as those 
exhibited by compound CS.4 had been reported for 15-acetoxy-/ra«5-e«?-cleroda-3, 13E -diene 
(Table 4.4) isolated previously from Parentucallia latifolia. The NOESY spectrum
[Spectrum 4.4.9] of compound CS.4 showed that the 3H-17, 3H-19 and 3H-20 were on the 
same face of the molecule whereas H-10, 2H-12 and H-8 were on the other face of the molecule. 
The measured optical rotation value for compound CS.4 was + 66.4° whereas those of the known 
15-acetoxy-/ra«5'-e«^cleroda-3, 13E -diene was -  30.0°.^^ Urones et al. (1989)^^ carried out the 
assignment of the ^^ C NMR spectra of the 15-acetoxy-/ra«5-e«^-cleroda-3, 13E -diene using 
DEPT experiments and ^H-^^C, one bond and long range correlations. However, they did not 
report how they determined the relative or absolute stereochemistry of 15-acetoxy-/ra«5-e«/- 
cleroda-3, 13E -diene.
Compound CS.4 was found to be an acetylated form of compound CS.3 and the positive optical 
rotation value for compound CS.4 allowed for its determination as the normal form of 15- 
acetoxy-/ra«5-cleroda-3, \2>E -diene. A literature search did not reveal any report of the normal 
form of 15-acetoxy-?rara-cleroda-3, 13E -diene.
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4.2.5 Structural elucidation of compound CS.5: 15-Acetoxy trfl«5-e«/-cleroda-3,13E-dien-2- 
one
Compound CS.5 was obtained from an inseparable mixture from the stem bark o f C. sylvaticus 
that was acetylated in order to separate the components and was isolated as a yellow oil and 
found to be a keto derivative o f 15-acetoxy-/râf«5'-cleroda-3, 13E- diene. Compound CS.5 was 
identified as the known 15-acetoxy trans-ent-c\eroda-3, 13E- dien-2-one.
,"20
=19
CS.5
Figure 4.9: Structure for compound CS.5: 15-Acetoxy-2-oxo-/ra«s-e«/-cleroda-3,13£'-diene
The LREIMS spectrum [Spectrum 4.5.1] for compound CS.5 gave a molecular ion peak at m/z 
346 which indicated a molecular formula o f C22H 34O3 . The LREIMS spectrum showed a 
fragment ion at m/z 286, [M-60]^ for a loss o f a acetic acid, CH3CO2H f r a g m e n t . A  double 
bond equivalence o f six was determined. The FTIR spectrum [Spectrum 4.5.2] displayed an 
absorption band at 1648 cm'^ that was assigned to a double bond stretch and an absorption band 
at 1736 cm'^ for an ester carbonyl group stretch. An absorption band for the a, p -  unsaturated 
carbonyl group, which was supported by the ^^C NM R spectrum (5 200.6) was thought to be 
shifted and was likely to be superimposed with the typical absorption band at 1648 cm'^ for a 
double bond s t r e t c h . T h e  NMR spectrum [Spectrum 4.5.4] displayed twenty-two carbon 
resonances, including those o f a ketone carbon resonance at 6  2 0 0 .6 , another carbonyl carbon at 
5 171.4 and four double bond resonances at 8  125.7, 172.9, 118.4 and 142.5. The NMR 
spectrum [Spectrum 4.5.3] indicated the presence o f an acetate group at C-15 as in CS.4 due to 
a singlet proton resonance which integrated to 3H at 8  2.02 (s) and a methyl doublet proton 
resonances at 8  0.80 (d, J =  2.50 Hz) ascribed to the 3H-17 resonance o f a clerodane diterpenoid 
skeleton.
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Further resonances observed in the NMR spectrum included four methyl proton resonances at 
5 0.77 (s), 1.08 (s), 1.65 (s) and 1.85 (d, J=  1.05 Hz), an oxymethylene group proton resonance 
at Ô 4.52 (2H, d, J =  7.05 Hz) and two double bond proton resonances at 8 5.69 (br s Wm = 9.46 
Hz) and 8 5.27 (dt, 1.05,7.05 Hz).
The ^H, and 2D NMR spectra (Table 4.4 and Table 4.5) showed that ring B and the side 
chain were the same for compound CS.4 and compound CS.5. The observed ketone group was 
therefore present in ring A. The COSY spectrum [Spectrum 4.5.8] displayed coupling between 
a proton resonance at 8 1.84 that was assigned as H-10 and a proton resonance at 8 2.32 (m) 
ascribed to 2H-1. The corresponding carbon resonance for 2H-1 was observed at 8 35.1 in the 
HSQCDEPT spectrum [Spectrum 4.5.6]. A correlation between the overlapped two H-1 (8 
2.32, m) proton resonances and the ketone carbon resonance at 8 200.6 in the HMBC spectrum 
[Spectrum 4.5.7] allowed for the placement of the ketone at C-2.
A double bond proton resonance at 8 5.69 (br s) was seen to correlate with the C-1 carbon 
resonance in the HMBC spectrum and was assigned as H-3. The H-3 proton resonance was also 
seen to correlate with carbon resonances at 8 40.1 and 19.2 that were assigned as C-5 and C-18 
respectively. The corresponding 3H-18 proton resonance was observed to be at 8 1.85 (d, J  =
1.05 Hz) in the HSQCDEPT spectrum. The 3H-18 proton resonance was seen to be correlated in 
the HMBC spectrum with carbon resonances at 8 125.7, 172.9 and 40.1 that were ascribable to 
C-3, C-4 and C-5 respectively. The carbon resonance at 8 171.4 was therefore assigned to the 
carbonyl carbon resonance of the acetate group. A correlation was seen between this carbon 
resonance and the typical acetate methyl group (8 2.02, s) proton resonance in the HMBC 
spectrum.Further,  correlation in the HMBC spectrum was observed between the H-14 (8 5.27, 
dt, J  = 1.05, 7.05 Hz) proton resonance and C-16 (8 17.0) and C-12 (8 32.5) carbon resonances. 
The COSY spectrum showed coupling between the corresponding two H-12 (8 1.85 and 1.73, m) 
proton resonances and the overlapped 2H-11 (8 1.80, m) proton resonance.
A search in the literature showed that compound CS.5 exhibited the same ^H NMR and ^^ C 
NMR chemical shifts as the known 15-acetoxy trans-ent-Q\Qvoda-3, \3E- dien-2-one (Table
1 4 2
4.5)/^' The measured optical rotation for compound CS.5 of - 9.8° was almost identical to that 
of the known compound of - 11.0 The NOESY spectrum [Spectrum 4.5.9] indicated the 
relative stereochemistry expected for a trans-ent-c\QvodanQ diterpenoid due to the observed 
correlations for the 3H-20 (5 0.77, s) proton resonance with 3H-19 (6 1.08, s) and 3H-17 (5 0.80, 
d, J =  2.50 Hz) proton resonances and a correlation for H-10 (5 1.84, m) proton resonance with 
H-8 (Ô 1.47, m) proton resonance. Compound CS.5 was identified to be the known 15-acetoxy 
trans-ent-c\QVoda-3, \3E- dien-2-one
Table 4.5: Correlation table for compound CS.5: 15-Acetoxy /ra/is-e/2t-cleroda-3,13Æ'-
dien-2-one
NMR (125 
MHz) CDCI3
NMR (50 
MHz) CDCla^*
^H NMR (500 MHz) 
CDCI3
N M R  ( 2 0 0  
MHz) CDCb^*
H M BC CO SY N O E SY
35.1 CH2 35.89 2.32 m’ - 2 , 5 , 1 0 1 0 6 ,1 8 ,1 9 ,2 0
2.32 m’ - 2, 5 ,1 0 1 0 6 ,1 8 ,1 9 ,2 0
200.6 C 199.97 - - - - -
125.7 CH 125.62 5.69 br s W \i2 =  5.25 Hz 5.71 br s 1 ,5 ,1 8 18 18
172.9 C 172.18 - - - - -
40.1 C 39.95 - - - - -
35.9 CH2 35.04 1.33 m' - 8 ,1 0 ,1 9 7 ,8 11 A, IIB , 20
1.33 m’ - 8 ,1 0 ,1 9 7 ,8 X
27.1 CH2 27.02 1.47’ - 17 6 18
1.47’ - 17 6 18
36.2 CH 36.15 1.47’ - 7 ,2 0 7 ,1 7 1 7 ,1 9 ,2 0
38.9 C 38.79 - - - - -
45.9 CH 45.86 1.84’ - 2 0 1 IIA , IIB
35.8 CH2 35.76 1.80 m’ - 2 0 12A, 12B 6 , 1 0
; 1.80 m’ - 2 0 12A, 12B 6 , 1 0
32.5 CH2 32.45 1.85’ - 16 11 A, 12B 6
i 1.73 m - 16 IIB , 12A Ac
142.5 C 142.18 - - - - -
118.4 CH 118.51 5.27 d tJ =  1.05, 7.05 Hz 5.30 6.80 Hz 12 ,16 15 A, 15B, 16 15 A, 15B
61.6 CH2 61.32 4.52 d J - 7.05 Hz’ 4.54 d J - 6.80 Hz 13,14, A c 14 14 ,16
; 4.52 d J =  7.05 Hz’ 4.54 d J =  6.80 Hz 13 ,14 , A c 14 14 ,16
17.0 CH3 16.77 1.65 s 1.67 br s 1 2 ,1 3 ,1 4 14 15 A, 15B
16.0 CH3 15.74 0.80 d J - 2.50 Hz 0.82 d J =  5.90 Hz 7, 8 ,9 8 8 , 2 0
19.2 CH3 17.87 1.85 d J =  1.05 Hz’ 1.87 d J =  1.50 Hz 3 ,4 ,5 3 1 ,3 , 7 ,1 9
18.6 CH3 18.84 1.08 s 1 . 1 0  s 4 , 5 , 6 ,1 0 - 1 , 8 , 18 ,20
18.1 CH3 18.45 0.77 s 0.80 s 8 , 1 0 , 1 1 - 1 ,6 , 8 , 17, 19
21.3 CH3 20.98 2 . 0 2  s 2.05 s Ac - 1 2 3
171.4 C 172.18 - - - -
Refer to superimposed proton resonances
^Resonances at 5 1.24 in the ^H NMR and 5 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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4.2.6 Structural elucidation of compound CS.6: Sylvaticinol
Compound CS.6 was isolated as a colourless oil from the hexane extract of the stem bark of C 
sylvaticus and identified as a new nor-clerodane diterpenoid, trivially named sylvaticinol.
11 20]
CS.6
Figure 4.10: Structure for compound CS.6: Sylvaticinol
The LREIMS spectrum [Spectrum 4.6.1] for compound CS.6 gave a molecular ion peak at m/z 
328 which indicated a molecular formula of C19H20O5. This compound decomposed before 
HRMS analysis could be done. A double bond equivalence of ten was calculated. The FTIR 
spectrum [Spectrum 4.6.2] was very broadened indicating the compound was decomposing, but 
gave an absorption band at 1642 cm'  ^ attributed to a double bond stretch. The NMR 
spectrum [Spectrum 4.6.4] for compound CS.6 showed nineteen carbon resonances including 
two carbonyl carbon resonances at 8 173.0 and 8 176.8 and six double bond carbon resonances. 
The 'H NMR spectrum [Spectrum 4.6.3] showed the presence of one methyl doublet proton 
resonance at 8 1.07 (d, J  = 7.00 Hz), an oxymethine proton resonance at 8 5.48 (dd, J =  2.05, 
9.08 Hz) and an oxymethine proton resonance at 8 4.78 (br d). The calculated double bond 
equivalence and the NMR and DEPT [Spectrum 4.6.4] spectra of compound CS.4 indicated 
that the compound was pentacyclic. On the basis of the five clerodane diterpenoids, compounds 
CS.l, CS.2, CS.3, CS.4, and CS.5 isolated from C. sylvaticus, compound CS.6 was thought to 
be a pentacyclic clerodane diterpenoid.
The ^H NMR spectrum displayed the presence of a p -  substituted furan ring due to coupled 
proton resonances at 8 6.34 (s), 8 7.46 (s) and 8 7.42 (s) that were assigned as H-14, H-15 and H- 
16 respectively.^^’ The corresponding carbon resonances were seen in the HSQCDEPT 
spectrum [Spectrum 4.6.6] to occur at 8 107.8, 144.5 and 138.7 respectively. The H-14 and H-
1 4 4
15 proton resonances were seen to correlate in the HMBC spectrum [Spectrum 4.6.7] with a 
fully substituted double bond carbon resonance at ô 125.0, which was assigned as C-13. 
Correlations that were observed in the HMBC spectrum between the C-13 and C-16 carbon 
resonances and an oxymethine proton resonances at 5 5.48 (dd, J=  2.05, 9.08 Hz), allowed for 
the assignment of the H-12 proton. The H-12 proton also showed a correlation in the HMBC 
spectrum with a carbon resonance at Ô 176.8 assigned as C-20. The H-12 proton resonance also 
displayed connectivity in the COSY spectrum [Spectrum 4.6.8] with proton resonances at ô 2.03 
(m) and 2.68 (dd, J  = 2.05, 9.08 Hz) that were assigned as the two H-11 proton resonances, 
which showed no further coupling.
The two H-11 proton resonances showed correlations in the HMBC spectrum with carbon 
resonances at 5 38.9, 5 47.2, 5 71.6 and 5 125.0 that were assigned as C-8, C-9, C-12 and C-13 
respectively. The corresponding C-11 (8 40.6) carbon resonance showed a correlation in the 
HMBC spectrum with a methine proton resonance at 8 2.91 (m) which was assigned as H-10. 
The H-8 (8 2.05) proton resonance displayed correlations in the HMBC spectrum with carbon 
resonances at 8 34.0, 8 19.0 and 8 176.8 that were assigned as C-1, C-17 and C-20 respectively. 
Coupling was observed between the H-8 methine proton resonance and the 3H-17 (8 1.07, d, J =  
7.00 Hz) methyl proton resonance in the COSY spectrum. The 3H-17 methyl proton resonance 
showed correlations in the HMBC spectrum with carbon resonances at 8 34.0, 38.9 and 47.2 that 
were assigned as C-1, C-8 and C-9 respectively. The corresponding two H-7 (8 2.41 and 1.21) 
proton resonances showed coupling in the COSY spectrum with an oxymethine proton resonance 
at 8 4.78 (br d) that was ascribed to H-6 which, in turn, showed a correlation in the HMBC 
spectrum with a carbon resonance at 8 165.9 assigned as C-5. Further correlations in the HMBC 
spectrum were observed between the C-5 carbon resonance and one of the H-3 (8 2.40) proton 
resonances. The COSY spectrum showed coupling between the two H-3 (8 2.40 and 2.20) 
proton resonances and two proton resonances at 8 2.19 and 1.85 that were assigned to the two H- 
2 protons which, in turn, were coupled to two proton resonances at 8 1.85 and 1.45 that were 
assigned to the two H-1 proton resonances.
Assuming that the relative stereochemistry of compound CS.6 at C-10 followed those of 
compounds CS.l, CS.2, CS.3, CS.4 and CS.5, therefore, eight stereoisomers teuflin, R.1, \2-epi
1 4 5
-  teuflin, R.2, teucvin, R.3, 12 -  epî - teucvin, R.4, 12 -  epi - teucvidin, R.5, teucvidin,R.6, 
unreported, R.7 and R .8 [Figure 4.11] are possible for compound CS.6 . The H-10 proton 
resonance displayed correlations in the NOESY spectrum [Spectrum 4.6.9] with the 3H-17 
proton resonance and with one of the H-1 (5 1.85) proton resonances. The 3H-17 methyl group 
and H-1 (5 1.85) were tentatively assigned the p configuration. The other H-1 (8 1.45) proton 
that was assigned to the a face of the molecule showed correlations with the two H-11 (8 2.03 
and 2.68) proton resonances, therefore the C-9/C-11 bond was on the opposite (a) side of the 
molecule.
11 20) 11 20)
R.1 R.4R.2 R.3
11 20) 11 2 0 )
R.5
R.6 R.7 R.8
Figure 4.11: Possible structures for compound CS.6
One of the H-11 (8 2.68) proton resonances showed correlations in the NOESY spectrum with 
the H-8 proton resonance. The H-8 proton was assigned the a configuration. Further 
correlations in the NOESY spectrum were observed for the H-8 proton resonances with the H-6 
and the H-12 proton resonances. The H-6, H-8 and H-12 were thus determined to be on a face of 
the molecule. Correlations were also observed in the NOESY spectrum between the H-12 proton
1 4 6
and the H-16 proton resonance of the fhran ring whereas the H-11 a proton showed correlations 
with the H-14 proton resonance. The furan ring was determined to be positioned on the a face of 
the molecule. Compound CS.6 gave an optical rotation value of + 4.64°.
A search in the literature showed that six stereoisomers (R.1 -  R.6) of this diterpenoid skeleton 
have been reported.^®’ A comparison of the reported ^^ C NMR chemical
shifts [Table 4.6] and the ^H NMR chemical shifts [Table 4.7] for the known compounds R.1 -  
R .6 showed that the ^^ C NMR chemical shifts of compound CS.6 were different from those of 
R.1 -  R .6 [Table 4.6].^^’ The observed NOESY [Spectrum 4.6.9] correlations showed that 
the stereochemistry exhibited by compound CS.6 had not been reported previously and agreed 
with structure R .8 [Figure 4.12].^^’^^  Compound CS.6 was found to be a novel e«r-clerodane 
norditerpenoid and was given the trivial name of sylvaticinol.
Figure 4.12; Selected NOESY correlations for compound CS.6
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4.2.7 Structural elucidation of compound CS.7: 7>««5-phytol
Compound CS.7 was isolated from both the stem bark of C. sylvaticus and identified as the 
widely known /ra«5-phytol.
'20
CS.7
Figure 4.13: Structure for compound CS.7: Jraws-phytol
The LREIMS spectrum [Spectrum 4.7.1] for compound CS.7 gave a molecular ion peak at m/z 
296 which indicated a molecular formula of C20H40O. A double bond equivalence of one was 
calculated. The FTIR spectrum [Spectrum 4.7.2] showed an absorption band at 3298 cm‘^  that 
was attributed to a hydroxyl group stretch. The NMR spectrum [Spectrum 4.7.3] for 
compound CS.7 showed the presence of four superimposed methyl doublet proton resonances, 
which integrated to I2H at 5 0.81 (d, J=  7.05 Hz, 3H-19), Ô 0.81 (d, J=  7.05 Hz, 3H-18), Ô 0.83 
(d, J=  7.05 Hz, 3H-17) and 6 0.83 (d, J=  7.05 Hz, 3H-I6) and a singlet methyl proton resonance 
at Ô 1.65 (s, 3H-20), an oxymethylene proton resonance at ô 4.10 (2H, d, J =  6.90 Hz, H-1) and 
one alkene proton resonances at 5 5.38 (t, J=  6.90 Hz, H-2).
The NMR spectrum [Spectrum 4.7.4] indicated the presence of twenty carbon resonances 
which included five methyls, ten methylenes, four methines and one quaternary carbon 
resonances. The NMR chemical shifts for compound CS.7 were compared to the ^^ C NMR 
data for trans-^hyXo\ from the literature (Table 4.8).^  ^ The data confirmed that compound CS.7 
was the known trans-p\\yXo\ isolated previously from the Raphanus sativus and many other 
sources. The measured optical rotation for compound CS.7 at + 8.7 was comparable to that 
found in the literature for trans-^\vyio\ at + 5.0
1 5 0
Table 4.8: Correlation table for compound CS.7: Jrflws-phytol
No. NM R (125 
MHz) C D C f
NM R (100 
MHz) CDCb^^
H NM R (500 MHz) CDCI3 H NMR (400 MHz) CDCb"^
1 59.7 CH2 59.4 4.10 t J =  5.0 Hz 4.13 t J =  6.7 Hz
2 123.3 CH 123.0 5.38 q J  = 6.9 Hz, 0.8 Hz 5.39 t J =  6.7 Hz
3 140.6 C 140.3 - -
4 40.1 CHa 39.9 1.96 m 2.0017 =  6.1 Hz
5 25.4 CHa 25.1 y
y 1.03-1 .41m *
\
M .05-1.42 m
6 36.9 CHa 36.6
7 33.0 CH 32.8
8 37.6 CHa 37.4
9 24.7 CHa 24.4
1 0 37.7 CHa 37.4
1 1 32.9 CH 32.7
1 2 37.5 CHa 37.4
13 25.0 CHa 24.7
14 39.6 CHa 39.4
15 28.2 CH 28.0 IAS  m 1.50 m
16 22.9 CHa 22.7 0.83 d / =  7.05 Hz* 0.84 d J =  6.5 Hz
17 23.0 CHa 2 2 . 8 0.83 7.05 Hz* 0.84 d J =  6.5 Hz
18 20.0 CHa 19.7 0.81 d J= 7 .05H z* 0.82 d J - 6.5 Hz
19 20.0 CHa 19.7 0.81 d J =  7.05 Hz* 0.82 d J =  6.5 Hz
2 0 16.4 CHa 16.2 1.65 s 1.64 s
Refer to superimposed proton resonances
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4.2.8 Structural elucidation of compound CS.8: (+) -  [5R, 6S, 9R] - 4, 5 -  Dihydroblumenol
A
Compound CS.8 was isolated as a clear crystalline solid from the hexane extract of C. sylvaticus 
and was identified as the known nor-sesquiterpenoid, (+) -  [5R, 6S, 9R] - 4, 5-dihydroblumenol 
A. OH
OH
CS.8
Figure 4.14: Structure for compound CS.8: (+) -  [5R, 65, 9R] - 4, 5-Dihydroblumenol A
The LREIMS spectrum [Spectrum 4.8.1] for compound CS.8 showed a molecular ion peak at 
m/z 226 which indicated a molecular formula of C13H22O3. The LREIMS spectrum showed a 
fragment ion at m/z 208, [M-18]^ for the loss of H2O. A double bond equivalence of three was 
calculated. The FTIR spectrum [Spectrum 4.8.2] of compound CS.8 gave an intense absorption 
band at 3422 cm'  ^that was ascribed to a hydroxyl group stretch and an absorption band at 1692 
cm'  ^ that was attributed to a carbonyl stretch. The ^H NMR spectrum [Spectrum 4.8.3] 
showed the presence of four methyl group proton resonances at 5 0.87 (d, J=  6.5 Hz), 0.92 (s),
0.96 (s) and 1.32 (d, J=  6.50 Hz). The presence of two methylene group proton resonances and 
four methine group proton resonances, which included an oxymethine proton resonance at ô 4.42 
(dqi, J =  1.00, 5.50 Hz) were also deduced from the ^H NMR, NMR [Spectrum 4.8.4], 
DEPT [Spectrum 4.8.5] and HSQCDEPT [Spectrum 4.8.6] spectra. The NMR spectrum 
[Spectrum 4.8.4] gave thirteen carbon resonances including four methyls, two methylenes, four 
methines and three quaternary carbons, which, included a ketone carbon resonance at 5 211.6 
and an oxygen bearing carbon at 5 77.2. This indicated that compound CS.8 could be a 
monocyclic megastigmane (famesene) dinorsesquiterpenoid.
The ^H NMR spectrum showed an ABXY system due to proton resonances at 5 5.69 (dd, J  =
1.00, 15.80 Hz), 5.83 (dd, J=  5.50, 15.80 Hz), 4.42 (dqi, J =  1.00, 5.50 Hz) and 1.32 (d, J =  6.50 
Hz) that were assigned as H-7, H-8, H-9 and 3H-10 of a megastigmane dinorsesquiterpenoid
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skeleton.^ ^ The H-7 proton resonance showed coupling with the H-8 proton resonance (/?, g = 
15.80 Hz) which, in turn, was seen to couple to H-9 in the COSY spectrum [Spectrum 4.8.8]. 
Long range coupling was seen between the H-7 and H-9 proton resonances (J?, 9 = 1.00 Hz). 
Further coupling in the COSY spectrum was seen between the H-9 and the 3H-10 methyl group 
proton resonance. The corresponding C-7, C-8, C-9 and C-10 carbon resonances were seen at Ô
132.0, 135.4, 68.5 and 24.1 respectively [Spectrum 4.8.6]. The H-8 proton resonance showed a 
correlation in the HMBC spectrum [Spectrum 4.8.7] with a carbon resonance at ô 77.2 that was 
assigned as C-6. The fully substituted C-6 carbon resonance displayed correlations in the 
HMBC spectrum with two singlet methyl group proton resonances at 6 0.96 (s) and 0.92 (s) that 
were ascribed to 3H-11 and 3H-12 respectively and a doublet methyl proton resonance at 6 0.87 
(d, J=  6.50 Hz) that was assigned as 3H-13. The 3H-11 and 3H-12 proton resonances showed 
correlations in the HMBC spectrum with carbon resonances at ô 42.8 (C) and 51.7 (CH2) that 
were assigned as C-1 and C-2 respectively.
A correlation was also observed in the HMBC spectrum between the corresponding two H-2 
proton resonances (5 2.83, d J =  13.55 Hz and 1.90 dd, J=  2.20, 13.55 Hz) and a ketone carbon 
resonance at 6 211.6 that was assigned as C-3. The C-3 carbon resonance was seen to correlate 
with the proton resonances at 5 2.41 (t, J=  12.78 Hz) and 2.20 (m) that were assigned as two H-
4. One of the H-4 proton resonance was seen to couple to a methine proton resonance at 6 2.25 
(m) that was assigned as H-5 which, in turn, was seen to couple with the doublet methyl proton 
resonance at 5 0.87 (d, J=  6.50 Hz) that was earlier ascribed as 3H-13.
A search in the literature showed that the ^H NMR and ^^ C NMR chemical shifts [Table 4.9] for 
compound CS.8 were similar to those of a known dinorsesquiterpenoid, 4, 5-dihydroblumenol A 
reported by Gonzalez et al?^ from Perrottetia multiflora except for the C-9 chemical shift which 
was at 5 68.5 for compound CS.8 and ô 58.74 for the reported 4, 5-dihydroblumenol A.^  ^
Further search in the literature showed that De Marino et al. isolated 4, 5-dihydroblumenol A 
from Laurus nohilis L., however, they reported a different chemical shift for C-9 at ô 69.4. 
Further, differences were observed in the measured optical rotation of compound CS.8 , which 
was found to be + 30.0° whereas a value of -  1.32° was reported for 4, 5-dihydroblumenol A 
isolated by De Marino and co workers^^ and + 2 reported for 4, 5-dihydroblumenol A by
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Gonzalez et al?^ It is possible that Gonzalez et aVs value was the result of a typographical 
error (5 68 vs ô 58) as 5 58 is not a typical chemical shift for an oxymethine carbon resonance.
The relative stereochemistry and not absolute stereochemistry of 4, 5 -  dihydroblumenol A has 
been postulated by Gonzalez et al?^ and De Marino et al?^ using ID and 2D NMR data, 
biogenetic grounds of blumenol A, the - double bond analogue of 4, 5 -  dihydroblumenol A 
whose C-6 and C-9 chiral centres were 6S and 9R respectively^^ and comparison of the ^^ C NMR 
chemical shifts and the optical rotation value of the known blumenol A. However, the C-5 chiral 
centre remained to be determined.
Figure 4.15: ORTEF illustration for compound CS.8: (+) -  [5R, 6S, 9R] - 4,5 -
Dihydroblumenol A
In order to confirm the stereochemistry for compound CS.8, the NOESY spectrum was 
examined and a single crystal X-ray study was undertaken. The NOESY spectrum [Spectrum 
4.8.9] showed correlations between one of the H-4 and the H-7 resonances. The H-7 resonance, 
in turn, showed a correlation with the 3H-I2 proton resonance. The 3H-I2 proton resonance 
showed a correlation with the H-5 resonance. The side chain was found to be on the same face of 
the molecule as the 3H-12 methyl group, one of the H-4 protons and the H-5. One of the H-2, 
3H-11 and 3H-13 were on the other face of the molecule, therefore confirming the relative 
stereochemistry proposed by both Gonzalez et al?^ and De Marino et al?^ The X-ray study 
showed that the C-5, C-6 and C-9 chiral centres possessed the R, S  and R configurations 
respectively. Compound CS.8 was identified as (+) -  [5R, 6S, 9R] - 4, 5 -  dihydroblumenol A.
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4.2.9 Structural elucidation of compound CS.9: (+) - Syringaresinol
Compound CS.9 was isolated from the methanol extract of C. sylvaticus as an amorphous white 
solid and identified as the known lignan, (+) -  syringaresinol.
CS.9
Figure 4.16: Structure for compound CS.9: Syringaresinol
The LREIMS spectrum [Spectrum 4.9.1] for compound CS.9 gave a molecular ion peak at m/z 
418 which suggested a molecular formula of C22H26O8. A double bond equivalence of ten was 
calculated. The FTIR spectrum [Spectrum 4.9.2] displayed an absorption band at 3400 cm'  ^
which was attributed to the presence of a hydroxyl group in the m o l e c u l e .A  = 282 nm 
was observed in the UV/Vis spectrum [Spectrum 4.9.10], which suggested that compound CS.9 
was a rom a t ic .T he  NMR spectrum [Spectrum 4.9.3] showed the presence of a methoxy 
group(s) due to a methyl group proton resonance at 5 3.91 (s), an aromatic methine proton 
resonance at ô 6.59 (s) and an oxymethine proton resonance at 5 4.73 (d, J  = 4.20 Hz) whereas 
the NMR spectrum [Spectrum 4.9.4] displayed eight carbon resonances suggesting the 
molecule was symmetrical. This data indicated that compound CS.9 might be the common 
lignan syringaresinol.
The singlet proton resonance at 5 6.59 (s) integrating to 4H was assigned to H-2, H-6, H-2’ and 
H-6’. The methine proton resonance at 5 6.59 (s) was observed to be correlated to the four 
aromatic ring resonances at Ô 132.4 (C-l/C-1’), 102.8 (C-2/C-2’/C-6/C-6’), 147.4 (C-3/C-3’/C- 
5/C-5’) and 134.6 (C-4/C-4’) in the HMBC spectrum [Spectrum 4.9.7]. The singlet proton 
resonance at 5 3.91 (s), integrating to 12H, was assigned to four methoxy groups at C-3, C-5, C- 
3’ and C-5’. The methoxy proton resonance at 5 3.91 (s) was seen to correlate in the HMBC 
spectrum with a carbon resonance at 5 147.4. A doublet proton resonance at 5 4.73 (d, J=  4.20 
Hz), integrating to 2H was assigned as H-7 and H-7’. The H-7/H-7’ proton resonance was seen
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to be coupled in the COSY spectrum [Spectrum 4.9.8] with an oxymethylene proton resonance 
at 5 4.30 (dd, J=  2.7, 11.4 Hz) that was ascribed as 2H-9 and 2H-9’. A search in the literature 
for the ^^ C NMR data for compound CS.9 confirmed that this compound was the known 
syringaresinol (Table 4.10).^^’ The measured optical rotation was found to be + 50° whereas
the reported optical rotation value for (+) -  syringaresinol was + 48.6.34
Table 4.10: Correlation table for compound CS.9: Syringaresinol
0 . "C  NMR (75 
MHz) CDCh
NMR (100 
MHz) CDCl,^^
^H NMR (300 MHz) 
CDCI3
^H NMR (400 MHz) 
CDCla^
HMBC (H ^C ) COSY NOESY
r 132.4 C 132.1 - - - - -
6 , 6 ' 102.8 CH 102.7 6.59 s 6.59 s 1,2/6,3/5,4,7 - 7 , 8 , OCH3 93
5,5’ 147.4 C 147.2 - - - - -
4’ 134.6 C 134.3 - - - - -
T 86.2 CH 8 6 . 1 4.73 d J - 4.2 Hz 4.74 d J=4.3Hz 2/6,8,9 8 2/6, 9 3
8 ’ 54.5 CH 54.4 3.09 m 3.11 m - 7 ,9a, 93 2 / 6
9’a 72.0 CH3 71.8 4.30 d d /=  2.7,11.4Hz 4.29 ddJ=9.2, 6 . 8  Hz - 8,93 9 3
9’P 3.90* 3.91 ddJ=  9.2, 3.6 Hz 7,8 8,9a 7 ,9a
;H3 56.5 CH3 56.4 3.91 s" 3.91 s 3/5 - 2 / 6
H 5.49 s 5.50 s 3/5,4 - -
Refer to superimposed proton resonances
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4.2.10 Structural elucidation of compound CS.IO: Lupenone
Compound CS.IO was isolated as a white solid from the stem bark of C  sylvativus and identified 
as the widely known lupane triterpenoid, lupenone.
192
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Figure 4.17: Structure for compound CS.IO: Lupenone
The LREIMS spectrum [Spectrum 4.10.1] for compound CS.IO gave a molecular ion peak at 
m/z 424, which was consistent with a molecular formula of C30H48O. A double bond 
equivalence of seven was calculated. The FTIR spectrum [Spectrum 4.10.2] for compound 
CS.IO showed an absorption band at 1707 cm'  ^that was attributed to a carbonyl group stretch. 
The NMR spectrum [Spectrum 4.10.4] showed thirty carbon resonances for compound 
CS.IO. Two double bond carbon resonances at 5 109.6 and 151.6 and a carbonyl carbon 
resonance at 6 218.6 in conjunction with the molecular formula suggested that compound CS.IO 
was a pentacyclic triterpenoid.
The analysis of the NMR [Spectrum 4.10.3], NMR [Spectrum 4.10.4] and DEPT 
[Spectrum 4.10.5] spectra showed that compound CS.IO possessed seven methyl proton 
resonances at ô 1.07, 1.02, 0.93, 1.07, 1.68, 0.96 and 0.79, ten methylene groups which included 
the characteristic lupane type-triterpenoid terminal double bond proton resonances at ô 4.69 (br s 
W\!2 = 5.10 Hz) and 4.57 (br s Wm = 5.32 Hz), assignable to the two H-29 protons, and five 
methine groups. The ketone carbon resonance, observed at 6 218.6, was ascribed to C-3 on 
biogenetic grounds.^^ A search in the literature showed that the NMR chemical shifts for 
compound CS.IO and those of the common compound, lupenone^^ isolated previously from Poa 
huecu Par., Madhuca butyracea, Mangifera indica and many other sources were the same (Table 
4.11).^^ Lupenone is known to have a wide spectrum of biological activities. It is reported to be
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active against both the gram positive {Bacillus subtilis) and gram negative {Pseudomonas 
pyocyanee) bacteria.^^’ Lupenone has also been found to show anti-fimgal activities against 
Saccharomyces cerevisiae and Microsporum gypseum?^ Lupenone is also known to show anti- 
oxidative activity on lipid-peroxidation by 6.4%.^^
Table 4.11: Correlation table for compound CS.IO: Lupenone
No. NM R (125 MHz) CDCb " C  NM R (67.9 MHz) CDCI3 "' H NM R (500 MHz) CDCI3
l a 39.8 CHz 39.6 1.90 m
IP 1.42'
2 a 34.4 CHz 34.1 2.48 m
2 P 2.42 m
3 218.6 C 217.9 -
4 47.5 C 47.3 -
5 55.2 CH 55.0 1.34 m
6 a 19.9 CHz 19.6 1.47 m '
6 P 1.47 m '
7a 33.8 CH2 33.6 1.43'
7P 1.43'
8 40.8 C 40.9 -
9 50.0 CH 49.8 1.39 m
1 0 37.1 C 36.9 -
1 1 a 21.7 CH2 21.5 1.43'
l ip 1.43'
1 2 a 25.4 CH2 25.2 1.69'
1 2 p 1 . 1 0  m
13 38.4 CH 382 1 .6 8 '
14 42.9 C 42.9 -
15 27.7 CH2 27.4 1 .6 8 '
15 1 . 0 2  m
16a 35.7 CH2 35.6 1.50 m
16P 1.41'
17 42.9 C 42.9 -
18 48.5 CH 48.3 1.39 m
19 47.9 CH 47.9 2.39 m
2 0 151.5 C 150.7 -
2 1 a 30.1 CH2 29.9 1.93 m
2 1 p 1.27 m
2 2 a 40.2 CH2 40.0 1.42'
22P 1 . 2 1  m
23 26.9 CH3 26.6 1.07 s'
24 21.3 CH3 2 1 . 0 1 . 0 2  s
25 16.0 CH3 15.8 1.07 s'
26 16.2 CH3 15.9 0.93 s
27 14.7 CH3 14.4 0.96 s
28 18.2 CH3 18.0 0.79 s
29A 109.6 CH2 109.2 4.69 br s = 5.10 Hz
29B 4.57 br s Wxti = 5.32 Hz
30 19.5 CH3 19.3 1 . 6 8  s '
Refer to superimposed proton resonances
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4.2.11 Structural elucidation of compound CS.ll: 3p-Acetoxylup-20(29)-ene
Compound C S.ll was isolated as a white powder from the stem bark of C. sylvaticus and
identified as 3P-acetoxylup-20(29)-ene commonly called lupeol acetate.
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Figure 4.18: Structure for compound CS.ll: 3p-Acetoxylup-20(29)-ene
The LREIMS spectrum [Spectrum 4.11.1] for compound C S.ll gave a molecular ion peak at 
m/z 468 which indicated a molecular formula of C32H52O2. The FTIR spectrum [Spectrum 
4.11.2] displayed an absorption band at 1732 cm‘  ^that was attributed to a carbonyl group stretch, 
and absorption bands at 1640, 1246 and 880 cm'  ^ that were ascribed to terminal double bond 
stretches .The  ^^ C NMR spectrum [Spectrum 4.11.4] showed thirty-two carbon resonances for 
compound C S.ll. The presence of a carbonyl carbon resonance at 5 171.2 and two double bond 
carbon resonances at 109.6 and 151.2 in conjunction with the molecular formula suggested that 
compound C S.ll was a pentacyclic acetylated triterpenoid.
The NMR spectrum [Spectrum 4.11.3] displayed seven methyl proton resonances at 5 1.68 
(s), 0.78 (s), 0.94 (s), 0.83 (s), 0.85 (s), 1.02 (s), 0.84 (s) and an acetate methyl group proton 
resonance at ô 2.04 (s).^  ^ Furthermore, the terminal double bond proton resonances at 5 4.68 (br 
s W\i2 = 6.09 Hz) and 6 4.57 (br s Wni = 6.62 Hz) were characteristic of the terminal double bond 
of a lupane type triterpenoid.^^ The two proton resonances at ô 4.68 (br s) and 5 4.57 (br s) were 
ascribed to the two H-29 protons.
A comparison of the NMR chemical shifts with those found in the literature^^ confirmed that 
compound C S.ll was the known 3|3-acetoxylup-20(29)-ene (Table 4.12). 3p-Acetoxylup- 
20(29)-ene has been previously shown to demonstrate anti-arthitic effects in CFA-induced
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arthritis rats/^ 3p-Acetoxylup-20(29)-ene is also known to exhibit anti-fertility effects on male 
Wistar rats."^ ^
Table 4.12: Correlation table for compound CS.ll: 3p-Acetoxylup-20(29)-ene
No. " C  NM R (125 MHz) CDCb " C  NM R (67.9 M H z)CD Cb ' NM R (500 MHz) CDCI3
la 38.6 CHz 38.4 1.69'
IP 0.98 m
2 a 23.9 CHz 23.7 1.60 m '
2 P 1.60 m '
3 81.2 CH 81.0 4.47 d d J =  11.0, 6.0
4 38.0 C 37.8 -
5 55.6 CH 55.4 0.78 m
6 a 18.4 Œ z 18.2 1.50 m
6 P 1.40'
7a 34.5 CHz 33.6 1.38'
7P 1.38'
8 41.1 C 40.9 -
9 50.6 CH 50.4 1.30 m
1 0 37.3 C 37.1 -
1 1 a 2 1 . 2  CHz 2 1 . 0 1.40'
l ip 1 . 2 2  m
1 2 a 25.3 CHz 25.1 1 .6 8 '
12P 1.07 m
13 38.3 CH 38.1 1 .6 8 '
14 43.2 C 42.9 -
15 27.7 CHz 27.5 1 .6 8 '
15 1 . 0 0  m
16a 35.8 CHz 35.6 1.48 m
16P 1.38'
17 43.1 C 43.0 -
18 48.2 CH 48.0 1.39'
19 48.5 CH 48.3 2.37 sextet J =  5.5
2 0 151.2 C 150.9 -
2 1 a 30.1 CHz 29.9 1.32 m
2 ip 1.27 m
2 2 a 40.2 CH2 40.0 1.38'
2 2 p 1 . 2 0  m
23 28.2 CH3 28.0 0.84 s
24 16.7 CH3 16.5 1 . 0 2  s
25 16.4 CH3 16.2 0.85 s'
26 16.2 CH3 16.0 0.83 s'
27 14.7 CH3 1 14.5 0.94 s
28 18.2 CH3 18.0 0.78 s
29A 109.6 CHz 109.4 4.68 br s fVj/2 = 6.09 Hz
29B 4.57 br s fVi/2 ~  6.62 Hz
30 19.5 CH3 19.3 (CH3 ) 1 . 6 8  s'
Ac 171.2 C 171.3 -
Ac 21.6 CH3 21.7 2.04 s
Refer to superimposed proton resonances
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4.2.12 Structural elucidation of CS.12: p - Amyrin
Compound CS.12 was isolated as a white crystalline compound from the stem bark of C. 
sylvaticus and was identified as P-amyrin.
HO
CS.12
Figure 4.19: Structure for compound CS.12: p - Amyrin
The LREIMS spectrum [Spectrum 4.12.1] for compound CS.12 gave a molecular ion peak at 
m/z 426 which was consistent with a molecular formula of C30H50O. A double bond equivalence 
of six was calculated. The FTIR spectrum [Spectrum 4.12.2] suggested the presence of a 
hydroxyl group in the molecule due to an absorption band at 3364 cm '\
The NMR [Spectrum 4.12.3], ^^ C NMR [Spectrum 4.12.4], DEPT [Spectrum 4.12.5] and 
HSQCDEPT [Spectrum 4.12.6] spectra displayed eight methyl proton resonances, typical of a 
pentacyclic triterpenoid, ten methylene and five methine carbons including an oxymethine group 
due to a proton resonance at 5 3.24 (dd J=  5.3, 10.74 Hz).^  ^ The ^^ C NMR spectrum gave 30 
carbon resonances which included two in the olefinic region at 5 I2I.9 (C-13) and ô 145.5 (C- 
14) and one carbon resonance that was oxygen bearing at 5 79.3 (C-3). A search in the literature 
showed that the ^^ C NMR chemical shifts for compound CS.12 and those of widely known P- 
amyrin isolated previously from many plants such as Camellia japonica L., Salvia triloba were 
the same (Table 4.13).^^ p - Amyrin has been reported previously from Croton hovarum^^
p-Amyrin is known to possess a wide spectrum of biological activities, such as its protective 
effect against acetaminophen-induced liver injury in mice."^  ^ p-Amyrin has also showed human 
platelet aggregation in vitro.^ p-Amyrin is also known to exhibit good anti-microbial activity
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against gram positive {Staphylococcus aureus. Bacillus subtilis and Bacillus sphaericus) and 
gram negative bacteria {Escherichia coli. Pseudomonas syringae and Salmonella typhi).^^
Table 4.13: Correlation table for compound CS.12: p -  Amyrin
No. NM R (125 MHz) CDCI3 " C  NMR (67.9 MHz) CDCI3 '  ' "H NM R (500 MHz) CDCI3
la 38.8 CH2 38.7 1 .6 T
IP 0.97 m
2 a 27.5 CH2 27.3 1 .6 T
2P 1.61*
3 79.3 CH 79.0 3.24 dd 5.3,10.74 Hz
4 3 9 . 0  c 38.8 -
5 55.4 CH 55.3 0.74 m
6 a 18.6 CH2 18.5 1.55*
6 1.38 m
7a 32.9 CH2 32.8 1.49 m
7p 1.34 m
8 38.8 C 38.8 -
9 47.9 CH 47.7 1.56*
1 0 37.4 C 37.6 -
1 1 23.8 CH2 23.6 1.87 m*
1 2 121.9 CH2 1 2 1 . 8 5.18 i J =  3.5
13 145.5 C 145.1 -
14 42.0 C 41.8 -
15a 26.4 CH2 26.2 1.76 m*
15P 1.76 m*
16a 27.2 CH2 27.0 2 . 0 0  m*
16P 2 . 0 0  m*
17 32.7 C 32.5 -
18 47.5 CH 47.3 1.94 m
19a 47.1 CH2 46.9 1 . 6 6  m
19p 1 .0 0 *
2 0 31.3 C 31.1 -
2 1 a 35.0 CH2 34.8 1.34 m
2 ip 1 . 1 0  m
2 2 a 37.2 CH2 37.2 1.41 m
22P 1 . 2 1  m
23 28.3 CH3 28.2 0.99 s*
24 15.7 CH3 15.5 0.79 s
25 15.8 CH3 15.6 0.94 s
26 17.0 CH3 16.9 0.97 s*
27 26.2 CH3 26.0 0.97 s*
28 28.6 CH3 28.4 0.83 s
29 33.6 CH3 33.3 0 . 8 8  s*
30 23.9 CH3 23.7 0.87 s*
Refer to superimposed proton resonances
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4.2.13 Structural elucidation of compound CS.13: Sitosterol
Compound CS.13 was isolated as a white crystalline compound from the leaves and the stem 
bark of C. sylvaticus and was identified as the known phytosterol, sitosterol.
28
27
HO
CS.13
Figure 4.20: Structure for compound CS. 13: Sitosterol
The LREIMS spectrum [Spectrum 4.13.1] for compound CS.13 gave a molecular ion peak at 
m/z 414, which suggested that compound CS.13 had a molecular formula of C29H50O. The FTIR 
spectrum [Spectrum 4.13.2] for compound CS.13 displayed absorption bands at 3414 cm‘^  for 
the hydroxyl group stretching.^®
The NMR spectrum [Spectrum 4.13.3] displayed proton resonances at 5 = 5.35 (m), assigned 
to H-6 . The oxymethine proton resonance at 5 3.52 m was assigned as H-3. The ^^ C NMR 
[Spectrum 4.13.4] data of compound CS.13 were compared to those reported by Kojima et 
for sitosterol and was found to be identical (Table 4.14).
Compound CS.13 was therefore identified as the widely known sitosterol.
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Table 4.14: Correlation table for compound CS.13: Sitosterol
No. " C  NM R (125 MHz) CDCI3 " C  NMR (67.9 MHz) CDCb ^ 'H  NMR (500 MHz) CDCI3
la 37.5 CH2 37.2 1.84'
IP 1.06 m
2 a 31.9 CH2 31.6 1.84'
2 P 1.50'
3 72.1 CH 71.8 3.52 m
4a 42.5 C 42.3 2.25 m '
4P 2.25 m '
5 141.0 C 140.7 -
6 122.0 CH 121.7 5.35 m
7 32.1 CH2 31.9 1.96 m
8 32.1 CH 31.9 1.49'
9 50.3 CH 50.1 0.91 m
1 0 36.7 C 36.5 -
1 1 a 21.3 CH2 2 1 . 1 1.47 m '
l ip 1.47 m '
1 2 a 40.0 CH2 3 ^8 2 . 0 0  m
12P 1.15'
13 42.5 C 42.3 -
14 57.0 CH 56.8 0.98'
15a 24.5 CH2 24.5 1.58 m
15P 1.08 m
16 28.5 CH2 2 & 2 1.83'
17 56.3 CH 56.0 1.09 m
18 12.1 CH3 11.9 0.84 s'
19 19.6 CH3 19.4 1 . 0 0  s '
2 0 36.4 CH 36.1 1.35 m
2 1 19.0 CH3 18.8 0.82 s'
2 2 a 34.2 CH2 33.9 1.32 m
22P 1 .0 1 '
23 26.3 CH2 26.0 1.15'
24 46.0 CH 45.8 0.92 m
25 29.4 CH 29.1 1.65 m
26 20.0 CH3 19.8 0.84 s '
27 19.3 CH3 19.0 0.80 s'
28 23.3 CH2 23.0 1.25 m
29 12.2 CH3 1 2 . 0 0 . 6 6  s
Refer to superimposed proton resonances
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4.2.14 Structural elucidation of compound CS.14: Lignoceryl-Zraws- ferulate
Compound CS.14 was isolated as a white solid from the hexane and stem bark of C  sylvaticus
and was identified as lignoceryl-^ra«5-ferulate.
CH
HO'
CS.14
Figure 4.21: Structure for compound CS.14: Lignoceryl - /raws - ferulate
The LREIMS spectrum [Spectrum 4.14.1] for compound CS.14 gave a molecular ion peak at 
m/z 530 which indicated a molecular formula of C34H58O4. A fragment ion was observed at m/z 
207, which was attributed to a fragment resulting from the cleavage at the heteroatom [Figure 
4.22]. A double bond equivalence of six was calculated for compound CS.14. The FTIR 
spectrum [Spectrum 4.14.2] displayed absorption bands at 3296 cm"^  and 1708 cm"^  which were 
attributed to the presence of a hydroxyl group and a, p -  unsaturated carbonyl group stretches. 
The ^^ C NMR spectrum [Spectrum 4.14.4] for compound CS.14 showed one carbonyl carbon 
resonance at 5 167.6 and eight double bond carbon resonances at 127.3, 144.8, 127.3, 109.5,
148.1, 147.0, 114.9 and 123.3.
The NMR spectrum [Spectrum 4.14.3] showed the presence of a typical methoxy group 
proton resonance at ô 3.89 (s), trans double bond proton resonances at 5 6.27 (d, J  = 15.9 Hz) 
and 7.60 (d, J=  15.9 Hz).^  ^ The integral of the proton resonances that occurred at 6 0.85 (3H, t, 
J  = 6.9 Hz), 1.23 (44H, hr s) and 1.67 (2H, t, J  = 6.6 Hz) for the aliphatic chain showed 
approximately 49H.
An aromatic ABX system was observed for this compound, due to proton resonances at 5 7.00 
(d, J =  1.5 Hz), 5 6.89 (d, J =  8.2 Hz) and 7.04 (dd, J=  1.5, 8.2 Hz) that were assigned as H-5, 
H-8 and H-9 respectively. The corresponding carbon resonances occurred at 5 109.5 (C-5), 
114.9 (C-8) and 123.3 (C-9) in the ^^ C NMR spectrum. A correlation in the NOESY spectrum
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between the methoxy group (6 3.89, s) and the H-5 resonance allowed for the placement of the 
methoxy group on C-6. This spectroscopic data showed that compound CS.14 is a /ra«^-ferulate 
derivative.
cleavage on
an heteroatom j^q .
HO
CH2
HO
m/z 207 m/z 207
Figure 4.22: Predicted fragment ion for compound CS.1410,49
The peak at m/z 207 corresponded to the fragment ion shown in figure 4.22 above. The 
difference between the molecular ion peak at m/z 530 and the fragment observed at m/z 207 
indicated a -  (CH2)23-CH3 fragment had been lost and that the esterifying alcohol was n- 
lignoceryl. This was in agreement with the value found from integrating the resonances due to 
the alkyl side chain of 49H. A search in the literature showed that compound CS.14 exhibited 
NMR chemical shifts that were almost similar to those of the known docosanyl-/ra«5'-ferulate 
(Table 4.15). The known docosanyl-/ra«5'-ferulate and compound CS.14 were found to slightly 
differ on the length of their side chains derived from saturated fatty alcohols.^® Compound CS.14 
was determined to be lignoceryl-7ra«5-ferulate.
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Table 4.15: Correlation table for compound CS.14: Lignoceryl-/rfl«s-ferulate
No. " C  NM R (125 MHz) CDCI3 "H NM R (500 MHz) CDCI3 H NM R (400 MHz) CDCb^"
1 167.6 C - -
2 116.0 CH 6.27 d J =  15.9 Hz 6.29 d J =  15.90 Hz
3 144.8 CH 7.60 d J =  15.9 Hz 7.61 d J =  15.90 Hz
4 127.3 C - -
5 109.5 CH 7.00 d J =  1.5 Hz 7.03 d 1.5 Hz
6 148.1 C - -
7 147.0 C - -
8 114.9 CH 7.04 d d /= 1 .5 ,  8.2 Hz 7.06 d J =  1.5, 8.1 Hz
9 123.3 CH 6.89 d J =  8.2 Hz 6.91 d 8.10 Hz
r 64.8 CH2 4.10 6 . 6  Hz 4.18 t J =  6 . 6  Hz
T 29.0 CH2 1.67 i J =  6 . 6  Hz 1.70 t J =  6 . 6  Hz
3’ - 2 2 ’ 32.2,29.9, 29.6, 29.5, 26.2,22.9 CH2 1.23 br s’ 1.25 br s
23’ 14.33 CH3 0.85 t J =  6.9 Hz 0.87 t J =  6.9 Hz
OCH 3 56.2 CH3 3.89 s 3.93 s
OH - 5.96 br s 5.83 s
Refer to superimposed proton resonances
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4.3 Conclusion
C  sylvaticus yielded five clerodane diterpenoids, /ra«5-annonene, CS.l,^^ 15, 16 -  dihydroxy- 
trans-ent-c\Qvoédi-?), 14-diene, CS.2,^^ 15-hydroxy-/ra«5'-e«/-cleroda-3, 13-dien-15-ol, CS.3,^  ^
15-acetoxy-/ra«.y-cleroda-3, 13-diene, CS.4,^^ 15-acetoxy-2-oxo-^ra«5'-e«/-cleroda-3, 13- diene, 
CS.5^  ^ that have been reported previously fi'om different plant families. Compound CS.l and 
CS.2 were found to belong to the ent-SQviQs of the clerodane class of diterpenoids whereas 
compounds CS.3 and CS.4 were tentatively assigned to belong to the normal series of the 
clerodane class of diterpenoids due to their positive optical rotation values despite their co­
occurrence with other compounds of the ent-SQries.
A  new clerodane norditerpenoid, named sylvaticinol, CS.6 was also isolated fi*om C. sylvaticus. 
However, sylvaticinol was found to be a 19-norditerpenoid whose H-10 was found to be on the 
same face as C-20 and C-17 (trans-trans-trans: H-10-C-20-C-17) as opposed to those 
biosynthetically expected of a clerodane {trans-anti-anti: H-10-C-20-C-17) and e«7-clerodane 
(anti-trans-trans: H-10-C-20-C-17) skeletons. It has been proposed that compounds, like 
sylvaticinol, which do not follow the biosynthetic routes of clerodanes or e«7-clerodane arise due 
to an epimerization involving the a, p -  unsaturated lactone in which the driving force is the 
relief of the 20-C=O: 6H interaction.^^
Previous studies have shown that clerodane diterpenoids are important bioactive compounds.^^ 
Clerodane diterpenoids are known for their anti-feedant and insecticidal properties.^^ Ajugarin I 
[R.9], isolated from the AJuga remota (Labiateae) have showed anti-feedant activity towards the 
African army worm, Spodoptera exempta and the African desert locust, Schisticerea gregaria.^^ 
Kolavenol [R.10] described from many sources (Compositae, Leguminosae and 
Aristolochiaceae) has been reported to possess anti-feedant activity against the leaf cutter ants, 
Atta cephalotes.^^ Ajugarin IV [R.11], also isolated from ihQAjuga remota (Labiateae) has been 
shown to act as an insecticide against the silkmoth. Bombyx morf^ whereas hardwickiic acid 
[R.12] isolated from Croton aromaticus and many other sources has been showed to possess 
insecticidal activity against cowpea aphid. Aphis craccivora.^^
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Figure 4.23: Clerodane diterpenoids which possesses anti-feedant and insecticidal
activities*’-
Clerodane diterpenoids have also been tested for many biological activities and have been found 
to be potentially useful as anti-tumour, anti-viral, anti-biotic, anti-peptic ulcer, anti-fungal and 
psychotropic agents.^^ Dehydrocrotonin [R.13] isolated from Croton cajucara, a Brazilian 
medicinal plant has been showed to present anti-ulcerogenic,^^ anti-tumour activities,^^ ability to 
lower blood glucose and triglyceride in rats^  ^ and anti-genotoxicity.^® Terpenteein [R.14] 
isolated from Kitasatosporia MF -  730 -  N6 (Actinomyes) has been found to be an anti-biotic 
and to have anti-tumour properties,^^ and clerocidin [R.15] that was isolated from Oidiodendron 
truncatum (Moniliales) has also demonstrated antibiotic potential.^^
Kolavenie acid [R.16] reported from Polyalthia longifolia y2ly. pendulla (Annonaceae) and many 
other sources (Aristolochiaceae, Caesalpiriaceae and Compositae) has been showed to possesses 
anti-microbial activity to most of the bacteria and anti-fimgal activity against the kanamycin 
resistant fungal strains, Asperigillus fumigatus and Candida albicans^^ whereas teuevin [R.17] 
which has been isolated from Mallotus sp. (Euphorbiaceae) and Teucrium sp. (Labiateae) has 
been showed to to be amoebicidal and also act as a root development inhibitor.^"  ^ Teuevin is also 
reported to possess anti-feedant activity against the Colorado potato beetle, Leptinotarsa 
decemlineata (Say), which is an economically important pest that has developed resistance to 
most classes of synthetic insecticides.^^ Tinospora cordifolia Miers (Menispermaceae) that is 
used in Agurvedic medicine in India has yielded compound R.18 which has been used against 
jaundice, urinary disease and rheumatism.^^
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Compound R.19 that was isolated from Casearia sylvetris (Flacourtiaceae) demonstrated anti­
tumour potential against sarcoma in mice.^^ Plaunol B [R.20] that was isolated from Croton 
suhlyratus (Euphorbiaceae) has shown anti-peptic ulcer properties'^ whereas the hallucinogenic 
Mexican mint. Salvia divinorum (Labiateae), has yielded salvinoron [R.21] that possesses 
psychotropic activity.^^ Solidago lactone [R.22] which is reported from Solidago sp. 
(Compositae) has been used as a piscicidal agent/^
OHOH
CHOCHO
CHO
R.16R.14R.13 R.15 R.17
HO,
HO,Me
'OH
'OAc/ /  hn HO" HO
OHR.18 R.19 R.20 R.22
Figure 4.24: Biocative clerodane diterpenoids^^ '
Other compounds that were isolated from the C. sylvaticus included the widely isolated acyclic 
diterpenoid, ^raw^-phytol, CS.7^^’ and the nor-cyclo-famesene sesquiterpenoid, (+) -  [5i ,^ 68, 
9R] - 4, 5 -  dihydroblumenol A, CS.8.^ ’^ Five other common compounds, lupenone, CS.IO, 
3p-acetoxylup-20(29)-ene, C S.ll, P-amyrin, CS.12, sitosterol, CS.13 and lignoceryl trans -  
ferulate, CS.14 were also isolated from C. sylvaticus. The absolute configuration of compound 
CS.8 had not been fully assigned and since the compound was isolated in crystalline form, the X- 
ray study was used to assign its relative stereochemistry as (+) -  [5R, 68, 9R] - 4, 5 -  
dihydroblumenol A. C13 -  isoprenoids such as 4, 5 -  dihydroblumenol A have been proposed to
171
be formed from up to three biosynthetic pathways.^*’ Some authors propose that they are 
formed from oxidative removal of the two terminal carbon atoms from (+) -  abscisic acid
[R.23].31
OH
""OHOH
HO' HO'
OH
R.24R.23 R.25
Figure 4.25: Structures of (+) -  abscisic acid,^  ^aripuanin and annuiononc
Other authors postulate that they are formed from carotenoids by two consecutive steps. Firstly, 
it involves the enzymatic degradation of carotenoids by oxidases to form a C13 -  isoprenoid 
carbonyl which possesses the oxidised backbone of the carotenoid. The second step involves 
modifications by oxidases and reductases to yield the C13 - isoprenoid [Figure 4.26].^^
6'R
a- Carotene
6R'
,OH
6R'
LuteinHO'siT
enzymatic degradation 
by oxidases
OH
modification by oxidations and reductases
OH
(+)- [5R, 68, 9R] - 4, S-dihydroblumenol
Figure 4.26: Proposed formation of 4,5 -  dihydroblumenol A from lutein71
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The other biosynthetic pathway that has been postulated for the formation of the C13 -  
isoprenoids such as aripuanin [R.24] isolated from Ficus aripuanensis and annuionone D [R.25] 
from an extract of sunflower leaves are through the cleavage of two carbons from a
monocyclofamesene sesquiterpenoid.72
The potential phytotoxic effects of C13 -  isoprenoids on germination, root and shoot elongation 
of lettuce, Lactuca sativa L. have been reported.^^ Compounds R.26, R.27 and R.28 have shown 
moderate phytotoxicity on both root and shoot elongations whereas compound R.29 showed 
more significant inhibition of the germination and root and shoot elongation.^^
R.26
OH
R.27
OGlc
R.28
OGlc
R.29
OH
OH
Figure 4.27: C13-  isoprenoids tested for phytotoxicity effects on Lactuca sativa L.73
The pulverized bark of C. sylvaticus is steeped in milk and used to treat severe abdominal pains. 
The bark powder is also used to treat rheumatism, chest pains, and inflammation by rubbing into 
scarifications. The bark is also used in Gazaland (modem day Zimbabwe and Mozambique) as a 
fish poison.^’  ^ The Swazi people use powdered bark to treat gall-sickness in cattle.^ The root 
is used as a remedy for indigestion and for the treatment of pleurisy. Some parts of the plant are 
also used to treat malaria.^
Compounds CS.l, CS.2, CS.3, CS.4, CS.5 and CS.9 were screened for their cytotoxicities 
against human liver tumour cells (HUH7 strain) and their results are discussed in section 6.1.2.2 
below.
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CHAPTER FIVE: THE PHYTOCHEMISTRY OF CROTONPSEUDOPULCHELLUS
PAX
5.1 Introduction
Croton pseudopulchellus Pax is a shrub that grows to about 4 m tall and is commonly called the 
small lavender-croton. C. pseudopulchellus is distributed in Mali, Nigeria, Somalia, Kenya, 
Ethiopia, Angola, Zimbabwe, Mozambique and South Africa.'’  ^ The leaves [Picture 5.1] of C. 
pseudopulchellus are small, lanceolate and densely covered with silvery scales which are dotted 
with a red brown colouration^. Its flowers are small, and yellow and the fruits are small and tri- 
lobed.^
Picture 5.1: The leaves of C. pseudopulchellus
The C. pseudopulchellus plant parts have varied uses in different places. In the coastal area of 
Kenya, C. pseudopulchellus, is used as a condiment. It is burnt and smoke is used to flavour 
fresh milk."^  The poles from C. pseudopulchellus, which are durable and termite-proof, are used 
for hut building in Tanzania.^ The leaves of C. pseudopulchellus are used in Tanzania to treat 
syphilitic ulcers and for the treatment of chest infections.^ A decoction from the roots is used to 
treat asthma^ and whereas the root powders are sniffed for colds. C. pseudopulchellus is also 
used for the treatment of viral and tussive infections.^ Watt and Breyer-Brandwijk (1962) report 
that the leaves and the root of C. pseudopulchellus contain the toxalbumin crotin (G 19), a 
glycoprotein that is attached to crotin, a dihydrochalcone [Figure 4.1] that is also reported from
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c. sylvaticus. The name '’^ pseudopulchellus'' is derived from Latin words ‘pseudo ’ for 'almost' 
and ‘pulchellus' meaning ‘beautiful'?
Meyer et al. report a minimal inhibitory concentration (IC50) of the acetone extract of the aerial 
parts of C. pseudopulchellus of 0.1 mg/ml against the Mycobacterium tuberculosis H37Rv strain 
by the radiometric method. The chloroform extract of the stem bark of C. pseudopulchellus has 
been found to possess 82% minimum inhibitory at 50 mg/ml against PfUPl, a chloroquine 
resistant strain of the malarial parasite Plasmodium falciparun? and a minimum inhibitory 
concentration (IC50) of 3.45 mg/ml against vervet monkey kidney cells.^
5.2 Structural elucidation of compounds isolated from C. pseudopulchellus 
The phytochemical analysis of the leaves and the stem bark of C. pseudopulchellus yielded seven 
gM^-kaurenoic acid derivatives, which included two new ones, one known labdane diterpenoid, 
two known triterpenoids, three known sesquiterpenoids and one phytosterol. Four e«/-kaurenoic 
acid derivatives were also prepared from the isolated compounds. E^r-kaur-16-en-19-oic acid, 
CP.l, g^r-kaur-16-en-19-al, CP.3, c«/-12p-hydroxykaur-l6-en-19-oic acid, CP.4, ent-\2^- 
acetoxykaur-16-en-19-oic acid, CP.5, e«/-14a-hydroxykaur-l6-en-19-oic acid, CP.8, 8i?, 13R - 
epoxylabd-14-ene, CP.12, p-amyrin, CP.14, eudesm-4( 15)-ene-1 p, 6a-diol, CP.15, and 
stigmasterol, CP.18 [Figure 5.1] were isolated from both the leaves and the stem bark of C. 
pseudopulchellus. ^« /-l5P-hydroxykaur-16-en-19-oic acid, CP.7 [Figure 5.2] was isolated from 
the leaves of C. pseudopulchellus. Ent-\4a, 17-dihydroxykaur-15-en-19-oic acid, C P .ll, acetyl 
aleuritolic acid, CP.13, (-) - 7-epivaleran-4-one, CP.16 and germacra-4(15), 5E, 10(14)-trien- 
Ip-ol, CP.17 [Figure 5.3] were isolated from the stem bark of C. pseudopulchellus and 
derivatives, methyl g^r-kaur-16-en-19-oate, CP.2, methyl 12p-hydroxykaur-16-en-19-oate,
CP.6, CM/-14-oxokaur-16-en-19-oic acid, CP.9 and cm/-14a, 17-diacetoxykaur-15-en-19-oic 
acid, CP.IO [Figure 5.4] were prepared from the isolated compounds.
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Figure 5.1: Structures of compounds isolated from both the leaves and stem bark of
C. pseudopulchellus
OH
^ O H  
 ^ CP.7
Figure 5.2: Structure of a compound isolated from the leaves of C. pseudopulchellus
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Figure 5.3: Structures of compounds isolated from the stem bark of C pseudopulchellus
OH
20. 20.
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Figure 5.4: Structures of derivatives prepared from the compounds isolated from C
pseudopulchellus
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5.2.1 Structural elucidation of compound CP.l: £«/-kaur-16-en-19-oic acid
Compound CP.l was isolated as a white crystalline compound from both the leaves and the stem 
bark of C. pseudopulchellus and was identified as the known e«r-kaur-l 6-en-19-oic acid.
 ^ CP.l
Figure 5.5: Structure for compound CP.l: jF«/-kaur-16-en-19-oic acid
The LREIMS spectrum [Spectrum 5.1.1] for compound CP.l gave a molecular ion peak at m/z 
302 which indicated a molecular formula of C20H30O2. The LREIMS spectrum showed fragment 
ions at m/z 287, [M -  15]  ^for the loss of a CH3 fragment. A double bond equivalence of six was 
calculated. The FTIR spectrum [Spectrum 5.1.2] exhibited absorption bands at 3383 cm'^ and 
1692 cm'’ which were attributed to hydroxyl and carbonyl group stretches respectively.” 
Further absorption bands at 1653 cm'’ and 875 cm ’ were observed in the FTIR spectrum that 
were attributed to exocyclic double bond stretches.” The ’^ C NMR spectrum [Spectrum 5.1.4] 
and DEPT spectrum [Spectrum 5.1.5] showed twenty carbon resonances, of which two were 
methyls, ten methylenes, three methines and five were quaternary carbons. The presence of two 
double bond carbon resonances at 5 103.2 and 156.1 and a carbonyl carbon resonance at 5 184.3 
in conjuction with the above molecular formula indicated that compound CP.l was a tetracyclic 
diterpenoid. Biosynthetically, kaurane diterpenes possesses a tetracyclic skeleton and usually 
possess an exocyclic double bond at C-16.’^ ’
The ’H NMR spectrum [Spectrum 5.1.3] displayed two methyl group singlet proton resonances 
at 5 1.24 (s) and 8 0.99 (s) each integrating to 3H, two double bond proton resonances at 8 4.80 
(br s) and 8 4.74 (br s) ascribable to the two H-17 protons of a kaur-16-ene and one allylic 
methine proton resonance, typical of H-13, at 8 2.64 (br s) of kaur-16-ene diterpenoids.’^  The ’H 
NMR spectrum further showed a proton resonance at 8 12.10 (br s), which in conjuction with the 
carbonyl carbon resonance at 8 184.3 observed in the ’^ C NMR spectrum and a broad absorption 
band at 2400 -  3600 cm ’ in the FTIR spectrum” indicated the presence of a carboxylic acid in
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compound C P.l.” Compound CP.l was determined to be a tetracyclic e«/-kaur-16-enoic acid 
compound.
The HMBC spectrum [Spectrum 5.1.7] showed correlations between the two proton resonances 
at 5 4.80 (br s) and 4.74 (br s) earlier ascribed to two H-17 protons and carbon resonances at 6 
44.1, 5 49.2 and 6 156.1 that were assigned as C-13, C-15 and C-16 respectively. The 
corresponding H-13 proton resonance at 6 2.64 (br s), that was assigned using the HSQCDEPT 
spectrum [Spectrum 5.1.6], showed correlations in the HMBC spectrum with carbon 
resonances at 5 44.4 and 5 103.2 that were assigned as C-8 and C-16 respectively. The H-13 
proton resonance showed coupling in the COSY spectrum [Spectrum 5.1.8] with two proton 
resonances at 8 1.60 and 1.47 which were assigned as the two H-12 proton resonances. The two 
H-12 proton resonances, in turn, showed correlations in the HMBC spectrum with carbon 
resonances at 8 55.3, 8 18.6, 8 44.1 and 8 39.9 that were assigned as C-9, C-11, C-13 and C-14 
respectively, whereas, the C-12 (8 33.3) carbon resonance displayed correlations with two proton 
resonances at 8 1.13 (dd, J  = 11.3, 4.85 Hz) and 1.99 (br d) that were attributed to two H-14 
protons. The H-9 proton resonance was seen at 8 1.06 in the HSQCDEPT spectrum.
The COSY spectrum further showed coupling between the H-9 proton resonance and the 
overlapped proton resonance at 8 1.60 that was assigned as 2H-11. Correlations in the HMBC 
spectrum between the H-9 proton resonances and C-8 and C-12 carbon resonances were also 
observed. The HMBC spectrum showed a correlation between the earlier assigned C-8 carbon 
resonance and proton resonances at 8 1.45 and 8 1.51 (t, 3.08 Hz) that were ascribed to two
H-7 protons. The two H-7 proton resonances, in turn, showed correlation in the HMBC spectrum 
with carbon resonances at 8 22.0 and 8 49.2 that were assigned as C-6 and C-15 respectively. 
The overlapping 2H-6 proton resonances at 8 1.83 (m) were seen to be coupled to a methine 
proton resonance at 8 1.07 that was ascribed as H-5. The H-5 proton resonance, in turn, showed 
correlation in the HMBC spectrum with carbon resonances at 8 43.9, 22.0, 29.1 and 184.3, which 
were assigned as C-4, C-6, C-18 and C-19 respectively. The C-4 carbon resonance was seen to 
be correlated to two proton resonances at 8 1.89 (m) and 1.45 that were assigned as the two H-2 
proton resonances. The two H-2 proton resonances were, in turn, seen to be coupled to proton 
resonances at 8 0.81 (td, J =  11.3, 4.0 Hz), 2.16 (d, J=  14.1 Hz) and 1.01 (td, J=  14.1, 4.30 Hz)
1 8 6
that were ascribed as one of the H-1 and the two H-3 protons respectively. The H-1 (5 0.81, td, J  
= 11.3, 4.0 Hz) proton resonance was seen to be coupled to the other H-1 proton resonance at 5 
1.89 (br d) in the COSY spectrum. Further correlations in the HMBC spectrum were seen 
between the two H-1 proton resonances and carbon resonances at 6 39.9 and 15.8 that were 
assigned as C-10 and C-20 respectively.
A comparison of the spectroscopic data for compound CP.l with those found in the literature’^ ’ 
’7,18,19 confirmed that compound CP.l was the widely known e«/-kaur-l6-en-19-oic acid (Table 
5.1). The NOESY spectrum was used to confirm the stereochemistry of compound CP.l. The 
H-5 (5 1.07, m), 3H-18 (6 1.24, s), H-9 (5 1.06, m) and one of the H-15 (5 2.05, m) protons were 
found to have the same orientation whereas 3H-20 (5 0.99 s), H-13 (ô 2.64, br s) and one of the 
H-11 (5 1.60) protons were on the other face of compound CP.l. The optical rotation of 
compound CP.l was determined to be -  84° (Literature [a] = -114.81).’^
^Mr-kaur-16-en-19-oic acid has been isolated in large quantities and for commercial purposes 
from Xylopia^^’ and Wedelia^^’ ^  species. Ghisalberti (1997) in his study of the biological 
activity of naturally occurring diterpenes, reported that e«/-kaur-l 6-en-19-oic acid possesses 
anti-inflammatory, anti-bacterial, anti-fungal, molluscical properties, anti-microbial, cytotoxic 
effects and anti-protozoal properties.^'’ Vieira et aî}^ reported trypanocidal activity of ent-kmv- 
16-en-19-oic acid and Garcia et al?^ reviewed the biological activities of kaurane diterpenes 
published since 1997 to November 2006 and their glycosides and reported that e«r-kaur-16-en- 
19-oic acid possesses anti-spasmodic, anti-diabetic, anti-obesity, anti-noniciceptive, anti-allergic, 
embryo-toxic, geno-toxic, hypoglycaemic, immunosuppressive activities and is an inductor of 
apoptosis, an inhibitor of vascular smooth muscle contraction, stimulant of egg deposition in the 
sunflower moth, Cochylis hospes and is toxic to insect pests (stored pests, Acanthoscelides 
ohstectus Say., Sitophilus grananus L. and Ephestia kuehniella Zell.)
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Table 5.1: Correlation table for compound CP.l: £w/‘-kaur-16-en-19-oic acid
NMR (125 
MHzl CDCk
' C NMR (50 
MHzl
NMR (500 MHz) 
CDCU
HMBC
fH-^Cl
COSY NOESY
i l
la, 23,30, 5
23
13,2 a, 23
23,33,18
13,3a, 18
13,23,6,18
7a, 143
73
11
13,20
9,153
13,17E
143, 153
11a, 12a, 14a, 143,17B
6 ,11a, 12a, 13,143
73,13,14a, 15
17B
73,9,123,143,17B
123,13,17B
153, 17A
3a, 33, 5, 6
11,14a
)H
Refer to overlapped/superimposed proton resonances
 ^Resonace at 5 5.29 in the ’H NMR spectrum is for methylene chloride residue.
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5.2.2 Structural elucidation for compound CP.2: Methyl e«/-kaur-16-en-19-oate
Purification of several fractions isolated from the crude extracts of the leaves and stem bark of C. 
pseudopulchellus proved difficult due to the large quantities of ent- kaur-16-en-19-oic acid 
present. A mixture containing gM -^kaur-16-en-19-oic acid, CP.l was methylated to enable 
separation of methyl e«^12p-hydroxykaur-l 6-en-19-oate, CP.6, eudesm-4(15)-ene-lp, 6a-diol, 
CP.15 and germacra-4(15), 5E, 10(14)-trien-lp-ol, CP.17. The méthylation and subsequent 
separation of the mixture resulted in the isolation of compound CP.2, methyl cMr-kaur-16-en-19- 
oate^^’ which was found to be a synthetic derivative of compound CP.l and has not been 
reported to occur naturally.
Figure 5.6: Structure for compound CP.2: Methyl e«/'-kaur-16-en-19-oate
The LREIMS spectrum [Spectrum 5.2.1] of the methylated compound CP.2 gave a molecular 
ion peak at m/z 316 which indicated a molecular formula of C21H32O2. The LREIMS spectrum 
showed a fragment ions at m/z 301, [M -  15]\ The FTIR spectrum [Spectrum 5.2.2] showed an 
absorption band at 1726 cm"^  that was attributed to a carbonyl stretch, this absorption band 
shifted from 1692 cm'  ^ in compound CP.l, for the carboxylic acid to 1726 cm'  ^ for the methyl 
ester. Further absorption bands at 1653 cm'  ^and 875 cm'  ^ for compound CP.2 were seen in the 
FTIR spectrum and were attributed to exocyclic double bond stretches.^^ The NMR spectrum 
[Spectrum 5.2.3] for the methylated compound CP.2 displayed the same proton resonances 
except for the presence of an extra methoxy group proton singlet resonance integrating to 3H at 8 
3.62 (s) [Table 5.1] whereas the NMR spectrum [Spectrum 5.2.4] showed an extra carbon 
resonance at 8 51.3 [Table 5.2].
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The optical rotation for compound CP.2 was found to be -  96° (Literature [a] = - 107.5°)^^
and a comparison of the NMR chemical shifts [Table 5.2] of compound CP.2 to those found 
in the literature confirmed the successftil méthylation of eM -^kaur-16-en-19-oic acid to its methyl 
ester.'''"'-""
Table 5.2: Correlation table for compound CP.2: Methyl e«/-kaur-16-en-19-oate
0 . "C  NMR (125 
MHz) CDCI3
" C  NM R (50 
MHz) CDCb^^
^H NM R (500 MHz) 
CDCI3
HMBC (H ^ C ) COSY NOESY
a 41.0 CH2 40.7 1.84' 2 ,3 , 2 0 IP IP
P 0.78 d J =  5.0 Hz 2, 3, 20 la la , 2 P
a 19.3 CH2 19.0 1.83' 3 2P, 3P, 3a 3a
P 1.42 m 1 2a, 3a, 3p IP
a 38.3 CH2 38.0 2.15 b rd 4 ,5 2a, 2P, 3P 2a, 3P
P 0.98 m 4,5 2a, 3a, 3p 3a, 18
t 4 4 . 0  c 43.8 - - - -
) 57.3 CH 57.0 1 . 0 2  m 18, 1 0 6 a 2p,18
a 2 2 . 1  CH2 21.9 1.72 m 5 ,7 ,8 7 7
P 1.82' 5 ,7 ,8 5 l ip
a 41.5 CH2 41.2 1.48 m ' 5, 14, 15 6 p 15a
P 1.48 m ' 5, 14, 15 6 p 6 p, 15P
i 44.4 C 44.2 - - - -
) 55.3 CH 55.0 1.03 m 1 ,4 ,12 , 20 1 1 l ip ,  15P, 17 A
0 39.6 C 39.4 - - - -
la 18.6 CH2 18.4 1.55' 9, 10, 12, 13 9 6 a , 9
IP 1.55' 9, 10,12,13 9 9
>a 33.3 CH2 33.1 1.56' 11,13,16 12p, 13 12P, 20
2 P 1.46 m 13, 16 12a, 13 1 2 a
3 44.1 CH 43.8 2.61 br s 8 , 15, 16,17 12a, 12P, 14P 14a, 14p
ta 39.9 CH2 39.6 1.94 br d 9, 12, 13, 15 14P 13, 14P, 20
tp 1.11 dd J= 4 .9 5 , 11.2 Hz 9, 12, 13, 15 1 3 ,14a 1 3 ,14a
)a 49.1 CH 48.9 2 . 0 2  br s' 9 ,1 3 ,1 4 ,1 6 ,1 7 17E, 17B 7, 9, 17E
5P 2 . 0 2  br s' 9 ,13 ,14 , 16,17 17E, 17B 7, 9 , 17E
6 156.0 C 155.8 - - - -
103.2 CH2 102.9 4.77 br s 13,15,16 15, 17B 9, 1 3 ,15a, 15P, 17B
4.71 br s 12, 13, 15,16 1 5 ,17A 17A
8 28.9 CH3 28.7 1.15s 3 ,4 ,5 - 5, 14a
9 178.3 C 178.0 - - - -
0 15.6 CH3 15.3 0.81 s 1 ,5 ,9 - 12a, OMe
51.3 CH3 51.1 3.62 s 19 - 20
Refer to overlapped/superimposed proton resonances
^Resonances at 5 1.24 in the 'H NMR and 8 29.9 in the "C  NMR spectra are for an impurity 
present in the sample.
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5.2.3 Structural elucidation of compound CP.3: £«/-kaur-16-en-19-al
Compound CP.3 was isolated as a colourless oil from both the leaves and the stem bark of C.
pseudopulchellus and was identified as the known ent-kmx-16-en-19-al.
CP.3
Figure 5.7: Structure for compound CP.3: £'«/-kaur-16-en-19-al
The LREIMS spectrum [Spectrum 5.3.1] for compound CP.3 gave a molecular ion peak at m/z 
286 which showed a molecular formula of C20H30O. The LREIMS spectrum showed a fragment 
ion at m/z 257, [M-29]^ for a loss of a CHO fragment of an aldehyde. A double bond 
equivalence of six was calculated. The FTfR spectrum [Spectrum 5.3.2] gave an absorption 
band at 1729 cm"^  that was attributed to a carbonyl s t r e t c h . The  NMR [Spectrum 5.3.4], 
DEPT [Spectrum 5.3.5] and HSQCDEPT [Spectrum 5.3.6] spectra showed the presence of 
twenty carbon resonances. The carbon resonances were found to belong to four quaternary 
carbons, which included one for a double bond carbon resonance at 5 155.8, four methine carbon 
resonances, including a carbonyl carbon resonance at ô 206.1, ten methylene carbon resonances, 
including one exocyclic double bond carbon resonance at 5 103.4 and two methyl carbon 
resonances at 5 1.00 (s) and 0.88 (s). From the calculated double bond equivalence and the 
and NMR spectra compound CP.3 was found to be a tetracyclic diterpenoid.
The NMR spectrum [Spectrum 5.3.3] of compound CP.3 displayed a proton resonance for
an aldehyde proton resonance at 5 9.75 (s), two exocyclic double bond proton resonances at 5 
4.80 (br s) and 4.75 (br s), two methyl group singlet proton resonances that integrated to 3H each 
and a methine proton resonance at 5 2.59 (br s). The above information indicated that compound 
CP.3 possessed a tetracyclic kaurane - like structure possessing an aldehyde.^^ A comparison of 
the and NMR spectral data (Table 5.1 and Table 5.3) showed that compound CP.3 only 
differed from compound CP.l in that the carboxylic acid in C-19 was present as an aldehyde.
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The presence of an aldehyde in C-19 for compound CP.3 was confirmed by the observed 
correlation in the HMBC spectrum [Spectrum 5.3.7] between a methyl group proton resonance 
at 5 1.00 (s) and the carbonyl carbon resonance at 5 206.1.
Attempts to compare the and ^^ C NMR data for e«/-kaur-l 6-en-19-al with literature data were 
not successful because the only reported assignment is a partial assignment (Table 5.3) done by 
Piozzi and co-workers in 1971.^  ^ The Dictionary of Natural products CD ROM (2007)^^ records 
that the ^^ C NMR data was reported by Hanson and co-workers in 1976 in their paper entitled the 
^^ C Nuclear Magnetic Resonance spectra of kauranoid diterpenes, however, an investigation of 
this source did not show the ^^ C NMR data for g^r-kaur-16-en-19-al.^^
The negative optical rotation value of -  80° (Literature [a] = - 95°)^  ^ confirmed that
compound CP.3 belonged to the g«/-series of kauranoid diterpenes. The relative 
stereochemistry for the g«/-kaur-l 6-en-19-al was further confirmed by the NOESY experiment. 
Correlations in the NOESY spectrum were observed between one of the H-15 (8 2.06, m) proton 
resonance and the H-9 (5 1.09, d, J =  7.50 Hz) proton resonance. The H-9 (5 1.09, d, J =  7.50 
Hz) proton resonance was also seen to correlate to the H-5 (ô 1.17, d, J  = 2.05 Hz) proton 
resonance, which, in turn, showed a correlation with the 3H-18 (5 1.00, s) methyl group proton 
resonance. The H-15, H-9, H-5 and 3H-18 protons were placed on one face of the molecule. 
The H-19 (6 9.64, s) aldehyde proton resonance was seen to be correlated with the 3H-20 (5 
0.89, s) methyl group proton resonance and one of the H-14 (8 1.99 dd 1.80, 11.4 Hz) proton 
resonances, which, in turn, was correlated to the H-13 (6 2.64, br s) proton resonance and hence 
on the other face of the molecule.
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Table 5.3: Correlation table for compound CP.3: £'«/-kaur-16-en-19-al
NM R (125 
MHz) CDCI3
H NM R (500 MHz) 
CDCI3
H NM R (100 
MHz) C C l ^
HMBC (H ^ C ) COSY NOESY
40.1 CH2 1.86' 1 0 IP Ip, 3a, 19, 20
0.79 td J =  4 .1 0 ,13.80 Hz 3, 10 la , 2 a, 2 P la , 2P,3P, 5 ,9
18.6 CH2 1.60 m 1,3 3a, 3p 2p ,3a
1.44 m 1,3 3P IP, 2a, 3P
34.4 CH2 2.14 br d J =  13.5 Hz - 2a, 3P la , 2 a, 3P
0.99 m 18, 19 2a, 3a, 3p ip ,3 a
48.7 C - - - -
56.9 CH 1.17 d J =  2.05 Hz 6 , 18, 19, 20 6 a, 6 p 6 a, 6 P, 7P, 9,18
2 0 . 1  CH2 1.70 m 7 5, 6 a, 7a, 7p 5, 6 a, 19
1.87' - 5, 6 a, 6 P, 7a 5,6P
41.4 CH2 1.58 m 5 ,6 ,8 6 a, 6 p, 7P 7P
1.51' 5, 6 , 8 6 a, 6 p, 7a 5, 7a
44.3 C - - - -
54.8 CH 1.09 d J =  7.50 Hz 1, 15,20 1 1 IP, 5, l ip ,  15P
39.5 C - - - -
1 18.5 CH2 1.60 m ' 9, 10,13 9 1 2 a, 2 0
3 1.60 m ' 9, 10,13 9 9, 12P
X 33.1 CH2 1.51' 16 13 11a, 12P
3 1.47 m 16 13 l ip ,  1 2 a
44.0 CH 2.64 br s 2.59 br s - 12a, 12P, 14a, 14p 14a, 17A
X 40.0 CH2 1.99 dd J =  1.80,11.4 Hz 12, 13,15,16 14p 13, 14P, 19
3 1.15 m - 1 3 ,14a 14a
X 49.2 CH2 2.06 m ' 2.03 d J - 1 8 , 9, 14,16 13, 17A, 17B 17B
3 2.06 m 2.03 d J = l 8 , 9, 14,16 13, 17A, 17B 9
155.8 C - - - - -
\ 103.4 CH2 4.80 br s 4.73 s 13,15 15 13
B 4.75 br s 4.68 s 13, 15,16 15 15a, 15p
24.5 CH3 1.00 s 0.97 s 3 ,4 ,5 , 19 19 2P, 5,19
206.1 CH 9.75 d J =  1.25 Hz 9.64 d J =  1.2 3 ,4 18 la , 6 a, 18, 2 0
16.6 CH3 0.88 s 0.89 s 1 ,5 ,9 - la , 14a, 11, 19
Refer to overlapped/superimposed proton resonances
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5.2.4 Structural elucidation of compound CP.4: jE'«t-12p-hydroxykaur-16-en-l9-oic acid 
Compound CP.4 was isolated as a white solid from both the leaves and the stem bark of C. 
pseudopulchellus and found to be a C-12 hydroxy derivative of compound CP.l and was 
identified as the known e«/-12p-hydroxykaur-l 6-en-19-oic acid.
OH
^ O H
CP.4
Figure 5.8: Structure for compound CP.4: JE'«t-12p-hydroxykaur-16-en-19-oic acid
The LREIMS spectrum [Spectrum 5.4.1] for Compound CP.4 gave a [M-1]^ ion at m/z 317 
which indicated a molecular formula of C20H34O3. A double bond equivalence of six was 
calculated. The FTIR spectrum [Spectrum 5.4.2] gave an absorption band at 3433 cm'  ^that was 
attributed to a hydroxyl stretch, and an absorption band at 1697 cm'  ^ for a carbonyl stretch.^* 
Further absorption bands at 1653 cm'  ^and 878 cm'  ^were also observed for compound CP.4 that 
were attributable to an exocyclic double bond stretch
An oxymethine carbon resonance was observed in the '^C NMR spectrum [Spectrum 5.4.4] at 5
72.4. The NMR spectrum [Spectrum 5.4.3] showed two methyl group proton resonances at 5 
1.27 (s) and 1.09 (s), two double bond proton resonances at 8 4.86 (br s) and 4.78 (br s), an 
allylic methine proton resonance at 5 2.69 (br s) typical of H-13 of an e«r-kaur-l 6-en-19-oic 
a c i d a n d  an oxymethine proton resonance at 5 3.88 (t, J=  4.50 Hz) (Table 5.4). The H-13 (ô 
2.69, br s) allylic methine proton resonance was seen to be coupled to a proton resonance at 5
1.02 (m) and an oxymethine proton resonance at 5 3.88 (t, 4.50 Hz) in the COSY spectrum
[Spectrum 5.4.8]. The oxymethine proton resonance at 8 3.88 (t, 4.50 Hz) was, in turn, seen
to be further coupled to a proton resonance at 8 1.85 that was assigned as one of the H-11 
protons. The H-11 proton showed further coupling with the H-9 methine proton resonance at 5
1.18 (d, J =  9.50 Hz) in the COSY spectrum. The oxymethine proton resonance at 8 3.88 (t, J=  
4.50 Hz) was assigned as H-12 whereas the proton resonance at 5 1.02 (m) was assigned to one
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of the H-14 protons [Figure 5.9]. A correlation was observed between the H-11 (ô 1.85) proton 
resonance and the C-12 (5 72.4) carbon resonance in the HMBC spectrum. More correlations in 
the HMBC spectrum that are presented in Figure 5.9 below confirmed the position of the 
oxymethine carbon resonance at C-12. The ^H and ^^ C NMR spectral data (Table 5.1 and table
5.4) showed that rings A, B and D were the same for compound CP.l and CP.4. However, the 
two compounds differed in that compound CP.4 was a hydroxylated form of compound CP.l. 
The optical rotation of compound CP.4 of [a] -  35.1° (literature value of - 44.7°)^°’
indicated that this compound belonged to the ent series of kaurane diterpenoids. A correlation 
was observed in the NOESY spectrum [Spectrum 5.4.9] between the two H-17 proton 
resonances assigned to the (3 -  face of the molecule and the H-12 (8 3.88 t J  = 4.50 Hz) 
oxymethine proton resonance. The hydroxy group was therefore assigned the a configuration. 
Compound CP.4 was therefore identified as e«^12p-hydroxy-kaur-l 6-en-19-oic acid.
OH
20 :
CP.4
^ O H
CP.4
Figure 5.9: Selected COSY (H H) and HMBC (H C) correlations for compound CP.4
Comparison of the chemical shifts of the ^^ C NMR spectra of compound CP.4 and the ^^ C NMR 
chemical shifts published in the literature^^’ confirmed that compound CP.4 was the
known e«/-12p-hydroxykaur-l6-en-19-oic acid (Table 5.4).
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Table 5.4: Correlation table for compound CP.4: £'/it-12p-hydroxykaur-16-en-19-oic acid
No NM R (125 
MHz) CDCI3
(125 MHz) 
CDCh^^
H NM R (500 MHz) 
CDCI3
HMBC (H -> C) COSY NOESY
la 41.0 CH2 40.7 1.85' 3, 5,10 IP, 2a, 2P IP, 7P
IP 0.80 m 3,5 , 10 la , 2 a, 2 p la , 6 P
2 a 19.3 CH2 19.1 1.90 m ' 3, 10 la , ip ,3 P la , 2P, 3a
2 P 1.45 m ' 4 la ,3 p 3P, 2a
3a 38.3 CH2 38.1 2.15 d J =  13.45 Hz 1,4 3a 2a, 3p
3P 0.96 m 2 , 2 0 2o ,2p ,3p 3a, 18
4 43.8 C 43.5 - - - -
5 57.2 CH 56.9 1.06 m 6 , 19,20 6 a, 6 p 18
6 a 2 2 . 0  CH2 21.9 1.83' 5 ,7 5,7P 2 0
6 P 1.83' 5 ,7 5, 7P IP, 7p,9
7a 41.4 CH2 41.2 1.48 m 6 ,9 7P 7P, 20
7P 1.60* 9, 14 6 a, 6 P, 7a 7a, 3p
8 . 44.1 C 43.7 - - - -
9. 56.2 CH 56.1 1.18 d J =  9.50 Hz 10, 11, 12, 14, 15,20 1 1 a 6 P, 13,15
1 0 . 38.9 C 38.6 - - - -
H a 26.9 CH2 26.2 1.85 m 8 , 9 ,10 ,12 9, l ip ,  12 U p, 13
u p 1.61' 8 , 9, 10,12 1 1 a 1 1 a, 1 2
1 2 72.4 CH“ 71.8 3.88 t 4.50 Hz 9, 13,14 u p ,  13 u p ,  17A, 17B
13 50.8 CH° 51.3 2.69 br s 8,11, 12 ,15,16,17 12, 14P 9
14a 33.3 CH2 33.1 2.33 d J =  11.50 Hz 9, 12, 15, 16 14P 14p
14P 1 . 0 2  m 9, 12,15 14a, 13 1 3 ,14a
15a 49.5 CH2 49.2 2 . 1 1  br s 8 , 9 ,1 3 ,1 6 ,1 7 17A, 17B 9
15P 2.14 br s 8 , 9 ,1 3 ,1 6 ,1 7 17 A, 17B 9, 17A
16. 152.6 C 152.7 - - - -
17A 105.4 CH2 104.8 4.78 br s 12, 13, 15, 16 15a, 15P, 17B 12, 15p, 17B
17B 4.86 br s 12,13 ,15 ,16 15a, 15P, 17A 12, 1 3 ,17A
18. 28.7 CH3 29.4 1.27 s 3 ,4 ,5 ,1 9 - 3P,5
19. 182.3 C 180.7 - ' - - -
20. 15.6 CH3 14.5 1.09 s 1 .3 ,5 ,9 - 6 a, 7a
Refer to overlapped/superimposed proton resonances
°The NMR chemical shifts were similar for compound CP.4 and the reported ent-\2^~ 
hydroxykaur-16-en-19-oic acid^  ^ except for C-12 and C-13. The use of ID and 2D NMR 
spectroscopic data for compound CP.4 supported an e«/-12p-hydroxykaur-l 6-en-19-oic acid 
structure.
^Resonances at 5 1.24 in the NMR and Ô 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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5.2.5 Structural elucidation of compound CP.5: ^«/-12p-acetoxykaur-16-en-19-oic acid 
Compound CP.5 was isolated as a yellow oil from both the leaves and the stem bark of C. 
pseudopulchellus and found to be an acetylated derivative of compound CP.4, the known ent- 
12p-acetoxykaur-16-en-19-oic acid.
 ^ C P .5
Figure 5.10: Structure for compound CP.5: jF«t-12p-Acetoxykaur-16-en-19-oic acid
The LREIMS spectrum [Spectrum 5.5.1] for compound CP.5 gave a [M-1]^ ion at m/z 359 
which indicated a molecular formula of C22H32O4. A double bond equivalence of six was 
determined. The FTIR spectrum [Spectrum 5.5.2] exhibited absorption bands at 1731 cm'  ^and 
1692 cm'  ^ attributed to acetate carbonyl and free carboxylic acid carbonyl stretches 
respectively.^^ An absorption band at 3422 cm'  ^ attributed to a hydroxyl group stretch and 
absorption bands at 1653em'^ and 879 cm'  ^attributed to an exocyclic double bond stretch,^^ were 
also observed in the FTIR spectrum.
The NMR spectrum [Spectrum 5.4.3] of compound CP.5 was the same as that of compound 
CP.4 except for the presence of an acetate group singlet methyl group proton resonance, which 
integrated to 3H, at 5 2.02 (s) and a downfield shift for the H-12 oxymethine proton 
resonance to 5 4.75 (t, J=  5.00 Hz).^  ^ The H-13 (6 2.75, t, J =  5.00 Hz) allylic methine proton 
resonance was seen to be coupled to the H-12 (5 4.75, t, J  = 5.00 Hz) oxymethine proton 
resonance in the COSY spectrum [Spectrum 5.5.8]. The NMR spectrum [Spectrum 5.5.4] 
displayed twenty-two carbon resonances, twenty for a normal diterpene skeleton which included 
a carbonyl carbon resonance at 5 184.2 for the C-19 carboxyl carbon and two extra carbon 
resonances at ô 170.6 and 21.3 attributable to the two acetate group carbons. The optical 
rotational value of [a]^^^o -  39.8° (literature value of -  38.0°)^  ^ confirmed that compound CP.5 
belonged to the ent series. A correlation in the NOESY spectrum [Spectrum 5.5.9] was
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observed between the acetate methyl proton resonance (5 2.03, s) and the 3H-20 (5 1.02, s) 
methyl group proton resonance, known to be on the a-face. The acetoxy group was therefore 
assigned the a configuration. Compound CP.5 was therefore identified as e«/-12p-aeetoxykaur- 
16-en-19-oic acid. Comparison of the chemical shifts of the NMR spectrum of compound 
CP.5 [Table 5.5] and the literature data published by Bohlmann et al?^ confirmed that compound 
CP.5 was e«^-12p-acetoxykaur-l 6-en-19-oic acid.
Table 5.5: Correlation table for compound CP.5: E«/-12p-acetoxykaur-16-en-19-oic acid
No. " C  NM R (125 
MHz) CDCI3
NM R (500 MHz) 
CDCI3
"H NM R (270 
MHz) CDCb^^
HMBC (H ^ C ) COSY NOESY
a 40.8 CH2 1.73 d J =  13.5 Hz 5 IP IP
P 0.78 m 3,9,20 la, 2 a , 2p la, 9
a 19.1 CH2 1.84’ 3 ip,2p,3a,3p 2p, 20
P 1.40 td J=  3.0,13.5 Hz - IP, 2a, 3P 2a
a 37.9 CH2 2.17 d J =  13.5 Hz 2.18 (br) J =  13 Hz 2 2a, 3P 3P,20
P 1.02 d d J= 3 .0 ,13.5 Hz’" 0.80 dddJ=13Hz^ 19 2a, 3a, 2p 3a
43.4 C - - - -
57.0 CH 1.07 m 6,18 6 9,18
a 21.9 CH2 1.82’ 4,5 5 ,7a, 7p l a
P 1.82’ 4,5 5 ,7a, 7P 7P
a 41.2 CH2 1.60’ 9,14 6,7P 6a, 7p
P 1.50 m 6, 9,14 6, l a 6p, la ,  15p
4 4 . 0  c - - - -
55.5 CH 1.21 d /= 9 .5 H z 1, 7,12,20 11a, 12 IP, 5, lip , 15P
0. 38.9 C - - - -
la 23.5 CH2 1.90 m 8,9,10 9,12 l i p , 12
IP 1.65 m 8,9,10,12,13 12 9 ,11a, 12
2 74.1 CH 4.75 XJ= 5.0 Hz 4.76 dd (br) J =  5 Hz 9,11,13,14, Ac 13,lip 11a, lip , 13
3 48.2 CH 2.75 t 5.0 Hz 2.76 dd (br) J= 5 Hz 8,12,14,15,16,17 12 12,14a, 14p 17A
4a 34.0 CH2 2.25 d J =  12.0 Hz 1 2 - ■ 13,14P
4P 1.60’ 8 ,9, 12,13 - 13,14a, 15a, 15p
5a 49.2 CH 2 . 1 2  br s’ 7 , 8 , 9,13,14,16,17 17A, 17B 14P
5P 2.12 br s’ 7, 8 , 9,13,14,16,17 17A, 17B 7P,9,14P
6. 151.1 C - - - -
7A 106.6 CH2 4.95 br s 4.96 br s 12,13,15,16 15a, 15P, 17B 13,17B
7B 4.83 br s 4.84 br s 12,13,15,16 15a, 15P, 17A 15a, 17A
8. 29.3 CH3 1.25 s 1.26 s 3,4, 5,19 - 5
9. 184.2 C - - - -
10. 14.3 CH3 1 . 0 1  s’ 1 . 0 2  s 1,5,9,10 - 2a, 3a, 12-Ac
lc- 1 2 170.6 C - - - -
lc-12 21.8 CH3 2.02 s 2.03 s Ac - 20
Refer to overlapped/superimposed proton resonances 
°Bohlmann, et al. (1980)^^ wrongly assigned the H-3p proton resonance 
 ^Resonace at 5 1.24 in the NMR spectrum is for an impurity present in the sample.
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5.2.6 Structural elucidation of compound CP.6: Methyl e«t-12p-hydroxykaur-16-en-19-oate 
Compound CP.6 was isolated as a yellow oil from méthylation of a mixture that had been 
isolated from the leaves of C. pseudopulchellus. The méthylation and subsequent separation of 
the mixture resulted in the isolation of compound CP.6, methyl e«/-12p-hydroxykaur-16-en-19- 
oate^ "^  which was found to be a synthetic derivative of compound CP.4 and has not been reported 
to occur naturally.
OH
Figure 5.11: Structure for compound CP.6: Methyl e«/-12p-hydroxykaur-16-en-19-oate
The LREIMS spectrum [Spectrum 5.6.1] for compound CP.6 gave a molecular ion peak at m/z 
332 which indicated a molecular formula of C21H32O3. The LREIMS spectrum showed fragment 
ions at w/z 314, [M-18]^ for a loss of a unit of H2O, m/z 299 [M -  18 - 15]  ^for a further loss of a 
CH3 fragment and m/z 255 [ M - 1 8 - 1 5  -  44]’*' for a further loss of a CO2 fragment. A double 
bond equivalence of six was calculated. The FTIR spectrum [Spectrum 5.6.2] showed a sharp 
absorption band of a secondary hydroxyl group stretch at 3435 cm"\ an absorption band at 1698 
cm"^  of a carbonyl stretch and absorption bands at 1665 cm"^  and 875 cm'  ^attributed to exocyclic
double bond strectches.11
The NMR spectral data [Spectrum 5.6.3] of compound CP.6 was the same as the NMR 
spectral data of compound CP.4 except for the presence of a methoxy group proton resonance 
integrating to 3H at 5 3.64 (s). The ^^ C NMR spectrum [Spectrum 5.6.4] for compound CP.6 
displayed twenty-one carbon resonances, the extra carbon resonance at 5 51.9 was attributed to 
the methoxy group carbon resonance. The methoxy group proton resonance (5 3.40, s) was seen 
to correlate in the HMBC spectrum with the C-19 carbonyl carbon resonances at ô 178.3. The 
H-13 (5 2.64 br s) allylic methine proton resonance was observed to couple in the COSY 
spectrum [Spectrum 5.6.8] with the H-12 (6 3.77 (t, J  = 5.01 Hz) oxymethylene proton
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resonance. A correlation in the NOESY spectrum [Spectrum 5.6.9] was observed between the 
H-17 (5 4.82, br s) protons assigned to the P -  face of the molecule and the H-12 (ô 5.01, t J  =
5.01 Hz) oxymethylene proton resonance. The hydroxy group was therefore assigned the a 
configuration. Compound CP.6 was therefore identified as methyl e«/-12p-hydroxykaur-16-en- 
19-oate. An optical rotation of [a]^^^o -  44.7° (Literature [a]D^ "^  = - 38°)^ "* and comparison of the 
chemical shifts of the ^H NMR spectrum of compound CP.6 [Table 5.6] with the literature data 
published by Bohlmann et confirmed that compound CP.6 was methyl ent-l2^- 
hydroxykaur-16-en-19-oate.
Table 5.6: Correlation table for compound CP.6: Methyl e«t-12p-hydroxykaur-16-en-19-
oate
J (125 MHz) 
CDCI3
NM R (500 MHz) 
CDCI3
"H NMR (270 
MHz) CDCb^^
HMBC
( H ^ C )
COSY NOESY
I 41.3 CH2 1.80’ 2 ,3 ,9 IP, 2a, 2P Ip, 2a
] 0.75 m 2 ,3 ,9 ,2 0 la , 2a, 2p la , 2p
I 19.1 CH2 1.84’ 1 ,3 ,4 , 10 3a, 3p 20
Î 1.84’ 1 ,3 ,4 , 10 3a, 3p 9
I 38.2 CH2 2.16 m 2.18 d b r 1 2 a ,2 p ,3 p 3P
Î 1.08 m“ 0.80 ddd^ 19 2a, 2P, 3a 3a
43.7 C - - - -
57.0 CH 1.05 m 18,19,20 6a, 6P 18, 19
I 22.0 CH2 1.84’ 4, 5,10 7a -
Î 1.84’ 4 ,5 ,1 0 5,7P 18
1 40.7 CH2 1.80’ 5 ,6 , 8, 9,15 6a, 6P, 7a 7p
3 1.58 m 5,6 , 8 ,9 ,15 6a, 6p, 7a 7a, 15p
4 4 . 0  c - - - -
56.1 CH 1.17 m 11, 12,20 11a, l ip 2 ,5 , l ip ,  15p
3 38.5 C - - - -
a 26.0 CH2 1.83’ 12 9,12 12
P 1.60 m 12 9, 12 9 ,12
2 72.1 CH 3.77 t J =  5.01 Hz 3.79 dd br 9 ,11 ,13 11a, l ip ,  13 11a, l ip ,  13, 17B
3 51.3 CH 2.64 s 2.64 dd br 8, 12,16,17 12, 14a, 14P 12, 17B
a 33.1 CH2 2.26 br d J =  11.5 Hz 1 2 14s 14P
P 1 . 0 1  m 1 2 14a 14a
a 49.2 CH2 2.08 s 16, 17 17A, 17B 17A
P 2.08 s 16, 17 17A, 17B 7p, 9, 17A
5 152.5 C - - - -
A 105.1 CH2 4.75 s 4.78 br s 13, 15 15a, 15p, 17A 15a, 15P
B 4.82 s 4.85 br s 13,15 15a, 15p, 17B 12, 13
ÿ 28.7 CH3 1.15 s 1.18 s 3 ,4 ,5 ,1 9 5
178.3 C - - - -
; 15.1 CH3 0.98 s 0.70 s 1 ,9 ,10 2
H3 51.9 CH3 3.64 s 3.64 s 19 -
*^Bohlmann, et a l (1980)^ "^  wrongly assigned the H-3p proton resonance as ô 0.80.
^Resonances at 6 1.24 in the ^H NMR and ô 29.9 in the NMR spectra are for an impurity 
present in the sample.
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5.2.7 Structural elucidation of compound CP.7: ^«t-15p-hydroxykauren-16-en-19-oic acid 
Compound CP.7 was isolated as a colourless oil from the leaves of C. pseudopulchellus and 
found to be a hydroxylated derivative of compound CP.l and was identified as the known ent- 
15P-hydroxykaur-16-en-19-oic acid.
OH
^ O H  
 ^ CP.7
Figure 5.12: Structure for compound CP.7: jE'«/-15p-hydroxykaur-16-en-19-oic acid
The LREIMS spectrum [Spectrum 5.7.1] for compound CP.7 gave a [M-1]^ ion at m/z 317 
which indicated a molecular formula of C20H34O3. The FTIR spectrum [Spectrum 5.7.2] 
showed a broad absorption band at 3413 cm'  ^ that was attributed to a hydroxyl stretch, an 
absorption band at 1708 cm'  ^ for the carbonyl stretch and an absorption band at 1630 cm'  ^for a 
double bond stretch.^^
The NMR and NMR spectral data (Table 5.1 and Table 5.7) showed that rings A, B and C 
were the same for compound CP.l and CP.7. However, the NMR spectrum [Spectrum
5.7.4] of compound CP.7 exhibited an oxymethine carbon resonance at Ô 82.9. The NMR 
spectrum [Spectrum 5.7.3] depicted similar chemical shifts to those of compound CP.l except 
for the presence of an oxymethine proton resonance at 6 3.84 (br s) [Table 5.7].
The NMR spectrum displayed two H-17 exocyclic double bond resonances at ô 5.21 (br s) 
and 5.07 (br s) and the allylic H-13 methine proton resonance at 5 2.74 (br s) of an kaur-16- 
en-19-oic acid. The two H-17 exocyclic double bond proton resonances were observed to be 
attached to a carbon resonance at 5 108.7 in the HSQCDEPT spectrum [Spectrum 5.7.6]. The 
C-17 carbon resonance was seen to be correlated to an oxymethylene proton resonance at ô 3.81 
(br s) in the HMBC spectrum [Spectrum 5.7.7]. The hydroxyl group was therefore placed at C-
15. The H-15 proton resonance showed long range correlations in the COSY spectrum 
[Spectrum 5.7.8] with the two H-17 exocyclic double bond proton resonances. Correlations
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were observed in the HMBC spectrum with the C-17 carbon resonance and carbon resonances at 
Ô 53.6, 42.5 and 36.4 that were attributable to C-9, C-13 and C-14 carbons. The position of the 
hydroxyl group was further confirmed by a comparison of the chemical shifts of the ^^ C NMR 
spectrum of compound CP.7 and the data reported in the literature.
The negative optical rotation of [a] d  ^ -  56.7° (literature value was -114°) that was 
determined for compound CP.7 indicated that it belonged to the e«/-kaurenoid s e r i e s . T h e  
stereochemistry of the C-15 hydroxy group was determined using the NOESY spectrum 
[Spectrum 5.7.9]. The presence of a correlation in the NOESY spectrum between the known, P 
-  configured H-9 (Ô 1.01) proton resonance and the H-15 (6 3.81 br s) proton resonance, 
indicated that the hydroxyl group was on the a face of the molecule. Compound CP.7 was 
further confirmed to be the known 15 P-hydroxykaur-16-en-19-oic acid which, was first
isolated from Espeletia grandiflora^^’ in 1968, by comparison of the ^^ C NMR chemical shifts 
with those reported in the literature (Table 5.7).^  ^ Piozzi et al. (1968) named this compound 
grandifiorolic acid and in 1969 when Brieckom and Poehlmann^^ isolated the same compound 
fi"om Espeletia schultzii they maintained the same name. However, Yahara et al. (1974)^^’ 
used the name grandifloric acid for this compound.
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Table 5.7: Correlation table for compound CP.7: £'«/-15p-hydroxykaur-16-en-19-oic acid
No " C  NM R (125 
MHz) CDCI3
NM R (125 
MHz) CDCla^®
^H NMR (500 MHz) 
CDCI3
HMBC
( H ^ C )
COSY NOESY
la 40.9 CH2 40.67 1.84' 9 IP IP, 2 0
IP 0.79 m 2 0 l a la
2 a 19.3 CH2 19.05 1 .8 6 ' 3 i p , 2 p 2P
2 P 1.40 m 3, 10 2 a 2a, 3 a
3a 38.0 CH2 37.74 2.15 m 18 2P,3P 2p,3p
3P 1 .0 0 ' 19 2a, 3 a 3a
4 43.9 C 43.70 - - - -
5 57.2 CH 56.97 1.06 m 19 6 a, 6 p 6 P
6 a 2 1 . 2  CH2 20.91 1.74 m 5 5, 7a, 7P 7a, 7P
6 P 1.92' 5 5, 7a, 7p 5
7a 35.4 CH2 35.20 1.94 m - 6 a, 6 p, 7P 6 a
7P 1.40' 8 ,9 6 a, 6 p, 7a 6 a
8 47.9 C 47.70 - - - -
9 53.6 CH 53.33 1 .0 1 ' 15,20 l ip 15
1 0 40.0 C 39.80 - - - -
1 1 a 18.5 CH2 18.26 1.60' 1 0 l ip ,  1 2 a 1 2 a
l ip 1.40' 1 0 9, 11a, 12a 14a
1 2 a 32.8 CH2 32.55 1.40' 14 1 2 a l l a , 1 2 p
12P 1.60' 17 1 2 a 1 2 a
13 42.5 CH 42.29 2.74 br s - 12a, 14a 12a, 14a
14a 36.4 CH2 36.20 1.90' 12, 15,17 14P l ip ,  1 3 ,14P
14P 1.40' 1 2 13, 14a 14a
15 82.9 CH 82.68 3.81 br s 9, 13, 14,17 17 A, 17B 9, 17A
16 160.5 C 160.25 - - - -
17A 108.7 CH2 108.28 5.21 br s 13, 15,16 15, 17B 15
17B 5.07 br s 13,15,16 1 5 ,17A 13
18 29.2 CH3 28.91 1.23 s 3 ,4 ,5 ,1 9 - -
19 184.0 C 183.80 - - - -
20 16.0 CH3 15.80 0.95 s 1 ,5 ,9 - l a
Refer to overlapped/superimposed proton resonances
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5.2.8 Structural elucidation of compound CP.8: £'w/-14a-hydroxykaur-16-en-19-oic acid 
Compound CP.8 was isolated from the leaves and stem bark of C. pseudopulchellus and found to 
be a novel e«/-kaur-l 6-en-19-oic acid derivative and was identified as e«?-14a-hydroxykaur-16- 
en-19-oic acid.
HO,2 0 .
Figure 5.13: Structure for compound CP.8: Ent-14a -hydroxykaur-16-en-19-oic acid
The HRMS spectrum [Spectrum 5.8.1] for compound CP.8 gave a [M-1]^ ion at m/z 317.2172 
which indicated a molecular formula of C20H30O3. A double bond equivalence of six was 
determined. The FTIR spectrum [Spectrum 5.8.2] of compound CP.8 showed absorption bands 
at 3340 and 1691 cm'  ^ that were assignable to hydroxyl and carbonyl stretches respectively.^^ 
The NMR [Spectrum 5.8.4] and DEPT [Spectrum 5.8.5] spectra showed that compound 
CP.8 possessed twenty carbon resonances, which included two double bond carbon resonances 
at 5 107.5 and 149.2, a carbonyl carbon resonance at 5 183.7 and an oxymethine carbon 
resonance at 5 69.4.
The NMR spectrum [Spectrum 5.8.3] of compound CP.8 showed the presence of two methyl 
group singlet proton resonances at 5 0.99 (s) and 5 1.24 (s) each integrating to 3H, one 
oxymethine proton resonance at 5 4.00, d, J  = 9.35 Hz and exocyclic double bond proton 
resonances at ô 4.84 (d, J=  1.93 Hz) and 5 4.68 (d, J=  1.93 Hz). The two exocyclic double 
bond proton resonances at 5 4.84 (d, J=  1.93 Hz) and 5 4.68 (d, J =  1.93 Hz) were assigned as 
the two H-17 protons.^^’^^  The two H-17 proton resonances were seen to be attached to a carbon 
resonance at 6 107.5 in the HSQCDEPT spectrum [Spectrum 5.8.6]. A methine proton 
resonance at 5 2.25 (d, J =  2.00 Hz) which integrated to IH was also observed, and assigned as 
the typical H-13 p r o tonand  was seen to be correlated to a carbon resonance at ô 44.9 in the
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HSQCDEPT spectrum. ^  The H-13 proton resonance was shifted upfield by circa 0.4 ppm 
in comparison with other derivatives of gM -^kaur-16-en-19-oic acid.^^’ 16,23,27,29,32,34,35
The ^H NMR and ^^ C NMR chemical shifts showed that rings A and B were similar for 
compound CP.l, CP.4 and CP.8 (Table 5.1 and Table 5.9). However, the ^^ C NMR spectrum 
[Spectrum 5.7.4] of compound CP.8 exhibited an oxymethine carbon resonance at 6 69.4. This 
carbon resonance at 5 69.4 was seen to be attached to a proton resonance at 5 4.00 (d, J  = 9.35 
Hz) in the HSQCDEPT spectrum. The COSY spectrum [Spectrum 5.8.8] showed that the 
oxymethine proton resonance at 5 4.00 (d, J=  9.35 Hz) and the earlier assigned H-13 (ô 2.25, d, 
J  = 2.00 Hz) proton resonances were coupled. Therefore, the 6 4.00 (d, J  = 9.35 Hz) proton 
resonance was assignable either as H-12 or H-14. However, since compound CP.5 (Section
5.2.5) had been isolated from this plant and a hydroxy group found to be attached to C-12, 
therefore the 6 4.00 (d, J=  9.35 Hz) proton resonance compound CP.8 was tentatively assigned 
to H-14. The two earlier assigned H-17 proton resonances were seen to be correlated to carbon 
resonances at 6 44.3, 46.9 and 149.2 that were assignable to C-13, C-15 and C-16 respectively. 
The C-15 carbon resonance was seen to be correlated to 5 1.96 (m) and 1.80 (m) proton 
resonances in the HSQCDEPT spectrum. These two H-15 proton resonances were observed to 
be correlated in HMBC spectrum [Spectrum 5.8.7] with the oxymethine carbon resonance at 5
69.4. The hydroxy group was confirmed to be attached to C-14. Furthermore, the two H-15 
proton resonances were seen to correlate to carbon resonances at ô 51.7 and 149.2 that were 
ascribed as C-9 and C-16 respectively.
The H-14 (5 4.00, d, J  = 9.35 Hz) oxymethine proton resonance fiirther showed a long range 
correlation in the HMBC spectrum with a carbon resonance at the ô 21.1 that was assigned as C- 
11, whereas the C-14 (ô 69.4) carbon resonance showed correlations in the HMBC spectrum 
with the two H-12 (5 1.90 and 1.42, m), H-13 (5 2.25, d, J =  2.00 Hz) and one of the H-17 (5 
4.84, d, J =  1.93 Hz) proton resonances. Selected COSY and HMBC (H —> C) correlations have 
been presented in Figure 5.14 below.
The optical rotation experiment gave a negative value of [a]^ "^ ^D -160° which confirmed that 
compound CP.8 belonged to the ent series, therefore, the H-13 proton resonance was known to
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be on the a face of the molecule/^' A correlation between the oxymethine H-14 (8
4.00, d, / =  9.35 Hz) proton resonance and the H-13 (8 2.25, d, J =  2.00 Hz) proton resonance 
and one of the H-12 (8 1.42) resonances indicated that the hydroxyl group was on the (3 face of 
the molecule. Compound CP.8 was found to be novel e«f-14a-hydroxykaur-l 6-en-19-oic acid.
HO,
OH//w
CP.8CP.8
Figure 5.14: Selected COSY (H H) and HMBC (H C) correlations for compound
CP.8
A search in the SciFinder Scholar and Dictionary of Natural Products databases showed that 3a, 
3p, 6a, 6p, 7a, ?P, 11a, lip , 12a, 12p, 15a and 15p-hydroxy e«^-kaur-l6-en-19-oic acid had 
been re p o r te d .H o w e v e r , the literature search further showed that ^H NMR and ^^ C NMR 
chemical shifts for 3a, 3p, 6a and 11 P-hydroxy cMt-kaur-16-en-19-oic acid have not been 
reported. Comparison of the oxymethine carbon chemical shift at 8 68.7 acquired in <7-pyridine 
and at 8 69.4 acquired in CDCI3 of compound CP.8 with those reported earlier^^ showed that the 
chemical shift of the oxymethine carbon did not match any of the reported compounds, therefore 
further confirming the placement of the hydroxy group at the C-14 position (Table 5.8).*^’^^ ’^^ ’^^ ’ 
3 2 ,34,35 Compound CP.8 was therefore found to be a novel ent-\Aa - hydroxykaurenoic acid.
2 0 6
Table 5.8: NMR chemical shift for the oxymethine carbon of the mono hydroxy ent-
kaur-16-en-19-oic acid derivatives16
Positiou/Solveut 6P 7a 7P 11a 12a 12P 15a 15P CP.8
d-Pyridine - - - - 71.2 71.5 82.6 82.3 68.7
CDCI3 66.3 74.7 76.2 70.8 - - 82.7 82.3 69.4
HO,20 .
Figure 5.15: Structure for compound R.1: Ent-l^a  -hydroxykaur-16-eu-19-oate
Interestingly, a search in the SciFinder database for 14-oxokaur-16-en-19-oic acid showed
that 4-oxokaur-16-en-19-oic acid has been synthesized and reported by Yun-Xing and Wei-
Shan (1993).^^ The precursor of 4-oxokaur-16-en-19-oic acid was methyl ent-\Aa-
hydroxykaur-16-en-19-oate [R.1], however, Yun-Xing et al.^^ gave incomplete spectral data for 
methyl e«/-14a-hydroxykaur-l6-en-19-oate [Table 5.9]. The oxymethine H-14 (8 4.00, d, J  = 
9.35 Hz) proton resonance for the novel compound CP.8 was comparable to the oxymethine H- 
14 (8 4.10, br s) proton resonance of the methyl e/ir-14a-hydroxykaur-16-en-19-oate"^  ^which 
further confirmed that compound CP.8 was ent-14a-hydroxykaur-16-en-19-oic acid.
207
*3as
.ao
cf\
§
VOvH
ig
I
T3
È
5Tf1-4
I
00
6
T5
g
gOa
S
Sk
<2
g
IkO
U
ô \
vi
ia
a
g
H
il
I ?
il
2 ù
li
y  u
i i
i i
I
QCl CD.
fN en . m
Ü a i
fS d (N
d CM d
CQ pq
a
(N
a
<N
ON
-4"
a
"4-
col
m CQ
0 \
NO
r '
NO
ON
Æ)
O 00
o
u 5 U B U
B B O
ffi
U B
ON
B
o
U B
(S
U U B
S X
o
(N
U
<N
U
1
1
I
fI
1
I
oo
o
(N
5.2.9 Structural elucidation of compound CP.9: £'/i/-14-oxokaur-16-en-19-oic acid
Jones oxidation of compound CP.8 yielded compound CP.9, 4-oxokaur-16-en-19-oic acid.
The oxidation experiment was used to confirm the position of the hydroxyl group at C-14 in 
compound CP.8 .^  ^ 14-oxokaur-16-en-19-oic acid has been synthesized and reported by
Yun-Xing and Wei-Shan (1993)."^  ^ Yun-Xing and Wei-Shan"^ ® provided incomplete spectral data 
for compound CP.9 and a complete assignment of the and ^^ C NMR data was therefore 
undertaken [Table 5.10].
2(L
^ O H
CP.9
Figure 5.16: Structure for compound CP.9: £«/-14-oxokaur-16-en-19-oic acid
The LREIMS spectrum [Spectrum 5.9.1] for compound CP.9 gave a molecular ion peak at m/z 
316 which indicated a molecular formula of C20H28O3. The FTIR spectrum [Spectrum 5.9.2] 
showed an absorption band at 3422 cm'  ^ that was attributed to a hydroxyl group stretch. Two 
absorption bands at 1722 and 1692 cm'  ^ were also observed in the FTIR spectrum and were 
attributed to ketone carbonyl and free carboxylic acid carbonyl stretches respectively.^^ Analysis 
of the ^^ C NMR [Spectrum 5.9.4], DEPT [Spectrum 5.9.5] and HSQCDEPT [Spectrum 5.9.6] 
spectroscopic data showed that compound CP.9 contained two carbonyl carbon resonances, four 
quaternary carbon resonances, including one for a double bond, three methine carbon 
resonances, nine methylene carbon resonances, including one for a double bond and two methyl 
carbon resonances.
The and NMR spectral data (Table 5.9 and 5.10) showed that rings A and B were the 
same for compounds CP.8 and CP.9. The NMR chemical shifts showed that rings C and D 
were different for the two compounds. Carbon resonances were shifted after the conversion of 
the hydroxy group in CP.8 to a ketone in CP.9 for C-10 (8 34.6 to 8 37.2), C-11 (8 21.1 to 8
209
27.4), C-12 (ô 39.9 to ô 46.7), C-13 (ô 44.9 to ô 55.5), C-14 (ô 69.4 to ô 213.1), C-16 (ô 149.2 to 
ô 143.0) and C-17 (ô 107.5 to 5 110.8).
The NMR spectrum [Spectrum 5.9.3] for compound CP.9 displayed two methyl group 
singlet proton resonances at ô 1.25 (s) and 0.75 (s) that each integrated to 3H, two exocyclic 
double bond proton resonances at Ô 4.93 (s) and 4.80 (s) consistent with the two H-17 protons and 
a methine proton resonance at ô 2.94 (s) consistent with an H-13 proton resonance. The 
corresponding C-17 and C-13 carbon resonances were observed in the HSQCDEPT spectrum to 
be 8 110.8 and 55.5 respectively. The H-13 and the two H-15 proton resonances displayed a 
correlation in the HMBC spectrum with a carbonyl carbon resonance at 8 213.1. The carbonyl 
carbon resonance was thus confirmed to be at the C-14 position. This assignment further 
confirmed the earlier placement of the hydroxyl group at C-14 in compound CP.8 (Section 
5.2.8). A negative optical rotation of - 101° was determined for compound CP.9. Compound 
CP.9 was therefore identified as e«/-l4-oxokaur-16-en-19-oic acid.
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5.2.10 Structural elucidation of compound CP.IO: Ent-l^a, 17-diacetoxykaur-15-en-19-oic
acid
An inseparable mixture was isolated from the stem bark of the C. pseudopulchellus. Acétylation 
of the inseparable mixture facilitated the purification of the acetylated compound CP.IO, ent- 
14a, 17-diacetoxykaur-15-en-19-oic acid. The precursor of compound CP.IO was determined to 
be a novel dihydroxy compound CP. 11, which is described in section 5.2.11 below.
20 .
^ O H
CP.IO
Figure 5.17: Structure for compound CP.IO: £'«/-14a, 17-dacetoxykaur-15-en-19-oic acid
The HRMS spectrum [Spectrum 5.10.1] for compound CP.IO gave a [M + Na]^ peak at m/z 
441.2851 which indicated a value of 418.2353 indicating a molecular formula of C24H34O6. 
A double bond of equivalence of eight was calculated. The FTIR spectrum [Spectrum 5.10.2] 
showed an absorption band at 3423 cm'  ^ that was attributed to a hydroxyl stretch. The FTIR 
spectrum also displayed two absorption bands at 1736 cm'  ^and 1692 cm'  ^that were attributed to 
acetate carbonyl and free carboxylic acid carbonyl group stretches respectively.^^ The NMR 
[Spectrum 5.10.4] and DEPT [Spectrum 5.10.5] spectra showed carbon resonances for four 
methyls, eight methylenes, five methines, seven quaternary carbons, three of which were 
carbonyl carbon resonances at 5 183.0, 171.1 and 170.6. Two oxygen bearing methine carbon 
resonances at 6 69.3 and 62.4 and two double bond carbon resonances at 5 142.1 and 140.2 were 
also observed.
The NMR spectrum [Spectrum 5.10.3] exhibited two singlet proton resonances at ô 2.08 (s) 
and 2.03 (s) attributable to acetoxy methyl group protons, two singlet proton resonances each 
integrating to 3H at 5 1.26 (s) and 1.02 (s) attributed to two methyl group proton resonances, one 
oxymethine proton resonance at 5 4.97 (br s, Wm = 13.11 Hz), an oxymethylene proton 
resonance at 5 4.66 (s) and an alkene proton resonance at Ô 5.47 (s).
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The and NMR spectral data (Table 5.1 and 5.12) showed that rings A, B and C were 
similar for compounds CP.8 and CP.IO. The modifications of the e«?-kaurenoid skeleton
were determined to be on ring D. The absence in the NMR spectrum of compound CP.IO of 
the typical downfield proton resonances of the two exocyclic H-17 resonances which usually 
occur between 4.74 -  4.90 ppm in e«/-kaur-l 5-en-19-oic acid derivatives,^^’ and
the presence of a deshielded proton at ô 2.63 (br s, Wia =10.13 Hz) characteristic of H-13 of ent- 
kaurenoid diterpenes suggested that the exocyclic double bond had been modified. The C-13 
carbon resonance was observed to be 5 46.2 in the HSQCDEPT spectrum [Spectrum 5.10.6]. A 
correlation was observed in the HMBC spectrum [Spectrum 5.10.7] between the C-13 carbon 
resonance and an oxymethylene proton resonance at 6 4.66 (s), which was assigned as the 2H-17 
protons. A V  coupling was observed in the COSY spectrum [Spectrum 5.10.8] between the 2H- 
17 resonance and an alkene proton resonance at ô 5.47 (s) that was assigned as H-15. The 
HMBC spectrum showed correlations between the 2H-17 (5 4.66, s) proton resonance and 
carbon resonances at 5 46.2, 5 142.1, 5 140.2 and ô 170.6 that were ascribed as C-13, C-15, C-16 
and C-17(Ac) respectively. The earlier assigned H-15 proton resonance showed correlations in 
the HMBC spectrum with the ô 38.7, 5 46.2, 140.2 and 5 62.4 that were assigned as C-8, C-13, 
C-16 and C-17 respectively. A shift of the double bond from the C-16(17) in an e«/-kaur-16-ene 
skeleton to position 15 followed by hydroxylation at C-17 was proposed for the compound.
The allylic H-13 (5 2.63, br s, Wm = 10.13 Hz) proton resonance^^’ was seen to be
coupled to two proton resonances at 5 2.40 (d, J =  11.0 Hz) and 1.32 (dd, J=  4.50, 11.0 Hz) that 
were assigned as two H-12 which, in turn, were observed to correlate in the HMBC spectrum 
with a carbon resonance at ô 47.7 ascribed as C-9. The corresponding H-9 (5 1.19, d, J =  10 Hz) 
proton resonance was, in turn, coupled to two proton resonances at 6 1.68 (m) and 5 1.59 (m), 
that were assigned as the two H-11 resonances. The earlier assigned H-13 proton resonance was 
also seen to be coupled in the COSY spectrum to a proton resonance at ô 4.97 (br s Wia = 13.11 
Hz) which was assigned as H-14. The corresponding C-14 carbon resonance at 8 69.3 was seen 
to be correlated with the earlier assigned H-9 proton resonance in the HMBC spectrum. The C- 
14 carbon resonance at 8 69.3 of compound CP.IO was similar to that of compound CP.8 that 
was observed at 8 69.4.
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The above assignment confirmed the modification of ring D of the e«/-kaur-l 5-en-19-oic acid 
derivative. The negative optical rotation % -  55.9°^ "^ ’ indicated that compound CP.IO 
belonged to the ent series of kaurenoic acid-type diterpenoids. The relative stereochemistry of 
compound CP.IO was assigned using the NOESY spectrum [Spectrum 5.10.9] with the aid of a 
model. The H-14 proton resonance displayed correlations in the NOESY spectrum with the H- 
13 proton resonances, which is known to be a -  configured for ent -  kaurenoid acids. The 
hydroxy group attached to C-14 was thus assigned the p -  configuration. The structure of 
compound CP.IO was fiilly established as ent-l4a, 17-acetoxykaur-15-en-19-oic acid. A search 
in the SciFinder and the Dictionary of Natural Products databases showed that compound CP.IO 
had not been reported.
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Table 5.11: Correlation table for compound CP.IO: Ent-l^a, 17-diacetoxykaur-15-en-19-
oic acid
0 . NM R (125 
MHz) CDCI3
'H  NM R (500 MHz) 
CDCI3
HMBC
(H->C)
COSY NOESY
1 40.6 CH2 1.71 m 9 IP IP
Î 0.79 m 2 0 la , 2 a, 2 p la
I 19.1 CH2 1.84 m X la . Ip, 3a 2P,18
3 1.42 12.0 Hz X 3a, 3P 2 a
1 38.0 CH2 2.17 b rd 5 2 a, 3P 3P
3 1 .0 1 * 5 2p ,3a 3a
4 4 . 0  c - - - -
56.7 CH 1.09 d J =  12.0 Hz 19, 20 6 3p, 6,18
I 2 0 . 6  CH2 1.81 m* 8 , 1 0 5, 7a, 7p 5, 18
3 1.81 m ' 8 , 1 0 5, 7a, 7p 5, 18
X 38.9 CH2 1 . 6 8  m 6 6,7P 7P
3 1.59 m 14 6 , 7a 7a
48.2 C - - - -
47.7 CH 1.19 d J =  10.0 Hz 10, 11, 12, 14, 20 1 1 a, l ip 1P,3P, 11,18
3 38.7 C - - - -
la 25.2 CH2 1.56 m 14 9, l ip 1 1 a
IP 2 . 0 1  m 12, 13 9 ,11a 5, 9, l ip
2 a 37.7 CH2 2.40 d J -  11.0 Hz 9, 13,16 12P 12P, 13, 20
zp 1.32 dd 4.50, 11.0 Hz 9, 13,14 12a, 13 12a, 13
3 46.2 CH 2.63 br s 10.13 Hz 1 2 12P, 14 3P, 6 p, 12a, 12P, 14,17
i 69.3 CH 4.97 b rs lF i/ 2 = 13.11 Hz 8 , 12,13 13, 14-Ac 13, 17
5 142.1 CH 5.47 s 8 , 13, 16,17 17 14, 17
5 140.2 C - - - -
7 62.4 CH2 4.66 s* 13, 15, 16, 17-Ac 15 5,3P, 15
4.66 s* 13, 15, 16, 17-Ac 15 5, 3P, 15
5 29.2 CH3 1.26 s 4, 19 - 2a, 5, 9
3 183.0 C - - - -
3 13.7 CH3 1 . 0 2  s* 1 ,5 ,9 - 1 2 a, 2 0
17-Ac 170.6 C - - - -
17-Ac 21.2 CH3 2.08 s 17-Ac - 6 P
14-Ac 171.1 C - - - -
14-Ac 21.7 CH3 2.03 s 14-Ac 13 -
Refer to overlapped/superimposed proton resonances
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5.2.11 Structural elucidation of compound CP.ll: £'«/-14a, 17-dihydroxykaur-15-en-19-oic
acid
Compound C P.ll was identified from an inseparable mixture that was isolated from the stem 
bark of the C. pseudopulchellus. Acétylation of the inseparable mixture facilitated the 
purification of the acetylated compound, CP.IO, which has been described in section 5.2.10 
above. The structure of compound C P.ll could therefore be deduced from the spectra of the 
unacetylated mixture and the purified acetylated compound CP.IO as the unacetylated form of 
compound CP.IO, ent-\Aa, 17-dihydroxykaur-15-en-19-oic acid.
HO.
OH
CP.ll
Figure 5.18: Structure for compound CP.ll: Ent-lAa^ 17-dihydroxykaur-15-en-19-oic acid
The LREIMS spectrum [Spectrum 5.11.1] of the mixture containing compound C P.ll gave two 
predominant peaks with the major peak, which was attributed to compound C P.ll, displaying a 
molecular ion peak at m/z 334 which corresponded to C20H30O4. The FTIR spectrum [Spectrum
5.11.2] of the mixture showed a strong absorption band at 3412 cm'  ^ that was attributed to a 
hydroxyl stretch and an absorption band at 1696 cm'  ^ attributed to a carbonyl group stretch.^  ^
The NMR [Spectrum 5.11.4], DEPT [Spectrum 5.11.5] and HSQCDEPT [Spectrum 
5.11.6] spectral data suggested that compound C P.ll possessed a carbonyl group due to a carbon 
resonance at 6 182.7, one double bond due to carbon resonances at 8 138.6 and 145.7 and two 
oxymethine carbons due to carbon resonances at 8 66.7 and 61.4. The NMR spectrum 
[Spectrum 5.11.3] for compound C P.ll showed presence of methyl group singlet proton 
resonances at 8 1.08 (s) and 1.21 (s) that each integrated for 3H each. The NMR spectrum 
further displayed a double bond proton resonance at 8 5.47 (s) which integrated for IH, and 
oxymethine proton resonances at 8 4.07 (br s, Wm = 14.02 Hz) and 8 4.21 (d, J=  4.5 Hz).
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The absence of an exocyclic double bond observed for compounds CP.l -  CP.9 in ring D of an 
gM^-kaur-16-ene diterpenoid suggested that compound C P .ll had been modified. The presence 
of a doublet methine proton resonance at 8 4.07 (br d, J  = 3.5 Hz) which integrated for IH 
suggested that hydroxylation had occurred in C-14 as earlier observed for compound CP.8 
described in section 5.2.8 above. The above information indicated that compound C P .ll was 
ent-\Aa, 17-dihydroxykaur-15-en-19-oic acid.
20 .
OH
^ O H
R.2
Figure 5.19: Structure for compound R.2: .E«/-17-dihydroxykaur-15-en-19-oic acid42
A literature search showed that compound R.2, 17-hydroxykaur-15-en-19-oic acid
has been isolated before fi’om the flowers of Baccharis illinita but a search in the SciFinder and 
the Dictionary of Natural Products databases showed that compound C P .ll, the 14-hydroxy 
derivative had not been reported previously. The assignment of ^^ C NMR and NMR values 
of compound C P .ll were performed by comparison with the assignment of the acetylated 
compound CP.IO described in section 5.2.10 above.
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Table 5.12: Correlation table for compound CP.ll: Ent-lAa, 17 -dihydroxykaur-15-en-19-
oic acid
No. "C  NMR (125 
MHz) CDCI3
NMR (500 MHz) 
CDCI3
HMBC (H-^C) COSY NOESY
la 40.7 CH2 1.80 m 3,5 ip ,2 IP, 2a, 3a, 20
IP 0.80 m 5,20 la la, 2(3
2a 20.7 CH2 1.84 m' 1, 10 la la
2P 1.84 m' 1, 10 la IP
3a 38.1 CH2 2.11 brd 1 3p la, 3P
3p 1.00 m 1 3a 3a
4 44.0 C - - - -
5 56.7 CH 1.08 m 4, 6,20 6 6,9,18
6a 28.7 CH2 1.60 m^ 7 5,6 5
6P 1.60 m ' 7 5,6 5
7a 38.5 CH2 1.30 m ' 6 7 6
7P 1.30 m ' 6 7 6
8 48.3 C - - - -
9 48.5 CH 1.15 d J =  9.5 Hz 7, 8,20 11a 5, 13
10 39.1 C - - - -
11a 19.2 CH2 1.95 m 9, 12 9, lip lip
lip 1.38 m 12 11a 1 la
12a 36.9 CH2 2.43 d J =  10.5 Hz 16 12p 13
12P 1.24 m 13 12a 13
13 47.9 CH 2.61 s - 14 9, 120,14, 17
14 66.7 CH 4.07 br s W\!2 = 14.02 Hz 13 13 13
15 138.6 CH 5.47 s 9,16,17 17 13
16 145.7 C - - - -
17A 61.4 CH2 4.21 d J= 4 .5 H z ' 15, 16 15 13
17B 4.21 d J= 4 .5 H z ' 15, 16 15 13
18 28.6 CH3 1.21 s 3,4, 5,19 - 5
19 182.7 C - - - -
20 14.7 CH3 1.08 s 1,5,9 - la
*Refer to overlapped proton resonances
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5.2.12 Structural elucidation of compound CP.12: 8R, X3R - Epoxylabd-14-ene 
Compound CP.12 was isolated as a white solid from both the leaves and stem bark of C 
pseudopulchellus and found to be the known 8R, 13J? - epoxylabd-14-ene.
18 CP.12
Figure 5.20: Structure for compound CP. 12: 87Î, 13i? - Epoxylabd-14-ene
The LREIMS spectrum [Spectrum 5.12.1] for compound CP.12 gave a peak at m/z 275 
attributed to [M-15]\ The NMR spectrum showed twenty carbon resonances. A molecular 
formula of C20H34O was therefore indicated for compound CP.12. The FTIR spectrum 
[Spectrum 5.12.2] showed absorption bands at 1638 cm'  ^ and 839 cm'  ^ that were attributed to 
exocyclic double bond stretches. A double bond equivalence of four was determined. The 
NMR [Spectrum 5.12.4], DEPT [Spectrum 5.12.5] and HSQCDEPT [Spectrum 5.12.6] spectra 
showed that compound CP.12 possessed five methyls, eight methylenes (including one double 
bond due to carbon resonances at Ô 148.0 and 109.7), three methines and four quaternary 
carbons, two of which were oxygen bearing at 8 76.3 and 73.5."^  ^ The NMR spectrum 
[Spectrum 5.12.3] showed five methyl group singlet proton resonances each integrating for 3H 
due to proton resonances at 8 1.22 (s), 1.13 (s), 0.84 (s), 0.77 (s) and 0.72 (s), and three double 
bond proton resonances typical of an AMX system^^^at 8 6.01 (dd, J=  11.0, 15.0 Hz), 8 4.97 (dd, 
J=  1.0, 15.0 Hz) and 8 4.91 (dd, J=  1.0, 1 l.OHz).^^
The AMX system suggested that compound CP.12 could either be a pimarane, clerodane or 
labdane d i t e r p e n o i d . T h e  HMBC spectrum [Spectrum 5.12.7] showed a correlation between 
two proton resonances at 8 4.97 (dd, J=  1.0, 15.0 Hz) and 4.91 (dd, J=  1.0, 11.0 Hz) and a fully 
substituted oxygen bearing carbon resonance at 8 73.5. The two proton resonances were 
assigned to the two H-15 while the carbon resonance was ascribed as C-13. The C-13 carbon 
resonance was, in turn, seen to correlate in the HMBC spectrum with proton resonances at 8 1.45
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and 1.47 that were assigned as one of the H-12 and the overlapped 2H-11 respectively. A 
correlation between the C-13 and a methyl proton resonance at 5 1.13 (s) that was assigned as 
3H-16 was also seen in the HMBC spectrum. The 3H-16 proton resonance was, in turn, seen to 
correlate in the HMBC spectrum with carbon resonances at 6 35.1 and 5 148.0 that were assigned 
as C-12 and C-14 respectively. The two fully substituted oxygen bearing carbon resonances at ô 
76.3 and 73.5 assigned as C-8 and C-13 respectively suggested the presence of an ether linkage. 
The pimarane skeleton was ruled out since an ether linkage is likely for clerodane and labdane 
skeletons, and the clerodane skeleton was further ruled out due to absence of methyl group 
doublet resonances. Therefore, compound CP.12 was determined to be a labdane diterpenoid.
13
The COSY spectrum [Spectrum 5.12.8] showed that the earlier assigned 2H-11 overlapped 
proton resonance was coupled to a proton resonance at 5 1.20 (m) which was assigned as H-9 
and, in turn, was seen to correlate to carbon resonances at 5 39.6 and 16.1 that were assigned as 
C-1 and C-20 respectively. The corresponding 3H-20 proton resonance was seen to occur at 5 
0.72 (s) in the HSQCDEPT spectrum [Spectrum 5.12.6]. The HMBC spectrum further showed 
correlations between the 3H-20 (5 0.72, s) proton resonance and carbon resonances at ô 39.6, 
56.7, 58.7 and 37.1 that were assigned as C-1, C-5, C-9 and C-10 respectively. The C-1 carbon 
resonance was seen to be attached to two proton resonances at Ô 0.85 (m) and 1.61 (m) in the 
HSQCDEPT spectrum. The two H-1 (5 0.85, m and 16.1, m) proton resonances were seen to 
correlate in the HMBC spectrum with a carbon resonance at Ô 18.6 that was assigned as C-2. 
Two proton resonances at ô 1.43 (m) and 1.58 (m) were assigned as two H-2. The two H-2 
proton resonanes were seen to correlate with a carbon resonance at ô 42.2 that was assigned as 
C-3. The C-3 carbon resonance was seen to be attached to two proton resonances at 5 1.34 (m) 
and 1.15 (m) that were assigned as two H-3. The two H-3 proton resonances were seen to 
correlate with a carbon resonance at ô 33.6 that was assigned as C-4. The H-5 (8 0.94, dd, J  = 
2.58, 10.0 Hz) proton resonance was seen to correlate with the earlier assigned C-20 carbon and 
another carbon resonance at 8 33.0 that was assigned as C-18. The earlier assigned C-9 carbon 
resonance was seen to correlate with a methyl group proton resonance at 8 1.22 (s) that was 
assigned as 3H-17. These assignments showed that compound CP.12 was an 8R, \3R - 
epoxylabd-14-ene.
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The optical rotation experiment gave a value of [a] -  12.9° which indicated that compound
CP.12 belonged to the normal series of labdanes/^ which means that the 3H-20 proton was 
therefore determined to be on the p face of the molecule whereas the H-5 proton was on the a 
face.^  ^ The NOESY spectrum [Spectrum 5.12.9] was used to confirm the stereochemistry of 
compound CP.12. The a configured H-5 proton resonance showed a correlation with the 3H-19 
proton resonance and the H-9 proton resonance. A correlation was also observed in the 
NOESY spectrum between the 3H-20 and the 3H-17 proton resonance which, in turn, was 
correlated in the NOESY spectrum with the 3H-16 proton resonance. The 3H-16 and 3H-17 
methyl groups were therefore found to possess a p configuration. A search in the literature 
showed that compound CP.12 showed similar NMR chemical shifts to those reported for SR, 
13R - epoxylabd-14-ene isolated from Grindilia tarapacana^^ Compound CP.12 was identified 
to be 8R, 13R- epoxylabd-14-ene.
Table 5.13: Correlation table for compound CP.12: SR, 13R - Epoxylabd-14-ene
No. NMR (75 
MHz) CDCI3
NM R (125 
MHz) CDCb^^
^H NMR(300 MHz) CDCI3 HMBC
(H -.C )
COSY NOESY
la 39.6 CH2 39.4 0.85' 2 IP 1 3
IP 1.61 m 2 la la, 20
2a 18.6 CH2 18.6 1.58 m 3 2P 2 3
2p 1.43’ 3 2a 2a, 20
3a 42.2 CH2 42.2 1.34' 4 3P 33
3P 1.15 m 4 3a 3a
4 33.6 C 33.3 - - - -
5 56.7 CH 56.5 0.94 d d J -2 .5 8 ,10.0 Hz 18,20 6a, 63 9,19
6a 20.1 CH2 19.9 1.64 m 10 63,9 63
6P 1.25 m 4 6a, 9 6a
7a 43.3 CH2 43.1 1 .7 7 td J= 3 ,10 Hz 6 73 7 3
7P 1.34' X 7a 7a
8 76.3 C 76.1 - - - -
9 58.7 CH 58.5 1.20 m 1,20 11 5,19
10 37.1 C 36.9 ■ - - - -
11 16.1 CH2 15.9 1.47' 13,17 9 20
1.47' 13,17 9 20
12a 35.1 CH2 34.9 2.21 m 1 2 3 1 2 3 , 20
12P 1.45' 13 12a 12a, 16,17
13 73.5 C 73.3 - - - -
14 148.0 CH 147.7 6.01 ddJ=  11.0, 15.0 Hz ISA, 15B ISA, 15B
ISA 109.7 CH2 109.5 4.97 dd 1.0, 15.0 Hz 13,14 14, 15B 12a, 14
15B 4.91 ddJ=  1.0,11.0 Hz 13 14, ISA 12a, 14
16 33.5 CH3 33.3 1.13 s 12,13,14 - 1 2 3 ,17
17 24.2 CH) 23.9 1.22 s 7,8,9 - 1 2 3 , 1 6 , 2 0
18 21.5 CH3 21.3 0.77 s 3,4,5 - 5,9
19 33.0 CH) 32.7 0.84 s' 3,4, 5,19 - 1 3
20 16.1 CH) 15.9 0.72 s 1,5, 9,10 - 1 3 , 2 3 , 1 1 3 , 1 7
Refer to overlapped/superimposed proton resonances
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5.2.13 Structural elucidation of compound CP.13: Acetyl aleuritolic acid
Compound CP.13 was isolated as a white crystalline compound from the stem bark of C
pseudopulchellus and found to be the known acetyl aleuritolic acid.
CP.13
Figure 5.21: Structure for compound CP. 13: Acetyl aleuritolic acid
The LREIMS spectrum [Spectrum 5.13.1] for compound CP.13 showed a molecular ion peak at 
m/z 498 which indicated a molecular formula of C3 2H5 0O4 . The FTIR spectrum [Spectrum
5.13.2] of compound CP.13 exhibited an absorption band at 3433 cm'^ that was attributed to a 
hydroxyl stretch. Two other absorption bands at 1731 cm'^ and 1686 cm'* that were were 
attributed to acetate carbonyl and free carboxylic acid carbonyl group stretches respectively** 
were also observed in the FTIR spectrum. An absorption band at 1242 cm * was also observed in 
the FTIR spectrum and was attributed to a C —  O stretch.** A double bond equivalence of eight 
was determined. The *^ C NMR [Spectrum 5.13.4], DEPT [Spectrum 5.13.5] and HSQCDEPT 
[Spectrum 5.13.6] spectra showed the presence of thirty-two carbon resonances in compound 
CP.13, two of which were carbonyl carbons due to carbon resonances at 5 184.3 and 171.2. Two 
alkene double bond carbon resonances at 6  160.8 and 117.1 were also observed. An acetate 
methyl group proton resonance at ô 2.03 (s) which integrated for 3H was observed in the *H 
NMR spectrum [Spectrum 5.13.3]. Compound CP.13 was deduced to be an acetylated 
pentacyclic triterpenoid.
The *H NMR spectrum showed seven singlet methyl group proton resonances at 8  0.95, 0.94, 
0.93, 0.91, 0.88, 0.88 and 0.85 that each integrated for 3H, one fewer than the expected eight 
methyl group proton resonances for a triterpene.*^’ *^  The *H NMR spectrum further displayed a 
proton resonance at 8  11.5 (br s) and the *^ C NMR spectrum showed a carbonyl carbon
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resonance at 5 184. 3, which indicated that one of the methyl group had been oxidized to a 
carboxylic acid.*  ^ The *H NMR spectrum also showed the presence of one double bond proton 
resonance at 5 5.53 (IH, dd, J=  3.35, 7.90 Hz) and an oxymethine proton resonance at 5 4.46 
(dd, J=  5.50, 10.4 Hz).
A literature search showed that compound CP.13 showed similar *^ C NMR chemical shifts to 
those of the known acetyl aleuritolic acid (Table 5.14)"*^ ’ which has heen reported previously 
from three Croton plants, C. cajucara^^’^^ , C. urucuranc^^^^^ and C. lacciferus?^
Acetyl aleuritolic acid has been found to be active against Salmonella aureus and Salmonella 
typhimurium, with a minimum inhibitory concentration of 0.1 mg/ml. Acetyl aleuritolic acid 
has also been found to possess anti-nociceptive effect (analgesic activity) with an inhibitory dose 
at 50% (IDso) of 21.63 mg/kg and a maximum inhibition per centage of 76.08±5. "^* Acetyl 
aleuritolic acid has been assessed for gastroprotective effect in the HCl/EtOH -  induced gastric 
lesions model in mice. A dose-response experiment at oral doses of 25, 50 and 100 mg/kg 
showed that acetyl aleuritolic acid displayed higher gastroprotective effect at the lowest dose, 
reducing lesions by about 50 %, with less effect at 50 and 100 mg/kg.^^
Table 5.14: Correlation table for compound CP.13: Acetyl aleuritolic acid
No. ^^ C NMR (125 MHz) 
CDCI3
"C  NMR (25 
MHz) CDCb^^
"H NMR (CDCI3)
la 37.6 CH2 37.4 1.60'
ip 1.00 m
2a 23.7 CH2 23.4 1.61'
2P 1.61'
3 81.1 CH 80.8 4.46 dd 5.50, 10.4 Hz
4 37.9 C 37.6 -
5 55.8 CH 55.6 0.85 m
6a 19.0 CH2 18.7 1.87 m'
6P 1.87 m'
7a 35.6 CH2 35.3 1.20 m
7P 1.09 m
8 39.3 C 39.0 -
9 49.3 CH 49.0 1.41 m
10 37.5 C 37.3 -
1 la 17.5 CH2 17.3 1.61'
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113 1.44 m
12a 31.5 CH2 31.2 2.35 m
12P 1.91 m
13 38.2 C 37.9 -
14 160.8 C 160.5 -
15 117.1 CH 116.8 5.53 dd J =  3.35, 7.90 Hz
16a 30.9 CH2 30.9 1.66 m
16P 1.39 m
17 51.7 C 51.5 -
18 41.6 CH 41.6 2.27 m
19a 41.0 CH2 40.7 1.97 m
19P 1.28 m
20 29.5 C 29.3 -
21a 33.9 CH2 33.6 1.74 m
2 ip 1.06 m
22a 32.1 CH2 31.8
22P
23 28.2 CH3 27.9 0.85 s
24 16.8 CH] 16.6 0.88 s'
25 15.9 CH] 15.7 0.94 s
26 28.9 CH] 28.6 0 .88'
27 26.4 CH] 26.2 0.95 s
28 184.3 C 184.4 -
29 33.5 CH] 33.3 0.93 s
30 22.5 CH] 22.4 0.91 s
Ac 171.2 C 171.3 -
Ac 21.5 CH] 21.6 2.03 s
-CO2H - - 11.5 br s
Refer to overlapped/superimposed proton resonances
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5.2.14 Structural elucidation of compound CP.14: p - Amyrin
Compound CP.14 was isolated as a white crystalline compound from both the leaves and the 
stem bark of C. pseudopulchellus and was found to be the common p - amyrin.
=27
HO'
CP.14
Figure 5.22: Structure for compound CP. 14: p - Amyrin
The LREIMS spectrum [Spectrum 5.14.1] for compound CP.14 showed a molecular ion peak at 
m/z 426 which indicated a molecular formula of C30H50O. The FTIR spectrum [Spectrum
5.14.2] of compound CP.14 exhibited an absorption band at 3364 cm'  ^that was attributed to a 
hydroxyl stretch. A double bond equivalence of six was determined.
The NMR [Spectrum 5.14.3] and NMR [5.14.4] spectra for compound CP.14 were 
found to be the same as those of compound CS.12 earlier isolated from Croton sylvaticus. The 
structural elucidation description of this compound was therefore the same as that of compound 
CS.12 which has been done in section 4.2.12.
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5.2.15 Structural elucidation of compound CP.15: Eudesm-4(15)-ene-ip, 6a-diol 
Compound CP.15 was isolated as a white crystalline material from both the leaves and the stem 
bark of C. pseudopulchellus and was found to be the known sesquiterpenoid eudesm-4(15)-ene- 
Ip, 6a-diol. The LREIMS spectrum [Spectrum 5.15.1] for compound CP.15 showed a 
molecular ion peak at m/z 238 which indicated a molecular formula of C15H26O2. The FTIR 
spectrum [Spectrum 5.15.2] of compound CP.15 exhibited an absorption band at 3428 cm'  ^that 
was attributed to hydroxyl stretch. A double bond equivalence of three was determined. The 
NMR [Spectrum 5.15.3] and ^^ C NMR [5.15.4] spectra for compound CP.15 were found to be 
the same as those of compound CG .ll earlier isolated from Croton gratissimus.
OH
OH
CP.15
Figure 5.23: Structure for compound CP.15: Eudesm-4(15)-ene-ip, 6a-diol
The NMR [Spectrum 5.15.3] and NMR [5.15.4] spectra for compound CP.15 were 
found to be the same as those of compound C G .ll earlier isolated from Croton gratissimus. 
Compound CP.15 was found to be 4(I5)-eudesmane-Ip, 6a-diol and the description of the 
structural elucidation has been done in section 3.2.6. The measured optical rotation for 
compound CP.15 was found to be + 43.8°, whereas compound CG .ll earlier isolated from 
Croton gratissimus gave an optical rotation value was + 45° (Section 3.2.11).
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5.2.16 Structural elucidation of compound CP.16: (-) - 7-Epivaleran-4-one 
Compound CP.16 was isolated as a white crystalline compound from the stem bark of C. 
pseudopulchellus. Compound CP.16 was identified to be a known isomer of (-) - valeran-4-one. 
(-) - Valeran-4-one was first isolated by Stoll et al. in 1957 from a European Valerian, Valerian
officinalis L.56,57,58
14
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CP.16
Figure 5.24: Structure for compound CP.16: (-) - 7-Epivaleran-4-one
The LREIMS spectrum [Spectrum 5.16.1] for compound CP.16 gave a molecular ion peak at 
m/z 222 which indicated a molecular formula of C15H26O. The LREIMS spectrum showed a 
fragment ions at m/z 207, [M -  15]  ^for the loss of a CH3 fragment and m/z 179, [(M -  43]^ for 
the loss of an isopropyl group fragment. The FTIR spectrum [Spectrum 5.16.2] showed an 
absorption band at 1693 cm'  ^ that was attributed to a carbonyl stretch.^ ^  A double bond 
equivalence of three was determined. The ^^ C NMR [Spectrum 5.16.4], DEPT [Spectrum
5.16.5] and HSQCDEPT [Spectrum 5.16.6] spectra displayed a carbon resonance at 5 217.5 that 
was attributed to a ketone carbon.^  ^ Four methyl carbon resonances, six methylene carbon 
resonances, two methine carbon resonances and two quaternary carbon resonances were also 
deduced from the ^^ C NMR, DEPT and HSQCDEPT spectra of compound CP.16. The ^H NMR 
spectrum displayed four methyl group proton resonances at 5 1.05 (s), 0.80 (s), 0.85 (d, J  = 6.75 
Hz) and 0.87 (d, 6.75 Hz) and a pair of allylic methylene group proton resonances at 5 2.65
(dt, J  = 7.80, 14.1 Hz) and 6 2.20 (m). The two doublet proton resonances at 0.85 (d, J  = 6.75 
Hz) and 0.87 (d, J  = 6.75 Hz) were seen to be coupled to the same methine proton resonance at Ô 
1.39 in the COSY spectrum [Spectrum 5.16.8]. The corresponding carbon resonances for the 
two methyls were observed in the HSQCDEPT spectrum to occur at 5 20.1 and 19.9 
respectively. The HMBC spectrum [Spectrum 5.16.7] showed correlations between the methyl 
group proton resonance at 0.85 (d, J  = 6.75 Hz) and the carbon resonance at 5 19.9, whereas the 
other methyl proton resonance at 5 0.87 (d, J  = 6.75 Hz) was seen to correlate with the methyl
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carbon resonance at ô 19.9. Compound CP.16 was therefore found to possess an isopropyl 
group. The presence of the isopropyl group and the ketone carbon, indicated that compound 
CP.16 was a valerane sesquiterpenoid.^^ In these compounds the keto group usually occurs at C-
The two methyl proton resonances at ô 0.85 (d, J  = 6.75 Hz) and 0.87 (d, J  = 6.75 Hz) were 
assigned as 3H-12 and 3H-13, whereas the methine proton resonance at ô 1.39 was assigned as 
H-11. The corresponding C-11, C-12 and C-13 carbon resonances were observed in the 
HSQCDEPT spectrum to be 5 33.1, 20.1 and 19.9 respectively. The carbonyl carbon resonance 
at 8 217.5 was assigned as C-4. The C-4 carbon resonance was seen to correlate with a methyl 
group proton resonance at 5 1.05 (s) which was assigned as 3H-15. The corresponding C-15 
carbon resonance was found to be 5 17.0 in the HSQCDEPT spectrum. The C-15 carbon 
resonance was, in turn, seen to correlate with two proton resonances at 5 1.16 (m) and 1.74 (t, J=  
12.6 Hz) that were assigned as two H-6. The two H-6 protons were seen to be coupled to a 
methine group proton resonance at 6 1.30 (m) that was ascribed to H-7.
The one H-6 (6 1.16, m) proton resonance showed a correlation in the HMBC spectrum with a 
carbon resonance at 5 25.0 which was assigned as C-8, whereas the other H-6 (ô 1.74, t, J =  12.6 
Hz) proton resonance was seen to be correlated to a carbon resonance at 5 38.8 that was assigned 
as C-10. The earlier assigned C-4 carbon resonance showed correlations in the HMBC spectrum 
with proton resonances at 6 1.88 (m), 2.20 (m) and 2.65 (dt, J=  7.80, 14.1 Hz) that were ascribed 
as the overlapped 2H-2 and the two H-3 protons respectively. The overlapped 2H-2 proton 
resonances were, in turn, seen to be coupled to proton resonances at 6 1.05 (m) and 2.40 (dt, J  = 
5.25, 13.5 Hz) which were ascribed to two H-1 protons. The corresponding C-1 carbon 
resonance was found to be 5 32.2 in the HSQCDEPT spectrum and, in turn, was seen to correlate 
to a methyl group proton resonance at 5 0.80 (s) that was assigned as 3H-14. The corresponding 
C-14 carbon resonance was found to occur at 8 24.8 in the HSQCDEPT spectrum. The 3H-14 
was seen to be correlated in the HMBC spectrum with carbon resonances at 8 32.2, 53.3 and 36.4 
that were assigned as C-1, C-5 and C-9. The C-14 carbon resonance was, in turn, seen to be 
correlated to two proton resonances at 8 1.4 (m) and 1.55 (m) that were assigned as the two H-9 
protons.
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Similar NMR chemical shifts (Table 5.15) to those of (-) - 7-epivaleran-4-one has been 
reported by Srikrishna et al. (2003).^^ The researchers synthesised both (+) -  valeran-4-one and 
(-) -  valeran-4-one from (+) -  carvomenthone and (-) -  carvomenthone.^^ The NOESY spectrum 
[Spectrum 5.16.9] was used to confirm that compound CP.16 was (-) - 7-epivaleran-4-one. The 
3H-12, 3H-13, 3H-14 and 3H-15 proton resonances were seen to be correlated to each other and 
the 3H-12, 3H-13, 3H-14 and 3H-15 protons were therefore determined to be on one face of the 
molecule whereas the H-7 proton was on the other face ot the molecule. A negative optical 
rotation value of -50.6° (literature value of -54.3 has been reported for (-) - valeran-4-one) was 
measured for compound CP.16.
14 14
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Figure 5.25: Structures for compound R.3, (-) - valeran-4-one and compound CP.16, (-) -  7
- epivaleran-4-one
Valeran-4-one [R.3] possesses 3H-14 and 3H-15 methyl groups on the opposite face to the 
isopropyl group. Valeran-4-one is a member of the sesquiterpenoid class called valeranes which 
possess a rearranged eudesmane carbon skeleton, another sesquiterpenoid class of natural 
products.^^’ Unlike eudesmane, the two methyl groups, 3H-14 and 3H-15 constituents are 
positioned at both ring junctions of the cw-decalin like system.^^ A literature search showed that 
(-) - valeran-4-one is a widely distributed sesquiterpenoid ketone in the members of the 
Valerianaceous family.^^ However, (-) - 7-epivaleran-4-one has not been isolated previously 
from natural sources.^^ This is the first report from a member of the Croton genus.
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Table 5.15: Correlation table for compound CP.16: (-) - 7-Epivaleran-4-one
0 . " C  NM R (500 
MHz) CDCI3
" C  NM R (100 
MHz) CDCIa^*
^H NM R HMBC
( H ^ C )
COSY NOESY
a 32.2 CH2 32.0 1.05 m - 1P,2 3a
P 2.40 dt J =  5.25, 13.5 Hz 2 la , 2 3P, 6 p, 15
a 21.9 CH2 2 1 . 8 1 . 8 8  m ' 4 3a, 3p 3a
P 1 . 8 8  m* 4 3a, 3P 3P, 15
a 37.2 CH2 37.0 2 . 2 0  m 2 ,4 2,3P la , 2, 3p
P 2.65 d t J =  7 .8 0 ,14.1Hz 4 2 , 3a IP, 2 ,3 a , 6 P, 15
t 217.5 C 217.5 - - - -
5 53.3 C 53.1 - - - -
a 37.6 CH2 37.4 1.16 m 8,15 6 a, 7 6 P
P 1.74 t J =  12.6 Hz 4, 5 ,10 ,15 6P,7 lp ,3P , 6 a
7 38.6 CH 38.5 1.30 m - 6 a, 6 P 14
a 25.0 CH2 24.9 1.58 m 1 0 8 P 8 p
:P 1.39' 12,13 8 a 8 a
•a 36.4 CH2 36.2 1.34 m 8 , 14 9a 9a
•P 1.55 m 8 , 14 9P 9p, 14
0 38.8 C 38.6 - - - -
1 33.1 CH 32.9 1.39' 6 , 12, 13 12, 13 12, 13
2 20.1 CH3 19.9 0.85 d J =  6.75 Hz 7,11 ,13 1 1 11,15
3 19.9 CH3 19.8 0.87 d J =  6.75 Hz 7,11 ,12 1 1 11, 15
4 24.8 CH3 24.7 0.80 s 1 ,5 ,9 - 2P,9P, 15
5 17.0 CH3 16.8 1.05 s 4, 5,10 - 1P,2P,3P, 12, 13, 14
*Refer to overlapped/superimposed proton resonances
^Resonances at Ô 1.24 in the NMR and 5 29.9 in the ^^ C NMR spectra are for an impurity 
present in the sample.
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5.2.17 Structural elucidation of compound CP.17: Germacra-4(15), 5E, 10(14)-trien-lp-ol 
Compound CP.17 was isolated as a colourless oil from the hexane extract of the stem bark of C.
pseudopulchellus and was identified as germacra-4(15), 5E, 10(14)-trien-l(3-ol.
C P .17
Figure 5.26: Structure for compound CP.17: Germacra-4(15), 5£, 10(14)-trien-lp-ol
The LREIMS spectrum [Spectrum 5.17.1] for compound CP.17 showed a molecular ion peak at 
m/z 220 which was consistent to a molecular formula of C15H24O. The LREIMS spectrum 
showed a fragment ions at m/z 205, [M -  15]  ^for the loss of a CH3 fragment, m/z 177, [M -  43]^ 
for a loss of an isopropyl group fragment and m/z 202, [M -  18]  ^for the loss of a unit of H2O. 
The FTIR spectrum [Spectrum 5.17.2] displayed a broad absorption band at 3421 cm'  ^ that was 
ascribed to a hydroxyl stretch. Other absorption bands that were observed in the FTIR 
spectrum included 3012 cm"^  attributed to a double bond C-H stretch, 2931 and 2855 cm'  ^
ascribed to C-H stretches. An absorption band at 1656 cm'  ^ in the FTIR spectrum that was 
attributed to a double bond stretch was also observed.^^ The absorption band at 1693 cm'  ^that 
was also observed in the FTIR spectrum could not be accounted for in compound CP.17 (a 
carbonyl carbon resonance was absent in the ^^ C NMR spectrum), and was attributed to an 
impurity that could have been present in the FTIR sample holder.
The NMR spectrum [Spectrum 5.17.3] displayed two doublet methyl group proton 
resonances at 5 0.82 (d, J  = 6.75 Hz) and 6 0.84 (d, J  = 6.75 Hz), one oxymethine proton 
resonance at ô 3.77 (m), two ^ra«5-configured double bond proton resonances at 6 6.00 (d, J  = 
15.90 Hz) and 5.43 (d, J=  10.50, 15.90 Hz) and four exo-methylene proton resonances at 8 5.27 
(s), 5.00 (s), 4.92 (s) and 4.84 (s). The ^^ C NMR spectrum [Spectrum 5.17.4] displayed fifteen 
carbon resonances, including six double bond resonances at 5 153.7, 147.0, 138.1, 129.9, 113.1 
and 110.8. On the basis of the calculated double bond equivalence of four, compound CP.17
2 3 1
was found to be a monocyclic sesquiterpenoid which possessed three double bonds, two of 
which were exocyclic.
Compound CP.17 was found to possess an isopropyl group due to the presence of two doublet 
methyl group proton resonances at ô 0.82 (d, 6.75 Hz) and 0.90 (d, J =  6.75 Hz) which were
seen to be coupled to one methine proton resonance at 5 1.49 (m) in the COSY spectrum 
[Spectrum 5.17.8]. The presence of the isopropyl group together with the above spectral 
features established that compound CP.17 belonged to the germacrane class of 
sesquiterpenoids.^^’ The two methyl group proton resonances were assigned as 3H-12 (5 
0.82, d, J =  6.75 Hz) and 3H-13 (6 0.90, d, J =  6.75 Hz). The corresponding carbon resonances 
were found to occur at ô 21.0 and 5 20.7 in the HSQCDEPT spectrum [Spectrum 5.17.6] 
respectively. The HMBC spectrum [Spectrum 5.17.7] showed correlations between the 3H-12 
and 3H-13 and carbon resonances at 5 32.0 and 6 52.7 that were assigned as C-11 and C-7 
respectively. The corresponding H-11 proton resonance was observed at 8 1.49 (septet J =  6.75 
Hz) and was, in turn, seen to be coupled to 3H-12 and 3H-13 proton resonances. Furthermore, 
the H-11 proton resonance was also coupled to a proton resonance at 5 1.79 (m) that was 
assigned as H-7. The H-7 proton resonance was, in turn, coupled to a proton resonance at 6 5.43 
(dd, J  = 10.50, 15.90 Hz) that was ascribed as H-6, which in turn was coupled to a proton 
resonance at 8 6.00 (d, J  = 15.90 Hz) assigned as H-5. The H-5 proton resonance showed 
correlations in the HMBC spectrum with carbon resonances at 8 30.1, 14.7, 52.7 and 113.1 that 
were ascribable to C-3, C-4, C-7 and C-15 respectively.
The corresponding H-3 proton resonances were seen at 8 2.20 (m) and 2.43, (td, J =  4.90, 12.90 
Hz) and were, in turn, coupled with proton resonances at 8 1.65 and 8 2.05 that were assigned as 
two H-2. One of the H-2 proton resonances at 8 1.65 showed correlations in the HMBC 
spectrum with carbon resonances at 8 76.2 and 153.7 which were assigned as C-1 and C-10 
respectively. The carbon resonance at 8 76.2 assigned as C-1 corresponded with an oxymethine 
proton resonance at 8 3.77 (br m, Wm = 24.43 Hz) in the HSQCDEPT spectrum. The H-1 
proton resonance was, in turn, correlated to carbon resonances at 8 153.7 and 110.8 assigned as 
C-10 and C-14 respectively. The assigned C-1, C-10 and C-14 resonances showed correlations 
in the HMBC spectrum with proton resonances at 8 1.65 and 2.64 (m) which were ascribed to
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two H-9 protons. The corresponding C-9 carbon resonance at 5 34.7 further showed correlations 
in the HMBC spectrum with proton resonances at 5 2.05 and 8 1.63 that were ascribable to two 
H-8. One of the H-8 proton resonance was seen to be coupled to the earlier assigned H-7 proton 
resonance in the COSY spectrum.
The measured optical rotation of -98.2 for compound CP.17 indicated that compound CP.17 
belonged to the normal series of germacrane sesquiterpenoids^^’ therefore the stereochemistry 
at C-1 and C-7 was The H-1 and H-7 protons were therefore assigned the a configuration 
whereas the isopropyl group (H-11, 3H-12 and 3H-13) protons were assigned a p configuration. 
Other NOESY correlations [Spectrum 5.17.9] observed for compound CP.18 have been 
summarized in Table 5.16 below and ^H -  ^H correlations are indicated in Figure 5.27 below.
Figure 5.27: The observed NOESY correlations for compound CP.17 indicated by a double
headed arrow from H -  H
The comparison of the ^H and ^^ C NMR chemical shifts (Table 5.16) for compound CP.17 
against literature values showed that compound CP.17 was the known germacra-4(15), 5E, 
10(14)-trien-ip-ol that has been isolated previously from the seeds of Artemisia annucF^ and 
from the the Japanese liverwort, Jackiella javanica. The optical rotation of germacra-4(15), 
5F, 10(14)-trien-ip-ol reported in the literature is -106
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5.2.18 Structural elucidation of compound CP.18: Stigmasterol
Compound CP.18 was isolated as a white crystalline compound from the both the leaves and 
stem bark of C  pseudopulchellus and identified to be the known phytosterol, stigmasterol.
27
HO'
CP.18
Figure 5.28: Structure for compound CP.18: Stigmasterol
The LREIMS spectrum [Spectrum 5.18.1] for compound CP.18 gave a molecular ion peak at 
m/z 412, which indicated a molecular formula of C29H48O. The FTIR spectrum [Spectrum
5.18.2] for compound CP.18 displayed an absorption band at 3401 cm'  ^ that was ascribed to a 
hydroxyl stretch and absorption bands at 2932 cm'  ^ and 2867 cm'  ^ that were attributed to CH
stretches. 11
The NMR spectrum [Spectrum 5.18.3] displayed proton resonances at 5 5.13 (dd, J =  8.5,
15.2 Hz), 4.99 (dd, J=  8.5, 15.2 Hz), 5.32 (d, J  = 5.0 Hz) for double bond proton resonances. 
An oxymethine proton resonance at 5 3.49 (m) was also observed for compound CP.18. The ^^ C 
NMR spectrum [Spectrum 5.18.4] for compound CP.17 showed 29 carbon resonances which 
were compareable to those reported by De-Eknamkul and Potdaung^^ for stigmasterol (Table 
5.17).
Compound CP.18 was therefore identified as the known stigmasterol which is very common in 
the Plant Kingdom.^^
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Table 5.17: Correlation table for compound CP.18: Stigmasterol
No. ^^ C NMR (125 MHz) 
CDCI3
^^ C NMR (125 MHz) 
CDCls)^^
^H NMR (500 MHz) 
CDCI3
la 37.5 CH2 37.22 1.81 m
IP 1.34 m
2a 31.9 CH2 31.63 1.95 m
2P 1.43 m
3 72.0 CH 71.80 3.49 m
4a 42.5 CH2 42.26 2.24 m'
4P 2.24 m'
5 141.0 C 140.72 -
6 121.9 CH 121.71 5.32 d J =  5.0 Hz
7a 32.1 CH2 31.87 1.81 m
7p 1.48 m
8a 32.1 CH2 31.87 1.48 m
8P 1.41 m
9 50.3 CH 50.10 0.90 m
10 36.7 C 36.48 -
11a 21.3 CH2 21.07 1.45 m
lip 0.78 m
12a 40.7 CH2 39.66 1.97 m
12P 1.14 m
13 42.5 C 42.26 -
14 57.1 CH 56.85 0.97 m
15a 24.5 CH2 24.34 1.56 m
15P 1.05 m
16a 29.1 CH2 28.91 1.23 m
16P 1.13 m
17 56.3 CH 55.93 1.08 m
18 12.2 CH3 12.03 0.65 s
19 19.6 CH3 19.39 0.81 s
20 40.7 CH 40.48 1.14 m
21 21.3 CH 21.07 0.99 m
22 138.6 CH 138.31 5.13 ddJ=  8.5,15.2 Hz
23 129.5 CH 129.25 4.99 dd J =  8.5, 15.2 Hz
24 51.5 CH 51.22 1.50 m
25 32.1 CH 31.87 1.48 m
26 21.4 CH3 21.20 0.79 s
27 19.2 CH3 18.96 0.79 s
28a 25.6 CH2 25.39 1.21 m
28p 1.06 m
29 12.6 CH3 12.23 0.65 s
Refer to superimposed proton resonances
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5.3 Conclusion
C  pseudopulchellus yielded seven ent-kmmnQ diterpenoids, ^«/-kaur-16-en-l 9-oic acid, 
CP 1 ,16 ,20 ,21 ,22 ,23  g„^_kaur-16-cn-19-al, CP.3,^^ e«M2p-hydroxykaur-16-en-l9-oic acid, CP.4,^^ 
29,30, 31 12 p-acetoxykaur-16-en-19-oic acid, CP.5,^^ 15 p-hydroxykaur-16-en-19-oic acid,
CP.7,^^ e«/-14a-hydroxykaur-l6-en-19-oic acid and CP.8, ent-\A% 17-dihydroxykaur-
15-en-19-oic acid, C P .ll. Compound CP.8 and C P .ll were found to be novel. Four ent- 
kaurenoic acid derivatives each based on compounds CP.l, CP.4, CP.8 and C P .ll were 
prepared. The four gM^-kauranoic acid derivatives were methyl gM -^kaur-16-en-19-oate, CP.2,^^’ 
methyl 12p-hydroxykaur-16-en-19-oate,^"  ^ CP.6, 14-oxokaur-16-en-19-oic acid,
CP.9 and ent-\A(x, 17-diacetoxykaur-15-en-l9-oic acid, CP.IO.
EM^-kaur-16-en-19-oic acid, CP.l and its derivatives are known to exhibit a wide variety of 
biological activities. ^E^r-kaurane diterpenoids have been demonstrated by various authors to 
possesses wide spectrum bioactivities such as anti-inflammatory,^"^’ ^  anti-microbial,^^’ 
anti-fungal,^^’ anti-protozoal,^^ cytotoxic,^^’ anti-HlV,^^ anti-fertility,^^ hypotensive,^^ and 
trypanocidal activity.^^ EM/-kaur-16-en-19-oic acid derivatives have also been demonstrated to 
show plant-growth regulating and insect-anti-feeding activity
E^r-kaur-16-en-19-oic acid, CP.l, isolated from Aralia cordata Thunb. has been reported to be 
significantly effective as an anelgesic in affecting acetic acid induced writhing and hyperthermia 
in rats.^^’ ^  Ent-\6^, 17-dihydroxykauran-19-oic acid, R.4, has been showed to exhibit anti­
inflammatory activity in the rat paw oedema test and in the protein heat coagulation test whereas 
its 17-acid derivative, compound R.5, also had anti-inflammatory activity
E^r-kaur-16-en-19-oic acid, CP.l, has been reported to have anti-microbial activity against 
Bacillus suhtilis (0.313 pg/ml),^^ Staphylococcus aureus (2.5 pg/ml),^^ Mycobacterium 
smegmatis (6.25 pg/ml) and Saccaromyces cerevisiae.^^ Methyl c^r-kaur-16-en-19-oate, CP.2, 
has been evaluated for its anti-microbial activity against M smegmatis (25 pg/ml).^^ Compound, 
R.6, has been found to be active in the disk-diflusion assays (50 - 100 pM) against gram-positive 
bacteria {S. aureus, S. suhtilis and Mycobacterium smegmatis) and acid-fast bacteria
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{Mycohacterium phlei and Mycobacterium smegmatidis)}^ Grandiflorenic acid, R.7, has been 
showed to be weakly active against Bacillus subtilis (0.625 pg/ml) compared to 
chloroamphenicol.^^
E«/-kaur-l 5-en-l 9-oic acid, R.8, was found to be 3 to 4 times more active than grandifloric acid, 
R.9, against the fungi Phythium ultimum and Rhizoctonia solani.^^ EM/-3 p-hydroxykaur-16-en- 
19-oic acid, R.10, and ew^kaur-16-en-19-oic acid, CP.l, have been showed to exhibit anti-fungal 
activity against Botrytis cinerea^^ £«^-3 p-hydroxykaur-16-en-19-oic acid, R.10, was observed to 
reduce the mycelial growth of B. cinerea^^
E^r-kaur-16-en-19-oic acid, CP.l, has been reported to exhibit activity against the protozoan 
flagellate. Trypanosoma cruzi, the causative agent of Chagas disease (American 
trypanosomiasis) which affects over 90 million people.^^ However, the acid showed a blood 
lytic activity on erythrocytes and also low solubility in the biological medium used for the test.^  ^
Vieira et al. (2002)^^ prepared several derivatives based on gM -^kaur-16-en-19-oic acid, CP.l, 
such as compounds R.11 and R.12 and evaluated them against the T. cruzi. The derivatives did 
not improve the activity observed for the g«/-kaur-l 6-en-19-oic acid, CP.l, and they also showed 
the same side effects earlier observed for the acid.^^
EM^-kaur-16-en-19-oic acid, CP.l, has been found to exhibit moderate in vitro inhibitory 
properties against the tumour cell lines A-549 (non-small lung), XF498 (central nervous system), 
SK-OV-3 (ovarian), SK-MEL-2 (skin) and HCT15 ( c o lo n ) .Ent-\6\^, 17-dihydroxykauran-19- 
oic acid, R.4, has also been showed to demonstrate selective toxicity against A-549 cells.^ "^  The 
diacetate, R.13 and the ester R.14 have showed modest activity against PC-3 (prostrate) at 17.71 
and 17.38 pg/ml.^^
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Figure 5.29: £'«/-kaur-16-en-19-oic acid and and its derivatives that have been tested for 
various biological activities'^' (Compounds CP.l, CP.2 and CP.3 have been isolated
from C. pseudopulchellus)
The ent-\6^, 17-dihydroxykauran-19-oic acid, R.15, has showed significant activity against HIV 
replication in H9 lymphocyte cells with an EC50 = 0.8 mg/ml and a therapeutic index of >5^ 
whereas the keto acid, R.16, protected cells from HIV at an EC50 = 0.5 pg/ml.^^ Bioassay guided 
fractionation of the roots of a poisonous plant from China, Tripterygium wilfordii (Celestraceae), 
which is traditionally used as an insecticide afforded tripterifordin, R.17, which exhibited anti-
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HIV replication activity in H9 lymphocyte cells at an EC50 = 0.5 Neotripterifordin, R.18,
an isomeric lactone was isolated from the same plant and found to be more potent inhibiting HIV
replication in H9 lymphocyte cells at an EC5o= 25 nM.^^
Montonoa genus is reported to be used traditionally in Mexican medicine in the form of tea or 
decoctions as an oral contraceptive. ^«/-kaur-16-en-19-oic acid, CP.l and grandiflorenic acid, 
R.7, have been isolated from Montonoa tomentosoa (Asteraceae). E«^kaur-16-en-19-oic acid, 
CP.l was tested for in vitro on human sperm mobility and viability and an ED50 = 374 pg/ml of 
immobilzation recorded. This reflected a moderate effect on mobility compared to verapamil 
(332 pg/ml).^^ Grandiflorenic acid, R.7 was found to show an in vitro uterine stimulant activity at 
0.21 pg/ml.^ "^
The ent-\6^, 17-dihydroxykauran-19-oic acid, R.4, has been evaluated for hypotensive activity 
(50 mg/kg/day for 10 days) and found to decrease blood pressure in rats with an effect equivalent 
to that of 75 mg of propanolol, a non specific clinical p-blocker which decreases heart rate and 
blood pressure.^"  ^ Ent-6^, 13-diacetoxy-l 1, 15-dioxokaur-16-ene, R.19 has been tested on 
isolated rat hearts subjected to a 40 min non-perfusion followed by 25 min reperfusion and found 
that at 0.25 pM it reduced the incidence of ventricullar fibrillation, increased coronary flow to
1.9 ml/min and improved the contractile fimction of the heart.^ "^  En^-kaurane diterpenoids have 
been shown to demonstrate plant-growth regulating and insect anti-feeding activities. Steviol, 
R.20 has been shown to stimulate leaf sheath elongation in the dwary maize bioassays whereas 
the cM -^kaur-16-en-19-oic acid, CP.l has been showed to completely restrict the growth of the 
sunflower, Helianthus annuus
SR, 13i? - Epoxylabd-14-ene, CP.12, acetyl aleuritolic acid, CP. 13, p-amyrin and stigmasterol, 
CP.18 were also isolated from Croton pseudopulchellus. Si?, 13i? - epoxylabd-14-ene, CP.12 
has been shown by Kalpuotzakis et a l ^  to exhibit anti-bacterial activity whereas aleuritolic acid, 
a derivative of acetyl aleuritolic acid has been shown to exhibit HIV reverse transcriptase 
inhibition.^^ P-Amyrin is known to possess a wide spectrum of biological activities, such as its 
protective effect against acetaminophen-induced liver injury in mice/^ and exhibits good anti­
microbial activity against gram positive {Staphylococcus aureus. Bacillus subtilis and Bacillus
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sphaericus) and gram negative bacteria {Escherichia coli. Pseudomonas syringae and 
Salmonella typhi)^^
CP.14, 4(15)-eudesmane-lp, 6a-diol, CP.15, (-) - 7-epivaIeran-4-one, CP.16, germacra-4(15), 
5E, 10(14)-trien-lp-ol, CP.17 were also isolated from Croton pseudopulchellus. These three 
sesquiterpenoids that are proposed to be biogenetically related [Scheme 5.1] have not been 
described for any biological activities.
OH
HOHnHO
Germacran-4(15), SE, 10(14)-trien9-ol
OH
HOi) Reduction
-H+ii) 1,2 methyl W -M shift
iii) Oxidation
" OH I 
4(I5)-eudesmane-l,6-dioI7-Epi valeren-4-one
Scheme 5.1: A proposed biogenesis of (-) - 7-epivaIeran-4-one and 4(I5)-eudesmane-lp, 6a- 
diol from germacran-4(15), 5E, 10(14)-trien-ip-ol
Compound CP.l was evaluated for its anti-plasmodial activity against F. falciparum (CQS) DIO 
strain and cytotoxicity on tumour liver cells (HUH7 strain). Compounds CP.2, CP.4, CP.5, 
CP.6, CP.7, CP.8, CP.9, CP.12, CP.13 and CP.16 were screened for their cytotoxicities against 
tumour liver cells (HUH7 strain). Their results are presented in section 6.0 below.
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CHAPTER SIX: SCREENING OF COMPOUNDS AND GENERAL CONCLUSION
6.1 Biological screening of compounds
6.1.1 Cytotoxicity
In the search for cytotoxic compounds, the demonstrated cytotoxicity should preferably be of a 
level, and mediated through a mechanism, that allows healthy cells to survive, but not tumour 
cells.*’  ^ Cytotoxic compounds are important in cancer therapy, and their primary objective is to 
prevent the growth of cancer cells.^ The biodiversity and chemodiversity encountered in nature 
have provided many anti-cancer agents, such as taxol, viblastine and podophyllotoxin [Section
1.2.2, page 3]"* and the discovery of sarcophytol [Section 3.3, Page 117],  ^ clearly indicates the 
potential of nature to yield more anti-cancer agents.
Several compounds isolated from C. gratissimus, C. sylvaticus and C. pseudopulchellus were 
evaluated for cytotoxicity against two human tumour cell lines, ovarian (PEOl and PEOlTaxR 
strains) and liver (HUH7 strain) in vitro by 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyl 
tétrazolium bromide (MTT) and lactate dehydrogenase (LDH) colourimetric assays respectively.
6.1.2 Colourimetric assays
Several colourimetric assays that rely on the conversion of metabolic dyes are employed for 
measuring cytotoxicity. The MTT and LDH colourimetric assays have been used in this study.
6.1.2.1 The 3-[4, 5-dimethyIthiazol-2-yl]-2, 5-diphenyl tétrazolium bromide (MTT) 
colourimetric assay
6.1.2.1.1 Principle
MTT is a water soluble tétrazolium salt which is converted into an insoluble purple formazan by 
cleavage of the tétrazolium ring by mitochondrial dehydrogenase within the mitoehodria [Figure 
6.1]. The formazan product is impermeable to the cell membranes and therefore it accumulates 
in healthy cells.^ The release of the mitochondrial dehydrogenase directly correlates with the 
amount of the formazan formed.
2 5 0
Damaged cell
N —N
Formazan
Mitochondrial
reductase
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT)
Figure 6.1: An illustration showing the the conversion of MTT to formazan by
mitochondrial reductase^
6.1.2.1.2 Results for chemosensitivity testing in taxane sensitive (PEOl) and taxane 
resistant (PEOlTaxR) human ovarian cancer cells for compounds CG.3, CG.4, CG.7 and 
CG.9
Table 6.1: Chemosensitivity testing in taxane sensitive (PEOl) and taxane resistant 
(PEOlTaxR) human ovarian cancer cells (data shown are IC50 drug concentrations in nm 
amounts)
COMPOUND PEOl PEOlTaxR RESISTANCE FACTOR
CG.3 125 135 < 1.0
CG.4 132 200 1.5
CG.7 316 380 < 1.0
CG.9 >500 398 < 1.0
PACLITAXEL 2.3 30.5 13.3
2 5 1
6.1.2.1.3 Discussion
All the four compounds tested displayed lower potency than paclitaxel but the sensitivity of the 
taxane sensitive and taxane resistant cells was similar when treated with CG.3, CG.4, CG.7 and 
CG.9 compounds. This could point to a tubulin binding site that is different to that for 
paclitaxel.^
6.1.2.2 Lactate dehydrogenase (LDH) colourimetric assay.
6.1.2.2.1 Principle
The LDH assay is based on the cleavage of a tétrazolium salt when LDH is present in the culture 
supernatant. In the first enzymatic reaction LDH reduces NAD^ to NADH + H^ by oxidation of 
lactate to pyruvate. In the second enzymatic reaction the catalyst (diaphorase) transfers H/H^ 
from NADH + i f  to iodonitrotetrazolium salt (INT) [Figure 6.2] yielding a coloured formazan 
dye, which is quantitated colourimetrically. The formazan dye formed is water -  soluble and 
shows a broad absorption maximum at 490 nm. The release of LDH into the supernatant directly 
correlates to the amount of the formazan dye formed.^
Damaged cell
N = N
N - N
NAD
-OH Formazan
NO2OH
Lactate
Diaphorase
Lactate 
Dehydrogenase 
_  (LDH) _
c rpyruvate
N - N
Iodonitrotetrazolium
Figure 6.2: An illustration showing conversion of INT to formazan in presence of LDH
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6.1.2.2.2 Results for the cytotoxicity tests of compounds isolated from C. gratissimus, C. 
sylvaticus and C pseudopulchellus (Table 6.2) against the human tumour liver cells HUH7 
strain
Table 6.2: The cytotoxicity test results of the compounds isolated from C. gratissimus, C. 
sylvaticus and C. pseudopulchellus against the human tumour liver cells HUH7 strain (% 
cell viability)
COMPOUND AVERAGE OPTICAL DENSITY % CELL VIABILITY
COMPOUNDS FROM CROTON GRATISSIMUS
CG.3 1.18 6.22%
CG.4 0.96 < 1%
ACETYLATED CG.7 0.99 < 1%
CG.8 0.94 <1%
CG.9 0.87 <1%
CG.IO 0.94 < 1%
C G .ll 1.07 2.20 %
CG.12 0.99 <1%
CG.14 0.87 < 1%
COMPOUNDS FROM CROTON SYLVATICUS
CS.l 0.79 < 1%
CS.2 0.93 <1%
CS.3 0.91 < 1%
CS.4 1.11 3.70 %
CS.5 0.94 < 1%
CS.9 0.94 <1%
COMPOUNDS FROM CROTON PSEUDOPULCHELLUS
CP.l 1.02 < 1%
CP.2 0.96 <1%
CP.4 0.96 <1%
CP.5 0.91 < 1%
CP.6 0.93 <1%
CP.7 0.87 < 1%
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CP.8 0.89 < 1%
CP.9 1.10 3.30 %
CP.12 0.86 <1%
CP.13 1.08 2.60 %
CP.16 0.89 <1%
CONTROLS
BLANK 1.01 -
BACKGROUND 1.07 -
1 % METHANOL 1.01 -
1% TRITON 3.74 100%
6.1.2.3 Discussion
Compounds CG.3, C G .ll, CS.4, CP.9 and CP.13 showed slight activity whereas the other 
twenty-four compounds tested displayed insignificant activity (< 1 %). The observed low 
cytotoxicities for all the compounds tested could be attributed to the following four factors:
(i) The compounds were rapidly metabolised by the liver cells and therefore were not cytotoxic,^
(ii) The compounds don’t passively diffuse through the cell membrane,^
(iii) The machinery for uptake of the compounds was not present,^ and
(iv) The incubation period of 24 h of the treated cells was inadequate to achieve meaningful 
cytotoxicity.
6.1.3 Anti-plasmodial activity
Malaria caused by Plasmodium falciparum is a major problem which causes over one million 
deaths each year in tropical and sub-tropical regions of the world that are malaria endemic. 
There is also an increase in resistance of Plasmodium to the anti-malarial drugs, and it is reported 
that more than 5 % of sixty-five cases examined in Southeast Asia are resistant to artemisinin 
and artesunate.^^ Therefore, with natural products successfully providing mankind with many 
substances to combat diseases in the past, there is need to evaluate more natural products as 
potential anti-malarial agents.
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Three crude extracts from C  pseudopulchellus, ew^-kaurenoic acid (CP.l) that was isolated from 
C. pseudopulchellus and compounds CG.3, CG.4 and acetylated CG.7 that were isolated from 
from C. gratissimus were tested against the P. falciparum (CQS) DIO strain.
6.1.3.1 Plasmodium lactate dehydrogenase (pLDH)
Plasmodium lactate dehydrogenase (pLDH), is a terminal enzyme used by blood-stage malaria 
parasites in their glycolytic pathway. pLDH is used to identify and quantify the malarial parasite 
growth. This is done in in vitro cultures using 3 -  acetylpyridine adenine dinucleotide (A?AD)
The pLDH converts A?AD to APADH and the release of pLDHand malstat reagent.
11,12directly correlates to the amount of APADH formed. ’
6.1.3.2 Results for the hexane, methylene chloride and methanol extracts of C. 
pseudopulchellus and gmt-kaurenoic acid against P. falciparum (CQS) DIO strain 
Table 6.3: In vitro anti-plasmodial activity of hexane, methylene chloride and methanol 
extracts of C pseudopulchellus against P, falciparum (CQS) DIO strain, n = number of data 
sets averaged
Sample ICso (pg/ml)
Hexane extract 21.14
Methylene chloride extract 25.00
Methanol extract 30.76
CQ (ng/ml) 16.37
Table 6.4: In vitro anti-plasmodial activity of ^«/-kaurenoic acid against P. falciparum 
(CQS) DIO strain
Compound ICso
E«/-kaurenoic acid 31.77 pg/ml
CQ 14.25 ng/ml
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6.1.3.3 Dose -  response curves for the hexane, methylene chloride and methanol extracts of 
C. pseudopulchellus and e«t-kaurenoic acid against P. falciparum (CQS) DIO strain
P.falciparum  D10 strain: 
Hexane extract
IS 100 -
2
■ ICs(, = 21.135pg/ml
3-1 0 1
Log n [ig/ml
2
P.falciparum  D10 strain: 
DIchloromethane extract
>  100-
■ IC50 = 25.0pg/ml
-1 0 1
Log n ng/ml
2 3
P.falciparum  D10 strain: 
M ethanol extract
>  100 -
■ ICso = 30.761 ng/ml
-1 1
Log 0  ng/ml
2 30
P.fylciparum  DIO strain: 
Chioroquine control
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■ IC5o =  16.368ng/ml
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Figure 6.3: Dose-response curves of the hexane, methylene chloride and methanol 
extracts of C pseudopulchellus against the CQS DIO strain of P. falciparum
p.falciparum  DIO strain: 
Kaurenoic acid
P.falciparum  DIO strain: 
Chioroquine
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Figure 6.4: Dose-response curves of g/z/-kaurenoic acid and reference drug, CQ against
the CQS DIO strain of P. falciparum
6.1.3.4 Discussion
The results showed that the three crude extracts and e«/-kaurenoic acid (CP.l) had no significant 
in vitro anti-malarial activity against the sensitive strain of P. falciparum (Table 6.3). The
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The sample was poorly dissolved due its hydrophobic properties thus poor solubility might 
contribute to the low activity.
6.1.3.5 Results for the screening of compounds CG.3, CG.4 and acetylated CG.7 against P. 
falciparum (CQS) DIO strain
Table 6.5: In vitro anti-plasmodial activity for the compounds CG.3, CG.4 and acetylated 
CG.7 against P./a/ciparwiw (CQS) DIO strain
Sample code IC50 (pg/ml)
CG.3 80.91
CG.4 20.80
Acetylated CG.7 13.52
Chioroquine control 27.04 ng/ml
6.1.3.6 Dose -  response curves for compounds CG.3, CG.4 and acetylated CG.7 against P. 
falciparum (CQS) DIO strain
p. fylcipanim  DIO strain 
Compound CG3
P. falciparum  DIO strain 
Compound CG4
IC50 =  2 0 .7 9 7  p g /r r t
l(7^r.80aoan3fml
Log Q pg/ml Log □ iig/ml
P. falciparum  DIO strain 
Compound CG7 acetate
P. falciparum  DIO strain 
 ChlnrnniiinR---------
IC50 =  13.521 ijg/ml
Ijjg n ng/ml
Figure 6.5: Dose-response curves of for the compounds CG.3, CG.4 and acetylated 
CG.7 against the CQS DIO strain of P. falciparum
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6.1.3.7 Discussion
Compound CG.7 acetate was slightly active with an ICso-value of 13.52 pg/ml (Table 6.5). 
Compounds CG.3 and CG.4 did not show activity against the sensitive strain of the parasite.
6.2 General conclusion
The phytochemical analysis of the three Croton species, C. gratissimus, C. sylvaticus and C. 
pseudopulchellus yielded compounds belonging to the sesquiterpenoid class (4), diterpenoid 
class (25), triterpenoid class (6), phytosterol class (3) and lignan derivatives (2). These plants 
did not yield compounds belonging to the limonoid, flavonoid and alkaloid classes as have been 
reported before from some of the over 700 Croton plants evaluated so far (Sections 2.2.1, 2.2.2 
and 2.2.5).^ "^  One of the objective of this study was to ascertain the presence of limonoids in the 
Euphorbiaceae family as was earlier reported by Kubo et a lP  The absence of limonoids from 
the three Croton plants evaluated in this study further raises doubts about the occurrence of 
limonoids from the Croton genus (Euphorbiaceae) and the correct identification of the C. 
jatrophoides Pax that was worked on by Kubo et al)^ and reported to yield limonoids.
It was also evident that the already observed chemical distribution pattern of the Croton plants 
by Salatino et al}^ that Croton species that occur on the African continent predominantly yield 
diterpenoids and do not yield alkaloids was supported by the three Croton plants evaluated in 
this study. C. gratissimus yielded ten cembranoid diterpenoids, the C. sylvaticus yielded one 
acyclic and six clerodane diterpenoids whereas the C. pseudopulchellus yielded one labdane and 
seven e«/-kauranoid diterpenoids.
Compounds CG.3, CG.4, CG.7 and CG.9 that were isolated from C. gratissimus showed 
cytotoxic effects in nM range against two human ovarian cancer cell lines (PEOl and 
PEOlTaxR) (Section 6.1.2.1.3). Even though these four compounds did not exhibit very high 
cytotoxicity effects compared to paclitaxel, they however displayed a very low resistance factor 
of < 1.5 as compared to that of paclitaxel of 13.3. The low resistance factor displayed by the 
four compounds was tentatively attributed to a tubulin binding site that is different to that for 
paclitaxel.^’ The observed activity in the nM range and the low resitance factors make these 
compounds potential cytotoxic agents.
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Compounds CG.3, C G .ll, CS.4, CP.9 and CP.13 of the twenty-nine (Section 6.1.2.2) 
compounds isolated from the three Croton plants, C. gratissimus, C. sylvaticus and C 
pseudopulchellus were tested for cytotoxicity against the human liver tumour cells (HUH7 
strain) in a single dose of 2 pM, and showed a slight potency whereas the other twenty-four 
compounds tested displayed insignificant potency (< 1 %). The observed low cytotoxicities of 
all the compounds tested were suggested to be as a result of compounds being rapidly 
metabolised by the liver cells and therefore non - cytotoxic,the compounds don’t passively 
diffuse through the cell m em brane,the machinery for uptake of the compounds was not 
p resen t,and  the incubation period of 24 h of the treated cells may have been inadequate to 
achieve meaningful cytotoxicity effects.
In vitro anti-plasmodial screening against Plasmodium falciparum (CQS) DIO strain was also 
done for three crude extracts (hexane, methylene chloride and methanol) of C  pseudopulchellus, 
cM/-kaurenoic acid (CP.l) isolated from C. pseudopulchellus and compounds CG.3, CG.4 and 
acetylated CG.7 that were isolated from C. gratissimus and were found not to possess any 
significantly activity. I C 5 0  values were achieved with sample dose concentrations of over 13 
pg/ml (Section 6.1.3.2 and 6.1.3.5) compared to chioroquine concentration of 16 ng/ml. 
Prozesky et al. (2001)^^ had earlier reported that the chloroform extract of the stem bark of C. 
pseudopulchellus possessed 82 % minimum inhibitory at 50 mg/ml against PfUPl, a chioroquine 
resistant strain of the malarial parasite P. falciparum.
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CHAPTER SEVEN: GENERAL MATERIALS AND METHODS
7.1 Spectroscopic and spectrometric analsysis
Various spectroscopic techniques including NMR, FTIR, UVA^isible, mass spectrometric 
analysis, measurement of optical rotations, determination of melting points and compound 
derivatization were employed to identify the chemical constituents of the C. gratissimus, C. 
sylvaticus and C. pseudopulchellus.
7.1.1 Nuclear Magnetic Resonance Spectroscopy (NMR)
Nuclear Magnetic Resonance spectroscopic experiments were performed on a 500 MHz Bruker 
AVANCE NMR spectrometer at the Division of Chemical Sciences, Faculty of Health and 
Medical Sciences, University of Surrey, Guildford, UK. The spectra were recorded in either 
deuteriochloroform (CDCI3), de -  pyridine or DMSO and the chemical shifts were recorded in 
ppm (parts per million) relative to the solvents. The deuteriochloroform was referenced 
according to the central line at 5 7.260 in the ^H NMR spectrum and at ô 77.23 in the the ^^ C 
NMR spectrum.
7.1.2 Fourier Transform Infrared Spectroscopy (FTIR)
The Infrared spectra were recorded using a Perkin-Elmer (2000 FTIR) spectrometer. The oily 
samples were dissolved in chloroform and analyzed using NaCl plates whereas the FTIR spectra 
of samples that were solids were determined using a solid FTIR sample holder at the Division of 
Chemical Sciences, Faculty of Health and Medical Sciences, University of Surrey, UK.
7.1.3 Mass Spectrometry (MS)
High resolution electro spray ionization mass spectra were recorded at Oxford University by Dr. 
Colin Sparrow on a Bruker MicroToF Mass Spectrometer using an Agilent 1100 HPLC to 
introduce the samples. The Low resolution electron impact mass spectra were acquired by Dr. 
Dan Driscoll using a Hewlett Packard G1800A GCD system at the Division of Chemical 
Sciences, Faculty of Health and Medical Sciences, University of Surrey, UK. The LCMS 
analysis for the acidic compounds were recorded at the Division of Biosciences, Faculty of 
Health and Medical Sciences, University of Surrey by Ms Anuska Mann on a QTOF Premier -
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Water Corp. instrument through direct infusion at lOpl/min. A negative MS scan on a range of 
100 -  1000 m/z was recorded.
7.1.3 Optical Rotation
Optical rotations were measured at room temperature in chloroform using a JASCO P-1020 
polarimeter at the Division of Chemical Sciences, Faculty of Health and Medical Sciences, 
University of Surrey, UK.
7.1.4 Melting Points
Melting points were carried out using a STUART melting point SMPIO apparatus at the Division 
of Chemical Sciences, Faculty of Health and Medical Sciences, University of Surrey, UK.
7.1.5 X -  ray analysis
Crystallographic data for compounds CG.3 and CS.8 were collected at the EPSRC National 
Crystallography Service using a Bruker-AXS FR591 rotating anode diffractometer with Mo-Kg
radiation (A = 0.71073 Â). Intensities were integrated from several series of exposures, each 
exposure covering a narrow angle in co or (j). Absorption corrections were applied, based on 
multiple and symmetry-equivalent measurements. The structure was solved by direct
methods/Patterson synthesis and refined by least squares on weighted values for all 
reflections. All non-hydrogen atoms were assigned anisotropic displacement parameters and 
refined without positional constraints. Hydrogen atoms were located in the electron density 
difference map, and refined with appropriate distance restraints. The positions of the methyl and 
hydroxyl hydrogen atoms were assigned by a rotating group refinement with fixed, idealised C-H 
or 0-H distances. All other hydrogen atoms were constrained to ideal geometries. All hydrogen 
atoms were assigned isotropic displacement parameters equal to 1.5 times (methyl and hydroxyl 
hydrogen atoms) or 1.2 times (all other hydrogen atoms) that of their parent atom. Refinement 
proceeded smoothly to give the residuals and complex neutral-atom scattering factors were used.
7.2 Chemical analysis
7.2.1 Méthylation of e«/-kaur-16-en-19-oic acid
Méthylation of the ent- kaur-16-en-19-oic acid was undertaken by adding powdered KOH to 
anhydrous acetone and the mixture was stirred for 5 minutes at 25 °C. Ent- kaur-16-en-19-oic
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acid was added to the reaction, followed by methyl iodide. Stirring was continued for 1.5 hours 
after which the reaction was poured into water (20 ml) and extracted with ethyl acetate (3 x 20 
ml). The combined organic extracts were washed with water (3 x 10 ml), dried over MgS04 , 
filtered and concentrated using a rotary evaporator.
7.2.2 Acétylation of hydroxylated compounds
Pyridine (1 ml) and acetic anhydride (1 ml) were added to the hydroxylated sample (15 mg) in a 
round bottomed flask. The reaction was left to stand for 48 hours. MeOH (5 ml) was added to 
the sample to remove the excess acetic anhydride and toluene (4 x 10 ml) was added 
successively to remove the pyridine. After each addition, the solvent was evaporated off on the 
Rotavapor. Thereafter, MeOH (5 x 10 ml) was added to remove the toluene. The sample was 
spotted on a T.L.C. plate to see whether the reaction had gone to completion or needed to be 
separated from the starting material.^
7.2.3 Oxidation of e«/-14a-hydroxykaur-16-en-19-oic acid
Jones reagent was freshly prepared before being used. Firstly, concentrated sulphuric acid (2 ml) 
was added to Na2Cr207.2H20 (2 g) followed by dropwise addition to the resulting solution of 
cold distilled water (6 ml). The Jones reagent was left at room temperature before being used. 
En/-14p-hydroxykaur-l6-en-19-oic acid (30 mg) was dissolved in acetone and the required 
amount of Jones reagent was added."^
7.3 Plant collection, extraction and isolation of the compounds
7.3.1 Plant collection
Plant materials were collected and identified by Professor N. Crouch of the South African 
National Biodiversity Institute (SANBI), South Africa and all the voucher specimens are 
deposited at the Natal Herbarium.
7.3.2 Extraction of plant extracts
Plant material was dried to a constant weight in the open away from sunlight and heat. The dried 
plant material was ground to a fine powder using grinding mills and extracted successively using 
hexane, methylene chloride, ethyl acetate and methanol in a Soxhlet extractor (hot extraction) for
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48 hours at the Howard College Campus, University of KwaZulu Natal, Durban, South Africa 
and the weights of the crude extracts were recorded [Table 7.1].
Table 7.1: The weights of crude plant extracts
Plant name Voucher no. Part Weight Hexane M. chloride E. acetate MEOH
C. gratissimus Burch. N. Crouch leaves 189g 8.46 g Z55g &84g 2T57g
1051,NH Stems 1570g l&53g 18.29 g 20.26 g 5 7 J9 g
C. sylvaticus Hoechst N. Crouch leaves 358g 6.67 g 6.49 g 11.61g 45.07 g
1056, NH stems 1640 g 15.02 g 21.98 g 14.35 g 118.37 g
C. pseudopulchellus Pax N. Crouch leaves 1570 g 18.53 g 10.17 g Z 50g 91.67 g
1050, NH stems 2600 g 22.46 g 11.42 g 14.17 g 9928g
7.3.3 Isolation and purification of compounds
Thin layer chromatographic analysis and column chromatography over silica gel (Merck 9385) 
with a hexane/methylene chloride step gradient starting with 100 % hexane and gradually 
increasing the methylene chloride concentration to 100 % followed by 5% methanol in 
methylene chloride was used to separate the constituents. Fractions that were the same when 
viewed using thin layer chromatographic (TLC) analysis were combined and further purified.
7.3.4 Chromatographic analysis of fractions
7.3.4.1 Chromatography of the combined hexane and dichloromethane extracts of the 
leaves of C. gratissimus
Fractions 1 8 -2 3 : (20% Methylene chloride: 80% hexane): Compound CG.6, (+) -  [17?, 107?] - 
cembra-2^, AE, IE, llZ-tetraen-20, 10-olide. This compound was purified using 5% ethyl 
acetate: 95% hexane.
Fractions 40 -  54: (50% Methylene chloride: 50% hexane): Compound CG.l, (+) -  [107?] - 
cembra-lE, 3>E, IE, IIZ, 15-pentaen-20, 10-olide) and and compound CG.2, (+) -  [107?] -  
cembra-lZ, 3Z, IE, IIZ, 15-pentaen-20, 10-olide. These two compounds were purified using a 
100% methylene chloride.
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Fractions 63 -  72: (60% Methylene chloride: 40% hexane): Compound CG.12, 3-e/?/-glutinol. 
This compound was purified using a 100% methylene chloride.
Fractions 77 -  80: (80% Methylene chloride: 20% hexane): Compound CG.13, lupeol. This 
compound was purified using a 100% methylene chloride.
Fractions 100 -  127: (100% Methylene chloride): Compound CG.9, (-) -  [IS, AS, 107?] - 1 , 4 -  
dihydroxycembra-2E, IE, IIZ- trien-20, 10-olide. This compound was purified using 1% 
methanol: 99% methylene chloride.
7.3.4.2 Chromatography of the hexane extract of the stem bark of C  gratissimus 
Fractions 10 -  18: (20% Methylene chloride: 80% hexane): Compound CG.6, (+) -  [17?, 107?] - 
cembra-2E, AE, IE, 1 lZ-tetraen-20, 10-olide. This compound was purified using 5% ethyl 
acetate: 95% hexane.
Fractions 50 -  67: (40% Methylene chloride: 60% hexane): Compound CG.l, (+) -  [107?] - 
cembra-lE, 3E, IE, IIZ, 15-pentaen-20, 10-olide). This compound was purified using a 100% 
methylene chloride.
Fractions 78 -  100: (50% Methylene chloride: 50% hexane): Compound CG.12, 3-^/-glutinol. 
This compound was purified using a 100% methylene chloride.
Fractions 168 -  192: (50% Methylene chloride: 50% hexane): Compound CG.3, (+) -  [17?, 2S, 
IS, SS, 127?] -  7, 8 - epoxy- 2, 12 - cyclocembra-3E, lOZ-dien-20, 10-olide and compound 
CG.14, 24-ethylcholesta-4, 22-dien-3-one. These two compounds were purified using 50% 
methylene chloride: 50% hexane.
Fractions 217 -  230: (100% Methylene chloride): Compound CG.4, (+) -  [17?, AS, 107?] - 4 - 
hydroxycembra-2E, IE, 1 lZ-trien-20, 10-olide and compound C G .ll, eudesm-4(15)-ene-lp, 6a- 
diol. These two compounds were purified using 100% methylene chloride
7.3.4.3 Chromatography of the methylene chloride extract of the stem bark of C. 
gratissimus
Fractions 137 -  145: (100% Methylene chloride): Compound CG.5, (+) -  [17?, 47?, 107?] - A - 
hydroxycembra-2E, IE, IIZ- trien-20, 10-olide. This compound was purified using 100% 
methylene chloride.
Fractions 198 -  223: (3% Methanol: 97% methylene chloride): Compound CG.7, (+) -  [IS, AS, 
7R, 107?] - 1, 4, 7 - trihydroxycembra-2F^, 8(19), IIZ- trien-20, 10-olide, compound CG.8, (-) -
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[IS, AS, IS, 107?] - 1, 4, 7 - trihydroxycembra-2Æ, 8(19), IIZ- trien-20, 10-olide, compound 
CG.9, (-) -  [1<S, 47? 107?] - 1, 4 - dihydroxycembra-2E, 6E, 1IZ- trien-20, 10-olide and compound 
CG.IO, (+) -  [15*, 45", %S, 107?] - 1, 4, 8 - trihydroxycembra-2E, 6E, 1 lZ-trien-20, 10-olide. These 
four compounds were purified using 1% Methanol: 99% methylene chloride.
7.3.4.5 Chromatography of the hexane extract of the stem bark of C. sylvaticus 
Fractions 2 - 6 :  (10% Methylene chloride: 90% hexane): Compound CS.l, trans-SLvmoncnQ. This
compound was isolated in pure form.
Fractions 7 - 1 8 :  (20% Methylene chloride: 80% hexane): Compound CS.4, 15-acetoxy-^ra«5- 
cleroda-3, 13-diene. This compound was purified using 30% Methylene chloride: 70% hexane. 
Fractions 22 -  29: (20% Methylene chloride: 80% hexane): Compound CS.7, 3p-acetoxylup- 
20(29)-ene. This compound was purified using 30% Methylene chloride: 70% hexane 
Fractions 31 -  40: (30% Methylene chloride: 70% hexane): Compound CS.IO, lupenone. This 
compound was purified using 50% Methylene chloride: 50% hexane.
Fractions 43 -  68: (40% Methylene chloride: 60% hexane): Compound CS.5, 15-acetoxy-2-oxo- 
rra«5-e«/-cleroda-3, 13- diene. This compound was purified using 50% Methylene chloride: 50% 
hexane.
Fractions 72 -  80: (60% Methylene chloride: 40% hexane): Compound CS.3, 15-hydroxy-/r««5'- 
cleroda-3, 13-dien-15-ol. This compound was purified using 40% Methylene chloride: 60% 
hexane.
Fractions 83 -  95: (80% Methylene chloride: 20% hexane): Compound CS.13, sitosterol and 
compound CS.14, lignoceryl trans — ferulate. These two compounds were purified using 60% 
Methylene chloride: 40% hexane.
Fractions 97 -  124: (100% Methylene chloride): Compound CS.6, sylvaticinol. This compound 
was purified using 100% methylene chloride.
7.3 4.6 Chromatography of the methylene chloride extract of the stem bark of C. sylvaticus
Fractions 10 -  18: (10% Methylene chloride: 90% hexane): Compound CS.l, /rara-annonene. 
This compound was isolated in pure form.
Fractions 43 -  68: (80% Methylene chloride: 20% hexane): Compound CS.12, p-amyrin. This 
compound was purified using 70% methylene chloride: 30% hexane.
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Fractions 70 -  87: (100% Methylene chloride): Compound CS.3, 15-hydroxy-?ra«^-cleroda-3, 
13-dien-15-ol and compound CS.7, trans-phytoX. These compounds were purified using 100% 
methylene chloride.
Fractions 91 -  105: (100% Methylene chloride): Compound CS.13, sitosterol and compound 
CS.14, lignoceryl trans -  ferulate. These two compounds were purified using 60% Methylene 
chloride: 40% hexane.
Fractions 113 -  122: (100% Methylene chloride): Compound CS.2, 15, 16 -  Dihydroxy-/ra«5- 
gMr-cleroda-3, 14-diene. This compound was purified using 10% ethyl acetate: 90% hexane. 
Fractions 127 -  132: (100% Methylene chloride): Compound CS.8, (+) -  [57?, 6S, 9R] - 4, 5 -  
dihydroblumenol A. This compound was purified using 100% methylene chloride.
7.3.4.7 Chromatography of the combined hexane and methylene chloride extract of the 
stem bark of C. pseudopulchellus
Fractions 10 -  19: (20% Methylene chloride: 80% hexane): Compound CP.3, e«/-kaur-16-en-19- 
al, compound CP.12, 87?, 137? - epoxylabd-14-ene and compound CP.16, (-) - 7-epivaleran-4- 
one. These compounds were purified using 10% methylene chloride: 90% hexane.
Fractions 50 -  120: (50% Methylene chloride: 50% hexane): Compounds CP.l, e«7-kaur-16-en- 
19-oic acid, compound CP.13, acetyl aleuritolic acid and compound CP.17. These compounds 
were purified using 100% methylene chloride.
Fractions 110 -  130: (60% Methylene chloride: 40% hexane): Compounds CP.14, p-amyrin and 
CP.18, stigmasterol. These compounds were purified using 60% methylene chloride: 40% 
hexane.
Fractions 125 -  138: (70% Methylene chloride: 30% hexane): Compound CP.15, eudesm-4(15)- 
ene-lp, 6a-diol. This compound was purified using 100% methylene chloride.
Fractions 150 -  153: (100% Methylene chloride): Compound CP.4, en/-12p-hydroxykaur-16-en- 
19-oic acid. This compound was isolated in pure form.
Fractions 155 -  158: (100% Methylene chloride): Compound CP.5, e«7-12p-acetoxykaur-16-en- 
19-oic acid. This compound was isolated in pure form.
Fractions 160 -  170: (100% Methylene chloride): Compound CP.8, e«/-14a-hydroxykaur-16-en- 
19-oic acid. This compound was purified using 100% methylene chloride.
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Fractions 200 -  212: (2% Methanol: 98% methylene chloride): Compound C P.ll, ent-\Aa, 17- 
dihydroxykaur-15-en-19-oic acid. This compound was purified through acétylation. The acetate 
form of compound C P.ll was purified using 100% methylene chloride
7.3.4.5 Chromatography of the combined hexane and methylene chloride extract of the 
leaves of C. pseudopulchellus
Fractions 9 7 -  113: (100% Methylene chloride): Compound CP.7, 15g-hydroxykaur-16-en-
19-oic acid. This compound was purified using 100% methylene chloride.
Compounds CP.l, CP.3, CP.4, CP.5, CP.8, CP.12, CP.14, CP.15 and CP.18 were also isolated 
from the leaves of the C. pseudopulchellus almost in the same order as were isolated fi*om the 
stem barks of C. pseudopulchellus.
7.3.5 Physical date for the compounds isolated from C. gratissimus., C. sylvaticus and C. 
pseudopulchellus
7.3.5.1 Constituents of C. gratissimus 
Physical data for compound CG.l
Name: (+) -  [107?] - Cembra-IE, 3>E, IE, 1IZ, 16-pentaen-20, 10-olide 
Yield: 30.0 mg
Physical description: Colourless oil
Mass spectrum: m/z 321.1825 (CioH i^eONa) Calculated m/z value = 321.18305 
Infrared spectrum: 2959 and 2863 cm'  ^ (C - H stretches) and 1753 cm'  ^(C = O stretch)
[a] = + 24.22° (c = 0.00044 g/ml, CHCI3)
'H, '^C NMR and 2D NMR data: Presented in Table 3.1 
Physical data for compound CG.2
Name: (+) -  [107?] -  Cembra-lZ, 3Z, IE, IIZ, 15-pentaen-20, 10-olide 
Yield: 19 mg
Physical description: Colourless oil
Mass spectrum: m/z 321.1819 (C2oH260Na) Calculated m/z value = 321.18305
Infrared spectrum: 3063, 2923 and 2856 cm'  ^(C -  H stretches) and 1749 cm'  ^(C = O) stretch
[ a ]  =  +  18.57° (c =  0.007 g/ml, C H C I 3 )
^H, ^^ C NMR and 2D NMR data: Presented in Table 3.2
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Physical data for compound CG.3
Name: (+) -  [17?, 2S, IS, SS, 127?] -  7, 8 - Epoxy- 2, 12 - cyclocembra-3£, lOZ-dien-20, 10-olide 
Yield: 6.1 mg
Physical description: Colourless oil (Needle-like crystals obtained from DMSO)
Mass spectrum: m/z 339.1921 (C2oH2s03Na) Calculated m/z value = 339.193615 
Infrared spectrum: 3103, 2964,2874 cm"^  (C - H  stretches) and 1777 cm'  ^(C = O) stretch 
[a] = + 39.5" (c = 0.0022g/ml, CHCI3)
’H, NMR and 2D NMR data: Presented in Table 3.3 
Physical data for compound CG.4
Name: (+) -  [17?, 45', 107?] - 4 - Hydroxycembra-2Z, IE, 1 lZ-trien-20, 10-olide 
Yield: 12 mg
Physical description: Yellow oil
Mass spectrum: m/z 341.2079 (C2oH3o03Na) Calculated m/z value = 341.209265 
Infrared spectrum: 3411 cm'  ^ (O - H  stretch) and 1738 cm'* stretch 
[a] = + 65.0° (c = 0.0018g/ml, CHCI3)
’H, '^C NMR and 2D NMR data: Presented in Table 3.4 
Physical data for compound CG.5
Name: (-) -  [17?, 47?, 107?] - 4 - Hydroxycembra-2E, IE, 1 IZ- trien-20, 10-olide 
Yield: 6.8 mg
Physical description: Colourless oil
Mass spectrum: m/z 341.2079 (C2oH3o03Na) Calculated w/z value = 341.209265 
Infrared spectrum: 3433 cm'* (O -  H stretch) and 1736 cm * (C = O stretch)
[a] D^ - °^ = - 82.93° (c = 0.0061 g/ml, CHCI3)
'H, '^C NMR and 2D NMR data: Presented in Table 3.6 
Physical data for compound CG.6
Name: (+) -  [17?, 107?] - Cembra-2E, AE, IE, 1 lZ-tetraen-20, 10-olide 
Yield: 23 mg
Physical description: Colourless oil
Mass spectrum: m/z 323.1980 (C2oH2g02Na) Calculated m/z value = 323.19870 
Infrared spectrum: 2952, 2918,2845 (C -  H stretches) and 1745 (C = O stretch)
[a] D^ ^^ ° = + 23.77° (c = 0.0042 g/ml, CHCI3)
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*H, *^ C NMR and 2D NMR data: Presented in Table 3.7 
Physical data for compound CG.7
Name: (+) -  [15, 45, 77?, 107?] - 1,4, 7 - Trihydroxycembra-2£, 8(19), IIZ- trien-20, 10-olide 
Yield: 9.7 mg
Physical description: Colourless oil
Mass spectrum: m/z 373.1978 (CioHgoOsNa) Calculated m/z value = 373.199094 
Infrared spectrum: 3411 cm * (O -  H stretch) and 1733 cm * (C = O stretch)
[a] = + 100° (c = 0.0004g/ml, CHCI3)
*H, *^ C NMR and 2D NMR data: Presented in Table 3.8 
Physical data for compound CG.8
Name: (-) -  [15,45, 75, 107?] - I, 4, 7 - Trihydroxycembra-2E, 8(19), IIZ- trien-20, 10-olide 
Yield: 6.5 mg
Physical description: Colourless oil
Mass spectrum: m/z 373.1980 (C2oH3o03Na) Calculated m/z value = 373.199094 
Infrared spectrum: 3428 cm * (O -  H stretch) and 1739 cm * (C = O stretch)
[a] = - 24.76° (c = 0.0042 g/ml, CHCI3)
*H, *^ C NMR and 2D NMR data: Presented in Table 3.10 
Physical data for compound CG.9
Name: (-) -  [15, 45 107?] - 1 , 4 -  Dihydroxycembra-2E, IE, 1 IZ- trien-20, 10-olide 
Yield: 40 mg
Physical description: Yellow oil
Mass spectrum: m/z 357.2037 (C2oH3o04Na) Calculated m/z value = 357.204179 
Infrared spectrum: 3429 cm * (O -  H stretch) and 1740 cm * (C = O stretch)
[a] = - 41.99° (c = 0.00752 g/ml, CHCI3)
*H, *^ C NMR and 2D NMR data: Presented in Table 3.11 
Physical data for compound CG.IO
Name: (+) -  [15, 47?, 85, 107?] - 1,4, 8 - Trihydroxycembra-2E, 6E, 1 lZ-trien-20, 10-olide 
Yield: 30 mg
Physical description: Colourless oil
Mass spectrum: m/z 373.1964 (C2oH3o05Na) Calculated m/z value = 373.199094 
Infrared spectrum: 3390 cm * (0 -  H stretch) and 1730 cm'* (C = O stretch)
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[a] = + 32.00° (c = 0.0010 g/ml, CHCI3)
'H, ’*C NMR and 2D NMR data: Presented in Table 3.12 
Physical data for compound CG .ll
Name: Eudesm-4(15)-ene-ip, 6a-diol 
Yield: 7.8 mg
Physical description: Colourless oil
Mass spectrum: w/z238 (C15H26O2), 163, 145, 107
Infrared spectrum: 3428 cm * (O -  H stretch)
[a] = + 44° (c = 0.0037 g/ml, CHCI3) (Literature [a] d = + 45.0°, c = 0.1) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 3.13 
Physical data for compound CG.12 
Name: 3a-Hydroxy-D: B-friedoolean-5-ene 
Yield: 15 mg
Physical description: White solids
Mass spectrum: m/z 426 ( C 3 0 H 5 0 O ) ,  393, 274, 259 (100), 205, 134, 95 and 55 
Infrared spectrum: 3447 cm * (O -  H stretch), 2929 and 2865 cm * (C -  H stretches) 
[a] = + 57.81° (c = 0.00064 g/ml, C H C I 3 )  (Literature + 96°, c = 1.0, CHCb)^
Mp: 200 - 205° (Literature 204 - 206°) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 3.14 
Physical data for compound CG.13 
Name: 3a-Hydroxylup - 20(29) -  ene 
Yield: 20.3 mg
Physical description: White solid
Mass spectrum: m/z 426 (C30H50O), 393, 365, 229, 207 (100)
Infrared spectrum: 3437 cm * (O -  H stretch), 3050 and 2928 cm * (C -  H stretches) 
[a] = + 24.50° (c = 0.0038 g/ml, C H C I 3 )  (Literature + 15.0°, c = 0.10, CHCb)^
Mp: 198 - 202° (Literature 200°) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 3.15 
Physical data for compound CG.14 
Name: 24-Ethylcholesta-4,22-dien-3-one 
Yield: 10.6 mg
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Physical description: White crystalline
Mass spectrum: m/z 410 (C29H46O), 269, 255, 207, 187, 174 (100), 121, 105, 91, 55 
Infrared spectrum: 3417 cm'* (O -  H stretch), 1669 (C = O stretches)
[a] = + 59.6° (c = 0.0053 g/ml, C H C I 3 )  (Literature [a] d^ °^+ 52.1°, c = 0.78, CHC^)^
Mp: 125 - 129° (Literature 127 - 128°)^
*H, *^ C NMR and 2D NMR data: Presented in Table 3.16
7.3.S.2 Constituents of C sylvaticus 
Physical data for compound CS.l
Name: Trara-annonene
Yield: 22.0 mg
Physical description: Yellow oil
Mass spectrum: m/z 2^6 (C20H30O), 206, 191, 121 (100), 109, 81, 69, 55
Infrared spectrum: 3019,2926 and 2853 cm'* (C -  H stretch) and 1655 (C = C stretch)
[a] = - 32.9° (c = 0.00158 g/ml, C H C I 3 )  (Literature [a] d = -  34.3°) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.1 
Physical data for compound CS.2 
Name: 15, I6-Dihydroxy-e«/-cleroda-3, 14-diene 
Yield: 13.0 mg
Physical description: Yellow oil
Mass spectrum: m/z 306 (C20H34O2), 273, 255, 189, 132, 107, 95 (100), 55
Infrared spectrum: 3413 cm * (O -  H stretch), 3018,2932 and 2873 cm * (C - H  stretch)
[a] = - 18.9° (c = 0.01168 g/ml, C H C I 3 )  (Literature^ d= - 19.82°, CHC^)^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.2 
Physical data for compound CS.3 
Name: 15-Hydroxycleroda-3, 13-diene 
Yield: 42.0 mg
Physical description: Colourless oil
Mass spectrum: m/z 290 ( C 2 0 H 3 4 O ) ,  233,189, 120, 95 (100), 55 
Infrared spectrum: 3413 cm * (O -  H stretch)
[a] = + 39.3° (c = 0.0032 g/ml, CHCI3) (Literature [a] d value for 15 -  hydroxy-e«/-cleroda-
3, 13-diene is -45.7°) ***
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*H, *^ C NMR and 2D NMR data: Presented in Table 4.3 
Physical data for compound CS.4 
Name: 15-Acetoxycleroda-3, 13-diene 
Yield: 7.6 mg
Physical description: Yellow oil
Mass spectrum: m/z 332 (C22H36O2), 257, 189, 120, 95 (100), 55
Infrared spectrum: 2946, 2917 and 2845 cm * (C -  H stretch) and 1741 (C = O stretch)
[a] 0 °^ = + 66.4° (c = 0.0011 g/ml, C H C I 3 )  (Literature[a] d value for 15 -  acetoxy-e«^-cleroda-3, 
13-diene is -30.0°)**
*H, *^ C NMR and 2D NMR data: Presented in Table 4.4 
Physical data for compound CS.5 
Name: 15-Acetoxy-2-oxo-e«/-cleroda-3, 13-diene 
Yield: 8.4 mg
Physical description: Yellow oil
Mass spectrum: m/z 346 ( C 2 2 H 3 4 O 3 ) ,  331, 286, 271, 205, 161, 135, 121 (100), 81, 55 
Infrared spectrum: 2957, 2918 and 2862 cm * (C -  H stretch) and 1736 cm * (C = O stretch)
[a] = - 9.8° (c = 0.006 g/ml, C H C I 3 )  (Literature [a] = -11.0°) *^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.5 
Physical data for compound CS.6 
Name: Sylvaticinol 
Yield: 5.6 mg
Physical description: Colourless oil
Mass spectrum: m/z 328 (C19H20O5), 234, 205, 161, 136, 105, 94 (100), 79, 55 
Infrared spectrum: 1642 cm * (intense C = O stretch) and 1565 cm * (C = C stretch)
[a] = + 4.64° (c = 0.0039 g/ml C H C I 3 )
*H, *^ C NMR and 2D NMR data: Presented in Table 4.6 
Physical data for compound CS.7 
Name: Trans-phytol 
Yield: 14.1 mg
Physical description: Colourless oil
Mass spectrum: m /z296 ( C 2 0 H 4 0 O ) ,  264, 222, 194, 153, 111, 83, 57 (100)
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Infrared spectrum: 3298 cm * (O -  H stretch)
[a] = + 8.7° c = 0.01 g/ml (Literature [a] d = + 5.0°, c = 0.01, C H C I 3 )  *^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.8 
Physical data for compound CS.8 
Name: 4, 5-Dihydroblumenol A 
Yield: 11.7 mg
Physical description: Clear crystalline
Mass spectrum: m/z226 ( C 1 3 H 2 2 O 3 ) ,  208, 165, 152, 141, 109, 97, 85 (100), 71, 53 
Infrared spectrum: 3422 cm * (O -  H stretch) and 1693 cm * (C = O stretch)
[a] = + 30.0° (c = 0.0024 g/ml, C H C I 3 )  (Literature value reported by De Marino et al.
was - 1.32°, c = 0.4, MeOH for 4, 5-dihydroblumenol A)*"*
Mp: 96 - 98°
*H, *^ C NMR and 2D NMR data: Presented in Table 4.9 
Physical data for compound CS.9 
Name: (+) -  Syringaresinol 
Yield: 7.8 mg
Physical description: Amorphous white solids
Mass spectrum: m/z 42^ (C22H26O8), 387, 251, 221, 193, 181 (100), 161, 123, 111 
Infrared spectrum: 3400 cm * (O -  H stretch) and 1612 cm * (C = C stretch)
[a] = + 50° (c = 0.00028 g/ml, C H C I 3 )  (Literature [a] + 48.6°) *^
UV/Vis spectrum: lmax= 278 nm (Literature ?tmax= 233, 271 nm) *^
Mp: 175 - 179° (Literature 180°) *^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.10 
Physical data for compound CS.IO 
Name: Lupenone 
Yield: 14.8 mg
Physical description: White solids
Mass spectrum: m/z 424 (C30H48O), 396, 329, 255,213, 145, 107, 81, 57 (100)
Infrared spectrum: 1707 cm * (C = O stretch)
[a] = + 60.6 (c = 0.00214 g/ml, C H C I 3 )  (Literature [a] d = + 62.8°, c = 1 g/ml, CHCb)^
Mp: 168 - 172° (Literature 169 - 170 ) ^
2 7 5
*H, *^ C NMR and 2D NMR data: Presented in Table 4.11 
Physical data for compound C S.ll
Name: Lupeol acetate 
Yield: 45.3 mg
Physical description: White powder 
Mass spectrum: m/z 468 (C32H52O2)
Infrared spectrum: 3070, 2943 and 2851 cm * (C -  H stretches) and 1732 (C = O stretch)
[a] 0 °^ = + 29.6° (c = 0.0036 g/ml, C H C I 3 )  (Literature [a] + 35.5°, c = 0.35 g/ml) ^
Mp: 213 -  217° (Literature 215 - 216°) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.12 
Physical data for compound CS.12 
Name: P-Amyrin 
Yield: 8.9 mg
Physical description: White crystalline
Mass spectrum: m/z 426 ( C 3 0 H 5 0 O ) ,  281, 218 (100), 203, 175, 135, 107, 69, 55 
Infrared spectrum: 3435 cm * (O -  H stretch) and 1641 cm * (C = C stretch)
[a] = + 68.9° (c = 0.0065 g/ml, C H C I 3 )  (Literature [a] d = + 88.0°, C H C I 3 )  ^
Mp: 192- 195° (Literature 193 - 195 ) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.13 
Physical data for compound CS.13 
Name: Sitosterol 
Yield: 25.6 mg
Physical description: White crystalline
Mass spectrum: m /z4\4  ( C 2 9 H 5 0 O ) ,  396, 329, 303, 213, 145, 107, 57 (100)
Infrared spectrum: 3414 cm * (O -  H stretch), 3018, 2931 cm * (C -  H stretches) and 1719 (C 
O stretch)
[a]o^  ^= - 28.9° (c = 0.015 g/ml, C H C I 3 )  (Literature [a] - 34.0°, c = 2 , CHC^)*^
Mp: 134 - 138° (Literature 136 - 138 ) *^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.14 
Physical data for compound CS.14 
Name: Lignoceryl-/ra«5'-ferulate
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Yield: 35.8 mg
Physical description: White solid 
Mass spectrum: m/z 530 (C34H58O4), 207
Infrared spectrum: 3296 cm * (O -  H stretch) and 1708 cm * (C = O stretch)
= + 62.7° (c = 0 . 0 1 0 2  g/ml, CHCI3)
Mp: 57 - 59° (Literature 57 - 58°) *^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.15
73.5.3 Constituents of C. pseudopuchellus 
Physical data for compound CP.l
Name: ^^r-kaur-16-en-19-oic acid
Yield: 2800 mg
Physical description: White crystalline
Mass spectrum: m/z 302 (C20H30O2), 207, 259, 241, 213, 131, 105, 91 (100), 79, 55
Infrared spectrum: 3383 cm‘*(0 - H  stretch), 1692 (C = O stretch), 1653 and 875 cm * (terminal
C = C stretches)
= - 84° (c = 0.050 g/ml) (Literature [a] = - 114.81°, c = 1.9 g/ml, C H C I 3 )  *^
Mp: 148 - 151° (Literature 149 - 150°)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.1 
Physical data for compound CP.2 
Name: Methyl ew7-kaur-l6-en-19-oic acid 
Yield: 15 mg
Physical description: White solid
Mass spectrum: w/z 316 (C21H32O2), 302, 273, 257, 241, 187, 131, 105, 91 (100), 79, 55 
Infrared spectrum: 3053, 2929, 2853 cm * (C -  H stretches), 1726 cm * (C = O stretch), 1655 and 
871 cm * (terminal C = C stretches)
[a] = - 96° (c = 0.0010 g/ml) (Literature [a] = - 107.5°, c = 1.2) *^
Mp: 84 - 86° (Literature 82°)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.2 
Physical data for compound CP.3 
Name: £’n/-kaur-16-en-19-al 
Yield: 36.0 mg
2 7 7
Physical description: Colourless oil
Mass spectrum: m/z = 286 (C20H30O), 257,243,225, 105, 91, 67, 55 (100)
Infrared spectrum: 3019, 2927, 2854 cm * (C -  H stretches), 1727 cm * (C = O stretch), 1650 and 
872 cm * (terminal C = C stretches)
[a] = - 80° (c = 0.0129 g/ml) (Literature [a] = - 95°) *^
Mp: 113-116° (Literature 114)^*
*H, *^ C NMR and 2D NMR data: Presented in Table 5.3 
Physical data for compound CP.4 
Name: £«/-12p-hydroxykaur-l6-en-19-oic acid 
Yield: 60.0 mg
Physical description: White solid 
Mass spectrum: [M - 3 1 7  ( C 2 0 H 3 0 O 3 )
Infrared spectrum: 3433 cm * (O -  H stretch), 3008, 2925, 2845 cm * (C -  H stretches), 1697 cm" 
* (C = O stretch), 1653 annd 878 cm * (terminal C = C stretches)
[a] = - 35.1° (c = 0.035 g/ml) (Literature[a] = -  44.7°, c = 1, CHCl3)^
Mp: 238 - 242° (Literature 240 - 243°)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.4 
Physical data for compound CP.5 
Name: Ent-12a-acetoxykaur-16-en-19-oic acid 
Yield: 38.6 mg
Physical description: Yellow oil
Mass spectrum: [M - H]^= 359 ( C 2 2 H 3 2 O 4 )
Infrared spectrum: 3422 cm * (O -  H stretch), 2928, 2845 cm * (C -  H stretches), 1731 and 1692 
cm'* (C = O stretches)
[a] = - 39.8° (c = 0.042 g/ml) (Literature[a] = -  38.0°, c = 1.9, CHChf"^
*H, *^ C NMR and 2D NMR data: Presented in Table 5.5 
Physical data for compound CP.6 
Name: Methyl 12p-hydroxykaur-16-en-19-oate
Yield: 26.0 mg
Physical description: Yellow oil
Mass spectrum: m/z 332 (C21H32O3), 314,299, 255, 107 (100), 91, 79, 55
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Infrared spectrum: 3435 cm * (O -  H stretch), 1698 cm * (C = O stretch), 1665 and 875 cm * (C = 
C stretches)
[a] = - 44.7° (c = 0.018 g/ml) (Literature[a] = - 38°)^ ^
*H, *^ C NMR and 2D NMR data: Presented in Table 5.6 
Physical data for compound CP.7 
Name: £'«^-15a-hydroxykaur-l 6-en-19-oic acid 
Yield: 17.9 mg
Physical description: Colourless oil 
Mass spectrum: [M - H]^ = 317 ( C 2 0 H 3 0 O 3 ) ,
Infrared spectrum: 3413 cm * (O -  H stretch), 1708 cm * (C = O stretch) and 1630 cm * (C = C 
stretch)
[a] = - 56.7° (c = 0.010 g/ml) (Literature -114 c = 0.22).^  ^ The differences in the optical
rotation values are thought to result from impurities present in compound CP.7.
Mp: 223 - 227° (Literature 226 - 228°)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.7 
Physical data for compound CP.8 
Name: jE^«/-14a-hydroxykaur-16-en-19-oic acid 
Yield: 58 mg
Physical description: White solid
Mass spectrum: [M - H]^ = 317.2124 ( C 2 0 H 3 0 O 3 )  Calculated m/z value = 317.2122
Infrared spectrum: 3340 cm * (O -  H stretch), 3078, 2929, 2851 cm * (C -  H stretches) and 1691
(C = O stretch)
[a]o^^^° = -160°
Mp: 126-129°
*H, *^ C NMR and 2D NMR data: Presented in Table 5.9 
Physical data for compound CP.9 
Name: Ent-14 -oxokaur-16-en-19-oic acid 
Yield: 15 mg
Physical description: Yellow oil
Mass spectrum: w/z 316 (C20H28O3), 281, 249, 203, 189, 135, 109, 95 (100), 55
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Infrared spectrum: 3422 cm * (O -  H stretch), 3070, 2926, 2845 cm * (C -  H stretches), 1722 and 
1692 cm * (C = O stretch)
= - 101° (c = 0.01 g/ml)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.10 
Physical data for compound CP.IO 
Name: Ent-\A^, 17-dihydroxykaur-15-en-19-oic acid 
Yield: 10 mg
Physical description: Colourless oil 
Mass spectrum: m/z 334 (C20H30O4)
Infrared spectrum: 3412 cm * (O -  H stretch) and 1696 cm * (C = O stretch)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.11 
Physical data for compound CP.ll 
Name: Ent-\A^, 17-diacetoxykaur-15-en-19-oic acid 
Yield: 6.0 mg
Physical description: Colourless oil
Mass spectrum: m/z 418.2353 (C24H34O6) Calculated m/z value = 418.235539 
Infrared spectrum: 3423 cm * (O -  H stretch), 1736 and 1692 cm * (C = O stretch)
[a] = - 55.9° (c = 0.005 g/ml)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.12 
Physical data for compound CP.12 
Name: 87?, 137? - Epoxylabd-14-ene 
Yield: 16.9 mg
Physical description: White solid
Mass spectrum: [M - Me] 275 (C20H34O), 257,245, 192, 177, 149, 137, 123, 95, 81 (100), 69 
Infrared spectrum: 2963, 2937 and 2868 cm * (C -  H stretches)
[a] = - 12.9° (c = 0.003 g/ml) (Literature [a] d = - 37°, c = 025)?^ The differences in the
optical rotation values are thought to result from impurities present in compound CP.12.
Mp: 96 - 99° (Literature 98 -  99.5°)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.13 
Physical data for compound CP.13 
Name: Acetyl aleuritolic acid
2 8 0
Yield: 36.9 mg
Physical description: White solids 
Mass spectrum: [M - H]^= 497 (C32H50O4)
Infrared spectrum: 3433 cm * (O -  H stretch), 3046, 2935 and 2855 (C — H stretches) 1731,
1686 cm * (C = O stretches) and 1242 cm * (C — O stretch)
[a] = + 31.84° (c = 0.0156 g/ml) (Literature [a] d = + 21.9°, c = 0.73, CHCI3 and [a] d = -
48.3°, c = 0.2 g/ml, CHCb)^
Mp: 300 - 305° (Literature 302 - 304°) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 5.14 
Physical data for compound CP.14 
Name: P-Amyrin 
Yield: 6.9 mg
Physical description: White crystalline
Mass spectrum: m/z 426 ( C 3 0 H 5 0 O ) ,  281, 218 (100), 203, 175, 135, 107, 69, 55 
Infrared spectrum: 3435 cm * (O - H  stretch) and 1641 cm * (C = C stretch)
[a] = + 68.9° (c = 0.0065 g/ml, C H C I 3 )  (Literature [a] d= +88.0°, C H C I 3 )  ^
Mp: 192 -  195° (Literature 193 - 195 ) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 4.13 
Physical data for compound CP.15 
Name: Eudesm-4( 15)-ene-1 p, 6a-diol 
Yield: 9.8 mg
Physical description: Colourless oil
Mass spectrum: m/z 238 (C15H26O2), 163, 145, 107
Infrared spectrum: 3428 cm * (O -  H stretch)
[a] = + 64° (c = 0.0037 g/ml, C H C I 3 )  (Literature [a] d = + 45.0°, c = 0.1) ^
*H, *^ C NMR and 2D NMR data: Presented in Table 3.13 
Physical data for compound CP.16 
Name: (-) - 7-Epivaleran-4-one 
Yield: 13.2 mg
Physical description: Colourless oil
Mass spectrum: m/z 222 (C15H26O), 207, 179, 161, 125, 98 (100), 95, 69, 55, 53
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Infrared spectrum: 3014, 2952,2929,2862 cm * (C -  H stretches) and 1693 cm'* (C -  O stretch) 
[a] = - 50.6° (c = 0.01 g/ml) (Literature[a] d = - 54.3 , c = 0.7, CHCI3)
*H, *^ C NMR and 2D NMR data: Presented in Table 5.15 
Physical data for compound CP.17 
Name: Germacra-4(15), 5E, 10(14)-trien-lp-ol 
Yield: 10.1 mg
Physical description: Colourless oil 
Mass spectrum: m/z 220 (C15H24O)
Infrared spectrum: 3406 cm * (O -  H stretch), 3018, 2930 and 2856 cm * (C -  H stretches)
[a] = - 98.2° (0.0036 g/ml) (Literature[a] d = - 106°)^^
*H, *^ C NMR and 2D NMR data: Presented in Table 5.16 
Physical data for compound CP.18 
Name: Stigmasterol 
Yield: 26.0 mg
Physical description: White solid
Mass spectrum: m/zA\2 (C29H46O) , 370, 327, 289, 271,229, 187, 147, 124 (100), 95, 45 
Infrared spectrum: 3401 cm * (O -  H stretch), 2932 and 2867 cm * (C -  H stretch)
[a] = - 46.9° (c = 0.021 g/ml) (Literature[a] d = - 60.8°)^ **
Mp: 169 - 172° (Literature 170 ) *^
*H, *^ C NMR and 2D NMR data: Presented in Table 5.17
7.4 Chemosensitivity testing in taxane sensitive (PEOl) and taxane resistant (PEOlTaxR) 
human ovarian cancer cells of four cembranoids from C. gratissimus.
7.4.1 Tissue culture
All tissue culture reagents were obtained from Sigma Aldrich (Poole, UK), unless stated 
otherwise. The PEOl ovarian cancer cell line was obtained from Prof F. Balkwill (formerly of 
ICRF laboratories, Lincoln Inn Fields, London, UK). The PEOlTaxR (paclitaxel resistant) cell 
line was derived in-house and possesses approximately 12- fold resistance to its inducing agent 
referred to in Coley et al. (2006).^  ^ PEOl cell lines were cultured as monolayers in RPMI-1640 
medium supplemented with 10% foetal calf serum (heat inactivated, obtained from Invitrogen, 
Paisley, UK) and 2 mM Glutamax (Invitrogen).
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7.4.2 Drug solutions
Working stock solutions of compounds were made up by dissolving the sample in chloroform to 
give a concentrated solution at 50 mM. This was used for chemosensitivity testing as described 
below.
7.4.3 MTT cytotoxicity testing
Cytotoxicity was determined using the MTT colourimetric assay [Figure 6.1]. Cultured cell 
monolayers were reduced to a single cell suspension (Section 7.4.1) and seeded into 96-well 
tissue culture plates at a density of 6 x 10^  cells per well for all cell lines. This was calculated to 
allow for exponential growth of the cultures throughout the incubation period. Cells were 
allowed to settle for 24 h, under standard culture incubation conditions and treated with the 
compound to be tested in quadruplicate with a dose range spanning 2-logs of drug concentration, 
each drug aliquot being administered in a 50 pi volume. All drug dilutions were carried out in 
complete culture medium. After 72 h incubation under standard culture conditions, MTT solution 
(5 mg/ml in PBS) was added in a 20 pi volume and incubated for a further 4 h. The 
MTT/medium mixture was removed and the resulting formazan crystals dissolved in 200 pi of 
DMSO. The optical density of the purple color product was measured at 550 nm in a plate 
reading spectrophotometer. The quantity of live cells was expressed as T/C values by 
comparison with untreated control microcultures. The concentration of complexes that 
decreased absorption by 50% were calculated by interpolation and expressed as IC50 values.
7.5 The cytotoxicity testing of compounds isolated from C. gratissimus, C. sylvaticus and C. 
pseudopulchellus (Table 6.2) against the human tumour liver cells HUH7 strain
7.5.1 Maintenance of culture
The human tumour liver cells (HUH7 strain) were obtained from Dr. Nick Plant’s laboratory 
(Division of Biochemical Sciences, University of Surrey). The HUH7 line was originally 
developed from a liver of a 57 year old Japanese man with well differentiated hepato cellular 
carcinoma. Cells were passaged every four to five days in the ratio of 1:4. When confluent, 
cells were washed once with 10 ml of phosphate-buffered saline (PBS), and incubated once with 
3 ml Trypsin-EDTA (TE) solution for approximately 5 minutes until the monolayer had
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detached. The TE was neutralised with 2 ml of Dulbecco’s modified eagle medium (DMEM), 
and the cells resuspended with a pipette. Then 1 ml of cell suspension was transferred to each of 
four fresh 75 cm  ^vented culture flask (Nunclon™, Nunc Brand Products) containing 14 ml of 
complete medium and incubated at 37°C in 4% CO2.
7.5.2 Drug solutions
Working solutions of compounds were prepared by dissolving the compound in methanol to give 
a solution of concentration of at 2 pM. This was used for the cytotoxicity studies as described 
below.
7.5.3 LDH cytotoxicity testing
Cytotoxicity was determined using the Cytotoxicity Detection Kit (Roche), a colourimetric assay 
for quantitation of LDH released from damaged/dying cells.^  ^ Cells were seeded in 96 -  well 
plates at a density of 5 x 10^  cells per well. Cells were incubated for 48 h to allow cells to attach 
and reach approximately 80% confluence. Since methanol had been used to prepare the working 
solutions, dilutions were further made using DMEM to achieve 1% methanol. The cells were 
drug treated in triplicate with a single dose of 2 pM in a 200 pi volume and incubated under the 
standard culture conditions for 24 h. 1% Triton was used as a positive control whereas 1% 
methanol and untreated cells (cells incubated alone) were used as negative controls. Prior to the 
assay, microplates were centrifuged at 250 g for 10 minutes to pellet cellular debris. Reaction 
Buffer (100 pi) was added to each well containing supernatant (100 pi) and incubated at room 
temperature in the absence of light for 30 minutes, prior to analysis using a multi-well ELISA 
reader. Cytotoxicity was calculated as follows: cytotoxicity (%) = (test value -  negative control 
value)/(positive control value -  negative control value) x 100.
7.6 In vitro anti-plasmodial activity of the hexane, methylene chloride and methanol 
extracts of the stem C. pseudopulchellus and e«t-kaurenoic acid and against P. falciparum 
(CQS) DIO strain
The test samples were tested in duplicate against the chloroquine sensitive (CQS) strain of 
Plasmodium falciparum (DIO). Continuous in vitro cultures of asexual erythrocyte stages of P. 
falciparum were maintained using a modified method of Trager and Jensen (1976). '^*
2 8 4
Quantitative assessment of anti-plasmodial activity in vitro was determined via the parasite 
lactate dehydrogenase assay using a modified method described by Makler (1993).^^
The three extracts were dissolved and diluted to give a 2 mg/ml stock solution in 10% DMSO 
and sonicated to enhance solubility. Samples were tested as a suspension if not completely 
dissolved. Ent-kaurenolc acid (CP.l) was also dissolved and diluted to a 2 mg/ml stock solution 
in 10% methanol and sonicated to enhance solubility. The samples were tested as suspensions. 
Stock solutions were stored at -  20 C. Further dilutions were prepared on the day of the 
experiment in complete medium. Chloroquine (CQ) was used as the reference drug in all 
experiments. A full dose-response was performed for all compounds to determine the 
concentration inhibiting 50 % of parasite growth (IC50 -  value). Test samples were tested at a 
starting concentration of 100 pg/ml, which was serially diluted 2-fold in complete medium to 
give 10 concentrations, with the lowest concentration being 0.2 pg/ml. CQ was tested at a 
starting concentration of 100 ng/ml. The highest concentration of solvent to which the parasites 
were exposed had no measurable effect on the parasite viability (data not shown). The IC50 - 
values were obtained using a non-linear dose-response curve fitting analysis via graph pad prism 
v.4.0 software.
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